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Structural and functional studies of Drosophila alcohol dehydrogenase.
The enzyme alcohol dehydrogenase of the fruit-fly Drosophila (DADH)
catalyzes the same reaction as the mammalian alcohol dehydrogenases,
transforming alcohols into aldehydes through the reduction of nicotinamide-
adenine-dinucleotide. Despite this identical chemical behaviour the enzyme's
structure belongs to a different class of proteins, called short-chain
dehydrogenases, which have a totally different three-dimensional architecture
to the mammalian alcohol dehydrogenases. The study of the structure-fuction
relationships of DADH is of interest because, while we still lack a crystal
structure for the protein, large amounts of biochemicafevolutionary and
genetical data have accumulated which require structural information on the
enzyme for its proper interpretation.
The aim of this project was two-fold: to set up a suitable system for the
undertaking of protein engineering studies on DADH and to start such studies
by producing and analyzing a first set of site-directed mutants. The first part
of the project involved: a) creating suitable genetic vectors for the introduction
of mutations, their sequencing and the expression of the mutated enzymes in
yeast; b) the development of a purification method to obtain pure enzyme
solutions from the expressing yeast culture; c) the development of biochemical
and biophysical assays for the evaluation of the mutation's effects and, d) the
construction of a three-dimensional model for the enzyme that could offer
structural explanations to such effects.
The second part consisted of the actual introduction of five different
mutations in the enzyme's sequence, and their further evaluation using the
system set up in the first place.
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1, Introduction
1.1 Historical review of Drosophila adh research.
The Drosophila alcohol dehydrogenase gene/enzyme system has been
the object of scientific analysis for some twenty-eight years. During the
same period the appearance of genetic engineering techniques and the
massive increase in protein structure information has allowed
researchers to gain a more molecular insight into biological problems.
This has not only altered the nature of our scientific methodology, but
to a large extent it has also turned scientific interests towards questions
that are better suited to our new technologies.
The research in the adh system is a very good example of this
scientific migration towards more molecular approaches, and, at the
same time, it constitutes a rather peculiar case, having remained a good
model system for many of the newly appearing research disciplines.
In the 1960's the Adh locus of Drosophila melanogaster started to be
used as a genetic marker for population studies (Johnson & Denniston,
1964). Today the adh system is used in research in ecology,
enzymology, molecular evolution, molecular genetics and protein
structure (Chambers, 1988).
Highlighting the main breakthroughs of all this scientific effort is, of
course, a matter of opinion. However, of special relevance to this thesis
must be :
(a) The determination of the sequence of the alcohol dehydrogenase
enzyme from D. melanogaster (Thatcher, 1980), (b) the cloning and
sequencing of the Adh gene of D. melanogaster (Benyajati et al.,
1980), (c) the discovery of the family of the short-chain
dehydrogenases into which the Drosophila alcohol dehydrogenases
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(DADH) were soon included (Jornvall et al. 1981), (d) the detailed
analysis of the kinetic behaviour of the enzyme (see Winberg et
al.,1982a, 1982b, 1983, 1985, 1986, 1988a, 1988b, 1989) and, more
recently, the determination of the three-dimensional structure of a
member of the short-chain dehydrogenase family, 3oc,20p-
hydroxysteroid dehydrogenase (Ghosh et al., 1991).
The determination of the DADH sequence allowed biochemists to start
to analyze the structure-function relationships of the enzyme, and,
through comparison between the behaviour of various natural and
laboratory-induced isoenzymes, start to identify the residues with
possible roles in the enzyme's mechanism (Thatcher & Retzios, 1980).
At the same time the first computer analysis of the sequence, in the
form of secondary structure predictions, were published (Thatcher &
Sawyer, 1980; Benyajati et al., 1980).
The cloning of the D. melanogaster Adh gene (Benyajati et al., 1980;
Goldberg, 1980) confirmed the protein sequence, and set the ground
for further extensive research on the molecular regulation of the gene
expression.
Most of our knowledge about the kinetics and reaction mechanisms of
DADH come from the work of Winberg and collaborators. Their
detailed enzymological studies of the enzyme have produced a complete
picture of the reaction mechanism, specificity, and order.
Recently, more detailed structural studies have started to be
undertaken. This has been due to the appearance of the techniques of
site-directed mutagenesis (Kunkel, 1985, Fritz and Eckstein, 1985) and
to the availability of the cloned adh gene, which has allowed the
construction of expression systems in microbial organisms (Atrian et
al., 1990, Chen et al., 1990).
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These structural studies, however, lack the vital information that only
a three-dimensional structure for the molecule can provide. The
publication of the crystallographic structure of a member of the short-
chain dehydrogenases family represents a very important step forward
(Ghosh et al., 1991). Based on this structure techniques of protein
modelling can be used to obtained a realistic picture of the three-
dimensional organization of DADH.
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1.2 The classification of dehydrogenases
The group of enzymes known as alcohol dehydrogenases (E.C.
1.1.1.1), by definition, catalyse the reaction shown below :
Alcohol + NAE)" O Aldehyde or Ketone + NADH+H
But, despite their identical catalytic reaction, alcohol dehydrogenases
do not constitute a uniform family of enzymes with generally applicable
characteristics. Today they are divided into three main groups, which,
according to their monomer sizes, are named: short-chain, medium-
chain and long-chain dehydrogenases with monomers of about 250,
380, or 750 amino acids respectively.
The best characterized of the three groups is the medium-chain one,
to which the mammalian alcohol dehydrogenases belong. These
enzymes form soluble dimers or tetramers, require zinc to carry out
their reaction, and prefer primary alcohols to other substrates. They
are present in a variety of organisms, from mammals and yeast to
plants, being generally involved in the catabolic metabolism of ethanol,
often in the form of several isoenzymes displaying tissue and substrate
specificity (Branden et al, 1975). Some members of this family, notably
a lens crystallin, lack the metal cofactor or, indeed, any dehydrogenase
activity. ^-Crystallin seems to have evolved towards structural roles
but it has kept significant sequence similarity to the rest of enzymes of
the group (Borras et al.1989).
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High resolution three-dimensional structures are available for the
human and horse liver enzymes, and their catalytic mechanism is
very well understood (Eklund & Branden, 1987). The structure of each
monomer has two domains, a substrate-binding domain in the N-
terminal half, and a nucleotide-binding domain in their C-terminal half.
Only parts of the nucleotide binding domain show some sequence
similarity to the short-chain dehydrogenases, and, as will be described
later, their reaction mechanisms are very different. There are few
reasons to believe that medium-chain dehydrogenases and short-chain
dehydrogenases may have evolved from a common ancestor, and they
are frequently pointed to as a classical example of convergent evolution
(Branden & Tooze, 1991).
The long-chain dehydrogenases form a recently defined group of
enzymes, and are, unquestionably the least known of the three groups.
These enzymes are found in ethanol fermentative bacteria, and show
sequence similarity to methanol dehydrogenases from methylotrophic
bacteria. They require pyrroloquinoline quinone as a prosthetic group,
and form membrane-bound polyenzymatic complexes with respiratory
functions (Inoue et al., 1989).
The third group of dehydrogenases, the short-chain ones, were
defined as a class of their own for the first time in 1981 (Jornvall et al.,
1981). The first two known members of this family were the
Klebsiella ribitol dehydrogenase and DADH. A glucose dehydrogenase
was soon added to the list of members of the group (Jornvall et ah,
1984), and new related enzymes have been discovered, notably among
hormone dehydrogenase enzymes. The list of members of the family as
of 1991 can be seen in table 1.
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The sequence identity between the different members of the family is
generally low, mainly ranging about 25%, and they show a great
disparity of substrates. Their sequence similarities, however, are
uniform throughout the sequence, their sizes are similar, they all
present the same patterns of hydrophilicity and similar secondary
structure prediction patterns, none of them uses metal cofactors, and
the proposed catalytic residues are conserved throughout the family
(Persson et al., 1991).
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Enzyme(DH=dehydrogenase) Species Reference
Alcohol DH D.melanogaster (I) Thatcher, 1980
Glucose DH B. megaterium (B) Jany et al., 1984
Ribitol DH E. aerogenes (B) Irie et al., 1987
Sorbitol-6P-DH E. coli (B) Yamada & Saier,
1987
Steroid DH Eubacterium sp. White et ah, 1988
11 (3-Hydroxysteroid DH Rat (M) Agarwal et al.,
1989
17 |3-Hydroxysteroid DH Human (M) Peltoketo et al.,
1988
20p-Hydroxysteroid DH S. hydrogenans (B) Marekov, Krook
& Jornvall, 1990
cA-Benzene glycol DH P. putida (B) Dothie et al., 1985




2,3Dihydroxybenzoate DH E. coli (B) Liu,et al.1989
1,2Dihydroxybenzoate DH P.pseudoalcaligenes
(B)
Neidle et al., 1989
FixR protein B. japonicim (B) Thony et al., 1897
NodG protein R. meliloti (B) Debelle & Sharma,
1986
Acetoacetyl-CoA reductase A. eutrophus (A) Peoples & Sinskey,
1989
Acetoacetyl-CoA reductase Z. ramigera (B) Peoples & Sinskey,
1989
Putative oxoacyl reductase S. coelicolor (B) Hallam,et al. 1988




Human (M) Krook, et al.1990
3{3-Hydroxysteroid DH P. testosteroni
(B)
Yin et al., 1991
Table 1. List of short-chain dehydrogenases. Adapted from Persson et
al., 1991. (I)= insect. (B)= bacteria. (M)= mammal.
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1.3 The structure of short-chain dehydrogenases
1.3.1 Structural similarities between members of the family
The disparity of enzymes listed in table 1 immediately suggests a
large amount of evolutionary divergence between the different
members of the short-chain dehydrogenase family. They are,
nonetheless, assumed to have a common structure which, if this
common fold assumption is correct, has now been revealed with the
solving of the three-dimensional structure of the enzyme 3a,20(3-
hydroxysteroid dehydrogenase (Ghosh et al., 1991).
Short-chain dehydrogenases form dimers or tetramers of about 250
amino acids per monomer and do not contain metal ions. The members
of the family show varying amounts of sequence similarity to each
other. In most of the cases sequence identities are about 25 %, but they
range between 14% to 54% (Persson et al., 1991). The necessary
amount of sequence identity required to be able to assume common
folding between polypeptides of more than 80 amino acids has been
calculated at about 24.8 % residues (Sander & Schneider, 1991). This
value is very close to the one generally observed between short-chain
dehydrogenases.
Other common aspects to all short-chain dehydrogenases support the
view of a shared structure. The majority of the enzymes of the family
catalyse red-ox reactions with the participation of NAD+, and most of
them share a common sequence near the N-terminus of the form
GxGxxG (G being glycine and x any amino acid).
ADHs from all Drosophila species have the sequence GxGxxG with
the exception of D. lebanonensis which has the sequence AxGxxG (A
being alanine) (Villaroya et al., 1989).
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The sequence GxGxxG was initially pointed at as a universal feature
of nucleotide binding folds (Argos, 1990). It was also suggested that the
sequence GxGxxG was universal for all NAD+ specific dehydrogenases
while those using NADP+ had the sequence GxGxxA (Scrutton et al.,
1990). Scrutton and collaborators (1990) proposed that the substitution
of the last residue of this sequence to alanine or glycine should be
enough to shift the cofactor specificity of any nucleotide binding fold.
Their proposal was strongly supported by their experiments on
glutathione reductase (Scrutton et al., 1990).
This view, however, has been challenged by the work of Lilley and
colleagues (1991), who have discovered the opposite specificity
relationship between the last base of the sequence and the cofactors
NAD+ and NADP+ in the enzyme glutamate dehydrogenase of
Clostridium symbiosum. This enzyme is highly selective for NAD+
despite having the sequence GxGxxA in its nucleotide binding fold.
Their results, and the sequences of the short-chain dehydrogenases,
indicate that the structure and specificity of the poly-glycine loops of
nucleotide binding folds do not only depend on the exact sequence and
Proteins residues sequence
Glyceraldehyde phosphate DH 1-15 SKIGIDGFGRIGRLV
Lactate DH 21-35 NKITVVGVGAVGMAC
Horse liver alcohol DH 193-207 STCAVFGLGGVGSVI
Drosophila alcohol DH 8-22 NVIFVAfiLfiGISLDT
Glutamate DH 233-247 KTVALA<zS£NVAWGA
Table 2. Sequence alignment of the poly-glycine loop of nucleotide-
binding domains of some NAD+-specific dehydrogenases (DH).
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The poly-glycine motif was identified as soon as the first sequences of
DADH were obtained, and the presence of a nucleotide binding domain
at the N-terminus of the enzyme was hypothesized on the basis of its
presence and from secondary structure predictions (Thatcher &
Sawyer, 1980; Benyajati et al., 1980). At the time a two domain
structure for the enzyme was proposed, clearly influenced by the
known structure of horse liver alcohol dehydrogenase (Eklund et al.,
1976). The presence of an N-terminal nucleotide binding domain and of
a C-terminal substrate binding domain was hypothesized. This view has
been proven to be wrong with the solving of the 3oc,20{3-
hydroxysteroid dehydrogenase structure.
Another part of sequence shared among all short-chain
dehydrogenases is found between positions 150 and 160 (DADH residue
numbers will always be used unless otherwise stated otherwise).
Tyrosine 152 and lysine 156 are conserved in all the sequences, and
have been pointed to as the possible amino acids involved in the proton
transfer reaction (Krook et al., 1990). In fact, site-directed mutagenesis
of the conserved tyrosine to phenylalanine or alanine render DADH, or
15-hydroxyprostaglandin dehydrogenase respectively, completely
inactive (Albalat et al., 1992; Ensor & Tai, 1991).
A common fold for all the members of the family finds further
confirmation in the similarity of sequence-based analysis, like
hydrophobicity plots and secondary structure predictions (Persson et
al., 1991).
Several secondary structure predictions for DADH have been
published (Thatcher & Sawyer, 1980; Benyajati et al., 1980; Ribas de
Pouplana et al., 1991). They show values of secondary structure typical
of a soluble, globular protein, and seem to detect an alternation of
helices and strands in the N-terminal part of the enzyme.
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Circular dichroism analysis of DADH (Ribas de Pouplana et al., 1991;
see results section) gave a value of helical structure of about 28%, and a
value of (3-strand of about 40%, very similar to the secondary structure
contents of horse liver alcohol dehydrogenase (Eklund et al., 1976).
1.3.2 The structure of 3a.20[3 hydroxvsteroid dehydrogenase.(SDH)
The solving of the structure of SDH (Ghosh et al, 1991) is one of the
main steps towards an understanding of the family of the short-chain
dehydrogenases.
Contrary to the predictions, the tetrameric SDH is composed of four
single-domain monomers. Each monomer constitutes a classical a-{3
alternating mononucleotide binding fold, somehow resembling a cubical
structure. Such a cube is composed of three layers of secondary
structure : an internal, parallel (3-sheet, packed on both sides by a-
helices. SDH has both the cofactor and the substrate binding sites in the
superior side of the cube, at the C-terminal side of each (3-strand
(figure 1-1).
Each monomer has two main interaction sites with other monomers.
One contact involves the pairing of the C-terminal (3-strand of the (3-
sheet of one monomer to the C-terminal (3-strand of another monomer.
These two adjacent (3-strands form an antiparallel and unconnected
hairpin, practically creating a 14-stranded (3-sheet that expands along
both monomers. The active sites of each monomer are placed at the
opposite faces of the dimer.
If, for the sake of clarity we take the described dimer as a unit, the
tetramer is then formed by the lateral assembly of two such units,
through the interaction of helices E and F (and their preceding turns)
of each monomer with the same helices and turns of an equivalent
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monomer from the second unit.(figure 1 -II). Of course the real
assembly order of the monomers is not necessarily the one used for the
description of the quaternary structure of the enzyme.
Figure 1-1. Schematic representation of the SDH structure. The top
view is perpendicular to the B-sheet. The bottom view looks down the
B-sheet from the C-terminal end of the strands.
The putative binding site for the steroid substrate of SDH is placed by
Ghosh and coworkers just above strand F, closely in contact with its C-
terminal loop (A.F1). This binding site would have some structural
contributions from the loop A.G, from the adjacent subunit. However,
this positioning is still hypothetical, since no steroid or substrate-








k <— c- terminus
Figure 1 -II. Schematic representation of the assembly of the SDH
tetramer. (a) monomer, (b) Dimer formation through pairing of the C-
terminal strands of their B-sheet, (c) Pairing of dimers along helices-D
and -E.
Of more relevance to this project is the architecture of the NAD+
binding site. The crystals of SDH used for the determination of the
enzyme structure had been grown in the presence of 4mM NADH. A
region of electron density was assigned by Ghosh et al. to the cofactor
structure. This solution locates the cofactor molecule in a totally
different position from the one previously found in other
dehydrogenases.
The NADH molecule in SDH is bound to a cleft generated by N-
terminal ends of a-helices B, C and D; C-terminal ends of (3-strands A,
B and C and midsections of (3D and aE.
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The nicotinamide end of the coenzyme is buried, in contact with
residues Ilell to Argl6, Ala36 to Leu39, Ala88 to Ile90 and IlellO, its
carboxamide group being at hydrogen bonding distance of Asp 37, a
residue conserved in most nucleotide binding folds (Eklund & Branden,
1987). The ribose ring of the cofactor is close to IlelO, while its
adenine moiety is sandwiched between Trp67 and lie 117.
The cofactor is in an extended conformation, 2 A longer than
observed in medium-chain dehydrogenases (Eklund et al., 1984).
An approximate comparison of the relative positioning of the
NAD+cofactor in medium-chain dehydrogenases and in the SDH
structure is shown in figure l-III. The cofactor in SDH is located much
more externally than in other nucleotide binding folds.
As a consequence, the residues that in other dehydrogenases make
contacts with the adenine (exterior) part of the cofactor in SDH are
located around the nicotinamide region, close to the supposed reaction
centre.
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Figure 1 -III. Schematic representation of the cofactor positioning in
the nucleotide binding fold of horse liver alcohol dehydrogenase (top)
and in SDH (bottom).
This result is in apparent contradiction with other published
observations from mutagenesis and kinetic experiments (Winberg,
1989; Chen et al., 1991). The poly-glycine loop, at positions 14 to 19,
is, as mentioned earlier, a common feature of many nucleotide binding
folds. Its role in the structure is meant to be that of allowing a very
sharp turn of the polypeptide backbone in that area, thus providing the
necessary space for entry of the cofactor into the binding cleft.
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The relative positioning of this loop with the cofactor is invariable in
all dehydrogenases: always being contiguous to the phosphate chain of
the cofactor (Eklund & Branden, 1987). In SDH the poly-glycine loop
is located close to the nicotinamide end, near what would be expected to
be the reaction centre of the enzyme.
Another conserved residue in most dehydrogenases (including SDH)
is Asp38. Its role in medium-chain dehydrogenases is that of providing
a hydrogen bond between the enzyme and the ribose of the adenine
moiety of the cofactor. Its mutation in DADH affects the recognition of
the cofactor by the enzyme (Chen et al., 1991; this thesis) in a way that
suggests that it could play a similar role to that in medium-chain
dehydrogenases.
The mutation of Asp38 to Gin changes the enzyme's specificity
towards NADP+ (Chen et al., 1991), again suggesting that the residue is
in close proximity of the adenine ribose of the coenzyme. In SDH,
however, Asp38 is in hydrogen-bonding distance of the carboxamide
group of the nicotinamide moiety. It is important to notice that in the
SDH structure another negative residue, Glu65, has a relative position
with the adenine ribose of the NAD+ similar to the one of Asp38 in
other medium-chain dehydrogenase structures.
Clearly, the positioning of the cofactor in the SDH structure is in
contradiction with the function of the mentioned residues in other
studied enzymes and with biochemical data obtained for other short-
chain dehydrogenases. Although the origin of the identical residues in
nucleotide binding folds is still in dispute; whether evolutionary
remains of a common enzyme or product of convergent evolution, one
would expect their function to be the same, since a common role is the
only obvious reason for their appearance in so many different proteins.
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A number of possibilities could explain the discrepancies between the
positioning of NAD"1" in the SDH structure and the rest of data in the
subject.
a) The NAD+ binding site of SDH has changed in respect to other
dehydrogenases to accommodate larger substrates than alcohols.
b) There are more than one possible NAD+ binding positions in SDH.
It is known that the enzyme is capable of recognizing its steroid
substrate in two different orientations and catalyses the dehydrogenase
reaction with both extremes of the steroid molecule (Ghosh et al.,
1991). This suggests a large degree of flexibility in the architecture of
the reaction centre. Perhaps such flexibility is in part achieved through
differential positioning of the cofactor molecule.
c) Short-chain dehydrogenases have a different binding mechanism
for NAD"1" from the rest of dehydrogenases. As mentioned, this is in
contradiction with the data on DADH, but this possibility can not be
ruled out until structures for other short-chain dehydrogenases are
obtained.
d) The cofactor position in the SDH is an artefact of crystallization.
To summarize, the solved structure of SDH probably shows the
general fold of all short-chain dehydrogenases. This structure can now
be used to model the structures of other members of the family. The
binding site for the substrate proposed by Ghosh and colleagues is
hypothetical, and in any case, can not be used to make predictions about
the substrate binding site of other short-chain dehydrogenases that
oxidize very different molecules. The cofactor positioning in the SDH
is novel, and in contradiction with biochemical data obtained for
DADH. The reasons for this discrepancy are not clear, and can not be
analyzed in depth as, unfortunately, Gosh and colleagues have not
17
released the whole set of published data to the Brookhaven protein data
bank for public examination. This unreleased data and the solving of
other short-chain dehydrogenases's structures will be required to
understand these structural discrepancies.
1.4 The biochemistry of Drosophila alcohol dehydrogenase.
1.4.1 The Adh gene and its regulation.
The enzyme alcohol dehydrogenase of Drosophila melanogaster is
encoded by a single gene, located at position 50.1 in the left arm of the
second chromosome (Grell et al., 1965). The function of the gene is to
produce high levels of ADH (around 1 % of total protein) in larvae and
adults. The gene was cloned simultaneously in two different
laboratories, during the early stages of gene cloning and construction of
genetic libraries (Maniatis et al., 1978; Goldberg, 1980). The total
length of the gene is 903 base pairs (bp), and it contains two small
introns of 65 and 70 bp, respectively.
The first intron is located between codons 32 and 33, the second one
between codons 167 and 168 (Benyajati et al., 1980). The Adh gene of
D. melanogaster is unusual in that it has two different promoters,
(distal and proximal, with respect to the ATG codon) which regulate
the expression of the gene at different stages of development (Benyajati
et al., 1983).
In larvae, transcription begins from the proximal promoter, located
70 bp 5' to the ATG. This transcript ends with a short 3' noncoding
segment, that includes the polyadenylation signal. In adults, the
transcription begins at the distal promoter, located some 700 bp 5' to
the proximal promoter, and the transcripts require the splicing of a
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large extra intron of 654 bp to produce the mature mRNA (Sofer &
Martin, 1987). The final polypeptide is identical in both cases, and the
reasons for the different promoters are not clear.
An isolated transcription factor that initiates expression from the
distal promoter is implicated in the regulation of, at least, two other
Drosophila genes (dopadecarboxylase and antennapedia) (England et
al., 1990), so it seems likely that the differential use of promoters may
be connected to more global changes in gene expression programs
during development. The structure of the gene is shown in figure 1-IV.
The research on the molecular regulation of the Adh gene expression
has unveiled a fascinating and extremely complex mechanism of
control. Many questions remain unanswered, and the Adh expression
system is probably one of the more intensively studied models for
eukariotic gene regulation. The description of the system is beyond the
scope of the this thesis (for a review see Chambers,
1991).
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Larval or proximal RNA
Adult or distal RNA
'2 ^3 pP
Developmental stage
Figure 1-IV. (a) Structure of the genomic region of Adh in D.
melanogaster. The boxes represent the exons of the gene. D.P.= distal
promoter, P.P. = proximal promoter. Dashed lines represent the
untranslated regions of the mRNA, including poly-A signals, (b) The
level of expression of the distal and proximal mRNA's during
development. The black area represents maternal mRNA. Hatched areas
represent proximal mRNA and dashed ones distal mRNA. (L= different
larval stages, pP= prepupae, P=pupae, A=adult)
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1.4.2 The Adh product, allelic variation.
1.4.2,1 Allelic variation within D. melanosaster.
The variation among Adh alleles within D. melanogaster has been
characterized both at the genetic and biochemical levels. The genetic
variation has been extensively analyzed by Kreitman and collaborators
(Kreitman,1983; McDonald & Kreitman, 1991).
In an attempt to study the mechanisms of genetic evolution, the
sequences of eleven Adh genes from five different populations of D.
melanogaster were compared (Kreitman, 1983). Out of 43 genetic
polymorphisms only one was a non-silent change, which resulted in the
substitution of Lysl92 by Thr. This very low ratio of substitutions to
silent mutations was interpreted as an indication of a high selective
pressure upon mutation. This nucleotide change defines the two main
isoenzymes found in natural populations: ADH-F (with Thr192) and
ADH-S (with Lysl92). Other isoenzymes are known and will be
described later on, but their frequency of appearance is very small
compared to the one of the F and S isoenzymes.
From the distribution of the polymorphisms Kreitman was able to
divide the eleven sequences into two groups. Those groups actually
separated the F alleles from the S alleles. Only three different
polymorphisms distinguished the two groups, suggesting a recent
separation event, but the group of Adh-S showed more heterogeneity
within itself than the Adh-F group. This suggests that Adh-S was the
ancestor allele. Interestingly a similar two-group classification has
come out of the biochemical analysis, which separates the molecules
between isoenzymes with Lys and Thr at positions 192.
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The biochemical analysis of the melanogaster isoenzymes has been
carried out by different groups over the years (Day et al., 1974;
Winberg et al., 1982; Chambers et al., 1984). Chambers and
collaborators analyzed thirteen different ADH variants from different
populations (see table 3). The analysis of the mobility of the isoenzymes
in isoelectrofocusing gels gave four different groups of enzymes,
namely ultraslow (isoenzyme ADH-US), slow (isoenzymes ADH-S and
ADH-Ss), fast (isoenzymes ADH-F, ADH-FChD, ADH-F71K, ADH-Fr,
ADH-Fs and ADH-FR.city) and ultrafast (isoenzymes ADH-UF and
ADH-D).
Classically, ADH isoenzymes have been classified using this method
because it allows a fast determination of the allelic content of many
individuals. Hence, for example, ADH-F (for "fast") migrates further
in isoelectrofocusing gels than ADH-S (for "slow"), due to the
mentioned substitution of a Lys in ADH-S for a Thr in ADH-F, at
position 192. However, the method only provides information about the
isoelectric point of each variant, and so other biochemical parameters
are necessary to compare the functionality of isoenzymes.
Drosophila ADHs are more active with secondary alcohols than with
primary ones (Winberg et al., 1982). An activity ratio was defined as
the ratio of activity recorded with propan-2-ol to that recorded with
ethanol (Gibson et al., 1980). This ratio, plotted against the specific










ADH-Ss Heat sensitive N. America not sequenced
ADH-S Standard ADH-S World-wide Standard
ADH-F See text. World-wide Lysl92 to Thr
ADH-Fr (a) Heat-stable N. America Lysl92 to Thr
Pro214 to Ser
ADH-FChD Heat-stable Australia Lysl92 to Thr
Pro214 to Ser




ADH-FR.city Heat-stable N. America not sequenced
ADH-F' Stable enzyme Africa Ala 51 to Glu
ADH-UF Ultra-fast mobi¬
lity
Spain Asn8 to Ala
Ala45 to Asp
Table 3. Data from Chambers, 1988. (a) Updated in Chambers, 1991.
The reference sequence is that of ADH-S (Ashbumer, 1985).
The result of the comparison clearly suggested the presence of two
different classes of enzymes : an ADH-S-like group, with values of
activity ratio between 4.14 and 4.86, and an ADH-F-like group with
variants of activity ratio between 6.16 and 7.44. The members of the F
group had higher specific activities than the S-like isoenzymes.
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In general, those enzymes with Thrl92 belonged to the F functional
class, although not necessarily to the F-mobility class. Similarly most
functionally S-like isoenzymes had Lysl92, although their mobilities
were not necessarily S-like. This clearly suggested that the residue at
position 192 was the determinant of the functional nature of the
isoenzyme, while the other changes present in the compared ADHs had
little effect on the functionality of the molecule, although they affected
the electrophoretic mobility.
The determination of proper kinetic constants with purified enzymes
was carried out by Winberg and collaborators (Winberg et al., 1982a,
1985). The isoenzymes ADH-F, ADH-UF and ADH-S and the ADH
from D. lebanonensis were purified and compared. The main
difference between ADH-S and the F-class enzymes is that the former
binds NAD+ more tightly. Winberg and colleagues (1983) proved that
the release of the cofactor was the rate-limiting step in the ADH
reaction. Hence the higher affinity for NAD+ showed by ADH-S must
be responsible for its lower specific activity, and it suggests a
positioning for residue 192 in proximity to the cofactor.
An exception to the two class distribution of isoenzymes is the
thermo-stable enzyme ADH-FChD, which belongs to the S-like
functional class but has a Thrl92, thus having F-like mobility. This
enzyme has a specific activity half the way between ADH-F and ADH-S,
but an activity ratio very similar to ADH-S. ADH-FChD, in fact,
belongs to a whole subgroup of thermo-stable isoenzymes : ADH-
FChD, ADH-FR and ADH-71K. These were initially found as isolated
polymorphisms in different parts of the world, but the sequencing of
the different enzymes has revealed a single change for all of them with
respect to the isoenzyme ADH-F: Pro214 to Ser (Chambers, 1991).
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These isoenzymes display a marked increase in thermal stability
(Chambers, 1984; Hernandez et al, 1986), retaining 75% of the activity
after 60 minutes at 44 °C; a temperature at which, after 40 minutes,
ADH-F and ADH-S lose all activity (Chambers, 1984). As already
mentioned, a comparison of their biochemical properties reveals that
these isoenzymes are more similar to ADH-S than to ADH-F, despite
the fact of having a threonine at position 192. Clearly the Pro214 to Ser
substitution has a double effect: it increases the stability of the enzymes
and, at the same time, decreases their specific activity, perhaps
increasing the strengths of binding to the cofactor. Interestingly, no
ADH-S with a Pro214-Ser mutation has been described. The
investigation of this observation is part of the subject of this thesis.
1.4,2.2 Allelic variation of Adh /ADH in the genus Drosophila
A great deal of research has been dedicated to comparing the
characteristics of the Adh genes and their products from different
species of Drosophila, mostly with a view to unravelling the neutral or
adaptive nature of their genetic evolution.
The genus Drosophila is divided into various radiations, or
subgenera, which, in turn, separate into groups and subgroups. The two
radiations that have been more intensively studied are Sophophora and
Drosophila, which are thought to have diverged approximately 40-60
million years (Myr) ago (Beverley & Wilson, 1985). Once again, the
research on the variation of the Adh /ADH system has concentrated on :
a) the genetic polymorphisms between species, and b) the biochemical
differences in the ADH enzymes.
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Many Drosophila Adh genes have been cloned and sequenced to date,
and every article reporting a new sequence invariably compares it to
those previously reported from different species (Kreitman, 1983;
Coyne and Kreitman, 1986; Bodmer and Ashbumer, 1984; Schaeffer
and Aquadro, 1987; Rowan and Dickinson, 1988; Fischer and Maniatis,
1985; Atkinson et al., 1988).
For the sake of clarity I will divide the gene in 5' regulatory
sequences, coding region (including introns) and 3' genomic regions.
The regulatory sequences at the upstream end of the gene are very
different between the members of the subgenera Sophophora and
Drosophila. In the former two different promoters exist, as described
previously. In the case of some members of the Drosophila radiation,
like D. mulleri , D. mojavensis and D. hidey, the system is totally
different : the gene has been duplicated and one of the copies has a
larval promoter while the other gene has an adult promoter (Fischer
and Maniatis, 1985, Atkinson et al., 1988). Other members of this
subgenus like D. ajfinisdisjuncta, however, have a two promoters
structure, similar to D. melanogaster (Rowan & Dickinson, 1988).
This variation in promoters organization makes finding an explanation
to the different expression mechanisms very difficult, because D.
affinisdisjuncta, belonging to the subgenus Drosophila, is a much closer
species to D. mulleri than to D. melanogaster, which, confusedly,
belongs to the subgenus Sophophora.
In the coding region the general structure of the genes is similar, and
the two introns found in the Sophophora group keep the same
approximate length and position in all the species analyzed. A striking
observation is a different grade of mutability in different parts of the
coding region.
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This phenomenon was first described by Bodmer and Ashburner, and
has been confirmed in other genes. There is a significant difference in
substitutive mutation accumulation between the three exons of the gene,
with exon three accumulating more mutations than one and two, and
number two being the most conserved of the three.
Despite the lack of structural evidence this distribution of mutation
rate was speculated to be due to conformational constraints, which were
connected to the distribution of functional domains in the enzyme. It
was suggested that the cofactor and substrate binding sites would be
encoded by exons one and two (Bodmer and Ashburner, 1984;
Schaeffer & Aquadro, 1987). More surprising was the finding that the
rate of silent mutation was also nonrandomly distributed, showing a
similar pattern as the one found for the substitutive mutations. This
observation can be explained by unknown mutational constraints in
supposed silent sites or by a change of mutational rates across the gene
(Schaeffer and Aquadro, 1987).
The overall amino acid variability encoded by the different genes
does not exceed 30% even in very distant species like D. affinisdisjuncta
and D. melanogaster (79% identical). This is not surprising when we
consider that all the comparisons are made within a single genus.
The downstream region of the gene had been shown by Kreitman
(Kreitman,1983) to have a high degree of conservation. During their
analysis of this part of the D. pseudoobscura gene, Schaeffer and
Aquadro (1987) discovered an open reading frame, which had a high
sequence identity with the Adh gene. This was proposed to be the
result of an ancient duplication of the gene. Such gene duplications have
been detected at the 3' end other Adh genes (Atkinson et al., 1988,
Marfany and Gonzalez-Duarte, 1991).
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Their transcription to mRNA has been proven but their translation
product, if any, has not yet been identified (Schaeffer & Aquadro,
1988).
The biochemical characterization of the ADH enzymes from different
Drosophila species has been the subject of intense research, in an
attempt to find a correlation between the observed genetic variations
and functional differences, either in the enzyme or the metabolism of
the whole fly . The different species of Drosophila studied (mainly by
the group of Gonzalez-Duarte : Juan & Gonzalez-Duarte, 1980; Atrian
& Gonzalez-Duarte, 1982; Atrian & Gonzalez-Duarte, 1985; Winberg
et al., 1986; Hernandez et al., 1988) occupy very different ecological
environments. The main physiological variable concerning the ADH
enzyme is , of course, the amount of alcohol present in the media, and
most of the studies attempted to find correlations between the activity
of the ADH enzyme of each species with its resistance to alcohols, and
the amount of them that the flies are likely to encounter in the wild.
Large variations of ADH activity can be found in crude extracts of
different flies, and these, generally, correlate well with the kind of
environment where the flies are found. In most cases the species more
resistant to alcohol ingestion were the ones with higher ADH activity in
crude extracts (Atrian & Gonzalez-Duarte, 1982). However, when the
enzymes were purified and their kinetic characteristics obtained they
were found to be quite similar to each other in terms of affinity for
substrate and cofactor, and in specific activity (Atrian & Gonzalez-
Duarte, 1985).
A variation was found in the amount of enzyme that could be
recovered from each species, suggesting that the difference in ethanol
tolerance depends on the amount of active enzyme in the fly more than
on the specific activity of the enzyme.
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This could be due to increased expression or a lower turn-over,
which, in turn, could be a function of the enzyme's sequence-induced
stability. The possible structural effects of the characterized
polymorphisms will be discussed in 1.3.5.
Although the amount of ADH activity per fly, their resistance to
ethanol and their presence or absence in alcohol-rich environments
correlate quite well, there are some exceptions. D. simulans, a sibling
species of D. melanogaster that has a somewhat smaller amount of
ADH activity to D. melanogaster, completely avoids the alcoholic
environments where D. melanogaster thrives. Possibly, this indicates
that ecological behaviour is a function of a large variety of factors, not
necessarily limited to ADH metabolism.
The kinetic parameters for many different pure Drosophila ADH
enzymes have been obtained. In general, and despite sequence
differences of up to 21 %, as in the case of D. lebanonensis and D.
melanogaster, their kinetic values are similar (Winberg et al., 1986;
Atrian & Gonzalez-Duarte, 1985). Enzymes purified from flies,
bacteria (Chen et al., 1990), or yeast (see results section), show the
same catalytic uniformity.
The Km for NAD+ is around 200 |iM for most species, Km's for
propan-2-ol are in the order of 1 mM and the ones for ethanol about 8
mM. kcat values for isopropanol are around 7/sec, and for ethanol
around 4/sec. The variability in catalytic activity is also small, and
ADH-S and ADH-F differ from each other by a maximum factor of
three. A certain amount of variability in these values can be found in
the literature, probably the more reliable measures are the ones by
Winberg and collaborators (Winberg et al; 1982a, 1985, 1986, 1988a)
because the authors developed and used a method for the quantification
of enzyme active-sites in solution.
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It is clear that the amount of polymorphism encountered in different
Drosophila ADH isoenzymes does not result in large kinetic variation.
The only reported kinetic value that significantly differs from the rest
is the Km for isopropanol of the ADH from D. affinisdisjuncta (Green
et al., 1989), which is about two orders of magnitude higher than the
mean value of the rest of species. This enzyme, expressed and purified
from bacteria, has a Km value for NAD+ of the same order as in other
species, and a similar specific activity. Unfortunately, the kinetic
constants for ethanol are not reported by the authors.
It seems clear from the studies at the genetic level that there is a
strong evolutionary pressure against changes in the genome that result
in amino acid variation. At the same time, most of the polymorphisms
at the protein level seem to have little effect on the enzyme's catalytic
mechanism. Also, Middleton and Kacser have reported that the
variations in ADH activity due to genetic polymorphisms do not cause
variation in the metabolic flux of alcohol utilization (Middleton &
Kacser, 1983). This seems to be in good agreement with Kimura's
neutral evolution theory, where most changes would be deleterious, and
the majority of the non-deleterious would be neutral (Kimura, 1983).
In contrast to this fact, McDonald & Kreitman (1991), with a simple
analysis of the ratios of amino acid substitutions to silent mutations
between and within species, conclude that such ratios can not be
explained by a neutral theory of evolution. They find many more
amino acid replacements compared to silent mutations between species
than within single species. If neutral evolution was the main cause for
sequence variation those rates would be expected to be equal both
between and within related species.
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If there is an effective selective pressure behind the sequence
variation in ADH it does not seems to be working solely on the catalytic
properties of the enzyme. As mentioned before, there may be many
possible factors involved in the suitability of a specific gene or protein
sequence. If the amount of ADH is important for the metabolism of the
fly, as the results described earlier suggest, then the stability of the
enzyme and its levels of expression may be more relevant factors than
catalytic alcohol dehydrogenase activity. Perhaps the differences found
in stability between the ADHs of different species are showing a
selection trend (Atrian & Gonzalez-Duarte, 1985).
The amount of gene expression is related to the codon usage in each
species (Grantham et al., 1981), and a difference in third-codon
position nucleotide content has been reported between the subgroups
Drosophila and Sophophora (Starmer & Sullivan, 1989). This
difference in third-base frequency seems to be specific for the Adh
gene, and it could mean that the evolutionary pressure concerning Adh
is applied at the expression level by altering the third-base frequency.
The third-base nucleotide content between the three species studied by
McDonald & Kreitman (1991) are similar, as they used members of the
Sophophora group only. This means that their definition of silent
mutations is correct. But codon usage values will have to be taken into
consideration when defining the concept of silent genetic change if
comparisons between Drosophila groups are to be made.
Finally, it has to be mentioned that the metabolic role of Drosophila
ADH is far from well understood, having even been suggested that the
enzyme could be involved in pheromone metabolism (Winberg et al.,
1982b) (see 1.4) . Clearly, no explanation for the observed non-neutral
evolution can be offered until the role of ADH is clear.
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1.5 The enzvmologv and structure of Drosophila ADH
As mentioned previously, most of the enzymological research on
Drosophila ADH has been carried out by Winberg and colleagues (see
Winberg et ah, 1982a, 1982b, 1983, 1984, 1985, 1986, 1988, 1988b,
1989). Their analysis of the catalytic mechanism of the isoenzymes
ADH-F, ADH-S and ADH-UF of D. melanogaster and the ADH
enzyme of D. lebanonensis offers a large amount of information
concerning the architecture and mechanism of the active site, the nature
of the residues involved in catalysis, and the differences between
isoenzymes.
1.5.1 The mechanism and kinetics of the cofactor binding and reduction
The nucleotide-binding site of Drosophila ADH is supposed to be very
similar to the one found in medium-chain dehydrogenases. As seen in
section 1.2.2, this is confirmed by the structure of 3a-20(3 SDH.
It was found that the reaction catalysed by Drosophila ADHs follows a
compulsory-order mechanism, where the cofactor binds first, followed
by the alcohol (Winberg et al., 1985, 1986, 1988a). In the case of
secondary alcohols the dissociation of the enzyme-NADH complex (ER)
becomes the rate-limiting step of the reaction. This is due to the high
binding affinity between the enzyme and NADH, which makes the
release of the reduced coenzyme a slower process than the proton
transfer. As a consequence, the strength of binding of the enzyme to the
coenzyme is directly related to the kinetic efficiency of the reaction,
and the isoenzymes that show strongest binding to NAD+ have the
lowest specific activities.
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Similar to horse-liver ADH (LADH), the analysis of the pH
dependence of the cofactor-enzyme complex formation showed that the
enzyme-NAD+ complex (EO) was inhibited by the protonation of two
groups with pKs of 6.5 and around 9, respectively.
The ER complex, on the other hand, was only dependant on the
protonation of a group with a pk of around 8. (Winberg & McKinley-
McKee, 1988a).
This implies that a group with a pk of 6.5 is responsible for the
inhibition of the formation of the EO complex but not of the ER
complex, hence this group must interact with the nicotinamide end of
the cofactor. This situation is similar in LADH, where residue His51
binds to the oxygens of the nicotinamide ribose and is suggested to
repel the oxidized cofactor when positively charged.
The ADHs of D. melanogaster have four histidines, two of which can
be chemically modified (Thatcher, 1981), but inactivation results from
the modification of only one of them (Retzios, 1982), and can be
protected by the cofactors NAD+ and NADH.
Another residue that affects coenzyme binding is Lys or Thrl92. As
described before, position 192 is the only amino acid difference found
between ADH-F and ADH-S. These isoenzymes differ in the strength
with which they can bind NAD+, with ADH-S (Lysl92) having a
stronger interaction than ADH-F (Thr-192).
If thio-NAD+ is used, the difference is abolished and the binding in
ADH-S takes ADH-F-like values, suggesting that Lysl92 interacts with
the nicotinamide part of the cofactor, possibly binding to the
carboxamide group. Lys 192 could be the residue that, in ADH-S, shows
a pk of about 9.2 affecting the coenzyme recognition. The pH
dependence of this process has not been determined in the Thrl92
containing enzymes (Winberg, 1989).
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Drosophila ADH contains two cysteines and no disulfide bridges, and
these cysteines have been pointed at as possible catalytic residues. Their
chemical modification was shown to abolish enzyme activity, while the
presence of the coenzyme protected them against chemical attack
(Thatcher, 1977, 1981; Chambers, 1984).
However, the substitution of both cysteines to alanines did not affect
the enzymes activity (Chen et al., 1990), proving that they are not
involved in the reaction mechanism. Nevertheless, they might be in
contact with the coenzyme and the substrate, which would explain the
observation that both substrate and cofactor protect Cys218 against
chemical modification. Interestingly, the binding of substrate and
coenzyme seems to make Cysl35 accessible to chemical attack (Chen et
ah, 1990).
The investigation of the pH dependence of the ER and EO dissociation
process showed the existence of a group, with a pk of 7.6 whose
protonation increases EO dissociation. Protonation of the same residue
also unstabilises the binding of alcohols and ethanol competitive
inhibitors to the EO complex (Winberg et al., 1988). Since this group
does not affect acetaldehyde binding or NADH dissociation in the pH
range 6 to 10, it must have a pk higher than 10 when in the ER
complex. Winberg and collaborators compared this behaviour to the
pk's of the zinc atom in medium-chain enzymes, which are 9 in the free
enzyme, 7.6 in the EO complex and 11.2 in the ER complex (Winberg
et al., 1988; Petterson, 1987). This residue has not been determined in
Drosophila, although Tyrl52 seems to be the a probable candidate, in
view of its total conservation and because its substitution abolishes all
enzyme activity (Krook et al., 1990; Ensor & Tai, 1991; Albalat et al.,
1992).
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Other residues are known to affect the binding of the coenzyme to
the enzyme. As described earlier isoenzymes where the residue Pro214
is changed to Ser show increased thermal stability and a reduction in
specific activity that makes them more similar to ADH-S despite the
fact that they contain Thr at position 192. This effect is due to an
increase in the binding energy to NAD+, which suggests that this
mutation occurs in the proximity of the cofactor binding site or
somehow modifies it.
At positions 1 and 82 respectively, all D. melanogaster isoenzymes
have Ser and Gin, while ADH from D. simulans has Ala and Lys. The
binding of the D. simulans ADH to the coenzyme is stronger than in
ADH-S from D. melanogaster, and it results in an even smaller catalytic
activity (Bodmer & Ashburner, 1984; Winberg, 1989).
This suggests that residue 82 is involved in the binding of the cofactor
(since residue number 1 is in an extremely variable region of the
enzyme, and is very likely to have a disordered structure). A possible
role of this residue is suggested by a computer model for the structure
ofDrosophila ADH (see modelling section of this thesis).
Asp38 is a conserved residue in most nucleotide-binding folds where
it hydrogen bonds to one of the hydroxyl groups of the adenine ribose
of the cofactor (see 1.2.2). As discussed earlier, in SDH this residue
seems to have a different relative positioning in respect of the
coenzyme, and a glutamic acid at position 65 seems to be closer to the
adenine ribose of the cofactor. In the light of a multiple sequence
alignment it has also been suggested that another aspartate residue
(Asp64) maybe the conserved aspartate in the nucleotide binding folds
of short-chain dehydrogenases (Persson et al., 1991).
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However these observations are in contradiction with experimental
results that sustain that Asp38 of D. melanogaster ADH interacts with
the cofactor in a similar way to the seen in medium-chain
dehydrogenases (discussed in 1.2.2)(Chen et ah, 1991).
Site-directed mutagenesis experiments have demonstrated the
anticipated proximity of the poly-glycine sequence G-X-G-X-X-G, at
positions 14-19 to the cofactor (Chen et ah, 1990; Results section of
this thesis). The mutation of Glyl4 to alanine reduces the enzymes
activity to 30%. Its mutation to valine totally inactivates the enzyme
(Chen et al., 1990; Results section of this thesis). This is in perfect
agreement with the structural role assumed for this part of the
sequence, that is, to provide an empty space to allow the
accommodation of the cofactor inside the binding-site. As predicted the
bigger the group that is introduced into the sequence the larger the
effect on the enzyme's mechanism, presumably because of increasing
distortion of the nucleotide recognition. The mutation of Glyl9 to Ala,
also affects the structure of the nucleotide-binding site (Results section
of this thesis).
1.5.2 The recognition of the substrate and kinetics of its oxidation
All Drosophila ADHs are more efficient oxidizers of secondary
alcohols like propan-2-ol than of primary alcohols like ethanol
(Winberg et al., 1982). This specificity indicates that the substrate
binding sites of Drosophila ADHs are probably very different to the
medium-chain structures, which recognize primary alcohols more
efficiently.
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The substrate specificities, and the activity ratios (see 1.3.1), of D.
melanogaster ADH-F, ADH-S and ADH-UF and D. lebanonensis ADH
are very similar (Winberg et al., 1982, 1985). The substitution of the
non-transferable hydrogen of ethanol by a methyl group in propan-2-ol
increases the kca^ value of the enzymes by a factor of 20 (Winberg et
ah, 1982a; Chambers, 1984; Atrian & Gonzalez-Duarte, 1985).
Through the comparison of the specific activity of ADH-S and ADH-
UF with a large range of primary and secondary alcohols, Winberg and
collaborators (Winberg et ah, 1982b) concluded that the enzyme binds
secondary alcohols through a double hydrophobic interaction, which, in
the case of propan-2-ol, affects the two methyl groups of the alcohol.
This is supported by the fact that the enzymes are not active with
charged or polar alcohols (Winberg et ah, 1984, 1986). This is
different to the substrate-binding mechanism of horse-liver ADH,
where the methyl group of the ethanol is bound to a single hydrophobic
funnel in the active site (Eklund & Branden, 1987).
Winberg (1989) assigns a difference on binding energy of -1.6 to
-1.8 kCal/mol between primary and secondary alcohols. Using the
calculated values for the free-energy of transfer of a methyl group
from water to n-octanol (-0.68 kCal/mol) he proposes that the second
methyl group of propan-2-ol binds to a region of the enzyme that is
about 2.5 times more hydrophobic than n-octanol.
The specificity of the active site is, however, extremely flexible and
the enzymes manage to oxidize alcohols of very different structures and
sizes, suggesting a very open conformation of the substrate binding-site.
In contrast, the enzymes show a marked preference for the R-
enantiomers of the substrates (Winberg et al., 1982a).
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The difference in substrate specificity between Drosophila ADHs and
the medium-chain ADHs makes clear that the structures of the binding-
sites are different between the two classes of enzymes, and so it is not
possible to extrapolate crystallographic data from the latter to the
Drosophila enzymes. At the same time the similarities in substrate
recognition between the ADHs of different Drosophila species do not
allow the identification of possible residues involved in the binding site.
1.5.3 The reaction mechanism
The dehydrogenase reaction is started with the binding of the cofactor
molecule to the enzyme. The reasons for this order are not clear, but
the observation that coenzyme binding may induce conformational
changes (Chen et ah, 1990) may indicate that structural shifts induced
by the cofactor may be necessary for substrate recognition, as it is
found in medium-chain ADHs. Once the substrate is bound the reaction
proceeds, supposedly with the participation of Tyrl52 or lysl56. The
speed of the reaction is much lower if primary alcohols are being
metabolized, and hydride transfer becomes a rate-limiting process
(Winberg et ah, 1986).
If secondary alcohols are used as substrate, the rate-limiting step
becomes the dissociation of the reduced coenzyme from the enzyme.
This has been proved by:a) the similar Vm shown for different
secondary alcohols, b) the substrate activation with some secondary
alcohols, c) the lack of primary kinetic isotope effects when deuterated
secondary alcohols were used (Winberg et al., 1984, 1985, 1986).
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In the reverse reaction, the maximum velocity for acetaldehyde
reduction was found to be the dissociation rate of NAD+ from the EO
complex, while with acetone a ternary complex interconversion seemed
to be rate limiting (Winberg & McKinley-McKee, 1988).
This reaction mechanism seems to be general to all the Drosophila
ADHs tested so far, as they all show similar substrate specificity and
consistently similar Vmax values for the secondary alcohols tested
(Thatcher, 1977; Chambers, 1984; Juan & Gonzalez-Duarte, 1980;
Atrian & Gonzalez-Duarte, 1985).
In contrast to this well documented mechanism it must be mentioned
that Heinstra and collaborators (Heinstra et al., 1988) have reported
that NADH can act as a competitive inhibitor with respect to ethanol as
a variable substrate, this observation would suggest a rapid equilibrium
random mechanism for the oxidation of primary alcohols. This appears
to be an isolated observation.
1.6 The physiological role of Drosophila ADH
The main physiological role of Drosophila ADH is the dietary
utilization of alcohols. In addition, a function of detoxification when
high levels of alcohols are present in the environment is also clear,
although the experimental results are better understood if the processes
of ethanol utilization and of ethanol resistance are treated as different
ones (Chambers, 1991). Other functionalities, like a role in pheromone
metabolism, have been proposed (Winberg et al., 1982: Madhavan et
al., 1973), but they have not been further investigated.
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1.6.1 Ethanol as a nutrient.
From experiments with Adh null strains, and population studies of
flies starved in ethanol rich environments it is clear that ethanol can be
used as a nutritional source (Parsons, 1981; Parsons & Spence, 1981).
The metabolic pathway of this utilization is not well understood,
although it is known that the ingestion of ethanol produces an
accumulation of triacylglycerides in the fat body. Acetate is supposed to
be an intermediate in this process (Geer et al., 1985).
ADH activity seems to be the main control point of this pathway,
having a control coefficient of nearly one according to 13NMR studies
on the ethanol —> lipid flux (Freriksen et al., 1991). This is in contrast
with the observation that flies with different Adh genotypes and
different global ADH activities do not show differences on the flux of
the alcohol metabolizing pathway (Middleton & Kacser, 1983). A
second enzymatic activity, oxidizing acetaldehyde to acetate, has been
shown for Drosophila ADH (Brooks et al., 1985), although this
activity has too high optimum pH (>10) to be significant in vivo
(Chambers, 1988).
The main question surrounding the role of ADH in the utilization of
ethanol is whether there is an adaptive connexion between the amount
of ADH activity that one fly obtains from its ADH isoenzymes and its
fitness in the population. The fact that ADH is such an abundant protein
in the fly's body (about 1% of total protein), and that D. melanogaster
and other species are mostly associated with fermenting habitats makes
it unavoidable that a connexion between ADH activity and ecological or
evolutionary fitness be searched.
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When comparisons between different species are made, a correlation
between amount of ADH activity and presence in ethanol-rich niches
seems to be well stablished (Oakeshott et al, 1982). However, when the
comparisons are made within D.melanogaster's different allelic
populations results are not so clear, and ADH-F flies, which contain
more ADH activity do not always outperform ADH-S flies when grown
in ethanol-rich environments (Oakeshott et al., 1984).
This last observation would agree with the previously mentioned
results of Middleton and Kacser and suggest that the differences
observed between different species may be the result of other, not taken
into account, differences between the species compared. The net
contribution of the ADH enzyme to the ecological and physiological
relationship between Drosophila and ethanol is not totally defined yet.
1,6.2 Alcohols as poisons.
Once again, a large amount of contradictory data has accumulated
concerning the relationship between ADH activity and the tolerance to
ethanol or other alcohols. Experiments involving inbred lines of flies
or laboratory strains generally show that ADH-F strains have an
advantage over ADH-S strains when grown in ethanol rich media
(> 6% ethanol) (Maroni et al., 1982). However, experiments using
freshly captured flies fail to demonstrate any increase of the ADH-F
alleles when grown in the same conditions (Gibson & Wilks, 1988). At
high concentrations of ethanol a toxic build up of acetaldehyde occurs,
and so the capacity of resisting high concentrations of ethanol will
depend on the capacity to digest ethanol and, also, on the capacity to
remove the accumulating acetaldehyde (Anderson & Bamett, 1991).
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Probably, a more important alcohol in terms of toxicity is propan-2-
ol, whose oxidation product, acetone, is highly toxic to the fly (Geer et
al., 1985). When flies are grown in the presence of propan-2-ol the
ADH activity is rapidly suppressed. This is due to the covalent
attachment of NADH and acetone to the enzyme, creating an inert
tertiary complex.
When Drosophila ADH is analyzed in isoelectrofocusing gels three
forms are observed with different mobilities: Adh-1, Adh-3 and Adh-5,
corresponding to dimers with two, one or nil NAD+ molecules bound,
respectively (Johnson & Denniston, 1964). In normal conditions, the
Adh-5 population represents about 90% of the total amount of enzyme
(Winberg, 1989), but the amount of Adh-3 and Adh-1 can be increased
if the enzyme is incubated with a mixture of NAD+ and acetone due to
the formation of this ternary complex (Jacobsen et al., 1972).
The ternary complex is irreversible, because In vivo the recovery of
ADH activity after incubation with propan-2-ol is totally due to de novo
synthesis of enzyme (Gonzalez-Duarte & Atrian, 1986).
Propan-2-ol can be an abundant alcohol in the organic environments
where Drosophila larvae prefer to grow, and it has been proposed that
the inactivation of the ADH activity is in fact a protection mechanism
against an excessive build-up of acetone in the larvae (Chambers,
1988). An NADP+-dependent aldo-keto reductase activity has been
reported in D. melanogaster and D. hidey , it is independent of ADH
activity and it has been proposed to have a detoxifying role, converting
aldehydes and ketones back to alcohols, a role that ADH cannot
perform due to the formation of the inert ternary complex (Atrian &
Gonzalez-Duarte, 1985).
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1.6.3 Other environmental factors affecting ADH activity and distribution
Adh alleles are not randomly distributed, and the different
polymorphisms follow a clinal geographic distribution. The search for
the factors that determine such distribution is intense, because these
may be the same factors that determine the actual existence of the
polymorphisms (Vigue & Johnson, 1973). The frequency of the allele
Adh-F increases with latitude both north and south of the equator,
while Adh-S behaves in an opposite way (Oakeshott et al., 1984; Vigue
& Johnson, 1983).
This allelic distribution is quite constant in all continents (Chambers,
1988), despite some variations like the very high frequency of ADH-
FChD in China (~ 30% of wild populations), which is thought to be
due to the fact that China is the area were the mutation first appeared.
Which are the factors that govern this distribution?. Temperature is
probably the main candidate. A correlation between altitude and
increase in ADH-F frequency has been found in mountains of Mexico
and Russia (Grossman et ah, 1970; Pipkin et ah, 1976). ADH-F, which
seems to be more common in cooler locations is reportedly less
thermo-stable than ADH-S, an allele which attains maximum
frequencies in the tropics.
As mentioned earlier, ADH-F is believed to have appeared from
ADH-S (Kreitman, 1983), and, from the clinal data, it would appear to
have colonized areas of lower temperatures more efficiently. Perhaps
flies with an F genotype tend to occupy niches where S genotypes no
longer have the advantage of thermal stability.
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Against the clinal observations we must cite the report of Sampsell &
Bamette (1985), which shows that ADH-F flies grown at 29 °C have
more enzyme activity than if grown at 20 °C. And, at both
temperatures, ADH-F flies have more ADH activity than ADH-S flies.
Also, a clinal analysis of the distribution of Adh alleles in South
Africa failed to show a latitudinal distribution, but found a positive
correlation between Adh-S distribution and increase in rainfall (Getz
& Grant, 1990). The authors try to explain such correlation with a
possible increase of amount of alcohols in zones of higher humidity,
due to lower evaporation. In such conditions they argue that a more
active enzyme like ADH-F would be selected against, because of the
larger amount of toxic intermediates that would accumulate in the flies
with such genotype.
Once again there seems to be a general trend that correlates Adh
allelic distribution with environmental factors (latitude, temperature),
but this correlation is confronted with contradictory reports that
reminds us that the factors involved in metabolic and ecological
processes are far to complicated to be explained by a single parameter.
The alcohol dehydrogenase gene/enzyme system, because of its well
described polymorphism and distribution, and its central role on the
metabolism of Drosophila, seemed a good candidate for obtaining
simple and general answers to many evolutionary and ecological
questions. As usual, this has proved not to be the case.
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1.7 Aims and strategy of the project
This project was originally planned as part of a collaborative effort
between the Department of Genetics of the University of Barcelona and
the Department of Biochemistry of the University of Edinburgh. The
overall goal remains the elucidation of the structure of Drosophila
ADH, the analysis of the structure-function relationships in the enzyme
and the study of the effect of the introduction of induced
polymorphisms into Drosophila populations. The project described
here aimed to investigate the role of residues of interest in the protein
by site-directed mutagenesis with the use of various biochemical and
biophysical characterization techniques.
Specifically, two main aspects of the enzyme structure were to be
investigated :
a) The existence of the proposed nucleotide-binding site at the N-
terminus of the protein was to be investigated through mutagenesis of
the residues Glyl4, Glyl9 and Asp38.
b) The thermal stability effect of the mutation Pro214 to Ser was to
be investigated, first by introducing the mutation into an ADH-S
isoenzyme, where it has not been found in natural populations.
To carry out these experiments the Adh-S gene was cloned into a
plasmid where all the mutagenesis and sequence analysis were
performed. The mutated genes where then subcloned again into a yeast
expression vector, and the mutated enzymes purified to homogeneity
from yeast cultures.
The mutant enzymes were then analyzed with a variety of techniques
in order to characterize the effect of the introduced changes.
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During the process of this research it became clear that the stmcture
of Drosophila ADH would not be readily available due to the low
quality of the crystals obtained from the enzyme. Since a three-
dimensional structure is essential for the proper understanding of site-
directed mutagenesis experiments, an alternative three-dimensional
model of the enzyme was necessary.
The recent publication of the structure of 3oc,20(3-hydroxysteroid
dehydrogenase, and the release of its a-carbon coordinates in the
Brookhaven database, provided the necessary material to build such a
three-dimensional model for Drosophila ADH, using the new
techniques of protein modelling. Such a model offers the unusual
possibility of analyzing the structural evolution of an enzyme for which
a large number sequences with a relatively small divergence time are
available.
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2. Experimental Materials and Methods.
2.1 Materials.
2.1.1 Cloning, expression, mutagenesis and sequencing materials.
2.1.1.1 Plasmids.
1. pUCl 15-3008, from Dr. W. Sofer, Waksman Institute, Rutgers
University, USA. Vector pUCl 18, containing the Drosophila
melanogaster Adh-S gene,
2. M13mpl8, from Bethesda Research Laboratories (UK) Ltd,
Cambridge, UK. MISmplSE'. coli bacteriophage DNA. Used for
mutagenesis and sequencing procedures.
3. PVT-U-101, from Dr. S. Atrian, Dept. of Genetics, Barcelona
University, Catalonia. Phagemid, capable of replicating in yeast, or in
bacteria as a bacteriophage. It contains the expression promoter of the
yeast ADH-1 gene, for protein expression in this organism.
2.1.1.2 Strains.
1. Escherichia coli TGI. K12, A(lac-pro), SupE, thi,
hsdDS/F'traD36, pro A+B+, lac 1^, lacZ AM15. From Amersham
pic., Aylesbury, UK.
2. Escherichia coli BW313. dut, ung, thi-1, relA, spoTl/F'lysA.
From Dr. T. McNally, Biochemistry Dept., Leeds University.
3. Sacharomyces cerevisiae WV36.201. Mat a, ura 3, trpl, ade2,
ade4, adhlA, adh2A, adh3. From Dr. S. Atrian.
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2.1.1.3 Enzymes
BamHI, EcoRI, Hindlll, PstI, Xbal, SacI and SphI were from
Northumbria Biologicals Ltd., Cramlington, UK.
Spel was from New England Biolabs, Cambridge, USA.
T4 DNA ligase and Rnase A were from Boehringer Mannheim,
Lewes, UK.
2.1.1.4 Media, antibiotics and related
Bacto peptone, purified agar and yeast nitrogen base w/o amino acids
were from Difco labs, East Molesly, UK.
Tryptone and yeast extract were from Oxoid Ltd., Haverhill, UK.
Ampicillin, Xgal, IPTG and all amino acids and nucleotides were
from Sigma Chemical Co., Poole, UK.
2.1.1.5 Oligonucleotides and radiochemicals
All oligonucleotides were synthesized by and purchased from Oswel
DNA service, Dept. of Chemistry, University of Edinburgh, except the
Ml3 sequencing oligonucleotides, which were from Amersham.
Deoxyadenosine 5'-a- (35S) thiotriphosphate, triethylammonium salt,
was from Amersham.
2.1.1.6 Kits.
All sequencing reactions were performed using the Sequenase™ DNA
sequencing kit, provided by Cambridge Biosciences, Cambridge, UK.
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2.1.1.7 Hardware.
DNA agarose electrophoresis was performed in a Pharmacia
(Pharmacia, Uppsala, Sweden) gel electrophoresis apparatus GNA-100,
connected to a Sandos (Sandos, Stockport, UK) power unit.
DNA sequencing was done on a Pharmacia sequencing cast connected
to a Pharmacia power unit.
2.1.1.8 Chemicals
All chemicals were supplied by Sigma, BDH (BDH, Poole, UK) or
IBI (IBI, New Haven, USA), and were of the best grade commercially
available.
2.1.1.9 Miscellaneous
Hyperfilm MP X-ray film was from Amersham. Polaroid 665 film
and agarose were from Sigma. Plastic tubes (Falcon, 5 and 50 ml) were
from A&J Beveridge (Beveridge, Edinburgh, UK).
2.1.2 Protein purification and analysis materials.
2,1.2.1 Chemicals.
Sepharose G-25, Blue Sepharose, Q-Sepharose FF, S-Sepharose FF,
Superose 6 and Superose 12, either unpacked or prepacked, were from
Pharmacia.
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Ammonium sulphate, dichloroisocumarin, 1,10 phenanthroline, E-64,
TEMED, ammonium persulfate, SDS, DTT, acrylamide, N,N'-
methylene-bis-acrylamide and Trizma base were from Sigma.
Methanol, H2O2 and 4-chloro-l-naphtol were from Merck, Schuchardt,
Germany.
2.1.2.2 hardware
Protein electrophoresis in SDS-polyacrylamide gels was done in
either Bio-Rad miniprotean systems (Bio-Rad, Hemel Hempstead, UK)
or in Hoeffer (Hoeffer, San Francisco, USA) SE 280 gel
electrophoresis units.
Protein blotting to nitrocellulose membrane was done in a Bio-Rad
mini trans-blot electrophoretic transfer cell using nitrocellulose filters
(Schleicher & Schuell, Dassel, Germany).
All Chromatographic steps were performed using :
- Gilson minipuls3 peristaltic pump
- Pharmacia-LKB redifrac fraction collector.
- Isco UA-5 UV detector and chart recorder.
- Pharmacia FPLC system LCC-500.
2.1.3 Enzyme characterization materials.
2.1.3.1 Enzymes.
Horse liver alcohol dehydrogenase was from Boehringer Mannheim,
yeast alcohol dehydrogenase was from Sigma. Alcohol dehydrogenase
from Drosophila melanogaster and Drosophila lebanonensis were
purified from adult flies by Drs Atrian and Gonzalez-Duarte as
published (Ribas de Pouplana et al., 1991).
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2.1.3.2 Chemicals.
Guanidinium chloride (Aristar grade), propan-2-ol and NAD+ (both
AnalaR grade) were from BDH.
NADH (grade I), Trizma base and kanamycin were from Sigma.
2,1.3.3 Hardware
Circular dichroism spectra were recorded using a Jasco J-600
spectropolarimeter.
Spectrophotometric assays were performed using a Phillips PU 8720
UV/VIS scanning spectrophotometer.
Temperature-controlled incubations and reactions were carried out






Although various alternative methods were tried at various points of
this project only the ones that were used for the final experiments will
be described here. The results obtained with the rest of methods used
will be discussed in the experimental results section.
2.2.1 Standard DNA and protein techniques.
The following DNA and protein techniques were performed
according to standard protocols, as described in "Guide to Molecular
Cloning" 2nd edition (Sambrook et al., 1989) :
Technique Page n°
-Enzymatic cleavage of double stranded 1.85
DNA
-Ligation of DNA fragments
-Growth and storage of E. coli
-Preparation and transformation of
competent E. coli
-Purification of plasmids and phage
DNA from E.coli .
-Protein SDS-polyacrylamide gel









The relevance of the principle of site-directed mutagenesis (SDM) to
the bio-molecular sciences is evidenced by the large number of methods
that have been designed to perform it. All these methods share a
common initial step where a single-stranded DNA (ssDNA) template
containing the sequence to mutagenize is annealed to a complementary
oligonucleotide whose sequence has the desired modification. This
oligonucleotide is then used as a primer for the polymerization of the
complementary strand of the template, giving way to a hybrid double-
stranded DNA molecule, one strand of which contains the desired
mutation. The crucial step is the selection of the mutated strand over
the wild type one. This is achieved by different strategies in each
method (for a review see Carter, 1986).
The method used in this project is that designed by Kunkel (Kunkel,
1985), which is based on the utilization of the E. coli strain BW313, a
strain deficient for the Dut and Ung genes. These genes code for the
enzymes dUTPase and uracil glycosidase, which are utilized by the cell
to digest uracil-containing DNA and to modify uracil to stop its
incorporation into replicating DNA. The lack of these enzymes creates
a bacterium that contains high levels of uracil in all its cellular DNA
molecules. As a consequence ssDNA isolated from such a strain will be
unable to survive in a normal cell, because it will be digested by the
uracil glycosidase. If such ssDNA is used as a template for annealing
with a mutation-containing oligonucleotide, and a second, mutant strand
is obtained by polymerization with normal nucleotides, a hybrid
molecule is obtained. One, containing the wild type sequence and a high
number of uracil bases, and another containing the desired mutation
and normal base content.
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If such double-stranded DNA is used to transform a Ung+ strain of E.
coli only the mutation-containing strand should survive since the uracil
containing DNA will be digested by uracil glycosidase.
This method provides an economic, efficient and elegant way of
introducing specific mutations into a DNA sequence.
Procedure :
M13mpl8 ssDNA containing the intronless Adh-S sequence
(hereinafter Adh gene') was purified from phages isolated from a
single phage plaque in E. coli BW313 infected plates. This DNA,
supposedly containing large quantities of uracil bases was tested for
such quality by transforming E. coli TGI cells with it. An infection
efficiency of less than ten plaques per plate was taken as an indication
of a satisfactory presence of uracil in the ssDNA.
Two pg of uracil-rich ssDNA were mixed with 2 pi of KGBxlO
buffer and the phosphorylated oligonucleotide containing the desired
mutation. The molar ratio between ssDNA template and oligonucleotide
was typically 0.2 to 0.5, water was added to a final volume of 16 pi.
This mixture was incubated at 65°C for 3 min and allowed to cool
down to room temperature, for at least one hour, to achieve optimum
annealing. The polymerization reaction was started by adding to the
mixture 2pl of a solution containing dATP, dTTP, dCTP and dGTP, at
a concentration of 7.5 pM each, 1 pi of Klenow fragment of DNA
polymerase at a concentration of 5 units/pl, and 1 pi of DNA ligase at a
concentration of 10 units/pl.
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The polymerization and ligation reactions were allowed to proceed
for 30 min at room temperature. The presence of dsDNA was checked
by agarose gel electrophoresis and, if this check was satisfactory, the
DNA from the reaction was separated from the enzymes by a phenol
extraction followed by ethanol precipitation. The final DNA sample
obtained was used to transform E. coli TGI cells. From the
bacteriophage plaques obtained three were randomly chosen, and their
ssDNA purified and sequenced to confirm the presence of the desired
mutation.
2.2.3 DNA subcloning.
Using standard DNA subcloning techniques the Adh gene contained
in the vector pUC-Ad/z-S was removed from this vector and subcloned
into M13mpl8 for the mutagenesis experiments.
The Adh genes from the Ml3 clones were then subcloned into PVT-
U-101, for further introduction and expression in yeast using
convenient restriction sites (see results chapter for a description of the
cloning steps and vectors used).
2.2.4 DNA sequencing.
DNA sequencing was used at three different stages of the site-directed
mutagenesis process:
First, the Adh gene in the plasmid pUC-Adh- S, provided by Dr.
Sofer, was totally sequenced to confirm its expected sequence.
Secondly, the ssDNA from the phage plaques obtained at the last stage
of the mutagenesis process were sequenced to confirm the presence of
the desired mutations. Finally, once each mutated gene was subcloned
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into the expression vector PVT-U-101 and transformed into yeast for
expression, the plasmid was recovered and the Adh gene fully
sequenced, to ensure that the introduced mutation was the only
difference between the mutant gene and the original Adh-S.
Procedures :
ssDNA sequencing of Adh in either Ml3 or PVT vectors was done
following Sanger's dideoxynucleotide method, which was used as
supplied in kit form (Sequenase™ DNA sequencing kit, from
Cambridge Bioscience). Sequencing gels were run on a Pharmacia gel
cast, fixed, dried on 3MM Whatman paper and autoradiographed using
Hyperfilm MP.
During the sequencing of the Adh gene present in the pUC-ADH
vector the following steps were performed in order to obtain ssDNA:
The dsDNA pUC-Adh was purified from 100 ml of liquid culture of
E. coli TGI cells by CsCl gradient ultracentrifugation. lOpg of the
DNA were denatured by adding NaOH and EDTA to a final
concentration of 0.2M and 0.2mM, respectively. The solution was then
neutralized by addition of ammonium acetate to a final concentration of
0.2M. The DNA was precipitated with ethanol, resuspended in 30|i.l of
ice-cold water and used immediately for standard sequencing.
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2.2.5 Growth and transformation of yeast .
The yeast strain S. cerevisiae WV.36.201, was used for the
expression of the Adh gene as published (Atrian et al., 1990). This
strain is auxotrophic for tryptophan, adenine and uracil, and it can be
grown either in rich non-selective media as YEPD (1% yeast extract,
2% bactopeptone, 2% glucose) or in selective media supplemented with
tryptophan, adenine and uracil, known as YD (0.67% yeast nitrogen
base, 2% glucose, 1% casein amino acids, 0.002% tryptophan, 0.002%
adenine, 0.002% uracil).
The expression plasmid used throughout this project, PVT-U-101
carries s functional Ura gene, so WV.36.201 cells carrying the plasmid
can be detected by their ability to grow in selective media without
uracil.
All the growth curves carried out with the strains expressing different
ADH variants were done as follows :
Single colonies were inoculated into small cultures (~5 ml) of
selective media and grown overnight at 30 °C in an orbital shaker.
After 24 hours, the optical density at 600 nm (OD600) was measured for
every culture. Different volumes of each small culture were transferred
to 50 ml cultures of either selective or non-selective media, to obtain
initial inoculates with approximately equal number of cells.
The growth of each culture was monitored by measuring the OD600 of
each culture at regular intervals. When necessary the cultures were
diluted before measuring their optical density to ensure that OD values
stayed on the 0.1 to 1.5 OD units range.
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Transformation of yeast :
The method described by Ito and colleagues (Ito et al., 1983) was
used. This is based on the treatment of yeast cells in exponential
growth state with alkali cations, in our case lithium acetate.
This method has a lower efficiency than that of Beggs (Beggs, 1978),
which used enzymatic digestion of the yeast cell wall with lyticase, but
it is simpler, faster and, for the purposes of this thesis, the most
convenient.
Procedure :
A 100 ml culture of WV.36.201 strain was grown up to a ODgoo of
0.3 and the cells were harvested with a 2 min centrifugation at 2000
rpm in a bench centrifuge. The collected cells were washed in 5 ml of
TE buffer (10 mM Tris-HCl pH 8, ImM EDTA), centrifuged again and
resuspended in 5 ml of 0.3 M lithium acetate.
The cells were incubated in this solution for an hour at room
temperature in an orbital shaker, then centrifuged again, resupended
once more in 5 ml 0.3M lithium acetate and divided into 0.3 ml
aliquots. Between 2 and 5 pg of DNA were added to each aliquot
together with lOpg of fragmented genomic DNA (from herring
sperm). The aliquots were then left at room temperature for 30 min
before 0.7 ml of a 50% solution of polyethylene glycol in TE buffer
were added. The mixtures were homogenized by inversions and
incubated at 30°C in a water bath for 30 min. The cells were then heat-
shocked at 42 °C for 5 min, centrifuged with a 10 second pulse in a
bench microfuge and resuspended in YEPD media. After 1 or 2 hours
at 30 °C, the cells were again centrifuged, resuspended in 200 pi of
water, plated onto plates containing YD without uracil, and left
incubating at 30 °C. Colonies appeared in 4-5 days.
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2.2.6 Analysis of yeast transformants and DNA isolation from yeast.
The yeast colonies that, after transformation, grew on a uracil
deficient selective medium had to be checked for the presence of the
expression construct, and this construct had to be isolated for the
sequencing of its Adh gene.
In practice, an intermediate step was used where the plasmid
contained in the transformed yeast was first transferred into E. coli,
from which it was later purified and analyzed. This technique, known
as plasmid rescue, provides the simpler way of checking for the
presence of a certain plasmid in yeast , provided such plasmid is
capable of replicating in bacteria and has a functional selection marker
in this organisms (Hoffman & Winston, 1987).
Procedure :
Yeast colonies that grew in uracil deficient YD were inoculated in 5
ml liquid cultures of the same media and incubated at 30 °C for 24-48
hours. Cells from 1 ml aliquots of culture were then collected by a 5
second centrifugation in a bench microfuge, and resuspended in 200 pi
of a solution containing : 2% Triton X-100, 1% SDS, 100 mM NaCl,
10 mM Tris pH 8.0, 1 mM EDTA.
To this solution 200 pi of phenol were added, and, immediately, glass
beads were added up to the meniscus of the solution surface. This
mixture was vortexed for 30 seconds and the tubes centrifuged in a
bench microfuge for 5 min. The objectives of this methods are: a) to
break the yeast cells and liberate their possible plasmid content and, b)
the separation of the DNA from the cellular protein by a phenol
separation.
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The aqueous phase obtained after the centrifugation was collected, and
its DNA content precipitated in ethanol and resuspended in a small
volume of water. This was then used to transform E. coli TGI cells,
and the presence of the plasmid was checked by testing the resistance to
ampicillin of the transformed bacteria.
The bacterial clones that showed resistance to ampicillin were
isolated, and their plasmid DNA isolated by standard methods. This
DNA could be used to check the presence of the correct construct by
restriction analysis in agarose gels or to confirm the presence of the
right gene sequence by DNA sequencing techniques.
2.2.7 The analysis of Adh expression in yeast .
The analysis of the expression of any gene can be undertaken at three
different levels. First, the content of mRNA being transcribed can be
quantified. This analysis gives a good measure of the amount of
expression activity at the gene level, and is the method of choice when
the effect of regulatory sequences on the amount of gene expression is
being studied. However, it does not necessarily give information on the
amount of protein actually being produced, because of the effect of the
codon content of the mRNA on its level of translation efficiency, and it
does not provide any information on the levels of active protein.
The amounts of total protein being synthesized from mRNA can be
checked by immunoblotting analysis of the protein content of the cells.
This method requires the availability of antibodies against the expressed
protein, but it can give very accurate accounts of the amounts of
protein being produced. The method will not discriminate between
inactive or active forms of the protein, and so it can not be used to
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check the protein activity levels in the expressing cells if, for instance,
the expressed polypeptide is an enzyme.
The quantification of the amount of protein activity in the expressing
cells can be achieved in vivo, if the activity of the expressed molecule
affects the metabolism of the expressing organism, or in vitro, either in
crude extracts or after the purification of the expression product, if a
suitable activity assay is available.
For the analysis of the expression of wild type and mutant DADHs in
yeast three different approaches were used. The amount of total protein
produced was analyzed by immunoblotting, the expressing cells were
analyzed in terms of their growth behaviour (see 2.2.5) and the amount
of DADH activity was measured in cell crude extracts.
2.2.7.1 Immunoblotting analysis of DADH expression in yeast.
A series of mouse monoclonal and polyclonal antibodies raised against
Drosophila ADH by Dr. J. Fibla (Fibla et al., 1989), of the Genetics
Department of the University of Barcelona were used for the
immunoblotting analysis.
Procedure :
Yeast cells containing the PVT-U-101 expression vectors with the
wild type and mutant Adh genes were grown in 50 ml cultures of YD
media without uracil. Yeast cells without plasmid, and cells with the
PVT-U-101 plasmid without the Adh gene were used as controls.
When each culture reached stationary growth the cells were harvested
by centrifugation at 5000 rpm, for 15 min at 4°C. The cell pellet
obtained was resuspended in an equivalent volume of ice-cold lysis
buffer (20 mM Tris HC1 pH 8.0, 10 mM MgCb, 1 mM EDTA, 5%
glycerol, 1 mM DTT, 0.3 M ammonium sulphate, 100 |iM
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dichloroisocumarin, 100 fiM 1,10 phenathroline and 20 fiM E-64).
Cells were lysed by filling the solution with glass beads up to the
surface meniscus and vortexing for 6 min in two min intervals,
separated by 2 min periods where the extract was cooled in ice. The
resulting crude extract was centrifuged at 10000 rpm for 30 min to
remove all insoluble material and cellular debris, and the supernatant
was kept for further analysis.
The total protein content of the crude extracts was determined using
the Bradford method (Bradford, 1976), and equal amounts of total
protein from each different strain analyzed were loaded onto a SDS-
polyacrylamide gel, for standard electrophoresis separation.
After electrophoresis the gels were transferred to a renaturizing
buffer (80% 50 mM Tris HC1 pH 7.6, 20% glycerol) as a previous step
to the electrotransfer of the protein bands to a nitrocellulose filter.
The bands were transferred to the filter with a Bio-Rad mini trans-
blot electrophoretic transfer cell, for 30 min. After that period the
filter was removed form the transfer apparatus for immunological
detection.
The protein-free areas of the filter were first saturated by incubating
the filter in a 10% solution of freeze-dried milk in phosphate buffer
saline (PBS, 0.8% NaCl, 0.02% KC1, 0.11% Na2HP04, 0.02%
KH2PO4), for 2 hours at room temperature, this step is designed to stop
non specific binding of the first antibody to the nitrocellulose fibres of
the filter.
Excess saturating protein was removed by washing the filter in PBS
in three 15-min periods. The filter was then incubated with the anti-
ADH polyclonal or monoclonal antibodies at adequate dilutions for 1
hour. The excess antibody was removed by washing the filter in a PBS
solution containing 0.5% freeze-dried milk in three 5-min steps.
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A second antibody, raised against mouse IgG antibodies and
complexed to the enzyme peroxidase, was then added to the filter at a
convenient dilution, for a period of 1 hour. The excess antibody was
again removed by washing the filter with PBS containing 0.5% freeze -
dried milk. The filter was then developed by adding two solutions
simultaneously (solution 1: 50 ml of PBS containing 0.035% hydrogen
peroxide. Solution 2: 50 ml of a 60% PBS, 40% Methanol, 0.001% 4-
chloro-l-naphthol). Bands containing material recognized by the
peroxidase-complexed antibody appeared as a result of the oxidation of
4-chloro-l. naphtol, which gives a coloured compound.
2.2.7.2 DADH activity measurements in crude extracts.
Crude extracts were prepared as described in the previous chapter
and their protein content also quantified using the method of Bradford
(Bradford, 1976), or the method of Layne (Layne, 1957). This last
method uses the differential absorbance of proteins and DNA at 280
and 260 nm. The concentration of protein is given by the equation :
[protein] = 1.55x (A280) - 0.76x(A26o)
Although this method is simpler and faster than the Bradford analysis
it has the disadvantage of not being able to discriminate between protein
absorbance at 280 nm or other aromatic compounds that might be
present in the crude extract. Once the total protein content of the crude
extracts was known, three different volumes of the protein solution
(typically 1, 5 and 10 pi) were assayed for enzyme activity. The ADH
activity was determined at 25 °C by monitoring the increase in optical
absorbance at 340 nm due to the production of NADH. The assays were
performed in 1 ml cuvettes, the assay mix contained 1 mM NAD, 10
mM isopropanol and 100 mM Tris-HCl pH 8.7.
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The crude extract sample was added first to the cuvette, and 1 ml of
reaction mix was pipetted inside the cuvette to rapidly mix the
components of the reaction. The reactions were linear for at least two
min, and one unit of enzyme was defined as the amount of enzyme that
catalyses an increment of 1 unit of absorbance at 340 nm per minute.
The activity of each sample and its protein concentration were used to
determine the specific activity of each crude extract, and the total
amount of ADH activity recovered from each different strain.
2.2.8 Protein purification methods.
Purification of DADH from either adult flies or third-instar larvae
have been reported for years, and a considerable amount of expertise
exists. However, the purification of the enzyme from yeast had not
been attempted before this project.
For this reason, a series of different chromatographic steps were
tested trying to take advantage of the already existing expertise in the
purification of the enzyme from flies. However, the final purification
procedure from yeast is quite different. Only the techniques that were
finally used will be described here (a more detailed account of the
results given by the other techniques tested is given in the results
section), but it is worth mentioning that one of the most effective
purification steps when dealing with flies or larvae, the affinity column
Blue-Sepharose (Ribas de Pouplana et ah, 1991), was shown to be less
effective in the purification of the enzyme from yeast . Another set¬
back of this technique, of course, was that very large behaviour
differences would have been expected when trying to purify enzymes
with mutations in the nucleotide binding site.
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2.2.8.1 Crude extract preparation and Ammonium sulphate fractionation.
For the purpose of the purification of DADH large cultures with high
cell density were required. These were obtained by growing cells from
a single colony in a pre-culture of 50 ml of YD minus uracil, for 24 to
48 hours. These cultures were then transferred to 750 ml cultures of
YEPD media, were they were allowed to grow at 30 °C, under
vigorous shaking, until stationary phase was reached.
Similarly as with small crude extract preparation cells were harvested
by 15 min centrifugation at 5000 rpm, resuspended in an equal volume
of the lysis buffer and the cells were lysed with glass beads as described
in 2.2.7.1 .
The ammonium sulphate concentration of the crude extract was then
raised to 35% saturation by slowly adding the necessary amount of the
salt while the extract was in ice and in moderate agitation. The salt
concentration was allowed to equilibrate for 30 min and then the crude
extract was centrifuged at 35000 rpm, for 20 min at 4 °C, to remove all
cellular debris and proteins that precipitated at 35% saturated
ammonium sulphate or less. In a similar fashion, ammonium sulphate
was again slowly added to the supernatant solution to a final 70%
ammonium sulphate saturation, and after a 30 min equilibration in ice it
was centrifuged again in the same conditions described. The amount of
ADH activity left in the supernatant was measured and, if found to be
less than 10%, the supernatant was discarded.
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2.2.8.2 Sepharose G-25 and O-Sepharose FF steps.
The pellet obtained at the last step of the ammonium sulphate
fractionation was resuspended in a 25 mM Tris HC1 pH 8.0 and the
solution (typically about 5 ml) loaded onto a Sepharose G-25 column
(20x400 mm), with a flow rate of 1 ml/min. Fractions containing ADH
activity were pooled (typically a total volume of ~ 12 ml) and passed
through a previously equilibrated Q-Sepharose FF column (15x60 mm)
with a flow rate of 60 ml/hour. Both chromatographic steps were
performed at 4 °C.
Fractions containing DADH activity did not stick to this column and
were directly recovered, identified and pooled (typically about 15 ml
total volume).
2.2.8.3 Sample concentration and Superose-12 steps.
The volume typically collected from the Q-Sepharose FF step (-15
ml) was too large to be applied to the Superose-12 column available in
the Department (25 ml), so the sample had to be reduced. This was
achieved by saturating the sample with ammonium sulphate and
centrifuging the precipitated protein at 35000 rpm, for 30 min at 4 °C.
The resulting pellet was then resuspended in a small volume (-1 ml) of
25 mM Tris HC1 pH 8.0 buffer.
The solution was injected onto the FPLC Superose-12 column in steps
of 200 pi. The column was run at a flow rate of 0.2 ml/min, at room
temperature. Fractions of 500 pi were collected ant assayed for ADH
activity. Those with such activity were kept and analyzed for purity in a
SDS-polyacrylamide electrophoresis gel stained with Coomassie blue.
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2.2.9 Characterization methods for pure DADHs.
Once the different ADH enzymes had been purified they had to be
analyzed in order to investigate the effects of the introduced mutations.
For this purpose three main analytical procedures were used : a) the
stability of the enzymes and the strength of their binding to the
coenzyme were analyzed by guanidine hydrochloride denaturation
kinetics monitored by circular dichroism and enzyme activity analysis,
this allowed the calculation of the AAG values of the cofactor binding
process, b) the thermal stability of the molecules was analyzed by
incubating them at different temperatures and monitoring the loss of
activity with time, and c) the kinetic parameters Kmapp, Vmax and kca^
were determined both for isopropanol and for NAD.
2.2.9.1 Guanidine hydrochloride denaturation studies.
The study of the denaturation kinetics of enzymes is an effective way
of quantifying the difference in free energy between the unfolded and
the folded states of the molecules, and obtaining information about their
structural stability (for a review see Pace, 1986). The denaturation
agents normally used are either temperature or chemical agents (mainly
urea and guanidine hydrochloride (GdnHCl)); and the systems used to
monitor the denaturation process are mainly optical systems
(fluorescence, circular dichroism (CD), UV difference spectroscopy,
optical rotatory dispersion), nuclear magnetic resonance, differential
calorimetry or biological activity measurements.
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In this study the denaturation process of the wild type and mutant
DADH's in the presence of GdnHCl was monitored both by CD
analysis and by ADH activity measurements. Also, the effect of the
binding of NAD4" on the enzyme's stability was studied by incubating
the enzyme with the cofactor prior to denaturation.
The denaturation kinetics of the enzymes monitored by ADH activity
measurements were used to determine the free energy values of the
folded enzymes in solution.
2.2,9.1.1 Circular dichroism analysis.
Circular dichroism activity (CD) is defined as the differential
absorption of left- and right-circularly polarized light by any molecule
in solution. This difference in absorption is directly dependent on the
structural asymmetry of the molecule, and so a molecule with a random
conformation in solution will show little CD activity, since no average
asymmetry will be present.
Molecules with high stmctural asymmetry and rigid conformations
will have measurable amounts of CD activity at certain wavelengths,
but will lose such property if their structure becomes random. Because
CD measurements are, in fact, optical absorbance measures, only the
regions of the light spectra where a molecule shows optical absorbance
will be useful to determine the CD activity of such molecule.
These characteristics of CD make it a highly informative way of
analyzing the conformation of proteins in solution. Protein structures
have two main regions of optical absorbance: the polypeptide backbone
of proteins in solution absorbs and is optically active in the far UV
region, below approximately 240 nm.
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The aromatic residues of polypeptides, on the other hand, have high
optical absorbance properties in the near UV region, around 280 nm.
Far UV CD activity of proteins is, hence, a measure of their backbone
asymmetry, which is a direct function of the amount of secondary
structure of the molecule. If a protein is subjected to denaturation the
fixed conformation of its structure disappears, and so does its CD
activity. In this way, CD values can be used to monitor the denaturation
of a certain polypeptide in solution.
Alpha-helical structures are much more asymmetrical than extended
or random regions and so they are the main contributors to the far UV
spectra of proteins (for reviews on CD techniques see Johnson, 1988
and Johnson, 1990).
GdnHCl is an excellent denaturing agent for such studies because it
does not absorb far UV radiation and, consequently, does not interfere
with the CD measurements (Pace, 1986)
Procedure :
ADH-F from D. melanogaster, ADH from D. lebanonensis, and
ADH's from horse-liver and yeast were used for the CD analysis. All
enzymes were diluted in the same buffer, and their concentrations had
been determined by amino acid analysis. GdnHCl solutions were
prepared from fresh GdnHCl, and their concentrations were checked by
refractive-index measurements (Nozaki, 1972). All CD analyses were
performed at the Scottish CD facility, Department of Molecular and
Biological Sciences, University of Stirling, which is ran by S. M. Kelly
and Dr. N. C. Price.
Firstly, the necessary incubation time to reach denaturation
equilibrium was determined for each enzyme using a low (0.5 M)
concentration of GdnHCl. All incubations were carried out at 25 °C,
for the amount of time found to be required to reach equilibrium.
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A fixed volume of enzyme was added to a microcentrifuge tube, and a
fixed volume of appropriately diluted GdnHCl was added to obtain the
desired final GdnHCl concentration. This mixture was left at 25 °C for
the period required to reach equilibrium and the CD spectrum was then
obtained, using cell pathlengths of 0.02 or 0.1 cm, depending on the
enzyme concentration. The samples where the cofactor binding effect
was being measured were treated equally, but for the addition of NAD+
to a final 220 pM concentration 5 min prior to the addition of the
denaturant. CD spectra were recorded over the range 250-190 nm.
Molar ellipticity values (CD activity/mol of enzyme) were calculated by
using a value of 108 for the mean residue weight (Thatcher, 1980;
Jornvall, 1970; Jornvall et al., 1975).
The secondary structure contents were derived by the CONTIN
procedure (Provencher & Glockner, 1981).
2.2.9.1.2 Denaturation monitored by ADH activity measurements.
The monitoring of the biological activity of an enzyme can be a very
sensitive way of detecting structural changes in the protein's structure
and of determining its denaturation kinetics. As it would be expected
this method of characterization is much more sensitive to subtle effects
of small structural modifications than methods like CD or fluorescence
spectroscopy. However, the results from this kind of analysis can be
difficult to interpret because the adding of protein denaturants can
seriously alter the solution conditions, hence altering the catalytic
constants of the enzymes being measured. Also, as the level of
denaturant increases and the proportion of folded enzyme decreases
changes in the relative amounts of substrates to enzyme can occur,
causing byphasic effects in the denaturation process (Shrake & Ross,
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1990). This last problem can be overcome by ensuring that the
substrate concentrations are at saturating levels at all times.
Procedure :
The denaturation process and enzyme activity determination for each
denaturant concentration point were done in duplicate, and the analyses
of the denaturation in the presence or absence of NAD+ were done
simultaneously. The GdnHCl, isopropanol, NAD+ and buffer stock
solutions used were always the same for all the analyses carried out in a
single day to minimize variation.
As a previous step to the development of the assay the following
controls were performed :
a) The time required for the denaturation process to reach
equilibrium at a low concentration of denaturant was determined and
used in all analyses. It was found that 15 min at 25 °C was enough to
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Figure 2.2.9-1. Evolution of ADH activity with time of incubation in
GdnHCl.
71
b) The reversibility of the denaturation process was analyzed by
incubating DADH in 0.6M GdnHCl for 15 min and then diluting the
sample 5 fold in buffer containing OM, 0.2M, 0.4M and 0.6M GdnHCl.
ADH activity was increasingly recovered with the dilution of the
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10
Figure 2.2.9-II. Recovery of ADH activity upon dilution .
c) The additive effect of the coenzyme in protecting DADH against
denaturation was checked by incubating the enzyme with increasing
amounts of cofactor. It was shown that the protection provided by the
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Figure 2.2.9-III. Effect of increasing concentrations of NAD4"
on the denaturation on the loss of ADH activity.
d) The specificity effect of NAD+ was checked by incubating the
enzyme with a control molecule, of a similar molecular weight but of a
totally different structure. Kanamycin was used for this purpose and it
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Figure 2.2.9-IV. The effects of addition of NAD+ and kanamycin on
the loss of ADH activity.
Small aliquots of the enzyme (typically 20 jllI) were placed at the
bottom of four spectrophotometer cuvettes. To two of the cuvettes 10
pi of a 10 mM solution of NAD+ were added and left to equilibrate at
25 °C for 5 min. After that period a calculated amount of buffer (100
mM Tris HC1 pH 8.7) was added to the four tubes, immediately
followed by the necessary amount of 2M GdnHCl to reach the desired
denaturant concentration in a total volume of 100 pi. The solutions
were mixed and left to incubate for 15 min at 25 °C.
During that period the reaction buffer was prepared for the four
cuvettes. The reaction buffer contained NAD, isopropanol and GdnHCl
in 100 mM Tris HC1 pH 8.7.
The concentrations of substrates and denaturant were such as to make
the final concentrations in the reaction as follows : NAD: 1 mM,
isopropanol: 10 mM, GdnHCl: same concentration as the one the
enzyme had been previously incubated in.
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2.2.9.1.3 Determination of the conformational free energy of the enzymes.
Provided that the denaturation kinetics of a protein comply with
certain conditions (i.e., denaturation equilibrium reached, reversibility
of the reaction, denaturation process following a two-step mechanism)
the free energy corresponding to the initial state of the protein
(AG(water)) can be estimated, and hence the differential AG induced by
specific mutations, or by the effect of the binding of a cofactor or
substrate, can be quantified. An example of an ideal denaturation curve
following the mentioned conditions is shown in figure 2.2.9-V.
Figure 2.2.9-V. Ideal denaturation curve of a protein upon addition of
denaturant.
In figure 2.2.9-V, Y represents the parameter used to measure the
unfolding process, A B and C are the three different regions of the
curve, f and u represent the proportion of folded and unfolded protein
at each region of the curve. In region A, at low concentration of
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denaturant, the folded state of the protein predominates. Region B
corresponds to the concentrations of denaturant where the folded-
unfolded transition occurs, while region C is the zone where the
unfolded state of the protein predominates.
If one defines Ff and Fu, as the fraction of unfolded and folded
protein present at any given concentration of denaturant then, at any
point of the curve
Ff + Fu = 1
and, clearly, the Y value at any point of the curve will be
Y = YfFf + YuFu
where Yf and Yu are the characteristic Y values of the folded and
unfolded states of the protein.
Combining both equations the value of Fu at any point is
Fu = (Yf-Y)/(Yf-Yu)
Since the equilibrium constant of unfolding K equals
K = Fu/(1-Fu) = Fu/Ff = (Yf-Y)/(Yf-Yu)
the Boltzmann equation can then be used to calculate the AG at any
point of the curve
AG = -RT In K = -RT In (Yf-Y)/(Yf-Yu)
where R is the gas constant (1.987 cal/deg/mol) and T is the absolute
temperature.
The value of K, however, can only be accurately measured in the
transition region B, because of the substantial experimental error that
occurs in regions A and C, where the one of the two conformational
populations is very small.
For this reason the AG values in the transition region B are used to
obtain the AG(water) value of the protein by extrapolation from the











Figure 2.2.9-VI. The extrapolation of the AG(water) value of a
Clearly, if the introduction of a certain mutation in the protein, or the
binding of a ligand, affects the thermal stability of the molecule
(without affecting the unfolding pathway), the Fu/Ff ratio at any
denaturant concentration will change, and different AG(water) values
will be obtained. The difference between the wild type and mutant (or
enzyme ligand) AG(water) values will be the AAG effect of the
introduction of the mutation (or of the ligand binding), as seen in
figure 2.2.9-VII .
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Figure 2.2.9-VII. The calculation of the AAG effect by subtraction
of the AG(water) extrapolated values.
2.2.9.2 Determination of the thermal stability of DADH's
The molecular effect of chemical denaturants like GdnHCl or urea is
not well understood (Creighton, 1988). It is generally believed that
their denaturing effect is due to their ability to increase the solubility of
hydrophobic groups of proteins, and hence decreasing the hydrophobic
energy that contributes to the tight packing of protein cores.
The effect of rising temperature is quite different and much more
extensive because a rise in the general energy state of the system
decreases the energetic constrains of not only the hydrophobic
interactions but also of the electrostatic and structural (backbone
rigidity etc.) forces that contribute to the architecture of the protein.
As described in the introduction, the thermal stability of DADH's is
one of the candidates to explain the differential distribution of
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isoenzymes, for this reason thermal stability analyses of DADH's are
common in the literature (eg. Atrian & Gonzalez-Duarte, 1985).
Since the conformational free energies of DADH's had not been
previously analyzed, the thermal stability of each enzyme purified in
this project was determined in order to be able to compare the effects
of the introduced mutations in DADH to published reports in stability.
Procedure :
Aliquots of each purified enzyme were incubated at three different
temperatures (0°C, 25°C and 40°C). Small volumes were removed from
the aliquots at fixed time periods and the ADH activity present was
immediately analyzed as described previously. All activity assays were
done in duplicate.
2.2.9.3 Determination of kinetic constants.
Determination of apparent Km's:
The Kmapp values for NAD, NADP+ and propan-2-ol were calculated
maintaining the concentration of one of the substrates constant in the
assay conditions and varying the concentration of the other substrate.
The assay conditions were as described in 2.2.7.2 except for the
substrate being analyzed. The Kmapp for isopropanol was calculated
keeping the NAD+ concentration at 1 mM and using the following
concentrations of propan-2-ol : 0, 0.25, 0.5, 1, 4 and 16 mM.
The Kmapp for NAD+ was calculated with a constant concentration of
propan-2-ol of 10 mM and with the following concentrations of the
cofactor : 0, 0.05, 0.2, 0.8, 1.6 and 3.2 mM.
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Similarly, the Kmapp for NADP+ was calculated keeping the propan-
2-ol concentration at 10 mM and using the following concentrations of
NADP+ : 0, 0.1, 0.4, 1.6, 3.2 and 6.4 mM.
All assays were done in triplicate, standard deviations were calculated
and an additional control with the higher substrate concentrations and
without enzyme was performed.
The Kmapp values were obtained from a Hanes plot ([substrate] vs.
[substratej/velocity), where Kmapp values are obtained from the plot
equation, and equal -x when y=0.
Determination of Vmax and kcat values.
Vmax values were also determined from the Hanes plot, as they are
defined as 1/m, where m is the slope of the equation.
kCat values were calculated as kca^ = Vmax/eo, where eo is the
enzyme concentration which was calculated using the published molar
absorption coefficients forD. melanogaster ADH (Cornish-Bowden &
Wharton, 1988; Juan & Gonzalez-Duarte, 1981). Although an
enzymatic assay is available for the determination of the active site
concentration of the enzyme (Winberg et ah, 1985), it requires large
amounts of enzyme at high concentrations, and is not normally used in
the literature.
80
3. Cloning, mutagenesis, sequencing and expression of ADH.
Results and discussion.
3.1. Cloning of the Adh gene into M13mpl8 and PVT-U-100.
The Adh gene included in the vector pUC-118 had to be subcloned
into M13mpl8 to obtain single-stranded DNA for the introduction of
site-directed mutations and to confirm the final Adh sequence by DNA
sequencing.
The restriction map of the plasmid pUC-118 is shown in figure 3.1-1.
The plasmid was digested with the enzymes Hindlll and Spel to isolate a
1.3 kb fragment containing the Adh coding sequence. Simultaneously,
the M13mpl8 DNA was digested with the restriction enzymes Hindlll
and Xbal, which cut once through the polylinker region of the phage's
DNA. The digested M13mpl8 DNA and the 1.3 kb fragment containing
Adh were ligated taking advantage of the compatibility of the hanging
sequences generated by Spel and Xbal (see figure 3.1-II for
representation of the resulting M13-Adh plasmid).
Once the subcloning conditions were optimized an M13mpl8 clone
containing the Adh insert was obtained, as demonstrated by the
restriction analysis in figure 3.1-III. This clone was called M13-Adh.
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Figure 3.1-1. Map of the plasmid pUCl 15-3008, provided by Dr.
Sofer, containing the Adh gene without introns.
Hind III
Figure 3.1 -II. Map of the plasmid M13-Adh obtained by subcloning
the Hind III/Spe I fragment of pUC-3008 containing the Adh-S gene







Figure 3.1-Ilia. Restriction analysis of the plasmids
pUC-3008 and M13mpl8 digested with the enzymes
Hind III and Spe I. (1) Molecular weight marker.
(2) pUC-3008. (3) M13mpl8.
1 2 3 4 5 6
Figure 3.1-EHb. Restriction analysis ofM13mpl8 and M13-Adh
digested with the enzymes Hind HI and Sac I. (1) M13mpl8.
(2-5) M13-Adh, the band of 1.3 Kb containing the Adh gene can
be seen at the end of each track. The intermediate band in tracks
2 and 5 corresponds to undigested plasmid in super-coiled form.
(6) Molecular weight marker.
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3.2. Site-directed mutagenesis of the M13-Adh clone and sequencing of the
mutations.
Rationale of the mutations introduced:
Table 3.2-1 summarizes all the mutations that were introduced into
the Adh gene of the M13-Adh clone, all mutations were introduced
using the Kunkel site-directed mutagenesis system (Kunkel, 1985).
Mutation Adh-S sequence and mutations introduced
Gly 14 to Ala
37-GTTGCCGGTCTGGGAGGC-54
GCT
Gly 19 to Ala
49-GGAGGCATTGGTCTGGAC-63
GCT
Asp 38 to Ala
109-ATCCTCGACCGCATTGAG-126
GCC
Asn 136 to Stop
403-ATCTGCAACATTGGATCC-420
TAA
Pro 214 to Ser
634-CCCACCCAGCCATCGTTG-651
TCA
Table 3.2-1. List of the mutations introduced into the Adh-S gene.
Below the native Adh sequence the codon mutated is indicated and the
bases changed are shown in bold characters.
Mutations G14A, G19A, D38A and 136Stop: as described in the
introduction, the main structural interpretation that could be made
from the sequence of Drosophila ADHs was the existence of a
nucleotide binding domain at the N-terminal part of the protein.
Although such hypothesis is now supported by the evidence from the
crystal structure of SDH, this information was only published at the end
of this project, and the need still remains for detailed information on
the enzyme-coenzyme interactions in Drososphila ADH.
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For these reasons a series of mutations affecting residues thought to
be important for the cofactor recognition were designed. Residues Gly
14 and Gly 19, located in the poly-glycine region of the N-terminal
sequence of the enzyme, were mutated to alanines in order to try to
disrupt the space that the glycines are meant to provide in the cofactor-
binding site. During the development of this project similar or identical
experiments have been reported in the literature (Scrutton et al., 1990;
Chen et al., 1991; Feeney et al., 1990), confirming the importance of
the poly-glycine sequence for cofactor recognition.
Residue Asp 38 in the short-chain dehydrogenases was originally
thought to correspond structurally to the Asp 223 of Horse liver
alcohol dehydrogenase, and to the conserved aspartic acid of other
nucleotide binding domains, where it creates a hydrogen bond with one
of the hydroxyl groups of the adenine ribose of the cofactor. To test
such possibility we decided to mutate Asp 38 to alanine, in order to
destroy any possible hydrogen bond of the side chain with the
coenzyme molecule.
The availability of antibodies against the enzyme encouraged the
attempt to introduce a stop codon at the end of the supposed N-terminal
NAD-binding domain. The purpose of introducing this mutation was to
test whether the N-terminal part of Drosophila ADH would be capable
of folding into a functional binding domain. The presence of a soluble
polypeptide expressed from the truncated gene could be tested with
antibodies against Drosophila ADH, and its dinucleotide binding
capacity analyzed by techniques like equilibrium dialysis.
Mutation P214S : The mutation P214S in ADH, as described in the
introduction, is found in some wild populations of D. melanogaster,
always in the ADH-F form of the enzyme. The mutation has a double
effect: it increases the thermal stability of the enzyme, and it modifies
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its kinetic properties making it ADH-S like, presumably by increasing
the binding affinity of the enzyme with the cofactor, hence slowing
down the tum-over rate (Chambers, 1984; Chambers, 1988). So far, no
ADH-S isoenzyme containing the P214S mutation has been found. The
effect of the mutation has hence a double interest: it is intrinsically
interesting to study the physical effect of the change that induces an
increase in structural stability; it is also interesting to find out what
kind of effect the change has in an ADH-S form of the enzyme.
Mutagenesis results :
The frequency of mutation was always 75% or higher (four clones
were selected for sequencing after every mutagenesis experiment, and a
minimum of 3 were always found to be mutant). The sequences of all
the mutants produced are shown in figure 3.2-1. At this point no
attempt was made to sequence the whole gene as this was to be done for
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Figure 3.2-1. Autoradiographs of
the sequencing gels showing the
five mutations introduced into the
Adh gene. The mutated bases are
underlined.
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3.3. Cloning of the wild type and mutated M13-Adh clones into
PVT-U-100.
The transfer of the wild type and all mutated Adh genes, except
Adhl36Stop, into PVT-U-100 was carried out using the restriction sites
Hindlll and SacI, both present in the polylinkers of M13mpl8 and
PVT-U-100 in the right orientation for expression from the ADH1
promoter present in the plasmid (see figure 3.3-1 for a restriction map
of PVT-U-100).
Adhl36Stop was subcloned into PVT-U-100 using the sites Hindlll
and BamHI, which produce a fragment of 570 bp, containing the
initiation codon ATG and the introduced stop codon ATT.
Figure 3.3-1. Map of the PVT-Adh plasmids obtained by subcloning
the Hindlll/SacI fragment of M13-Adh that contained the Adh gene
into M13mpl8 digested with Hindlll and SacI. The mutant Adh-
136Stop was digested from M13 with Hindlll and BamHI (the latter
cutting the gene 30 bases upstream from the introduced stop codon) and
subcloned into M13mpl8 using the same restriction sites. .
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Photographs of the agarose gels containing restriction analysis samples
of the PVT-U-100 clones with the wild type and mutagenized Drosophila
Adh genes are shown in figure 3.3-II. It can be seen that new plasmids,
carrying the Adh containing fragments, were obtained.
1 2 3 4 5 6 7
Figure 3.3-II. Restriction analysis of the PVT-Adh . (1) Molecular
weight marker. (2) pUc-3008. (3) pUC-3008 digested with Hind III and
Spe I as in figure 3.1-HI. (4) PVT-Adh. (5) PVT-Adh digested with Hind
HI and Eco RI, this digestion produces a fragment of 1.8 Kb containing
PVT material, and a larger fragment of 6.4 Kb containing the entire
coding sequence of Adh. (6) PVT-Adhl36Stop. (7) PVT-Adhl36 Stop
digested with Hind III and Eco RI, the large fragment contains the Adh -
136Stop codifying sequence. As it can be seen the larger band is smaller
than that containing the entire Adh coding sequence run in track 5.
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3.4 Transformation of yeast, rescue and sequencing of the whole Adh
genes.
The plasmids obtained by subcloning of the various Adh mutants into
PVT-U-100 were used to transform the yeast strain WV.36.201 as
described previously. Once the yeast clones containing the desired
plasmids were obtained, the plasmids were rescued, their presence
tested by restriction analysis and their Adh genes wholly sequenced to
confirm that only the desired changes were present.
To our surprise several unreported mutations were found in the
sequence. All the new changes were found in all the plasmids
sequenced, ruling out possible artifacts of mutagenesis or yeast
transformation, and pointing to a common origin for all of them.
To confirm the presence of the changes in the original Adh sequence
obtained from Dr. Sofer the whole Adh gene of the plasmid pUC-118
was sequenced in both orientations, between the nucleotide 129
upstream from the initiation codon to nucleotide 201 downstream from
the termination codon. This confirmed that all the new changes detected
had their origin in the starting Adh coding sequence.
Table 3.4-1 lists all the changes found with respect to the 'consensus'
ADH-S sequence as described by Kreitman (Kreitman, 1983).
Autoradiographs of the sequencing gels containing the described
changes are shown in figure 3.4-1.
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Position of the change Change from
consensus
Transcriptional effect
1 Nucleotide 518 T changes to C lie 173 changes to Thr
2 Nucleotide 531 C changes to G Silent change
3 Nucleotide 540 C changes to T Silent change
4 Nucleotide 684 G changes to A Silent change
5 Nucleotides 786 to 795 Deletion of A Past termination codon
6 Nucleotide 819 Insertion of a T Past termination codon
7 Nucleotides 849 to 850 Deletion of a T Past termination codon
Table 3.4-1. List of changes found in the Adh sequence used in this
thesis relative to the 'consensus' sequence proposed by Kreitman
(Kreitman, 1983). The nucleotide numbering starts at the first
nucleotide of the initiation codon of the gene.
Discussion :
Of all the changes found in the Adh sequence, three of them, at
positions 531, 540 and 684, had already been described as
polymorphisms by Kreitman, although these were not found together in
the same gene.
Of the four remaining changes, two (insertion of T at position 819,
and deletion of a T at positions 849-850) have not been reported
previously. The remaining two (change of a C by a T at position 518,
and deletion of an A between positions 786-795) are located in areas
found by Kreitman to be polymorphic between different populations,
but the changes that we found are of different nature. The mutation at
position 518, that creates a change in the protein sequence was, in fact,
found by Kreitman at position 519, where the change is silent.
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Figure 3.4-1. Autoradiographs showing the new nucleotide changes
found inside the coding region of the Adh gene provided by Dr. Sofer.
The new nucleotides found are underlined and their correspondent
number (from the initiation codon) is shown.
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The strategy used by Dr. Sofer's group for the construction of the
intron-less Adh gene is of relevance in this discussion because it
involved various genetic manipulations that could have resulted in the
introduction of changes in the sequence.
The final gene is in fact a mosaic, constructed by hybridising a DNA
primer, containing a fragment of an ADH-S clone ranging from
nucleotides 568 to 1003, to an mRNA molecule encoding for ADH-F.
The DNA primer did not contain any of the intron sequences of the
Adh gene and it was extended with reverse transcriptase, using the
mRNA molecule as template, and producing a hybrid DNA-RNA
molecule. The RNA was then digested leaving a single stranded DNA
molecule encoding for Drosophila ADH, without the intron sequences.
This DNA molecule originated from an Adh-F mRNA from
nucleotides 1 to 567, and from an Adh -S gene from nucleotides 711
(this numbering includes intron sequences) to its end. Dr. Sofer's group
was interested in constructing an intronless Adh -S 'gene' for
expression studies, and since the only known difference between ADH-S
and ADH-F is at amino acid 192 (caused by a change at nucleotide 575)
they assumed that the DNA produced would encode for an -S type
ADH. They confirmed that by checking the isoelectrofocusing analysis,
but the final sequence of this mosaic 'gene' was not obtained (Clarke,
1988). To further complicate matters, the sequence of the mRNA used
for the construction of the intronless Adh was not checked.
As can be seen from all the exposed and table 3.4-1, the changes
numbered 1, 2 and 3, found during this project, must belong to the
sequence of the mRNA molecule, while the rest of the changes
correspond to the original sequence oiAdh -S .
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However one cannot rule out the possibility that some of these
changes may have been introduced during the genetic engineering
manipulations used for the construction of the final coding sequence.
Strongly against such possibility argues the fact that most of the changes
are either previously described polymorphisms or similar to these in
both position and nature. The only two novel changes are in the non
coding upstream region of the gene.
Of major relevance to this work was the finding of the change at
position 518, which determines a non-reported difference in the
sequence of the enzyme, substituting the expected isoleucine by a
threonine. The amino acid that is changed, lie 173, is conserved in all
the Drosophila ADH enzymes sequenced so far. Although a change of
an isoleucine for a threonine can be considered as a rather conservative
substitution its appearance made it mandatory to fully characterize the
new enzyme (which, for simplicity, we will continue to call ADH-S in
this thesis), in order to be able to compare the mutations introduced in
it with the rest of published data on ADH-S.
3.5 Analysis of growth behaviour of the different yeast strains and of
ADH activity in crude extracts.
The yeast clones transformed with the PVT-U-100 plasmids
containing the wild type, G14A, G19A, D38A, 136Stop and P214S
forms of Adh will be named respectively : WVwt, WV14A, WV19A,
WV38A, WV136Stop and WV214S. The cells containing the plasmid











Figure 3.5-1 . A) Growth curves for the different strains described.
Strains WV136Stop and WV214S showed identical behaviour to strain
WV, and are not displayed for clarity. B) Logarithmic transformation
of the original growth values.
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The growth curve for each of these clones was obtained several times
and a consistent difference was found in the growth behaviour of the
different cells analyzed (figure 3.5-1). Simultaneously, the amount of
ADH specific activity found in crude extracts of the different clones at











W W14A W38A W214S
WVwt W19A WV136Stop
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Figure 3.5-II. The specific activity values for the crude extracts of the
different strains relative to the activity of the activity of the crude
extract of the WVwt strain.
The relationship between the different clones according to maximum
cell density attained in liquid culture is as follows :
WVwt > WV38A > WV14A > WV19A > WV214S = WV136Stop = WV
Similarly, the relationships according to ADH specific activity in
crude extract are :
WVwt > WV38A > WV19A > WV14A > WV214S > WV136Stop = WV = 0
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The main differences between these two comparisons are : a) crude
extracts of WV19A cells have higher specific activity than WV14A
cells, but they grow to slightly lower cell densities in cell cultures, b)
WV214S cells do not grow to higher cell densities than WV136Stop or
WV cells, but a certain amount of ADH activity can be detected in the
former, while, as expected, neither WV136Stop or WV cells have any
detectable ADH activity in their crude extracts.
Discussion :
As clearly shown by the growth curves of the different strains used in
this thesis the expression of the Drosophila Adh gene has an enhancing
effect on the growth rate and on the attainable cell density properties of
its expressing yeast cells. Although it would be necessary to check
whether such effects are lost when the enzyme is expressed in wild type
yeast cells, it seems very probable that the reason for such enhancement
may be a complementation of the ADH activity that in the strains used
has been eliminated through deletion of the three yeast Adh genes.
In wild type yeast growing in glucose-rich media and in aerobic
conditions the main ADH activity (carried out by the ADH-1
isoenzyme) is dedicated to the production of ethanol from the
acetaldehyde that is obtained from the glycolytic pathway. When
ethanol is used as a carbon source the first step of utilization involves
its oxidation to acetaldehyde by the effect of ADH-2 (Wills, 1990). In
the case of the WV.36.201 cells used in this project, the lack of ADH-1
should, in glucose-rich conditions, lead to an accumulation of
acetaldehyde, to a decrease in the available pool of NAD+ in the cell
and to a lack of ethanol as a metabolite once the glucose pool has been
depleted. Also, the lack of ADH-2 should lead to a poor utilization of
ethanol.
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Drosophila ADH could be partially complementing both alcohol
dehydrogenase activities, by shifting the equilibrium towards the
production of ethanol as acetaldehyde accumulated and, inversely,
catalyzing the oxidation of ethanol once the glucose pool had been
depleted. This explanation would agree with the fact that the growth
capacity of the cells used in this project generally correlates with the
ADH activity detectable in their crude extracts, which, in turn, gives a
preliminary indication of the level of activity of the different mutants
expressed in the cells.
However, the level of ADH activity found in the crude extracts and
the effect of each enzyme in its expressing cells is not only a function of
the enzyme's catalytic efficiency. It is a combination of chemical
efficiency with expression and stability, and so it will also depend on
the level of production of each mutant, in its physical stability, and in
its resistance to proteolytic cleavage. Differences in these two last
factors may be the causes for the apparent contradiction between the
results of growth of WV14A and WV19A cells and their relative ADH
activity in crude extracts. WV14A cells grow slightly faster and to
slightly higher densities than WV19A cells, but the crude extracts of the
latter have higher ADH specific activity. This could be due to a
relatively higher instability of the enzyme ADH G14A, that could result
in a higher loss of its activity, due to denaturation or proteolysis,
during the crude extract preparation process.
Without any analysis of enzyme production or kinetic evidence from
purified enzyme solutions it was not possible to know at this stage if all
the detected differences are, or are not, due to differences in the level
of expression, enzyme activity or stability of each of the ADH variants.
These analyses will be described in the rest of this chapter.
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3.6 Immunological analysis of ADH expression.
The presence of cross-reacting material with monoclonal and
polyclonal antibodies against Drosophila ADH was tested in WV,
WVwt, WV14A, WV38A and WV136Stop cells. The results for the
different clones and antibodies used can be seen in figure 3.6-1.
Because similar amounts of total protein were used from all the cells
analyzed the intensity of the recognized bands can be used to assess the
relative amounts of ADH in each cell type. All the antibodies used
recognized a band of the same molecular weight as Drosophila ADH in
WVwt, WV14A and WV38A cells, and several bands of lower
molecular weight that can be attributed to degradation products because
their band patterns are similar to the ones found in crude extracts from
Drosophila flies (Fibla et al., 1989). No such bands were detected in
the WV and WV136Stop cells.
Three of the antibodies used (polyclonal serum and the monoclonal
antibodies LLBE8 and 10BB2) cross-reacted with other proteins of
higher molecular weight that were present in all the clones tested,
including WV (which does not contain an Adh gene). The monoclonal
antibody MMBB8 did not cross-react with any bands in the WV or
WV136Stop cells, hence showing specific reaction with ADH.
As it can be seen in figure 3.6-1, no significant differences in amount
of seropositive material can be seen between clones WVwt, WV14A
and WV38A. The rest of the clones analyzed (WV and WV136Stop)
had no seropositive material when the monoclonal antibody MMBB8
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Figure 3.6-1. Immunodetection of ADH in crude extracts of yeast cells.
Lanes 1 to 5 show the results with similar amounts of crude extract of
the strains WVwt, WVG14A, WVD38A, WV136Stop and WVPVT




The results obtained seem to indicate that the level of expression of
the wild type enzyme is largely equivalent to the expression of the
mutants ADH G14A and ADH D38A. That, in turn, points to
differences in intrinsic enzyme properties as the cause for the
differential growth characteristics seen in the previous section, at least
for the strains expressing these three enzymes. The final determination
of the nature of these differences required the analysis of pure
preparations of the enzymes.
A second important result of the immunological analysis of the
different strains was the finding of no cross-reacting material in the
WV136Stop cells, specially when polyclonal antibodies were used.
Although such result is not conclusive, it seems to suggest that no
soluble peptide is being produced by that strain, either because the
truncated gene is not expressed, its mRNA its not correctly processed
or translated, or because the translated peptide is not stable and either
precipitates or is degraded. In any case, no further analyses were done
on that mutant. It is unfortunate that the expression levels of the Adh
genes could only be tested for five of the seven strains used in the
project, but, as it will be seen in the purification results, there is no
evidence of different levels of expression in the untested strains
WVG19A and WVP214S.
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4. Purification and characterization of wild type and mutant
ADH enzvmes. Results and Discussion.
4.1 Purification of Drosophila ADH from yeast cells .
General considerations :
In the Materials and Methods section of this thesis I have described
only the procedures that form the final purification protocol used to
obtain pure ADH from yeast cultures. However many different
purification techniques were actually tried before reaching the definite
purification scheme. In this section the results of each of the steps
finally used for all the enzymes purified will be described, and a
mention will be made of the results that were obtained with related
techniques that were also tried.
4.1.1 Cell harvesting and lysis .
The procedure for cell harvesting and lysis was essentially a scale-up
of the methods used to check for the presence of ADH activity in crude
cell extracts, and so the results obtained from this step are essentially
the same as those described in section 3.5. The total protein
concentrations at this stage of the purification oscillated from 1 to 10
mg/ml depending on the cell density attained by the yeast cultures used
(See tables 4.1-1 to 4.1-5).
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4.1.2 Ammonium sulphate fractionations and de-salting procedures.
Two ammonium sulphate cuts were carried out on the crude extracts
at concentrations of salt of 35% saturation and 70% saturation. That
step had four main consequences on the sample : the lysate was
homogenized and freed of general debris, the total volume of the
samples was reduced by a factor of approximately 4, the total protein
concentration was increased and the specific ADH activity of the
samples was enhanced.
The specific activity values suggest a purification factor of around
three after the salt cut. However, the treatment of ADH with
ammonium sulphate enhances the activity of the enzyme, which suggests
that such purification factor may partially be an artifact.
The ammonium sulphate that remained in the crude solution after the
second fractionation was removed by running the samples through a
Sephadex G-25 column as described. This step increased the volume of
the sample by a factor of 3 to 5 and allowed recoveries of 80-85% of
the total enzyme activity (see results tables 4.1-1 to 4.1-5).
Membrane dialysis was tried as an alternative at this stage of the
purification but the method is slower and allows for much poorer
recoveries of enzyme activity. Typically 30 to 40 % of the enzyme
activity was lost, probably due to enzyme denaturation and proteolysis.
4.1.3 Anion exchange chromatography.
As described in the materials and methods section, it was felt that
ionic exchange columns would be more suitable for the purification of
ADH than the previously described affinity methods. To determine the
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optimal conditions to apply to our system a battery of small columns of
anionic and cationic exchange nature was prepared (see table 4.1.4-1).
The most encouraging results were obtained with the ion exchange
matrix Q-Sepharose, equilibrated at pH 8.00. Under this conditions a
large amount of the protein content of the samples was retained by the
column, but almost 90% of the loaded ADH activity was eluted directly
out of the matrix, giving rise to a 20 fold purification or more for the
ADH wild type enzyme (tables 4.1-1 to 4.1-5, and figure 4.1.4-1).
A set back of this procedure is the loss of the sample concentrating
advantages of normal ion-exchange methods, where, after a positive
binding of the protein of interest, a salt gradient can be applied to elute
the material in a small volume of solvent. In our case the volume of the




Figure 4.1.4-1. Photograph of an SDS-polyachrilamide gel showing samples
at different stages of the purification of ADH-S. (1) Molecular weight markers.
(2) Crude extract of WVwt yeast cells. (3) Sample of the fractions with ADH
activity pooled after the Q-Sepharose column. (4-6) Consecutive fractions with
ADH activity eluted from the Superose-12 column.
4.1.4 Gel filtration chromatography and previous concentrating step.
As can be seen in figure 4.1.4-1, a remarkable purification of the
ADH enzyme was achieved after the anion-exchange column, but some
contaminants were still present at this stage. The main contaminant
band appeared to be of a much higher subunit mass (-55 kDa) than the
ADH monomer. A good choice to separate these two molecules was,
hence, a gel-filtration technique.
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Three different gel-filtration approaches were tried, the Pharmacia
Superosel2 FPLC column (exclusion mass of 2x10^ Da), a combination
of a Superosel2 column followed by a Superoseb column (exclusion
n
mass of 4x10 Da), and the Pharmacia Superdex FPLC column. The
best results were obtained with the first approach. The combination of
Superose 12 followed by Superose 6 gave slightly better resolution of
peaks but. due to the lower flux that Superose 6 columns can support,
the processing times were dramatically increased. That factor, coupled
to the lack of refrigeration system in the FPLC system used, gave rise to
unacceptably high losses of enzyme activity due to denaturation.
On the other hand, the Superdex column gave poor resolution of peaks
compared to the Superose 12 column alone. In figure 4.1.5-1 a
chromatogram of a typical Superose 12 separation is shown. That
separation yielded samples of pure ADH when analyzed by Coomasie
staining of SDS-polyacrylamide gels (figure 4.1-1). One of the mutants
produced, D38A, behaved differently (figure 4.1.5-11), and was always
eluted with variable, but detectable, amounts of a second protein of an
apparently slightly larger monomerie molecular weight.
0 Optical absorvance (280 nm) (Continous line) 0.2
0% ADH activity (Dashed line) 100%
Figure 4.1.5-1. Chromatogram of the Superose 12 results.
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1 2 3 4 6 7 8 mol. vvt.
Figure 5.1.5-11. SDS-polyacrylamide gel with samples of various stages of the
purification of ADH-D38A. (1-3) Fractions from the Superose-12 column with
higher ADH activity.(4) Pure ADH-S control. (5) sample of the fractions with
ADH activity pooled after the Q-sepharose column. (6) Crude extract of
WVD38A yeast cells. (7) Molecular weight markers.
By reducing the volume of the fractions collected the amount of such
contaminant was reduced, but, as a result of its presence the purification
of ADH D38A could not be achieved at better than 80% of the total
protein. The difference in behaviour of this mutant enzyme is difficult
to explain. Although its difference in charge may be responsible for
differences in its aggregation properties this enzyme eluted from the
Superose column at the same times as those of the rest of the ADHs
purified, and so the possibility that D38A could be somehow
aggregating with the contaminant protein seems unlikely.
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Although this technique allowed for efficient recoveries of purified
enzyme it had a major inconvenience in the low capacity of the columns
that were available. The volume of the Superose columns was 20 ml,
hence limiting the volume of the sample to a maximum of 200 pi if
optimal resolution was to be achieved.
As has been described in the previous chapter the peculiar nature of
the ionic-exchange method used actually increased the volume of the
final sample to typical values of about 15 ml. The processing of these
volumes with the Superose 12 columns available would have been
extremely slow and inefficient, so the introduction of a concentrating
step was decided.
This was achieved by saturating the sample obtained from the Q-
Sepharose column with ammonium sulphate, collecting the precipitated
protein by centrifugation and resuspending in a smaller volume of
buffer (~ 500 pi). This step accomplished the necessity of reducing the
total volume of protein sample, and allowed a much more efficient use
of the gel-filtration system. However, this step proved to have two main
problems which, as can be seen in tables 4.1-1 to 4.1-5 made of it the
most inefficient step of the purification procedure.
Firstly, the recoveries of ADH activity from this step were far from
ideal, and from 30 to 40 % of the activity recovered from the Q-
Sepharose column was normally lost. The explanations for this poor
efficiency are probably that : a) the protein concentrations of the
samples eluting from the anion-exchange columns were too low to
allow a very efficient protein precipitation and, b) the necessity to keep
the final volume of the sample to a minimum meant that poor
solubilization efficiencies were attained.
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Despite the problems described this concentrating step was carried out
on all the samples due to its global convenience. There are a number of
alternative techniques that should be tried in the future to try to reduce
the loss of enzyme activity at this stage of the purification. Techniques
of sample concentration by filtration, either using vacuum, tangential
flow or centrifugal force could provide better ways to concentrate the
samples.
4.1.5 General evaluation of the purification protocol.
To summarize, a rapid, small-scale method to purify Drosophila
ADH from yeast cultures expressing different forms of the enzyme was
developed. The purification grade obtained was to homogeneity in SDS-
polyacrylamide gels stained with Coomassie blue, except for the mutant
D38A. A second contaminant, that amounted to 20% of the total
protein, could not be removed from the preparations of this latter
mutant with the method described. This purification method was used













C. E. 9 ml 90 mg 93 lu./mg 100 0
A.S. 1 2.4 ml 19.2 mg 72 3.7u./mg 77 3.7
G-25 12 ml 18.5 mg 70 3.8u./mg 75 3.8
Q-Seph. 15 ml 2.6 mg 63.5 24u./mg 68 24
A.S. 2 0.5 ml 2.3 mg 40 17u./mg 43 17
Superose 4.5 ml 1.3 mg 31 24u./mg 33 24














C. E. 15 ml 60 mg 22.5 0.3u./mg 100 0
A.S. 1 4 ml 18 mg 15.8 0.8u./mg 70 3.5
G-25 12 ml 16 mg 14.8 0.9u./mg 66 3.6
Q-Seph. 13 ml 1.9 mg 13.9 7.3u./mg 51 23.5
A.S. 2 0.4 ml 1.3 mg 7.6 5.8u./mg 34 17
Superose 4 ml 0.5 mg 6.3 12.4u./mg 28 22













C. E. 7 ml 13 mg 10.5 0.8 100 0
A.S. 1 2 ml 3.5 mg 7.6 2.2 76 2.7
G-25 6 ml 3.2 mg 6 1.9 57 2.3
Q-Seph. 8 ml 0.35 mg 4.5 12.9 43 16
A.S. 2 .25 ml 0.22 mg 3.5 15.9 33 20
Superose 2 ml 0.09 mg 2.9 32.6 28 41














C. E. 20 ml 85 mg 134 1.6u./mg 100 0
A.S. 1 4 ml 19.7 mg 92 4.6u./mg 69 2.9
G-25 20 ml 19.6 mg 68 3.4u./mg 51 2.2
Q-Seph. 25 ml 4.1 mg 57.5 14u./mg 43 8.7
A.S. 2 0.5 ml 3.4 mg 40 12u./mg 31 7.3
Superose 6 ml 1.6 mg 32 20u./mg 24 12.5













C. E. 7 ml 11 mg 5.5 0.5u./mg 100 0
A.S. 1 2 ml 4.4 mg 4.9 l.lu./mg 85 2.2
G-25 6 ml 4.2 mg 4.5 l.lu./mg 82 2.2
Q-Seph. 8 ml 0.8 mg 4.1 5.1u./mg 74 10.2
A.S. 2 0.25 ml 0.6 mg 2.3 3.8u./mg 42 7.6
Superose 2.5 ml 0.25mg 1.9 7.5u./mg 34 15
Table 4.1-5. Purification results for the enzyme ADH P214S.
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4.2 Characterization of the wild type and mutant ADH enzymes.
4.2.1 Enzyme kinetics .
Results:
Figures 4.2.1-1 to 4.2.1-XIV show the Michaelis-Menten and Hanes
plots for each of the enzymes and substrates studied. Table 4.2.1-1
summarizes the Km, kcat and kca[/Km values obtained for all the












ADH wt 0.18 16.6 89.5 1.4 3.9 1.8 0.6 16.7 27.7
G14A 0.36 7.1 19.8 2.4 1.3 0.5 0.64 7.14 11.2
G19A 0.32 17.2 53.7 No detectable activity 0.66 17.2 26.06
D38A 0.45 9 20 4.27 1 0.2 1.99 9 4.5
P214S 0.09 3 33.3 1.9 0.5 0.3 0.47 3 6.66
Table 4.2.1-1 . Kinetic results for all the enzymes and substrates
studied. All the rate values measured had standard errors lower than ±
5%, except for two points : 6.4 mM NADP+ for the enzyme ADH
D38A (± 24%, figure 4.2.1-X)and 0.8 mM NAD+ for the enzyme
































Figure 4.2.1-1 . Kinetic plots for ADH wild type and NAD+, (a)
Michaelis-Menten plot, (b) Hanes plot using the mean rate values
(simple regression calculated with the program CRICKET GRAPH).
The equation defining the regression line and its regression coefficient
































Figure 4.2.1-II. Kinetic plots for ADH wild type and NADP+. (a)
Michaelis-Menten plot, (b) Hanes plot using the mean rate values
(simple regression calculated with the program CRICKET GRAPH).
The equation defining the regression line and its regression coefficient










































Figure 4.2.1-III . Kinetic plots for ADH wild type and isopropanol.
(a) Michaelis-Menten plot, (b) Hanes plot using the mean rate values
(simple regression calculated with the program CRICKET GRAPH).
The equation defining the regression line and its regression coefficient




























Figure 4.2.1-IV. Kinetic plots for ADH G14A and NAD+. (a)
Michaelis-Menten plot, (b) Hanes plot using the mean rate values
(simple regression calculated with the program CRICKET GRAPH).
The equation defining the regression line and its regression coefficient



























Figure 4.2.1-V. Kinetic plots for ADH G14A and NADP+. (a)
Michaelis-Menten plot, (b) Hanes plot using the mean rate values
(simple regression calculated with the program CRICKET GRAPH).
The equation defining the regression line and its regression coefficient

































Figure 4.2.1-VI. Kinetic plots for ADH G14A and isopropanol. (a)
Michaelis-Menten plot, (b) Hanes plot using the mean rate values
(simple regression calculated with the program CRICKET GRAPH).
The equation defining the regression line and its regression coefficient





























Figure 4.2.1-VI. Kinetic plots for ADH G19A and NAD+. (a)
Michaelis-Menten plot, (b) Hanes plot using the mean rate values
(simple regression calculated with the program CRICKET GRAPH).
The equation defining the regression line and its regression coefficient


































Figure 4.2.1-VIII. Kinetic plots for ADH G19A and isopropanol. (a)
Michaelis-Menten plot, (b) Hanes plot using the mean rate values
(simple regression calculated with the program CRICKET GRAPH).
The equation defining the regression line and its regression coefficient




















Figure 4.2.1-IX. Kinetic plots for ADH D38A and NAD+. (a)
Michaelis-Menten plot, (b) Hanes plot using the mean rate values
(simple regression calculated with the program CRICKET GRAPH).
The equation defining the regression line and its regression coefficient
























Figure 4.2.1-X. Kinetic plots for ADH D38A and NADP+. (a)
Michaelis-Menten plot, (b) Hanes plot using the mean rate values
(simple regression calculated with the program CRICKET GRAPH).
The equation defining the regression line and its regression coefficient































Figure 4.2.1-XI. Kinetic plots for ADH D38A and isopropanol. (a)
Michaelis-Menten plot, (b) Hanes plot using the mean rate values
(simple regression calculated with the program CRICKET GRAPH).
The equation defining the regression line and its regression coefficient





















Figure 4.2.1-XII . Kinetic plots for ADH P214S and NAD+. (a)
Michaelis-Menten plot, (b) Hanes plot using the mean rate values
(simple regression calculated with the program CRICKET GRAPH).
The equation defining the regression line and its regression coefficient


























y = 551.65 + 289.45x FT2 = 0.975
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INADP]
Figure 4.2.1-XIII. Kinetic plots for ADH P214S and NADP+. (a)
Michaelis-Menten plot, (b) Hanes plot using the mean rate values
(simple regression calculated with the program CRICKET GRAPH).
The equation defining the regression line and its regression coefficient




































Figure 4.2.1-XIV. Kinetic plots for ADH P214S and isopropanol. (a)
Michaelis-Menten plot, (b) Hanes plot using the mean rate values
(simple regression calculated with the program CRICKET GRAPH).
The equation defining the regression line and its regression coefficient
are shown at the base of the plot.
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Discussion:
As described in the introduction chapter, Drosophila ADH catalyzes
the oxidation of alcohols through a ternary-complex, ordered
mechanism, where NAD+ binds first to the enzyme. The release of the
reduced cofactor is the limiting step of the reaction, and it can be seen
by studying different isoenzymes that an increase in affinity for the
cofactor results in a slower reaction due to a decrease in the
dissociation constant of NADH (Chambers, 1988).
This immediately suggests that a mutation that may be capable of
decreasing the affinity constant of the enzyme for the cofactor without
affecting the reaction rate will result in a faster enzyme. The Michaelis
constant (Km) is not a simple measure of affinity, it is negatively
dependent on the constant of formation of the enzyme-substrate
complex, and positively dependent on the dissociation constant of such a
complex plus the constant of its transformation into the complex
enzyme -subs trate.
Due to this fact, it is expected that mutations that increase the Km
values for a substrate in ADH will fall into two categories: those that
affect the affinity of the enzyme for the cofactor but do not affect the
rate of reaction and those that, while affecting the affinity for NAD, do
also decrease its rate of reduction. The first class of mutations would be
expected to accelerate the reaction rate of the enzyme, because a lower
affinity of the enzyme for the cofactor would allow the release of
NADH to occur at higher rate, hence approaching the reaction rate to
the rate of proton transfer. The second class of mutants would probably
be slower enzymes, because of loss of reaction efficiency.
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Clearly, any mutation is likely to have a certain effect on all the rates,
and its global effect in the Km will be the result of the sum of the
effects in all the constants. The two cases described above are the
extreme cases where one constant is affected by the substitution while
the others are not. However, from the comparison of the values of the
different mutants it should be possible to draw conclusions on the
predominant effect of each change.
Enzyme ADH-S:
The kinetic results obtained with the ADH-S enzyme expressed and
purified in this project are similar to the various kinetic data published.
Perhaps more importantly, they are very similar to the kinetic values
published by Chen and colleagues (1990), which were used as reference
for their site-directed mutagenesis experiments on the enzyme. This
result has two main implications for this project: it makes the kinetic
results directly comparable to the ones reported by Chen and
colleagues, and it shows that the amino acid change at position 173
caused by the unexpected change found in the gene sequence has no
effect on the enzyme's mechanism.
Enzyme ADH G14A:
The G14A mutation has already been analyzed by other investigators
(Chen et al., 1990), and they reported similar kinetic effects to the ones
found in this work. The enzyme shows a two fold increase in the Km
for both NAD+ and NADP+, while it seems to have no effect in the
recognition of isopropanol. These results agree with the expected
positioning of G14 in the enzyme, at the nucleotide binding site.
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The fact that the kca^ is also reduced two fold may indicate that the
mutation somehow disrupts the normal positioning of the NAD,
impairing the catalytic efficiency of the enzyme. Because the same kind
of effect is seen for both NAD+ and NADP+ it is likely that the residue
G14 does not interact with the phospho group of NADP+.
Enzyme ADH G19A:
This mutation also produces a two-fold increase in Km for the
cofactor but, interestingly, it does not impair the speed of the reaction.
In fact, a small increase in the kcaj value is obtained. This increase is
probably not significant, but it shows that in this mutant, the loss in
cofactor recognition is probably compensated by a faster rate of
enzyme turn-over, which leaves the catalytic efficiency of the enzyme
untouched.
A very important indication of the spatial positioning of this residue
is given by the fact that no detectable activity could be measured with
this mutant when NADP+ was used as a cofactor. This seems to indicate
that residue 19 is in close proximity to the phospho group of NADP+,
and that the introduction of a methyl group totally disrupts its
environment. Again the mutation does not seems to have any effect on
substrate recognition, supporting a location distant from the alcohol
binding site and from the reaction centre.
Enzyme ADH D38A:
Mutations in this amino acid have already been reported by Chen and
colleagues (1991), although no substitution to alanine was done in their
work. Chen and colleagues worked on the hypothesis that D38 may be
the residue that is responsible for hydrogen-bonding the hydroxyl
groups of the adenine-ribose of NAD.
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As mentioned in the introduction, this hypothesis is based on the
general structure of NAD+ binding sites, although some alignment
results and the structure of SDH indicate that such interactions may be
between the cofactor and residue 64, another aspartic acid (Marekov et
al., 1991; Ghosh et al., 1991).
Chen and colleagues found that mutating D38 to hydrophobic
(leucine) or positively charged (arginine) residues resulted in
inactivation of the enzyme. But mutating the aspartic side-chain to
asparagine, hence removing its charge but maintaining its capacity to
form hydrogen bonds, resulted in an enzyme capable of utilizing
NADP4 as efficiently as NAD.
The mutation to asparagine increased the Km for NAD4 by 50%, and
also increased the catalytic efficiency (kcat) two fold. This is expected
since, as discussed, a mutation that removes binding energy between the
cofactor and enzyme without affecting their three-dimensional
positioning will produce a faster enzyme. The same mutation, however,
reduced the Km for NADP+ by a factor of 60 and increased the kcat by
a factor of 10, making the enzyme almost as efficient with NADP+ as
with NAD.
In their work the authors argue that the negative charge of aspartic
acid must be responsible for the low affinity of ADH for NADP4, due
to direct charge repulsion between the side-chain and the phospho
group of the cofactor. They propose that such repulsive interaction is
eliminated when a glutamine is introduced at position 38, producing an
enzyme capable of using both NAD4" and NADP4.
There can be little doubt than the removal of the negative charge of
the aspartic acid allows the enzyme to use NADP+. However that is not
necessarily an indication of direct interaction between the cofactor and
the enzyme. In fact, Chen et al. do not try to explain how is the extra
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phospho group is sterically accommodated in the NAD+ binding site of
the enzyme. This is of major importance, because if residue 38 is
located within hydrogen bonding distance of the hydroxyl groups of the
adenine ribose a substitution of one of these hydroxyls by a phospho
group is likely to create pure steric clashes that would not be avoided if
a residue of similar size to aspartate is placed at position 38.
Nothing can be concluded from the inactivation that the authors find
when substituting the residue 38 by leucine and arginine, because the
structural effects of these mutations were not investigated.
The introduction of an alanine at position 38 done as part of this
project introduces at this position a side-chain of smaller size, not
capable of creating hydrogen bonds. With respect to NAD+ the
mutation results in a two-fold increase in Km and a two-fold decrease
in kcat, indicating that the mutation probably affects both the affinity
for the cofactor and the reaction efficiency.
Since the enzyme is active and the mutation abolishes the negative
charge of the aspartate 38, if the proposition of Chen and colleagues is
true one would expect this mutant to have better kinetic constants for
NADP+ than the wild type enzyme. Instead ADH D38A shows an 3-
fold increase in Km for NADP+, and a four fold decrease in kca^,
suggesting that the effect of the mutation has similar effects in the
kinetics of both NAD+ and NADP+.
The kinetic results for isopropanol of ADH D38A are surprising,
since the mutation increases the Km for the alcohol by three-fold. This
result could suggests that residue 38 may be positioned close to the
active site, or interacting with residues involved in the recognition of
the alcohol. This would argue against the proposed hypothesis of
residue 38 having a similar role as that in long-chain dehydrogenases,
and, by default, would support the works of Marekov and colleagues
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(1991) and Ghosh and colleagues (1991). Surprisingly, Chen and
colleagues (1991) do not report the kinetic constants for alcohol of
their D38N mutant.
The results obtained for our mutant at position 38 could have been
affected by the fact that the purity of the enzyme was not higher than
80%, with a second contaminant that could not be removed (see
purification results). However, interferences from such contaminant
seem unlikely because it has no isopropanol dehydrogenase activity,
since crude extracts of WV.36.201 cells show no such activity.
Enzyme ADH P214S:
The P214S substitution is found in nature, but only in ADH-F type
isoenzymes. It seems to have two main consequences: it largely
increases the thermal stability of the molecule and it changes the kinetic
characteristics of the enzyme making it more similar to ADH-S.
(Chambers, 1984; Chambers, 1988; Winberg, 1989).
The reasons for the increase in thermal stability are not clear, but the
change in the kinetic constants are thought to be due to an increase in
the affinity of the enzyme for the cofactor, which, as discussed, does
slow down the enzyme velocity (Winberg, 1989).
The same mutation at position 214 has not been reported in an ADH-S
enzyme. That fact becomes clear when the kinetic constants of the ADH
P214S produced in this project are analyzed. The enzyme has a two¬
fold reduced Km for the cofactor in respect to the wild type enzyme
which, as expected, results in a slower reaction speed, with a kca^
reduced by a factor of 5.5, making this enzyme the slowest of all those
tested.
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The mutation has little effect on the Km for isopropanol, causing a
reduction of about 20%. Winberg and colleagues (1982) have proposed
that the substrate binds to ADH in two hydrophobic pockets.
The residue at position 214 is clearly affecting the interaction with the
cofactor NAD, and, since it is located at he C-terminal part of the
enzyme, is also possible that it could be in the environments of the
reaction centre. However, from the kinetic results obtained in this
project it seems likely that this residue is not in direct contact with the
substrate.
The effect of this mutation on the stability of the enzyme required
other kinds of analysis to be investigated. They will be described in the
next sections of this chapter.
133
4.2.2 Guanidine-induced denaturation studies of Drosophila ADH
monitored by CD and enzyme activity .
4,2.2.1 Studies based on enzyme activity measurements.
Figures 4.2.2-1 to 4.2.2-VI show the results obtained from
monitoring the enzyme activity remaining in enzyme solutions
incubated in different concentrations of guanidine chloride. The second
part of each figure shows the transformation used to calculate, in each
case, the AG(water) (units: cal/mol) of the holoenzymes and of the
enzymes saturated with cofactor NAD+. The results are joined and





ADH-F 0.4 0.58 3.2 4.5 1.3
ADH-S 0.38 0.74 3.9 7.4 3.5
ADH-G14A 0.26 0.52 2.6 5.9 3.3
ADH-G19A 0.18 0.19 2.8 3.2 0.4
ADH-D38A 0.28 0.31 2.4 2.7 0.3
ADH-P214S 0.64 0.95 7.7 11.4 3.7
Table 4.2.2-1. Joined results of the denaturation studies monitored by
enzyme activity. The "GdnHClso" values show the guanidine
hydrochloride concentrations at which 50% of the initial activity is lost.
AAG(NAD) values are the difference between the extrapolated AG(water)
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Figure 4.2.2-1 . a) Loss of enzyme activity of a solution of ADH-F
purified from D. melanogaster after incubation with increasing
concentrations of guanidine hydrochloride, with and without NAD. b)
The transformation of the ratio of inactivated enzyme against activated
enzyme into free energy values, and their extrapolation to the AG(Water)












































. » AAG ADH-S + NAD
y = 3858.4 - 1.0356e+4x
y = 7442.0 - 1.0294e+4x
RA2 = 1.000
RA2 = 0.998
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[GndHCI]
Figure 4.2.2-II . a) Loss of enzyme activity of a solution of ADH-S
purified from S. cerevisiae after incubation with increasing
concentrations of guanidine hydrochloride, with and without NAD. b)
The transformation of the ratio of inactivated enzyme against activated
enzyme into free energy values, and their extrapolation to the AG(water)




























♦ ADHG14A + NAD
[GdnHCl]
Figure 4.2.2-IIIb
24.5x R*2 = 0.997
0885e+4x R*2 = 0.981
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Figure 4.2.2-III . a) Loss of enzyme activity of a solution of ADH
G14A purified from 5". cerevisiae after incubation with increasing
concentrations of guanidine hydrochloride, with and without NAD. b)
The transformation of the ratio of inactivated enzyme against activated
enzyme into free energy values, and their extrapolation to the
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Figure 4.2.2-IV . a) Loss of enzyme activity of a solution of ADH
G19A purified from S. cerevisiae after incubation with increasing
concentrations of guanidine hydrochloride, with and without NAD. b)
The transformation of the ratio of inactivated enzyme against activated
enzyme into free energy values, and their extrapolation to the AG(water)
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Figure 4.2.2-V . a) Loss of enzyme activity of a solution of ADH
D38A purified from S. cerevisiae after incubation with increasing
concentrations of guanidine hydrochloride, with and without NAD. b)
The transformation of the ratio of i
nactivated enzyme against activated enzyme into free energy values,
and their extrapolation to the AG(water) (cal/mol) value for the enzyme

























Figure 4.2.2-VI . a) Loss of enzyme activity of a solution of ADH
P214S purified from S. cerevisiae after incubation with increasing
concentrations of guanidine hydrochloride, with and without NAD. b)
The transformation of the ratio of inactivated enzyme against activated
enzyme into free energy values, and their extrapolation to the AG(water)
(cal/mol) value for the enzyme with and without NAD.
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Discussion:
The stability of each of the enzymes tested is determined by the
AG(water) value extrapolated from the AG values of various points in
the denaturation curves. As discussed in the Materials and Methods
chapter, the binding of the cofactor induces an increase in enzyme
stability which can be quantified by determining the AG(water) value for
each enzyme when NAD+ is present in the solution. The difference
between the value obtained in the absence and presence of the cofactor,
the AAG(NAD)Value of cofactor binding, is a measure of the energy
effect of cofactor binding. Since the energy of binding between the
enzyme and the cofactor is a major determinant of the reaction speed it
would be expected to find a correlation between the catalytic constants
of each enzyme and its AAG(NAD) value of cofactor binding.
ADH-S and ADH-F:
Previous attempts to compare the stability properties of these two
natural isoenzymes using crude thermal denaturation studies showed
that results were variable and dependant on assay conditions
(Chambers, 1984). However, when the stability of the enzymes was
investigated by thermal gradient electrophoresis the isoenzyme ADH-S
was found to be more stable than ADH-F (Thatcher and Sheikh, 1981).
This difference in stability seems to be confirmed by our studies, which
show a difference in free energy of about 700 cal/mol in favour of
ADH-S.
Confirming the also known fact that ADH-S binds tighter to NAD+
than ADH-F, a difference between the AAG(NAD) values of about
2.3kCal/mol was found. This value is similar to the calculated energies
for a hydrogen bond between tyrosyl-tRNA synthetases and their
substrate (Fersht, 1987), which range from 0.5 to 1.8 kCal/mol.
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Although the estimated energy of a hydrogen bond depends on a large
number of factors and the values estimated in the literature vary
largely between 1 and 20 kCal/mol (Williams, 1991), the result
obtained in this project can at least be compared to the published values,
and seems to suggest that the difference in binding NAD+ between
ADH-F and ADH-S can be due to a single interaction. To know how
this relates to the amino acid substitution at position 192 that constitutes
the only difference between these two isoenzymes will require three-
dimensional information on the contacts between protein and cofactor.
Interestingly, the difference between the apo forms and the holo
forms of the two isoenzymes are not equal, the difference between the
apo forms is 674.3 cal/mol while the difference between the holo forms
is 2939 cal/mol. This difference seems to show that the substitution at
position 192 does have a larger effect on the binding of the cofactor
than on the intrinsic energy of the enzyme.
Enzymes ADH G14A, G19A and D38A:
The AG(water) values of these three enzymes are all reduced from the
original wild type ADH-S by similar amounts (from 1.4 to 1 Kcal/ml).
However, they present variation in the slopes of their denaturation
curves, which is thought to be an indication of changes in the solvation
energy of the denatured state of the polypeptide (Green et al., 1992).
This variation in slope results in an apparent contradiction, where
ADH G19A loses 50% of its activity at lower GndHCl concentrations
despite having a higher AG(Water) value than the other two enzymes.
If this interpretation of the slope of the denaturation curves is correct,
ADH G19A is marginally more stable in water than the other two
enzymes (a maximum of 371 cal/mol of difference). There is a large
variation, however, in the energy that NAD+ binding transfers to each
of these mutants. ADH G14A shows an energy of NAD+ binding only
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slightly smaller than the one of ADH-S. This result is very interesting
when compared to the kinetic values obtained for this mutant with
NAD. ADH G14A shows a two-fold increase in Km and a two-fold
reduction in kca^, suggesting that the mutation primarily impairs the
reactivity of the enzyme. This is confirmed by this analysis, showing
that the overall energy of binding is not changed, hence the reason for
the increase in the Km is probably due to changes in the catalytic
constant. A possible structural explanation is that the mutation induces a
small repositioning of NAD, maintaining its normal interactions but
affecting the architecture of the reaction centre.
ADH G19A and ADH D38A, on the other hand, show a very small
increase in the energy of binding of NAD. Their AAG(NAD)Values of
about 0.3 Kcal/mol represent a reduction on binding energy of about
3.3 Kcal/mol in respect to ADH-S. In the case of ADH G19A this result
fits very well with the catalytic constants determined for this enzyme,
where the rise in Km is not accompanied by a decrease in kca^, and
hence one can deduce that the recognition of the cofactor has not been
affected, but that the interaction energy between both enzymes has been
reduced.
ADH D38A has a similar behaviour to ADH G19A, but these results
are difficult to interpret because the mutation could have various effects
on the recognition system of the enzyme. Not taking into account trivial
structural distortions of three-dimensional structure, there are two
major possibilities for the kind of effect observed: the side-chain binds
directly with the cofactor, and its loss reduces the interaction energy,
or the side-chain is not in contact with the NAD+ molecule, but its
absence increases the entropic energy of the surroundings of the
binding surface, hence decreasing the free energy of binding.
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As described in the Materials and Methods chapter, all the
denaturation curves in the presence of cofactor were carried out by
incubating the enzymes with 1 mM NAD. This concentration was used
because it is about ten fold the published Km values of the wild type
enzyme for NAD, hence ensuring saturation. Since the Km values of
the mutants ADH G14A, ADH G19A and ADH D38A are higher than
the Km of the wild type enzyme it could be possible that the difference
in the protective effect of NAD+ was due to the fact that the enzymes
were not saturated.
However the mutant ADH G14A shows a similar AAG(NAD)value to
the wild type enzyme despite having a higher Km, suggesting that this
enzyme was also saturated. To find out whether ADH G19A and ADH
D38A were undersaturated the same analysis should be repeated at
higher concentrations of NAD.
Enzyme ADH P214S:
The results obtained with this enzyme confirm that the substitution of
the proline at position 214 for a serine has the same stabilizing effect in
ADH-S as the one observed in ADH-F isoenzymes. The mutant enzyme
has a AG(water) value of 7.7 Kcal/mol, 3.8 Kcal/mol higher than the
original ADH-S molecule. From the kinetic studies it is clear that ADH
P214S has a higher affinity for the cofactor than ADH-S, but this
doesn't seem to be reflected in the difference in AAG(NAD)Values for
both enzymes which are quite similar (only 150 cal/mol higher for
ADH P214S).
It may be possible that the stabilizing effect of substrates follows a
sigmoidal behaviour, reaching saturation above a certain value of
AG(water) ^or t^ie enzyme. This is however pure speculation as very
little information is available on the energy behaviour of protein-ligand
complexes.
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Another possibility may be that the residue at position 214 does not in
fact interact with the cofactor directly, but with parts of the enzyme
structure that are involved in the recognition of the NAD+ molecule.
This last possibility would explain why the mutation has a large effect
on the AG(-water) of the apoenzyme, but does not change considerably
the AAG value of NAD+ binding.
One of the purposes of developing the denaturation assay described in
this project was that of trying to correlate changes in the kinetic
behaviour of the enzyme with physical parameters directly linked to the
molecule's structure and its interaction with the substrates. Although it
is possible to correlate the energy of NAD+ binding of some of the
mutants with their kinetic behaviour a general relationship does not
exist between the AAG(NAD)Values obtained and the Km or kcat
constants determined.
Clearly, other factors than binding energy are determining the
changes in catalytic values; perhaps alterations of the binding pocket
that result in positional distortions of the substrates. In any case the
determination of the molecular effect of each mutation will require the
availability of a high-resolution crystal structure for ADH.
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4.2.2.2 Circular dichroism monitoring of the denaturation kinetics.
Results :
Figure 4.2.2-VII displays the results obtained by monitoring the
circular dichroism values of solutions of ADH-F purified from D.




Figure 4.2.2-VII- Denaturation curve of ADH-F monitored with
circular dichroism. (•) Enzyme in the presence of NAD. (°) Enzyme in
the absence of NAD.
Discussion:
Since the parameter measured in circular dichroism of far UV is the
amount of secondary structure it is expected that the denaturation curve
would show a more shallow gradient that the ones obtained when
monitoring enzyme activity. However, the CD results still confirm the
protective effect of the cofactor on the enzyme, at similar
concentrations of denaturant as found in the enzyme activity analyses.
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4.2.2.3 Comparative studies with horse liver ADH and yeast ADH.
To be able to compare the denaturation kinetics and the effect of
NAD+ on the unfolding of Drosophila ADH to other alcohol
dehydrogenases, the same kind of analyses performed on DADH were
carried out with solutions of alcohol dehydrogenase from horse liver
and from yeast. The results are shown in figures 4.2.2-VIII and -IX.
Discussion:
The monitoring of the denaturation kinetics of two long-chain
dehydrogenases was done with the intention of obtaining data on other
NAD+ binding enzymes that could be compared with the results
obtained with Drosophila ADH. However, both horse liver ADH and
yeast ADH proved to behave in a quite different manner in their
denaturation process. From our data, it appears that horse liver ADH is
more stable to GdnHCl than is the short chain alcohol dehydrogenase
from Drosophila . Moreover, it appears that only the latter enzyme can
be stabilised by addition of NAD. The precise structural reasons for
this contrasting behaviour must await a detailed structure of the
Drosophila enzyme, but presumably are a consequence of different
domain and subunit organisations in the two dimeric enzymes.
In the experiments with the tetrameric long-chain enzyme from yeast
it was found that NAD+ offers no protection against inactivation or
unfolding by GdnHCl, i.e. a similar result to the horse liver (long-
chain) enzyme. In the case of the yeast enzyme inactivation occurs at
lower concentrations of GdnHCl, consistent with earlier reports
(Branden et al., 1975) which indicate that the yeast enzyme is less stable
than the horse-liver enzyme towards thermal inactivation. The greater
instability of the yeast enzyme is thought to be related to a greater ease
of dissociation into monomers.
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Previous observations on the effect of NAD+ on the stability of the
yeast and horse-liver enzymes have been somewhat contradictory.
Thus, Sekuzu et al. (1957) reported that NAD+ (> 1 mM) protected
yeast alcohol dehydrogenase against inactivation by urea, but Wiseman
& Williams (1971) found that NAD+ at these high concentrations had a
destabilising effect on the enzyme against thermal inactivation.
In the case of the horse-liver enzyme, there appears to be at least one
intermediate in the unfolding process as indicated by the plateau region
of figure 4.2.2-VIII (Strambini & Gonelli, 1990). In the plateau
region (0.5 M GdnHCl) there is a 30% loss of activity and a 10% loss
of secondary structure (as judged by the ellipticity at 225 nm). The
nature of this (these) intermediate(s), including its (their) quaternary
structure, would require further investigation, possibly by use of




Figure 4.2.2-VIII. Results of the monitoring of the decrease in
enzyme activity for horse liver ADH (continuous line) and yeast ADH
(dashed line) when incubated with increasing concentrations of
guanidine hydrochloride in the presence (o) or absence (•) of NAD.
Figure 4.2.2-IX
[GdnHCl] (M)
Figure 4.2.2-IX. Results of monitoring the decrease in circular
dichroism activity for horse liver ADH (continuous line) and yeast
ADH (dashed line) when incubated with increasing concentrations of
guanidine hydrochloride in the presence (o) or absence (•) of NAD.
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4,2.3 Thermal denaturation studies of Drosovhila ADH.
As described in the materials and methods chapter, the loss of enzyme
activity with time during incubation at different temperatures was
analyzed for the enzyme ADH-S and all the mutants produced. Figures
4.2.3-1 to 4.2.3-III show the results obtained from the experiments
carried out at 4, 25 and 40 °C respectively.
Discussion:
Although thermal denaturation has been used regularly as a way to
measure the stability of Drosophila ADH from crude extracts and in
purified form (Chambers, 1984; Hernandez et al., 1988; Chen et ah,
1990, 1991) the results from this kind of analysis are subject to too
many different factors (thermal stability, enzyme concentration, purity,
proteolytic activity) to be able to be used reliably to determine small
differences in stability.
Large modifications, as in the case of the thermo-stable ADH-FChD,
can however be consistently observed (Chambers, 1984). The results of
the experiments carried out in this project show that, over the time
analyzed all the enzymes are stable when kept at 4°C. At 25 °C two
groups of enzymes seem to appear, ADH-S and ADH P214S are stable
at this temperature, and retain 80 and 95% of their respective activities
after 150 minutes of incubation. The ADHs G14A, G19A and D38A are
much more labile, retaining 50, 40 and 5% of their respective original
activities. Proteolytic cleavage cannot be discarded in any case,
especially in the case of ADH D38A, where pure enzyme solutions
could not be obtained. However, the results correlate quite well with
the AG(water) values obtained for all the enzymes, confirming the
general pattern of stability.
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At 40 °C all the enzymes but ADH P214S had lost all their activity
after 30 minutes of incubation. This is slightly faster than other
reported experiments (Chambers, 1984; Chen et al., 1991).
ADH P214S retains 50 % of its activity after 40 minutes at 40 °C, and
20% after 60 minutes. This results confirmed the increased structural
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Figure 4.2.3-III. Loss of activity at 40°C.
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5. Computer modelling of Drosophila ADH. Introduction.
methods, results and discussion.
5.1 Introduction
Several attempts at crude three-dimensional modelling of Drosophila
ADH have been published over the years (Thatcher & Retzios, 1980;
Thatcher & Sawyer, 1980; Benyajati et al, 1980). These attempts were
directed at the N-terminal part of the enzyme, and tried to superimpose
the predicted secondary structure of this part of the sequence on the
NAD-binding domain of horse liver alcohol dehydrogenase.
Although the basic philosophy of these experiments is the same that is
behind the modern techniques of protein modelling, the lack of a
proper frame-structure for the model and the crudeness of the
comparisons gave very little information about the actual structure of
ADH. Today, the need to close the gap between the huge sequence
databases and the structural database of the Brookhaven databank has
forced researchers to develop a large number of methods that allow the
construction of accurate protein models for sequences with sufficient
similarity to existing structures.
The definition of 'sufficient similarity' is not a simple one, because
we still do not understand what are the determinants of protein
structure. The parameter of sequence identity alone is not very
adequate unless other information is used, like length of the sequences
compared, biological activity, etc.. For sequences of over 80 amino
acids it is believed that identities of over 25% indicate the existence of
a common fold between both proteins (Sander & Schneider, 1991).
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However, some ancient protein families, like the aminoacyl-tRNA
synthetases, have common structures despite having sequences far
below 20% identical (Schimmel, 1987). It is clear from the existing
databases that the variability in protein folds is much smaller than that
found in the sequences, and the assumption that protein families that
share biological function, monomer length and significant sequence
identity will have similar three-dimensional folds is generally accepted
(Blundell et al., 1987). As discussed in the introduction the family of
the short-chain dehydrogenases complies with these three conditions,
and hence the availability of a crystal structure for a member of the
family made it possible and logical to try to model the structure of
Drosophila ADH on it.
The rationale of a modelling experiment starts by identifying the
sequence equivalences between the frame-structure and the protein to
be modelled. This is achieved through sequence alignment analysis and
by comparison of the secondary structure contents of the frame-
structure with the secondary structure predictions of the problem
protein.
Once the parts of the problem sequence that correspond to the main
secondary structure elements of the frame-structure have been
determined the process of building the three-dimensional model begins.
Firstly, the pieces of sequence of the problem protein can be fit into the
secondary elements of the structure taking into account their predicted
secondary structure, the distribution of hydrophobicity and charges, the
presence of residues normally found at definite positions in secondary
structure elements, etc. (Richardson, 1985).
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The result of this first exercise provides an initial base, over which
the parts of the problem sequence that showed poor relationships to the
frame structure have to be added. These sequences will normally
correspond to the loops connecting major secondary structure elements,
and the way of incorporating them will depend on the amount of three-
dimensional information available. In the cases where only one
structure is used as reference, loops with little sequence identity to the
original ones can be constructed through extensive database search
procedures, which will identify regions of the database with better
sequence identities and similar length and N- and C-terminal structural
positioning.
The result at this stage is a crude approximation to the final model,
which includes the total sequence of the problem protein, with large
numbers of incorrect angle and bond geometries, large steric clashes,
and many local structural incongruities.
The task of improving this first model is done by means of hand
refinement, energy minimisation, and molecular dynamics. All three
procedures try to correct errors in the structure, hand refinement can
be used to remove large steric clashes or improve the environment of
determinate side-chains. Energy minimisation is effective in reducing
the structural constraints and correcting angles and distances between
atoms at a local scale. Finally, molecular dynamics procedures are used
to search for a global minimal energy conformation for the whole
molecule.
Clearly the whole procedure must be monitored at all stages by
comparing the incoming results with biological data on the protein and
general data on protein structures, to ensure that no gross mistake is
incorporated at any point in the construction of the model.
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5.2 Modelling methods.
5.2.1 Sequence alignment procedures.
The direct comparison of DNA and protein sequences was initially
used by evolutionary biologists as a way to define pathways of
speciation. With the growth of the databases, the appearance of the first
three-dimensional structures of proteins and the growth of interest in
the molecular structure-function relationships of enzymes, the methods
of sequence comparison and alignment have become basic tools for the
detection of topological and functional similarities.
Several methods have been devised to carry out pair-wise and
multiple sequence alignment analysis (for reviews see Doolittle, 1990
or Argos et al., 1991). They differ in their way of scoring sequence
similarities and in the method of regulating the creation of gaps in the
sequence alignment. Changes in these parameters can largely affect the
sensitivity of the alignment procedure, while the characteristics of the
alignment algorithm will determine the computational efficiency of the
method.
However, the importance of correctly determining the proper
alignment parameters, which is usually a matter of experience,
increases with the phylogenetic distance between the compared
sequences , and with their difference in length (Argos et al., 1991). In
the case reported here, where the length of all the sequences compared
is very similar, the determination of the conserved residues is
straightforward, and no big differences in the alignment results could
be seen between different alignment methods.
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One pair-wise alignment algorithm (GAP, UWGCG package,
Devereux et al., 1984), and two multiple alignment programs
(PILEUP, UWGCG package, Devereux et al., 1984; and CLUSTAL,
Higgins & Sharp, 1988) were used for the final model construction. All
the sequences used were retrieved from either the Protein Information
Resource (PIR) databank (National Biomedical Research Foundation,
Maryland, USA), or from the Genebank (EMBL, Heidelberg,
Germany).
The alignment program GAP uses the Needleman and Wunsch (1970)
algorithm, which gradually searches all the possible alignment positions
by locating the sequences in a matrix and calculating the scores of all
possible residue pairs using the Dayhoff PAM matrix (Dayhoff et al.,
1983). Once this matrix is calculated the best alignment is found by
checking the pairs with higher scores, starting at the bottom right (the
last residues of each sequence) of the matrix. The penalties for gaps are
applied to the the pair scores, allowing breaks to be introduced only if
the final score of the pairing is still higher than without the gap.
The multiple alignment algorithms used in this project apply a pair-
wise system by which all possible pairs between all the sequences are
aligned, the best pair is chosen and the rest are added and aligned
successively by order of affinity to the first pair.
The search for the best possible alignment between Drosophila ADH
and the sequence of SDH (corresponding sequence to the frame
structure) was started by carrying out multiple alignment analysis of
several Drosophila ADHs, with the purpose of defining the conserved
parts of the sequence which, in turn, will correspond to the structural
core of the structure or to residues with a direct role in the catalytic
mechanism.
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Since the core of related protein structures tend to be more conserved
(Greer, 1981), the conserved sequences between the ADHs analyzed are
the parts of the enzyme's sequence that should have clearer equivalents
in the sequence of SDH. This expected conservation was then used to
analyze the result of the ADH-S alignment with the SDH sequence, to
search for significant alignment results.
5.2.2 Secondary structure prediction methods.
The prediction of the secondary structure contents of proteins from
their primary sequence has been attempted by many authors for the last
20 years (Lim, 1974; Chou & Fasman, 1978; Gamier et al., 1978;
Levin & Gamier, 1988; Gilbert, 1992).
The first, and still most widely used methods, use statistical analysis
of the tendency of each amino acid to appear at certain kind of
secondary structure type. The sequence, divided in short windows of a
few residues, is compared to these calculated values for each residue
and a prediction of structure is made on the basis of the score obtained.
The problem with this statistical approach is that is largely biassed by
the database used for the calculations, and that, considering the
sequence of the protein as a linear concatenation of residues, the effect
of long-range interactions is not taken into account. These algorithms
rarely manage to predict the correct conformation for more than 65%
of the total sequence analyzed, and the introduction of three-
dimensional information into the predicted algorithms has been
attempted recently, with promising results (Garratt et al., 1991;
Gilbert, 1992).
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In the process of molecular modelling the secondary structure
prediction of the problem sequence is a tool that, in conjunction with
the sequence alignments, is used to decide what parts of the problem
protein will be modelled into the secondary structure elements of the
frame structure.
To such purpose we used a protein prediction program (PREDICT,
E.E. Eliopoulos, University of Leeds, UK) that contains in itself six
different classical secondary prediction algorithms (Gamier et al.,
1978; Lim, 1974; Chou & Fasman, 1974; Nagano, 1973; Burgess et al.,
1974; Dufton & Hider, 1977). These prediction algorithms differ
among each other in the scoring matrices used to analyze the sequence,
the way they define secondary structure elements and the length of
sequence windows used for the analysis. PREDICT carries out each
individual prediction analysis and finds a consensus prediction based on
the overall results.
5.2.3 Model construction methods.
The process of building and manipulating the computer model for
ADH was done using the modelling package SYBYL version 5.4
(Tripos Associates Inc.), run on an Evans and Sutherland ESV10
workstation. The frame structure of SDH used in this project has only
been released to the databank in the form of a-carbon coordinates, so it
was necessary to build a proper protein backbone based on this
information. This is done using the 'backbone construct' facility of
SYBYL, based on a algorithm designed by Claessens and colleagues
(1989).
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This method uses a database of high resolution crystal structures to
search for fragments of 4 residues with total overall length equal to
groups of 4 contiguous a-carbons in the structure to be built. The
algorithm proceeds linearly, one residue at a time, from the N-terminus
of the structure, finding suitable groups of peptides which are then
further selected by comparing the distances between all the a-carbons
in the fragments to the ones in the protein being constructed. The best
fragments are kept and selected again on the basis of an RMS fit
between the equivalent a-carbons in the fragment and in the structure.
This method produces a protein backbone with an expected mean error
of 0.3 to 0.6 A.
Once the backbone was constructed the sidechains were added. The
procedure for the incorporation of sidechains does not rely in database
searching methods, as these will be extremely computationally
expensive. It relies rather in general conformational values and, as a
result, is expected to introduce a significant amount of error in the
structure (estimated by SYBYL manufacturers at -2.45A).
For the purposes of the construction of a protein model this is not a
very large problem. The correctness of the a-carbon coordinates is
much more crucial, as the side chains are directly substituted with the
problem sequence and steric clashes and high energy conformations
between rotamers can be lately removed by molecular dynamics (see
section 5.2.4).
Once the sequence of ADH had been fitted to the parts of the structure
suggested by the sequence alignments and the secondary structure
predictions, the sequences of ADH that had no identity with the SDH
sequence had to be incorporated to the model.
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These sequences invariably corresponded to connective structures
between helices and strands, and were constructed using a loop search
algorithm included in SYBYL. The loop construction procedure
requires an initial educated guess of which residues may constitute the
end and beginning of the particular pair of secondary structure
elements that are to be connected.
Once these have been established the program will search the database
of crystallographic structures for sequences that have the following
characteristics: same length as the sequence that is going to be
incorporated to the structure, similar relative three-dimensional
positioning of the residues defined as previous and following to the
loop sequence and sequence similarity to the sequence of the problem
protein. The program will produce the 25 loop structures that best fit
these parameters, and these can be then analyzed for coherence with the
adjacent parts of the model.
Every small modification made to the SDH structure was followed by
a cycle of energy minimisation, with the intention of eliminating
structural and steric constraints introduced during the previous stages.
This process calculates the energy state of each atom for each of its six
degrees of freedom (three translational and three rotational). The value
obtained, calculated in arbitrary units, is a function of the amount of
bad contacts and angles of each residue. The minimisation process used
in this project is a combination of an initial, non-derivative method,
which will work atom by atom reducing the energy of each of them
below a certain threshold followed by 100 cycles of a first-derivative
method known as steepest descent, which adjusts the coordinates of all
the atoms contemporarily, using the first derivative of the energy
equation for all the degrees of freedom.
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During the performance of this kind of energy minimisation the
electrostatic energies of the model atoms were not considered, because
their inclusion made the calculations far too intensive for the computer
power available. It is important to stress that these energy corrections
were only applied locally, during the process of construction of the
first complete model. These methods are not capable of searching the
entire experimental space for a protein structure, and are not adequate
for the searching of a global minima state for the model.
5.2.4 Molecular dynamics methods.
As argued in the last section, the methods of energy minimisation
used for local modelling operations are not powerful enough to find an
energy state of global minimum for the model. This is due to the fact
that this methods do not force the energy of the model up at any
moment, they just look for possible energy decreasing pathways from
the given conformation.
Molecular dynamics methods, in contrast, search the conformational
space of the structure analyzed in a much thorough way, by first
increasing the internal energy of the atoms of the models by thousands
of degrees. This sets the atoms in theoretical motion and, as they are
computationally cooled down, allows them to reach much lower energy
configurations (Karplus & Petsko, 1990).
The program X-PLOR (Brunger et al., 1987) was used for the
molecular dynamics calculations. Typically, the structure was subjected
to 200 iterations of energy minimisation to remove large steric clashes
before the molecular dynamics procedure. The dynamics analysis was
started by increasing the energy of the molecule to 2000 °K, followed
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by 34 steps of cooling where the temperature was decreased 50 °K at a
time, to reach a final 300 °K.
Although the inclusion of solvent in molecular dynamics calculations
is the recommended procedure (Gunsteren & Mark, 1992), water
molecules were not included in our calculations because the whole
modelling process was carried out in a single monomer. The reason for
this is that the modelling of a monomer-monomer interface is far too
complex to be carried out with sequences of low identity.
Because the protein surfaces involved in subunit interactions normally
have large amounts of hydrophobic residues (Chothia & Lesk, 1987)
the inclusion of solvent in the molecular dynamic calculations
performed in a single subunit will produce large structural shifts due to
the high solvation energy of the hydrophobic residues exposed in the
monomer-monomer interaction surface.
5.2.5 Quality assessment methods.
Unlike in protein crystallography, where the quality of a certain
crystal structure can be assessed by physical parameters like atomic
resolution or temperature factors, there is no experimental way of
quantifying the quality of a computer model. This problem of quality
assessment is a major one and attempts have been made to provide tools
that may allow to examine the likeliness of a model.
Some of them are classical crystallographic parameters, like the
Ramachandran analysis of the (p and (() angles of the amino acids
(Ramachandran & Sasisekharan, 1968), or the rational rules that
determine side chains orientations (Blundell et al. 1987); others rely on
the comparisons between the three-dimensional analysis of the
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environments of the residues of the model with the environments found
in crystal structures of the database (Liithy et al., 1992).
When biological data is available, as in the case of ADH, it can be
used to asses the likelihood of the final residues distribution, together
with the positions of variable and conserved parts of the protein
sequence.
The quality of the model obtained for ADH was studied using all the
methods mentioned. The Ramachandran analysis was performed using
SYBYL. The program PROFILE (Liithy et al., 1992), compares the
environment of each residue of the model to the normal environments
found for residues of the same type in the same kind of secondary
structure elements in the database of crystal structures. It produces a
plot that indicates the parts of the model where anomalous
environments are found, and these have been shown in various
examples to correspond to incorrectly constructed models. PROFILE
was used to analyze both the SDH structure and the ADH model
obtained for it, to check for regions of impaired quality.
The most important quality assessment made involved the contrast of
the biologic data described in the introduction chapter with the final
model structure. The residues known to have some role in the enzymes
mechanism can be checked for positioning compatible with their
expected role, and regions of the ADH sequence that are strictly
conserved, or largely variable, can be used to look for structural
incongruities (no variable sequences should be expected to be found in
the core of the structure, for instance).
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5.3 Results and discussion.
5.3.1 Sequence alignment and secondary structure predictions.
Results and discussion.
The sequence alignment used for the assignment of ADH sequences to
the SDH structure is shown in figure 5.3-1. The total identity between
the two sequences amounts to 21.5%, a value slightly lower than the
found by Sander and Schneider (1991) to be necessary to be able to
assume a common fold between two polypeptides. However, as
discussed along this thesis, there is good evidence to believe that both
enzymes share a common fold.
The similarity between both sequences is not uniformly distributed
along the alignment but rather clustered in 11 groups separated by
divergent patches of sequence or, in two cases, by gaps.
The distribution of this conserved clusters is identical to the one
found when ADH is aligned to 15-prostaglandin-dehydrogenase (figure
5.3-II), another member of the family, suggesting that the conserved
clusters may correspond to conserved parts of the structure of these
enzymes, possibly the structural core of the fold.
When the three sequences (ADH, SDH and 15-prostaglandin-
dehydrogenase) are aligned together the amount of similarity drops, as
it would be expected from a triad of enzymes that have evolved in
independent directions, but regions of higher similarity still appear at
the same positions of the conserved clusters between ADH and SDH
(figure 5.3-III). The comparison between the secondary structure
contents of SDH with the alignment results (figure 5.3-IV) reveals that
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Figure 5.3-1. Alignment results obtained from the sequences of ADH and SDH
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TTSKGIHFQDYDTTPFQAKTQ
ijDLGT LEAIQWTKHWDSGI
Figure 5.3-II. Alignment result of the comparison of the sequences of ADH
and 15-prostaglandin dehydrogenase (ProsDH) with the program GAP, using a

















































































Figure 5.3-III. Alignment results from the comparison of the sequences of
ADH, SDH, and 15-prostaglandin dehydrogenase (ProsDH), using the multiple
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Figure 5.3-IV. Alignment of the sequences of SDH and ADH as in figure 5.3-1.
On top of the SDH sequence the helical and extended regions of the structure
are indicated with circles and bars respectively. The same code, underneath the
ADH sequence, is used to show the results of the secondary structure
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Figure 5.3-V. Alignment of the sequence of ADH from D.
melanogaster with the conserved residues from the multiple alignment
of 25 Drosophila ADHs. All the regions of the Drosophila sequences
that have two or more conserved residues separated by not more than
one variable amino acid are boxed. The multiple alignment was done
with the program CLUSTAL. The conserved residues found between
ADH and SDH are marked at the bottom.
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Of the eleven clusters of conserved sequences that can be seen in the
alignment between ADH and SDH, seven are at the positions of the
seven strands of SDH. The strands of SDH account for only 20% of the
total sequence, so it can be considered significant that more than 50%
of the conserved residues between SDH and ADH falls into the strand
sequences.
It is very interesting to notice that of the six helices of SDH only one
shows some sequence similarity to ADH. This conserved helix (helix-E)
forms one of the main monomer-monomer binding surfaces in the SDH
tetramer, and the same region of ADH that shows identity to this part
of SDH constitutes part of the larges similarity cluster between ADH
and 15-prostaglandin-dehydrogenase. It seems to indicate that, with the
core of the protein, the region involved in this monomer-monomer
interaction has also been preserved in the family. Since ADH is a
dimer, this similarity is an indication of the possible location of the
monomer-monomer binding-site.
Figure 5.3-V shows an alignment of the sequence of Drosophila
melanogaster ADH (the sequence used for the model) with the
conserved sequence from the alignment of the 25 different Drosophila
ADHs available in the databases. The residues that are conserved
between ADH and SDH are also shown, and it can be seen that all the
regions of the sequence that have high identity with SDH correspond to
well preserved areas among ADHs. This seems to indicate that the
variable regions are the same between ADHs and short-chain
dehydrogenases in general, a clear suggestion of the existence of a
common fold for the whole family.
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All the secondary structure predictions of ADH published (Thatcher
& Sawyer, 1980; Benyajati et al., 1980; Ribas de Pouplana et al., 1991)
show an alternation of strands and at the N-terminal part of the protein
that was normally considered to correspond to the N-terminal domain.
In figure 5.3-IV the prediction done with PREDICT is superimposed
to the sequence alignment between SDH and ADH, and to the secondary
structure contents of SDH. In general, the predictions for ADH match
quite closely the structure of SDH for the first 100 residues. The first
divergence, appears at the sequences that match the helix-D of SDH.
This sequence has little similarity to SDH and is, in fact predicted as
extended structure. Helix-D of SDH forms also part of the monomer-
monomer binding surface, like helix-E, although contributing less
surface to the recognition.
From this position onwards the alignment of the secondary structures
of SDH with the predictions for ADH becomes less clear. The stranded
regions of SDH have clear equivalents in the predictions for ADH, but a
number of shifts are introduced in the predictions for the remaining
helical structures. The region with similarity to helix-E of SDH
contains a predicted helical structure of shorter length, this discrepancy
could be due to the special residue content of this part of the sequence,
which is very hydrophobic. The hydrophobicity of that fragment could
again be an indication of involvement in the monomer-monomer
recognition surface.
A region of similar length to the helix-G of SDH is predicted in ADH
with a shift nine residues. helix-G is delimited by the presence of
prolines at both its N- and C-terminal, as does the region predicted as
helix in ADH. The structure of SDH, between helix-G and the next
strand contains a large loop region that was poorly resolved during the
crystallographic study of the enzyme (Ghosh et al., 1991). The
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sequence of ADH that is aligned to that part of SDH, between residues
215 and 230, has a predicted helical configuration.
5.3.2 Structure modelling. Results and discussion.
Table 5.3.1 shows the fragments of the ADH sequence that, based on
the alignment and secondary structure prediction results were selected
to construct the main secondary structure elements of the model. As it
can be seen, the length of the secondary structure elements was not
necessarily conserved. Other parameters, mainly the presence of
prolines, alignment gaps or regions of poor sequence similarity, were
taken into account for the assignment of the length of a particular
element. The residues of the regions that are shown in table 5.3.1 were
directly substituted into the SDH structure and were locally refined to
remove steric clashes. Once the core structure was created the
connecting loops were searched using the method described earlier in
this chapter, the list of loops used in the model is shown in table 5.3.2.
The crystal structure of SDH revealed a large loop of 32 residues
between helix-G and strand-G (Ghosh et al., 1991). This region of the
enzyme is virtually impossible to model because that part of the SDH
sequence has no similarity to ADH, and it is far too long to use any
standard database search algorithms. Another part of the enzyme that
could not be modelled is the c-terminal end, after the strand-G. This
region provides very low electron density and has a very large
temperature factor in the SDH structure. Again, this region has poor
similarity to ADH, in fact, it appears to be a very variable region
among all short-chain dehydrogenases. These regions were simply
substituted with the sequence of ADH and energy minimized without
any further modification. It is important to mention at this point that
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the high temperature factor and the poor electron density of the c-
terminal tail of SDH suggests that this region may be undergoing large
structural shifts. The possible relevance of this fact will become
apparent later.
Once the whole polypeptide was constructed and local structural
incongruities removed by means of energy minimisation the whole
molecule was minimized with molecular dynamics, using X-PLOR. The
final fold of the model can be seen in figure 5.3-VI .

























18 9-LVHKFNSWLDVE-2 0 0
Strand-G 234-GAELA-238
235-KLDLG-239
Table 5.3.1. List of the secondary structure elements of the SDH
structure and the fragments of the ADH sequence used to substitute
them in the model.
The backbone of the ADH model has a mean structural difference of
1.6 A rms in respect to the backbone of SDH. Obviously the fold shape
is generally identical, and the process of modelling has not disrupted
the general hydrogen bond pattern of the proteins core, suggesting a
compatibility of the fold with the sequence of ADH. Apart from the
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low-electron density zones of SDH, the main differences between the
original stmcture and the model are at the regions of the loops between
strand-D and helix-E, between strand-E and helix-F and between
strand-F and helix-G, which is expected since these regions are the
ones that were constructed using the database search methods for loop
sequences. Large structural differences were introduced by the
dynamics procedure in the large loop between residues 200 and 230,
and at the C-terminal tail of the enzyme.
It is difficult to interpret the meaning of the structural features of the
ADH model. The sequence alignments and secondary structure
prediction analysis clearly suggest that the regions of higher sequence
divergence are located at the loop regions of SDH. That sequence
differences may not necessarily mean a large structural change in these
areas, and the results from the loop searching algorithm offer only the
more probable conformation for the sequences searched given the used
database. Table 5.3.2 shows the list os loop sequences constructed using
the loop search algorithm.
In general, the structural accuracy of a certain model is a direct
function of its sequence identity with the original stmcture (Blundell et
al., 1987), as a result the resolution of the ADH model is bound to be
low, and extreme care must be taken before linking its structural
features to functional properties of the enzyme.
However, the model can be tested with the biochemical data available
on the enzyme, and it may offer possible explanations to its catalytic
behaviour. This possible explanations can then be used as working
hypothesis for experimental tests, a possibility that is not existent at the
moment.
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Loop sequence Frame structure Arms % Identity
14-GLGI-17 1PYP 0.9 50
30-DLKN-33 8ADH 0.6 6
4O-IENP-4 3 1LZT 0.49 6
54-PKVTVTFY-61 5CPA 0.48 11
68-PIAE-71 3TLN 0.74 27
83-LKT-85
96-LDDHQIE-102 3ADK 0.72 25




17l-PITG-174 1PHH 0.57 46
182-PGITRTT-188
Table 5.3.2. List of the fragments of the ADH sequence used to
construct the loops connecting the secondary elements of the model.
The frame structure is the set of coordinates from which the best fitting
loop coordinates were selected. A RMS refers to the spatial difference
between the residues at the beginning and end of the loop region in the
model and the equivalent regions in the loop of the frame structure.
The identity value refers to the sequence identity between the loop
added to the model and the equivalent loop of the frame structure.
An indication of the soundness of the model comes from the position
on it of the parts of the Drosophila sequences that are not conserved
among ADHs. The analysis of variability carried out by Villaroya and
Juan (1991) was used for that analysis.
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The variable regions found by these authors accumulate at the furthest
possible position of the NAD binding site, mainly at the loops preceding
the helices of the structure (figure 5.3-VII). The regions of the model at
the C-terminal ends of helices, which construct the surface of the
structure that are meant to construct the active-site of the enzyme, are
highly conserved. The two largest helices of the model, D and E, are also
mainly conserved, but not so the region of the last strand of the model and
its preceding loop. Since the two large helices and the last strand form the
two main subunit contact surfaces of the SDH tetramer that difference in
conservation found in ADH may be of relevance for the identification of
the dimer interface, as will be discussed later.
Figure 5.3-VI. Ribbon representation of the general fold of the model.
(J-terminal tail
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Figure 5.3-VII. Analysis of the distribution of the variable regions of
Drosophila ADH sequences in the model for ADH. The variability
analysis of Villaroya & Juan (1991) was used to colour the regions
differentially. The regions were divided in 5 groups according to their
variability score.Totally conserved regions are in dark blue (score 0),
scores 1-4 are in pale blue, 5-10 in green, 11-15 in orange and highly
variable areas (more than 15) are in red. The NAD molecule in its
proposed positioning is in bright yellow. The bottom left view is over the
NAD molecule with the enzyme below it, the bottom right view is the
opposite, the enzyme being above the cofactor.
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5.3.2.1 NAD+ binding site. Results and discussion.
As discussed in the introduction, Ghosh and colleagues found that the
position of NAD+ in the SDH structure was far more external to the
positions found in other dehydrogenases. From their cofactor
positioning they suggested an steroid binding site that would include a
cleft that runs along the surface of the protein. Residues Tyr 152 and
Lys 156, conserved in all the members of the family, seemed to have a
simple role of recognition of the substrate, being too far away from the
cofactor to be able to participate in the catalysis. Ghosh and colleagues
proposed that residue Arg 16, which is only present in three other
short-chain dehydrogenases (Persson et al., 1991), could be involved in
catalysis.
The positioning of the NAD+ molecule in ADH in a similar position
as the one found in SDH leaves the nicotinamide part of the cofactor at
least 10 A away from any residue with catalytic activity. Since the
results of the site-directed mutagenesis experiments exposed in this
thesis and by others (Chen et al., 1990 and 1991) suggest a very
different positioning of NAD, it was attempted to find an alternative
location in the constructed model that could satisfy the range of
biochemical observations made on ADH.
The effect of the mutation at position G19, which selectively knocks
out activity with NADP+, suggested a binding more likely to that found
in medium-chain dehydrogenases. Similarly the results obtained
comparing the binding strength to NAD+ of ADH-S and ADH-F
suggest that the residue 192 is in the proximity of the cofactor. Also,
the results of mutating the residue Tyr 152 (Ensor and Tai, 1991;
Albalat et al., 1992) suggest that this residue can be involved in
catalysis.
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A molecule of NAD, in a similar conformation to the one described
by Ghosh and colleagues as bound to SDH, was used to try different
positionings that could agree with an structural proximity of all the
mentioned residues to the cofactor molecule. A rotation and translation
movement of the cofactor, without modifying its conformation, was
enough to locate it in a position where the carbamide atom of the
nicotinamide ring finds an environment typical of a non-metal
dehydrogenase active site (Adams, 1987). Figure 5.3-VIII shows the
environments of the NAD+ molecule in this conformation.
The loop between residues 39 and 46 interacts with the adenine ring
and its adjacent ribose. The strand preceding that loop, together with its
following helix and the strand formed by residues 92 to 94 form a cleft
that could accommodate both the adenine ring and its ribose.
Their extension of burial inside the cleft is difficult to determine, but
seems probable that the adenine ribose may pack against the
hydrophobic lie 40, Val 12 and Ala 93, which form the bottom of the
cleft, this environment is similar to the one found in other
dehydrogenases, like malate dehydrogenase (Grau, 1982).
Unfortunately it is not possible to decide whether the ribose may be
hydrogen bonding to residue Asp 38 or to Glu 41, as it would depend
in its position inside the cleft. If this positioning of the cofactor is the
correct one, the residue Asp 64, proposed by Jornvall and collaborators
(Persson et al., 1991) as the one responsible for hydrogen bonding to
the ribose, is too far away to carry out this function.
The ribose of the adenine moiety of the cofactor, and the first atoms
of the pyrophosphate are in close contact with the loop from residues
11 to 19. This is the polyglycine loop characteristic of all nucleotide
binding domains. The residues 12 to 15 of the loop bend inwards
creating a a pocket close to the ribose, capable of accommodating a
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phosphate group as the one in NADP+. Figure 5.3-IX shows this loop
with the cofactor. Residue Gly 14 is at the bottom of the pocket
mentioned, pointing outwards. The incorporation of a methyl group by
mutating residue 14 to alanine seems likely to produce steric clashes
with the neighbouring loop at about position 40, but the methyl group
is well accommodated by the loose packing around residue 14 itself.
In contrast, Gly 19 is in very close packing to the backbone of
residues 12 and 13, and the introduction of a methyl group at its
position could distort the overall structure of the loop, especially the
pocket created by residues 12 to 15. That may be able to explain the
inability of the ADH G19A to use NADP+, because its perturbation of
the loop may be enough to make impossible the accommodation of the
phosphate group of that cofactor.
This may also be the reason for the difference found in AAG of
NAD+ binding between the two enzymes. While ADH G14A has a AAG
value of NAD+ binding similar to the wild type enzyme, in ADH G19A
this energy is reduced by 90%.
Maybe this is due to unfavourable interactions caused by the larger
perturbation of the mutation G19A compared to G14A. Although both
glycines at positions 14 and 19 are conserved among all the short-chain
dehydrogenases (Persson et al., 1991), an exception exists among the
Drosophila ADHs, the enzyme from D. lebanonensis having an alanine
at position 14.
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Figure 5.3-VIIL The suggested environment of the NAD molecule
in the ADH model. The ribbon diagram alsho shows the Van der
Waals surfaces of Lys 152 (yellow) and isopropanol (green).
Figure 5.3-IX. The modelled polyglycine loop and the possible effect of
the mutations G14A and G19A. the top images show different
perspectives of the loop with its original sequence and the Van der Waals
surface of A13, G14 and G19. The bottom views are identical except for
residues 14 and 19, which are now alanines.
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Another part of the model in contact with this adenine moiety of the
cofactor is the sequence Gly-Ala-Gly, at positions 92 to 94. The Ala-
Gly sequence is conserved in 17 of the 20 sequences of short-chain
dehydrogenases aligned by Jornvall and colleagues (Persson et al.,
1991), and the three residues are totally conserved among all the
Drosophila enzymes. These three residues form part of the strand-D of
the model, and they role is probably the same postulated for the Gly-
rich loop of NAD+ binding structures, that is to produce the space to
allow the cofactor to enter the binding pocket (Branden et al., 1975).
Such recognition role for these residues has not been proposed so far,
and it should be tested by mutating these sidechains to bulkier ones that
may affect the binding of the cofactor without modifying the extended
conformation of this part of the molecule.
The rest of the pyrophosphate groups and the ribose of the
nicotinamide moiety have major interactions with the loop formed by
residues 182 to 190, the residue Thr 185 is at 2.5 A of the hydroxyl
groups of the ribose, and could hydrogen bond to them. The structure
of this loop is interesting for two reasons. Firstly, the residue 192,
responsible for the difference between ADH-F and ADH-S as it changes
from threonine to lysine, modifies the strength of recognition of the
cofactor. In this model, residue 192 is located at the exterior part of the
first turn of the helix that follows the 182-190 turn.
In this position a direct interaction between that residue and the
cofactor seems unlikely, and an explanation of the effect of the
mutation is not simple. A possible reason could be an interaction
between the residue 186, an arginine that points towards the exterior of
the loop, and the residue at position 192. But such theory is pure
speculation and would require several mutagenesis experiments of the
residues in the area to be properly analyzed.
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Secondly, the loop at this region is of interest because it has a striking
similarity with a region of bacterial lactate dehydrogenases also
involved in the catalytic mechanism. The region between residues 100
to 120 of the lactate dehydrogenase enzyme form part of the highly
mobile loop that directly participates in catalysis through closure over
the active site (Parker & Holbrook, 1977).
The analysis of the sequences of this loops in various lactate
dehydrogenases done by Gernstein and Chothia (1991) shows a high
degree of sequence conservation between the loops of bacterial
dehydrogenases. As can be seen in figure 5.3-X, the region between
182 and 190 of ADH shares a high similarity with that region of lactate
dehydrogenase. It also shares a similar three-dimensional function,
connecting an internal strand of the nucleotide binding fold to an
external helix. In lactate dehydrogenase the loop in question closes over
the active site, removing water, and allowing the reaction to proceed
(Parker & Holbrook, 1977).
B. stearo. LDH AGANQl PGETRLDLVDKniaifrs
B. meaat. LDH AGANQ7 PGETRLDLVEB nvxifex
L. casei LDH AGAPKC PGETRLDLVN1 lnkilks
k k k • kkkkkkkkkkk k •
Drosophila ADH 176- TAYTVIS PGITRTTLVH? fnswldv-199
: ; * * * * . * * . 7k • •
Figure 5.3-X. Alignment of the sequence of the catalytic loop of
various bacterial LDHs (modified from Gernstein and Chothia, 1991)
with the sequence of Drosophila ADH around residue 192.
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The similarity between these two protein regions may be not
significative, but it is tempting to speculate that ADH may have a
similar loop-closing mechanism. Clearly, all dehydrogenases require
structural shifts to exclude water from the active site and allow the
proton transfer reaction to occur.
The two domains of horse liver alcohol dehydrogenase close over
each other to allow water exclusion (Eklund & Branden, 1987), but
smaller enzymes like lactate dehydrogenase use smaller structural
shifts. Perhaps the 182-190 loop, maybe with other structures in the
enzyme, undergoes similar structural shifts, closing over the region of
the nicotinamide ring of the cofactor, and excluding water. In such
situation, the effect of change at position 192 may have a different
implication, as it may be affecting the dynamics of the loop.
In the binding position being described, the nicotinamide ring of the
cofactor lies over a set of hydrophobic residues, namely lie 95, Leu 96
and He 137. The C-4 of the ring gets in close proximity to residues Lys
156 and Ser 139, also in the vicinity of the nicotinamide ring are
residues aspartic 97 and tyrosine 152. Although the conformation of
this last sidechain seems to point its OH group in a different direction,
the definition of the model is not good enough to provide information
about the real conformation of the sidechains. Although the process of
molecular dynamics can find the minimal energy conformation for
them, a conformation of the tyrosine pointing towards the nicotinamide
ring of the cofactor can not be ruled out.
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5.3.2.2 A reaction mechanism hypothesis.
As described in the introduction a number of residues are good
candidates to participate in the catalytic mechanism of ADH. The
chemical modification of one of the four histidines of ADH results in
the inactivation of the enzyme (thatcher, 1981; Retzios, 1982). Of the
four histidines only three are totally conserved, at positions 191, 210
and 250.
In the model presented here His 210 is not in the proximity of the
active site of the enzyme, His 191 is the same helix as Lys 192, and its
chemical modification could have a certain effect on the interaction of
its preceding loop with the cofactor but the residue does not directly
interact with either cofactor or substrate. On the other hand His 250 is
part of the C-terminal tail, a region of very little sequence similarity to
the SDH sequence, and which, in the latter, and on the basis of its poor
electron density, is probably a largely mobile structure.
Using pH dependent kinetics, Winberg and colleagues identified a
group in the enzyme which, in the range of pH 6-10, shows different
effect on the binding of the alcohol or aldehyde. The binding of
acetaldehyde is not affected in that pH range, but that of isopropanol is
destabilized by a residue with a pK of 7.6 (Winberg & McKinley-
McKee, 1988).
Winberg and colleagues propose the existence of a group that binds
the hydroxyl of the alcohol and the oxygen of the acetaldehyde, and
which has a pK of 7.6 when bound to the former, and one over 10
when bound to the latter. The four candidates proposed for such
behaviour are histidines, tyrosines, lysines and cysteines. Cysteines,
however have been shown to play no role on the activity of the enzyme
by site-directed mutagenesis (Chen et al., 1990).
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The two best known classes of dehydrogenase reactions are
epitomized by horse liver alcohol dehydrogenase and by lactate
dehydrogenase (Adams, 1987). The former uses zinc in the active site
to act as a Lewis acid and catalyze the proton transfer reaction (Eklund
and Branden, 1987), the latter does not have any metals and rely on a
histidine group which, in the dehydrogenase reaction, removes the
hydrogen of the lactate's hydroxyl (Parker & Holbrook, 1977), the
limiting step of that reaction is the dissociation of the reduced cofactor,
which depends on the opening of a mobile loop of the enzyme that
covers the active site.
Drosophila ADH contains no metal ions, and the limiting step of its
reaction is also the dissociation of NADH (Thatcher, 1981; Winberg et
al., 1986), the similarity to the lactate dehydrogenase mechanism also
extends to clear structural identity between lactate and isopropanol.
However, the pH dependence of ADH seems to be more similar to horse
liver alcohol dehydrogenase than to lactate dehydrogenase (Winberg
and McKinley-McKee, 1988).
The proposed binding position of NAD+ in the computer model for
ADH clearly delimited a possible active site space (figure 5.3-XI). The
analysis of this space showed an striking similarity with the three-
dimensional arrangement of the lactate dehydrogenase binding site.
In this hypothetical reaction centre lysine 156 and aspartic 97 are
aligned in a very similar positioning to that of arginine 109 and aspartic
168. No histidine residues are present in that region of the molecule,
but the C-terminal tail of the enzyme is in the vicinity, and histidine
250 could easily reach the active site in the right angle if the C-terminal
tail closed over the proposed catalytic centre (figure 5.3-XII).
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Figure 5.3-XI. Photograph of the space around the carbamide group
of the NAD+in the model. The isopropanol molecule placed in the
active site is shown.
Figure 5.3-XII. Representation of the proposed closing of the
C-terminal tail of the enzyme over the active site.
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An attempt was made to locate an isopropanol molecule in the right
positioning in respect to the C-4 of the nicotinamide ring, and no steric
clashes or conformational constrains were found that prevented such
orientation. In this positioning one can propose a theory for a reaction
mechanism involving residues aspartic 97, lysine 156 and histidine 250,
which would be essentially identical to the reaction mechanism of
lactate dehydrogenase (Parker & Holbrook, 1977; Clarke et ah, 1989).
We propose that the cofactor binds first and somehow modifies the
environment of the active-site allowing it to receive the substrate
molecule (lysine 156 hydrogen bonds to the oxygen of the substrate's
hydroxyl) and triggering the closing of the C-terminal loop over the
reaction centre. Histidine 250 acts then as a general base binding to the
hydrogen of the alcohol's hydroxyl group, and promotes the hydride
transfer to the NAD. The imidazolium ion is stabilized by aspartate 97.
Once the dehydrogenase reaction is complete the loop opens its
conformation, perhaps due to electrostatic repulsion with NADH and
the products are released. Having lost the stabilizing effect of Asp 97,
His 250 loses its proton to the solvent, and the reaction is repeated
(figure 5.3-XIII).
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Figure 5.3-XIIIa. First step of the proposed reaction mechanism for
Drosophila ADH. The NAD+ molecule enters the active site followed by
the alcohol, which is stabilized by hydrophobic interactions and by a
hydrogen bond with the residue Lvs 156.
Figure 5.3-XIIIb . The C-terminal loop closes over the active site and
His 250 acts as a general base promoting the hydride transfer to NAE)t
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Figure 5.3-XIIIc. The product ketone is formed by transfer of the
proton of the hydroxyl to His 250. The imidazolium ion formed is
stabilized by Asp 97.
Figure 5.3-XIIId. The C-terminal loop opens and products dissociate
from the enzyme. The imidazolium ion looses the stabilizing effect of Asp
97 and deprotonates.
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This reaction mechanism offers explanations for the effect of
chemical modification of histidines, and for the rate-limiting effect of
the release of NADH, as this would be a function of the opening of the
C-terminal loop, also, all the residues involved are totally conserved in
all the ADHs sequenced so far.
It should be stressed, however, that this reaction mechanism can not
apply to all the group of short-chain dehydrogenases, because the
residue His250 is not conserved in the family (Persson et ah, 1991).
Whether this is due to the existence of different kinds of reaction
mechanisms in short-chain dehydrogenases, to the fact that Drosophila
ADH does not use His250 in its reaction mechanism, or to different
positionings of catalytic His residues in different members of the family
will require further investigation.
The positioning of the isopropanol molecule, which is highly
determined by the presence of the cofactor and other sidechains, is such
to pack the methyl groups of the substrate against residue 140, a valine
also conserved in all ADHs. This is consistent with the observations of
Winberg and colleagues, which lead them to believe that each methyl
group of the substrate interacts with a hydrophobic group of the
enzyme. Tyrosine 152, is part of the active site architecture, and it
could be hydrogen bonding to the cofactor. Although its mutation to
phenylalanine inactivates the enzyme (Albalat et al., 1992) that could be
due to non-specific perturbations of the active site structure.
Holbrook and colleagues (Clarke et al., 1989) have studied the
reaction mechanism of lactate dehydrogenase with a series of site-
directed mutants whose effects were found to be highly predictable
using their reaction mechanism.
The same kind of analysis, helped by the model, should be undertaken
to prove or dismiss the hypothetical reaction centre proposed here.
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5.3.2.2 Monomer-monomer binding site. Results and discussion.
The three-dimensional structure of SDH shows that the four subunits
forming the tetramer assemble through two main interactions. One is
formed through the antiparallel pairing of the last strand of the fold of
two subunits, forming a twisted sheet of 14 strands that runs along two
subunits. This type of interaction is similar to the assembly method of
horse liver alcohol dehydrogenase (Eklund And Branden, 1987), where
the two nucleotide-binding folds are joined to form the dimer.
The other main interaction involves the pairing of helices D and E
against the same helices of another subunit. Each helix runs along its
equivalent helix, creating a two-fold axis of symmetry. The most
important of this is the contact between helix E and its preceding loop,
with themselves. In this interaction less important contacts exist
between the large loop following helix-G of one subunit with the C-
terminal tail of the other subunit.
ADH is a dimer, and if, as suspected, shares a common origin with
SDH, it is reasonable to expect that its monomer-monomer binding site
will be one of the two found in SDH. If this is accepted, then a certain
sequence similarity between the common recognition sequences is also
expectable, while the region that serves as monomer-monomer binding
site only in SDH will probably have evolved differently, as it has
different constrains in each of the enzymes.
It is obvious from the alignments shown in figures 5.3-1 and 5.3-II,
that the region at the C-terminal of both enzymes is highly divergent,
while there is a region of high similarity between positions 127 to 170
of the ADH sequence. The last twenty-odd residues of that region
correspond to the helix-E of SDH, being one of the helical regions of
SDH with highest identity with a sequence of ADH.
192
The similarity in this region is even higher between ADH and
prostaglandin dehydrogenase, making that region of the sequence the
most likely subunit interaction area of ADH. The construction of the
dimer was attempted by duplicating the model structure for the
monomer and assembling the two monomers with the same orientation
of their helices E as the one found in SDH (figure 5.3-XIV).
Interestingly, the regions modelled as helices D and E in ADH have a
large number of hydrophobic residues, that can not be organized in the
normal amphiphilic distribution of helices on the surface of proteins.
This abundance of hydrophobic residues may be the reason why the
secondary structure predictions of this part of the enzyme has a
prediction for strands, despite being aligned with parts of SDH that are
helical. The abundance of hydrophobic residues is also consistent with a
monomer-monomer binding role, as this kind of surfaces are very rich
in hydrophobic-hydrophobic interactions (Richardson, 1985).
Once a model dimer of ADH is constructed in this way the main
features of the interactions between the two monomers are as follows :
The main helix-helix interaction is that of helix-E, with its N-terminal
loop. The loop of one monomer interacts with the C-terminal end of
the same helix of the second monomer, through a hydrophobic packing
of the residues Val 149 and Pro 150 of the loop with Leu 166 and Leu
169 of the helix. With the exception of D. affinisdisjuncta and D. picta
(where the residue Leu 166 is isoleucine), the four residues are
conserved among the 25 ADHs aligned.
A second hydrophobic interaction between the central part of the pair
of helices-E seem to occur between residue Phe 162 and Gly 154,
residue 162 is conserved in all ADHs, and in prostaglandin
dehydrogenase, residue 154 is a glycine in half of the sequences and an
alanine in the rest, including prostaglandin dehydrogenase.
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At the middle point of this helices interaction, residues Ala 157 and
Ala 158 pack against their equivalents in the other helix, both residues
are also conserved among all ADHs. Finally, the sidechain of Ser 165 is
at hydrogen bonding distance (2.9 A) of the Gin 148 sidechain of the
pairing helix, both residues are also totally conserved, with the
exception of D. mojavensis, where position 148 is a proline in the
enzyme encoded by the second Adh gene of this species.
The second helix-helix interaction is the antiparallel pairing of helix-
E. In this case a very interesting combination of hydrophobic
interactions occurs. Helix-E has three pairs of hydrophobic residues
pointing out of the enzyme's core, Leu 112 and Val 113, at the N-
terminus of the helix, lie 105 and Ala 106 at the middle and lie 119 and
Leu 120 at the C-terminus. At the pairing of the helices the first pair of
residues faces the last pair of the other helix, while the middle pair
packs against its equivalent. The middle pair, He 105-Ala 106 is
conserved through all the ADHs, but the other two pairs are not.
Half of the sequences of the aligned ADHs have Leu-Val as first pair,
while the other half have Thr-Val, and exactly the same half that have
Leu-Val as first pair has Ile-Leu as third pair, while the rest have now
lie-Met.
Clearly, if the interaction between the two helices is totally
symmetric, the first residue of the first pair will face the second residue
of the third pair, and vice-versa. And it is highly interesting to see that
the enzymes where the first residue of the first pair is hydrophobic
(Leu), have a hydrophobic residue as second amino acid of the third
pair, while the enzymes where the first residue of the first pair has
hydrogen-bonding capabilities (Thr), have a second residue of the third
pair with the same capacity (Met).
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This suggests that the evolution of this amino acids may have been
coupled, perhaps to ensure optimal arrangement of the sidechains at this
interaction. It would be interesting to check whether the two groups of
enzymes differ in strength of monomer-monomer association.
Finally, the association of the models suggests the possibility of
interactions between the C-terminal tail of one monomer with the large
30-residues loop between helix-G and strand-G, from positions 200 to
230. This suggestion would be too weak to be mentioned if it was not
the only simple way to explain the effect of the mutation P214S on the
stability of the enzyme.
The residue 214 of the model, located at the mentioned loop, is too
far away from the core of the enzyme, or from the active site of its
own monomer for the effect of its change to serine to be easily
explained. If, however, the loop that contains it is interacting with the
other subunit of the dimer, the change in stability due to the mutation
may be related to the strength of that interaction. Clearly, further
experimentation will be necessary to test this possibility.
Figure 5.3-XIV. The modelled ADH dimer from two perspectives.
An NAD*molecule is added to each monomer at their proposed location.
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5.3.2.4 Assessment of the structural correctness of the model.
The compatibility of the model with the existing biochemical data on
ADH has been discussed in the previous sections of this chapter. Other
methods of assessment that are independent of biological function were
used to test for structural incongruities in the proposed model.
The Ramachandran plot of SDH shows six nonglycine residues in non
allowed regions of the plot (Ghosh et al., 1991), all belonging to loop
areas of poor electron density. The model of Drosophila ADH has 21
residues in non allowed regions of the plot. Of these, eleven are located
at the large loop preceding strand-G, which could not be modelled. Six
are at the C-terminal tail, which was not modelled either, and the 4
remaining ones are distributed in three loop regions. That result
indicates that the two non-modelled regions of the structure probably
have very different conformations to SDH.
A more sophisticated method of assessing the structural correctness of
a protein structure has been devised recently by Liithy and colleagues
(Liithy et al., 1992). The method, included in the program PROFILE,
tests the structural likeliness of a set of coordinates by checking the
environment of each residue and comparing it to the average
environments found for residues in the same three-dimensional
positioning in a database of high-resolution structures.
A set of 20 parameters is used to define each residue, and its
environments are defined by three parameters: the area of the residue
that is buried, the fraction of the side-chain area that is covered by
polar atoms (O and N) and the local secondary structure.
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The compatibility of segments of the sequence with their assigned
three-dimensional structure can be assessed by plotting the average
score of each residue (in a window of defined length) against the
sequence number. The method has been proven able to discriminate
between correct models and misfolded proteins (Liithy et al., 1992),
and to detect mistaken regions of crystallographic structures. As an
average the authors found that correct models scored generally above
0.2 all around the sequence, and never had negative values (figure 5.3-
XV).
The scoring plots calculated by the authors for various proteins shows
a large variability in the score along their sequences. This is expectable
since the method, albeit more sophisticated and thorough than the other
assessment techniques, still relies in the statistical occurrence of certain
kind of environments and their variability in the database used. Regions
that are highly constrained structurally in the database are likely to give
extreme scores, because the similar regions of the model will either fit
the database largely or present large differences, in contrast variable
structural domains may show a more graded score as different levels of
similarity may be encountered. Seemingly, protein regions that are
poorly represented in the database may give systematical low scores,
their low frequency being interpreted as structural errors.
Although the authors do not discuss the statistical bias that the
database used may be introducing in the analysis, it is reasonable to
expect that regions were the environments of residues are not constant,
like subunit interaction regions for instance, will score low values,
while regions like B-sheets, where the packing of side-chains follows
general and abundant patterns, will be judged with higher accuracy.
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The results obtained on the SDH structure constructed from the a-
carbon coordinates are shown in figure 5.3-XV. The plot shows large
fluctuations in the scores obtained along the sequence.
Since the side-chain environments were constructed artificially it is
difficult to use this analysis to asses the quality of the structure,
however the side-chains were added in a knowledge-based way, and
regions with low scoring may be indicating regions of the enzyme were
the structure shows peculiarities. On the other hand the regions with
higher scores probably correspond to regions of the molecule were the
side-chains have been correctly constructed thanks to a regular
backbone fold. 110 residues (43% of the total sequence of SDH) has
scores below 0.2, which would be considered a sign of misfolding,
although such conclusion can not be reached here, as discussed earlier.
Three regions (residues 55-70, 90-105 and 188-192) score below zero
with some or all of the window lengths used for the analysis (see figure
5.3-XV, and figure 1 -I, page 12, for the structure of SDH). The first of
them corresponds to strand C, which is partly exposed. The other two
regions correspond to loop regions at the C-terminal ends of strands D
and F. The regions scoring above 0.2 cover regions 10-35, 75-85, 115-
180 and 200-210. This covers the majority of the sequence that forms
the internal B-strands of the monomer (not the last strand, G), helices
A, C, part of helix D and helix E. The initial region of the large loop
between residues 202-234 scores also above 0.2, but the quality of the
model decreases steadily from then on.
The length of the window used to analyze the structures is arbitrary;
although the authors of the program suggest a window of 21 residues
I could find no significant differences in the overall shape of the plot
using windows of 15, 20, 25 or 30 residues. The plots shown in this





Figure 5.3-XV. PROFILE plot for the SDH structure used as basis for
the modelling of ADH. Protein sequences form the X axis and the score at
each position the Y axis.




Figure 5.3-XVI. Comparision of the PROFILE plot for SDH (dark
line) with the plot for the ADH model (lighter line). Protein sequences
form the X axis and the score at each position the Y axis.
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The external regions of the structure generally perform worse than
the internal ones, and regions in the two main subunit interactions of
the tetramer have scores below 0.1 (residues 90-110 which correspond
to helix D and its preceding loop, and 230-245 which cover the last
strand of the structure), confirming the possibility that regions with
peculiar structural constraints may be underscored by the program.
The comparison of the PROFILE plots for ADH and SDH (figure
5.3-XVI) immediately shows that both structures behave in a very
similar way along their sequences although the score for the ADH
model is consistently lower ( by a difference of about 0.1) than that for
SDH.
A possible interpretation of this behaviour may be the following : the
construction of a model of ADH based on the SDH structure can
introduce two main kind of architectural errors: firstly, errors of
ineffective packing, that is regions where the general fold of the model
is correctly similar to the frame structure but minor changes in the
environment of the side chains have not been well accounted for, and
produce a general all-along decrease in the quality of the final
structure; secondly, gross errors of folding, where the final model is
largely incorrect, due to big differences between the frame structure
and the real architecture of the modelled enzyme.
The first kind of error may be expected to produce a uniform
decrease in the score of the model as calculated by PROFILE, but the
general pattern of the plot would stay similar because the sequence of
the model is equally suited to its fold as the one of the original
structure.
In the second case, however, one may expect large changes in the
pattern of the plot, because as sequences that actually create different
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kinds of folds are compared, their suitability for the measured structure
will be very different.
The region between residues 10 to 85 of SDH and ADH seem to show
the first kind of error in the model. The pattern of both plots is largely
the same, but the ADH model accumulates a constant amount of penalty
which may be assigned to small mistakes in the side-chain packing. The
region between residues 90 and 140, is the best performing one in both
enzymes, and buy very similar values.
The region 140-190, where the hypothetical active site of ADH has
been proposed (see 5.3.2.2) displays again a parallel behaviour between
SDH and ADH, but the difference between the score of both models is
here of about 0.2 in favour of SDH.
Between residues 190 and 225 a difference in the pattern appears, and
the score of ADH continues to fall while SDH improves in the plot.
This is what one would expect in the second kind of mistake discussed
earlier, and it is very interesting to see this happening in the part of the
sequence that covers the large loop between residues 200 and 230,
which has already been described as a largely unmodelable region, due
to its highly undefined nature. Very significantly, the quality of the
ADH score rises again when the sequence of the modelled last strand
comes along, between residues 235 and 239, reaching similar values to
SDH in this zone.
If the interpretation of the differences between both plots discussed
earlier is correct, the differences found in the PROFILE analysis of
SDH and ADH suggest the following conclusions :
- The general fold of SDH is compatible with the sequences of ADH
that have been assigned to it, although a certain amount of systematical
error is introduced mainly in the regions 10-85 and 140-190.
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- The region between residues 85-180 of ADH seems correctly
folded, implicating that the whole N-terminal region of the model up to
residue 180 has been correctly assigned to the sequence of ADH.
- Although the profiles follow the same pattern a large difference of
about 0.2 exists between both structures in the region 140-180, this is
the region proposed as active site of ADH. The difference may be due
to different functionalities of that part of the structure between both
enzymes, and/or to mistakes in the final packing of the side-chains of
ADH in that area.
The fact that helix-E, the main subunit interaction surface of the
proposed ADH dimer, is in this part of the structure may be another
reason for the divergence, as the orientation of the residues of this helix
is difficult to define in the model.
- The loop region between residues 200-230 is probably wrong in the
model, and this region of ADH may be very different to the equivalent
area of SDH. That was suggested too by the Ramachandran plots of the
ADH model.
Finally, the sequence assigned to the last strand of ADH is probably
correctly located, as it reaches a similar score to the one obtained by
the SDH structure in the same region. Unfortunately nothing can be
said about the C-terminal tail of the enzymes, because the window
regions used for the analysis leave the values for the first and last
residues of the plot without any meaning.
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6. Final conclusions and future work.
1- A suitable system for the mutagenesis and expression of Drosophila
ADH in yeast has been devised and a fast and simple method for the
purification of ADH from yeast cells has also been produced. The
method has been used to purify wt ADH, and three of the four mutant
enzymes studied, to homogeneity. The method should be modified to
improve the purification of the enzyme ADH D38A.
2- The sequence of the chimeric gene used for the expression of ADH
was obtained and several unreported mutations were found. One of
them encodes for a new amino acid difference in the enzyme, which
does not seem to have any effect on the functional characteristics of the
protein.
3-A denaturation assay, coupled to enzyme activity determination, for
the calculation of the AG(water) values of the enzymes and the AAG
effect of cofactor binding was devised. The assay, and circular
dichroism measurements were used to study the denaturation of
Drosophila ADH-F, ADH-S, horse liver ADH and yeast ADH (see
paper attached).
4-Four different site-directed mutations were introduced in ADH.
The mutant enzymes were totally sequenced, expressed in yeast,
purified and analyzed kinetically. Their AG(water) values and the AAG
effect of cofactor binding were calculated for all of them. They were
also analyzed for their resistance to thermal denaturation.
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5- The mutation performed in residue P214 confirms that the thermo¬
stable effect that this mutation confers to the isoenzyme ADH-F can be
transfered to an ADH-S isoenzyme reproducing the P214S change. The
mutation G19A was found to knock out detectable activity with NADP,
suggesting a positioning of the cofactor that is in contradiction with that
found by Ghosh and colleagues (1991) in the structure of SDH.
Similarly the mutations at positions 14 and 38 confirmed the
importance of that part of the molecule for the recognition of NAD.
The results obtained complement and confirm other work published
during the development of this thesis on the importance of residues
G14, and D38 of ADH in the recognition of NAD.
6- Based on the structure of SDH a computer model was constructed
to try to find structural explanations for the observed effects of the
mutations introduced. The model is largely compatible with the
existent biochemical data on the enzyme. The positioning of NAD+
supported by the results of the G19A mutation suggests a well defined
possible active site. A reaction mechanism based on that putative
reaction centre is proposed. The mechanism is very similar to that of
lactate dehydrogenase, and would involve the closure and opening of
the C-terminal tail of the enzyme which carries the proposed catalytic
residue H250.
7- A possible monomer-monomer interaction site was identified in
ADH, and a hypothetical model of the dimeric structure was
constructed.
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The project presented here describes the set-up and initial utilization
of a general system for the study of an enzyme. There are several ways
in which the project may be continued:
1 - If large quantities of the enzyme are desired for the production of
crystals the expression system should be optimized, possibly by
attempting the expression of the enzyme in bacteria.
2- The structural model presented in this thesis does now suggest a
larger number of residues that can be studied for their possible role in
the mechanisms and structure of the enzyme. This is a significant
improvement as it introduces a rational basis to the design of further
ADH mutants. A number of mutations can now be introduced to test
the hypothesized active-site and the monomer-monomer interaction
surface, the recognition mechanism of NAD, the broad substrate
specificity displayed by the enzyme, the function of the region around
residue 192, and the role of the large loop at the region 200-235.
3- The model itself should be improved as better data for SDH
becomes available. An improved model might be used efficiently for
the application of molecular replacement techniques to the existing
crystallographic data on ADH.
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Structural properties of long- and short-chain alcohol
dehydrogenases
Contribution of NAD+ to stability
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Structural studies were undertaken on long-chain and short-chain alcohol dehydrogenases (from horse liver and
Drosophila respectively). Far-u.v. c.d. measurements were used to estimate the secondary structure contents of the
enzymes. For the horse liver enzyme, the results agree well with the X-ray data; for the Drosophila enzyme (for which a
crystal structure is not yet available), the results are in good agreement with those obtained by applying a range of
structure-prediction procedures to the amino acid sequence of this enzyme. The conformational stabilities of the two
enzymes were investigated by studying the unfolding brought about by guanidinium chloride (GdnHCl) by using activity
and c.d. measurements. The unfolding of the Drosophila enzyme was analysed in terms of a two-state model; the presence
of the substrate NAD+ leads to considerable protection against unfolding. By contrast, the unfolding of the horse liver
enzyme shows a plateau effect at intermediate concentrations of GdnHCl, indicating that a two-state model is not
appropriate in this case. NAD+ affords little, if any, protection against unfolding for the horse liver enzyme.
INTRODUCTION
Alcohol dehydrogenases (ADH; EC 1.1.1.1) are enzymes
that occur widely across the range of living organisms, where
they are important for the detoxification and metabolism of
ethanol and other alcohols. They catalyse the oxidation of
primary and secondary alcohols to the corresponding aldehydes
and ketones, with the concomitant reduction ofNAD+. They can
be grouped into two main families (Jornvall et al., 1981, 1984),
which appear to be unrelated at the sequence level. Long-chain
ADHs are characterized by a preference for primary alcohols
(Dalziel & Dickinson, 1966), by a requirement for Zn2+ ions
(Dunn & Hutchinson, 1973) and by hydride transfer with 4-pro-
R stereospecificity (You, 1982). In contrast, short-chain ADHs
prefer secondary alcohols (Sofer & Ursprung, 1968; Winberg
et al., 1982), have no requirement formetal cofactors (Chambers,
1984) and show A-pro-S stereospecificity (Benner et al., 1985). It
is clear from these observations that the catalytic mechanisms of
the two types of ADH must be different, although the overall
reactions are the same.
Long-chain alcohol and polyol dehydrogenases have approx.
350 amino acid residues per subunit, and examples include the
familiar mammalian liver ethanol dehydrogenase, as well as
ADHs from birds, plants, yeast and bacteria. Mammalian
sorbitol dehydrogenase is also a member of the long-chain ADH
family (Jornvall et al., 1981, 1984). The short-chain ADHs have
been found in mammals, insects and bacteria. These enzymes
have approx. 250 amino acid residues per subunit, and examples
include Drosophila ADH (Thatcher, 1980), bacterial ribitol,
glutamate and 20/?-hydroxysteroid dehydrogenases (Jornvall
et al., 1984; Marekov et al., 1990), and mammalian
17-hydroxysteroid (Pcltoketo et al., 1988) and 15-hydroxy-
prostaglandin (Krook et al., 1990) dehydrogenases.
The three-dimensional structure of the long-chain ADH from
horse liver is known in great detail from crystallographic and
sequence studies (Eklund et al., 1976; Jornvall, 1970; reviewed in
Eklund & Branden, 1987). It is reasonable to assume that the
other members of the homologous long-chain ADH family have
similar topologies. The short-chain family is as yet much less well
characterized, although suitable crystals of Drosophila ADH
have recently been obtained, and diffraction data are currently
being collected (E. Gordon & L. Sawyer, personal communi¬
cation). In the absence of a crystal structure, it is of interest
to explore predicted structures derived from sequences and
spectroscopic data. A secondary-structure prediction for ADH
from Drosophila melanogaster (Thatcher & Sawyer, 1980) gives a
strong suggestion that the TV-terminal half of the enzyme folds
into the alternating a-helix//?-strand structure characteristic of
nucleotide-binding domains [reviewed in Richardson (1981)].
The C-terminal half does not appear to have an alternating a//?
structure.
Each subunit of the long-chain dehydrogenases (as exemplified
by the horse liver enzyme) folds into two domains, with the
active site at the interface between the domains [reviewed in
Eklund & Branden (1987)]. One molecule of NAD+ binds to this
interdomain region and makes contacts with both domains. It
thus may be expected that the cofactor could stabilize the enzyme
to a variety of insults such as heat or denaturing agents. It is the
main aim of the present study to compare the structural properties
of long-chain and short-chain ADHs (such as those from horse
liver and from Drosophila), and the contribution which NADT




ADHs from horse liver and from yeast (Saccharomyces cere-
visiae) were purchased from Boehringer and Sigma respectively.
Before use, the crystalline suspension of liver ADH was dialysed
for 18 h against 20 mM-Tris/HCl, pH 8.0. Yeast ADH was
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Fig. 4. Structural changes in ADH upon addition of GdnHCI as
demonstrated by c.d.
(a) D. melanogaster; (b) horse liver ( ) and yeast ( ).
O, Without NAD+; «. with NAD+.
[GdnHCI] (m)
Fig. 5. Inactivation of horse liver ( ) and yeast ( ) ADI1 by
GdnHCI
Details of the procedures are given in the Experimental section.
• . Enzyme in the presence of NAD+; O, enzyme in the absence
of NAD\
are depicted in Fig. 4(b). As with the Drosophila enzyme, these
changes occur at higher GdnHCI concentrations than do the
changes in activity. There is no significant effect of NAD+ on the
structural changes, consistent with the data from the activity
studies. Similar protection experiments with yeast ADH also
showed that NAD+ provides little protection to this enzyme
(results not shown).
DISCUSSION
In this paper we report on the analysis of the secondary
structure of the short-chain ADH from Drosophila. The far-u.v.
c.d. spectrum provides estimates for a-helix and /"-sheet which
are in good agreement with results of the structure-prediction
methods, and the validity of the c.d. approach has been confirmed
with reference to the horse liver enzyme, where a crystal structure
is available. Previously Benyajati et al. (1981) published an
amino acid sequence (derived from cDNA sequence) for the
Drosophila enzyme. Apart from residues 25 and 251, their
sequence was identical with that published previously by
Thatcher (1980), which was determined by direct protein
sequencing. However, Benyajati et al. (1981) reported the result
of a structure prediction using the Chou-Fasman method as
suggesting that the enzyme contained 50% a-helix, a value
considerably larger than that reported by Thatcher & Sawyer
(1980) using this predictive method. The cause of this discrepancy
is not clear, but it should be noted that the results of our multiple
prediction studies are closer to the value obtained by Thatcher &
Sawyer (1980). Benyajati et al. (1981) also mentioned that
analysis of the c.d. spectrum gave a value of 50 % a-helix, in
accordance with their structure-prediction results. We are unable
to explain the discrepancy between their value and our values
(Table 1), because they did not provide the primary data on
which the analysis was based.
At present, no crystal-structure information is available for
the Drosophila enzyme, although preliminary results are en¬
couraging (E. Gordon & L. Sawyer, personal communication).
We are therefore at present unable to confirm the validity of the
c.d. analysis. The analysis suggests that the enzyme contains
significant amounts of both a-helix and /J-strand structures. The
presence of large amounts of these secondary structures would
indicate that a typical NAD+-binding site exists in this enzyme;
this proposal would be consistent with other data, including the
binding of the enzyme to Cibacron Blue (Juan & Gonzalez-
Duarte, 1980).
The conformational stability (AG(H G)) of the Drosophila
enzyme has been estimated by a linear extrapolation procedure
as shown in Fig. 3(b). Although the justification for using this
procedure has been the subject of considerable debate [see Pace
(1986) and references therein], the value obtained [13.5 kJ/mol
(3.20 kcal/mol)] can at least be used as a basis for discussion. It
lies at the lower end of the range of values [21-63 kJ/mol
(5-15 kcal/mol)] quoted by Pace (1990) for the stabilities of a
number of globular proteins. However, it should be noted that in
any particular case the exact value can be markedly affected by
factors such as temperature, pH and ionic strength, and no
attempt was made in the present study to optimize the stability
of the enzyme.
The inclusion of NAD+ (220 /tM) serves to increase the
conformational stability of the Drosophila enzyme by
6.61 kJ/mol (1.57 kcal/mol) (Fig. 3b). Although this value may
seem low when the number of likely interactions between the
enzyme and the substrate is considered, it is ofa similar magnitude
to other examples of ligand-induced stabilization, e.g. the
stabilization of 2.1 kJ/mol (0.5 kcal/mol) afforded to lysozyme
by inclusion of the competitive inhibitor (/V-acetylglucosamine)3
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9. Coordinates of the ADH model in Brookhaven database format
HEADER PROTEIN
COMPND ADH.EVOLVING
AUTHOR Lluis Ribas de Pouplana PhD
SEQRES 1 255 SER PHE THR LEU THR
SEQRES 2 255 GLY LEU GLY GLY ILE
SEQRES 3 255 LEU LYS ARG ASP LEU
SEQRES 4 255 ILE GLU ASN PRO ALA
SEQRES 5 255 ASN PRO LYS VAL THR
SEQRES 6 255 THR VAL PRO ILE ALA
SEQRES 7 255 ILE PHE ALA GLN LEU
SEQRES 8 255 GLY ALA GLY ILE LEU
SEQRES 9 255 ILE ALA VAL ASN TYR
SEQRES 10 255 ALA ILE LEU ASP PHE
SEQRES 11 255 GLY GLY ILE ILE CYS
SEQRES 12 255 ASN ALA ILE TYR GLN
SEQRES 13 255 ALA ALA VAL VAL ASN
SEQRES 14 255 ALA PRO ILE THR GLY
SEQRES 15 255 GLY ILE THR ARG THR
SEQRES 16 255 TRP LEU ASP VAL GLU
SEQRES 17 255 ALA HIS PRO THR GLN
SEQRES 18 255 PHE VAL LYS ALA ILE
SEQRES 19 255 TRP LYS LEU ASP LEU
SEQRES 20 255 THR LYS HIS TRP ASP
ATOM 1 N SER 1 -6.758
ATOM 2 CA SER 1 -5.902
ATOM 3 C SER 1 -7.008
ATOM 4 O SER 1 -8.192
ATOM 5 CB SER 1 -5.135
ATOM 6 OG SER 1 -5.659
ATOM 7 HG SER 1 -5.141
ATOM 8 H SER 1 -6.963
ATOM 9 N PHE 2 -6.725
ATOM 10 CA PHE 2 -7.654
ATOM 11 C PHE 2 -8.544
ATOM 12 O PHE 2 -9.660
ATOM 13 CB PHE 2 -8.411
ATOM 14 CG PHE 2 -8.669
ATOM 15 CD1 PHE 2 -8.478
ATOM 16 CD2 PHE 2 -9.063
ATOM 17 CE1 PHE 2 -8.679
ATOM 18 CE2 PHE 2 -9.236
ATOM 19 CZ PHE 2 -9.065
ATOM 20 H PHE 2 -5.787
ATOM 21 N THR 3 -8.163
ATOM 22 CA THR 3 -8.929
ATOM 23 C THR 3 -8.093
ATOM 24 O THR 3 -7.143
ATOM 25 CB THR 3 -9.134
ATOM 26 OG1 THR 3 -9.511
ATOM 27 CG2 THR 3 -10.272
ATOM 28 HG1 THR 3 -9.921
ATOM 29 H THR 3 -7.245
ATOM 30 N LEU 4 -8.312
ATOM 31 CA LEU 4 -7.529
ATOM 32 C LEU 4 -8.129
ATOM 33 O LEU 4 -9.139
ATOM 34 CB LEU 4 -7.603
ATOM 35 CG LEU 4 -6.553
ATOM 36 CD1 LEU 4 -5.195
ATOM 37 CD2 LEU 4 -6.799
ATOM 38 H LEU 4 -8.945
ATOM 39 N THR 5 -7.365
ATOM 40 CA THR 5 -7.807
ATOM 41 C THR 5 -7.145
ATOM 42 O THR 5 -6.370









































































































ATOM 44 OG1 THR 5 -7.833 -11.434 -8.776 1.00 0.00
ATOM 45 CG2 THR 5 -7.690 -13.379 -7.324 1.00 0.00
ATOM 46 HG1 THR 5 -7.153 -10.754 -9.117 1.00 0.00
ATOM 47 H THR 5 -6.611 -9.341 -7.534 1.00 0.00
ATOM 48 N ASN 6 -7.344 -10.059 -4.283 1.00 0.00
ATOM 49 CA ASN 6 -6.574 -10.148 -2.987 1.00 0.00
ATOM 50 C ASN 6 -7.269 -9.542 -1.754 1.00 0.00
ATOM 51 O ASN 6 -7.539 -8.318 -1.681 1.00 0.00
ATOM 52 CB ASN 6 -5.168 -9.454 -3.117 1.00 0.00
ATOM 53 CG ASN 6 -4.473 -9.545 -4.451 1.00 0.00
ATOM 54 OD1 ASN 6 -4.963 -9.147 -5.530 1.00 0.00
ATOM 55 ND2 ASN 6 -3.360 -10.311 -4.436 1.00 0.00
ATOM 56 HD22ASN 6 -2.918 -10.582 -5.291 1.00 0.00
ATOM 57 HD21ASN 6 -3.118 -10.671 -3.582 1.00 0.00
ATOM 58 H ASN 6 -7.959 -9.298 -4.406 1.00 0.00
ATOM 59 N LYS 7 -7.790 -10.306 -0.745 1.00 0.00
ATOM 60 CA LYS 7 -8.366 -9.721 0.453 1.00 0.00
ATOM 61 C LYS 7 -7 .323 -8.827 1.098 1.00 0.00
ATOM 62 O LYS 7 -6.086 -9.089 1.044 1.00 0.00
ATOM 63 CB LYS 7 -8.757 -10.854 1.338 1.00 0.00
ATOM 64 CG LYS 7 -9.466 -10.322 2.569 1.00 0.00
ATOM 65 CD LYS 7 -9.405 -11.156 3.819 1.00 0.00
ATOM 66 CE LYS 7 -9.440 -10.218 4.967 1.00 0.00
ATOM 67 NZ LYS 7 -9.095 -10 .975 6.159 1.00 0.00
ATOM 68 HZ1 LYS 7 -8.884 -10.388 6.975 1.00 0.00
ATOM 69 HZ2 LYS 7 -8.227 -11.540 5.947 1.00 0.00
ATOM 70 HZ3 LYS 7 -9.880 -11.605 6.431 1.00 0.00
ATOM 71 H LYS 7 -7.836 -11.297 -0.827 1.00 0.00
ATOM 72 N ASN 8 -7.757 -7.780 1.789 1.00 0.00
ATOM 73 CA ASN 8 -6.820 -6.723 2.161 1.00 0.00
ATOM 74 C ASN 8 -7.134 -6.191 3.554 1.00 0.00
ATOM 75 O ASN 8 -8.266 -6.490 4.005 1.00 0.00
ATOM 76 CB ASN 8 -6.943 -5.635 1.057 1.00 0.00
ATOM 77 CG ASN 8 -8.324 -5.125 0.641 1.00 0.00
ATOM 78 OD1 ASN 8 -9.047 -4.487 1.386 1.00 0.00
ATOM 79 ND2 ASN 8 -8.648 -5.331 -0.626 1.00 0.00
ATOM 80 HD22ASN 8 -9.547 -5.031 -0.971 1.00 0.00
ATOM 81 HD21ASN 8 -8.025 -5.930 -1.126 1.00 0.00
ATOM 82 H ASN 8 -8.645 -7 .784 2.048 1.00 0.00
ATOM 83 N VAL 9 -6.155 -5.565 4.184 1.00 0.00
ATOM 84 CA VAL 9 -6.462 -4.932 5.527 1.00 0.00
ATOM 85 C VAL 9 -6.447 -3.358 5.621 1.00 0.00
ATOM 86 O VAL 9 -7.196 -2.836 6.491 1.00 0.00
ATOM 87 CB VAL 9 -5.484 -5.379 6.669 1.00 0.00
ATOM 88 CGI VAL 9 -5.870 -5.050 8.064 1.00 0.00
ATOM 89 CG2 VAL 9 -5.425 -6.817 6.609 1.00 0.00
ATOM 90 H VAL 9 -5.275 -5.925 4.046 1.00 0.00
ATOM 91 N ILE 10 -5.699 -2 .57 6 4.812 1.00 0.00
ATOM 92 CA ILE 10 -5.615 -1.124 4.915 1.00 0.00
ATOM 93 C ILE 10 -5.423 -0 .429 6.32 9 1.00 0.00
ATOM 94 O ILE 10 -6.386 -0.199 7.123 1.00 0.00
ATOM 95 CB ILE 10 -6.837 -0.463 4.233 1.00 0.00
ATOM 96 CGI ILE 10 -7.282 -1.115 2.953 1.00 0.00
ATOM 97 CG2 ILE 10 -6.429 0.975 3.896 1.00 0.00
ATOM 98 CD1 ILE 10 -8.510 -0 .404 2 .258 1.00 0.00
ATOM 99 H ILE 10 -5.317 -3.015 4.001 1.00 0.00
ATOM 100 N PHE 11 -4.180 0.000 6.552 1.00 0.00
ATOM 101 CA PHE 11 -3.741 0.649 7.767 1.00 0.00
ATOM 102 C PHE 11 -4.402 2.012 8.040 1.00 0.00
ATOM 103 O PHE 11 -5.312 2.103 8.894 1.00 0.00
ATOM 104 CB PHE 11 -2.158 0.750 7.697 1.00 0.00
ATOM 105 CG PHE 11 -1.417 -0.305 8.582 1.00 0.00
ATOM 106 CD1 PHE 11 -0.287 0.056 9.180 1.00 0.00
ATOM 107 CD2 PHE 11 -1.860 -1.621 8.615 1.00 0.00
ATOM 108 CE1 PHE 11 0.480 -0.934 9.830 1.00 0.00
ATOM 109 CE2 PHE 11 -1.152 -2 .62 6 9.207 1.00 0.00
ATOM 110 CZ PHE 11 0.040 -2.214 9.806 1.00 0.00
ATOM 111 H PHE 11 -3.483 -0.047 5.826 1.00 0.00
ATOM 112 N VAL 12 -4.023 3.102 7.404 1.00 0.00
ATOM 113 CA VAL 12 -4.712 4.382 7.610 1.00 0.00
ATOM 114 C VAL 12 -6.222 4.473 7.409 1.00 0.00
ATOM 115 O VAL 12 -6.839 5.287 8.054 1.00 0.00
ATOM 116 CB VAL 12 -3.965 5.455 6.730 1.00 0.00
ATOM 117 CGI VAL 12 -4.186 5.098 5.238 1.00 0.00
ATOM 118 CG2 VAL 12 -4.511 6.853 7.008 1.00 0.00
ATOM 119 H VAL 12 -3.199 3.041 6.913 1.00 0.00
ATOM 120 N ALA 13 -6.740 3.560 6.649 1.00 0.00
ATOM 121 CA ALA 13 -8.094 3.276 6.317 1.00 0.00
ATOM 122 C ALA 13 -9.194 4.348 6.335 1.00 0.00
ATOM 123 O ALA 13 -9.612 4.8 62 5.348 1.00 0.00
ATOM 124 CB ALA 13 -8.605 2.181 7.293 1.00 0.00
ATOM 125 H ALA 13 -6.056 3.063 6.123 1.00 0.00
ATOM 126 N GLY 14 -9.515 4.747 7.559 1.00 0.00
ATOM 127 CA GLY 14 -10.644 5.629 7.814 1.00 0.00
ATOM 128 C GLY 14 -10.531 7.116 7.515 1.00 0.00
ATOM 129 O GLY 14 -11.279 7.8 62 8.131 1.00 0.00
ATOM 130 H GLY 14 -8.909 4.578 8.295 1.00 0.00
ATOM 131 N LEU 15 -9.616 7.572 6.692 1.00 0.00
ATOM 132 CA LEU 15 -9.559 8.988 6.352 1.00 0.00
ATOM 133 C LEU 15 -9.903 9.049 4.893 1.00 0.00
ATOM 134 O LEU 15 -9.231 8.402 4.074 1.00 0.00
ATOM 135 CB LEU 15 -8.172 9.635 6.604 1.00 0.00
ATOM 136 CG LEU 15 -8.128 11.175 6.487 1.00 0.00
ATOM 137 CD1 LEU 15 -8.619 11.835 7.792 1.00 0.00
ATOM 138 CD2 LEU 15 -6.649 11.664 6.217 1.00 0.00
ATOM 139 H LEU 15 -8.866 6.965 6.440 1.00 0.00
ATOM 140 N GLY 16 -10.984 9.721 4.593 1.00 0.00
ATOM 141 CA GLY 16 -11.531 9.935 3.282 1.00 0.00
ATOM 142 C GLY 16 -10.642 10.509 2.238 1.00 0.00
ATOM 143 O GLY 16 -11.096 11.025 1.235 1.00 0.00
ATOM 144 H GLY 16 -11.490 10 .158 5.276 1.00 0.00
ATOM 145 N GLY 17 -9.291 10.425 2.273 1.00 0.00
ATOM 146 CA GLY 17 -8.416 10.986 1.266 1.00 0.00
ATOM 147 C GLY 17 -7.812 9.861 0.477 1.00 0.00
ATOM 148 O GLY 17 -7.470 10.040 -0.703 1.00 0.00
ATOM 149 H GLY 17 -8.931 10.026 3.089 1.00 0.00
ATOM 150 N ILE 18 -7.526 8 .704 1.091 1.00 0.00
ATOM 151 CA ILE 18 -6.861 7 .552 0.474 1.00 0.00
ATOM 152 C ILE 18 -7.489 6.168 0.826 1.00 0.00
ATOM 153 O ILE 18 -8.046 5.584 -0.074 1.00 0.00
ATOM 154 CB ILE 18 -5.328 7 .324 0.835 1.00 0.00
ATOM 155 CGI ILE 18 -4.679 8.558 1.563 1.00 0.00
ATOM 156 CG2 ILE 18 -4.612 7.170 -0.523 1.00 0.00
ATOM 157 CD1 ILE 18 -4.614 8.316 3.050 1.00 0.00
ATOM 158 H ILE 18 -7.763 8.615 2.083 1.00 0.00
ATOM 159 N GLY 19 -7.537 5.670 2.093 1.00 0.00
ATOM 160 CA GLY 19 -8.018 4.350 2.443 1.00 0.00
ATOM 161 C GLY 19 -9.377 4.020 2.057 1.00 0.00
ATOM 162 O GLY 19 -9.655 3.145 1.164 1.00 0.00
ATOM 163 H GLY 19 -7.154 6.250 2.770 1.00 0.00
ATOM 164 N LEU 20 -10.313 4.665 2.707 1.00 0.00
ATOM 165 CA LEU 20 -11.761 4.493 2.464 1.00 0.00
ATOM 166 C LEU 20 -12.250 4.598 1.038 1.00 0.00
ATOM 167 O LEU 20 -12.960 3.700 0.558 1.00 0.00
ATOM 168 CB LEU 20 -12.589 5.501 3.263 1.00 0.00
ATOM 169 CG LEU 20 -14.141 5.611 3.399 1.00 0.00
ATOM 170 CD1 LEU 20 -14.729 4.377 4.069 1.00 0.00
ATOM 171 CD2 LEU 20 -14.381 6.867 4.177 1.00 0.00
ATOM 172 H LEU 20 -10.018 5.286 3.485 1.00 0.00
ATOM 173 N ASP 21 -11.653 5.513 0.291 1.00 0.00
ATOM 174 CA ASP 21 -11.782 5.694 -1.192 1.00 0.00
ATOM 175 C ASP 21 -11.219 4.500 -2.054 1.00 0.00
ATOM 176 O ASP 21 -11.817 4.212 -3.128 1.00 0.00
ATOM 177 CB ASP 21 -11.119 7.052 -1.661 1.00 0.00
ATOM 178 CG ASP 21 -12.126 8 .165 -1.881 1.00 0.00
ATOM 179 OD1 ASP 21 -12 .556 8.808 -0.932 1.00 0.00
ATOM 180 OD2 ASP 21 -12.523 8 .311 -3.010 1.00 0.00
ATOM 181 H ASP 21 -11.015 6.079 0.797 1.00 0.00
ATOM 182 N THR 22 -10.059 3.928 -1.617 1.00 0.00
ATOM 183 CA THR 22 -9.585 2.815 -2.335 1.00 0.00
ATOM 184 C THR 22 -10.606 1.659 -2.226 1.00 0.00
ATOM 185 O THR 22 -10.886 0.939 -3.198 1.00 0.00
ATOM 186 CB THR 22 -8.244 2.287 -1.805 1.00 0.00
ATOM 187 OG1 THR 22 -7.341 3.418 -1.541 1.00 0.00
ATOM 188 CG2 THR 22 -7.642 1.348 -2.777 1.00 0.00
ATOM 189 HG1 THR 22 -7.661 3.843 -0.816 1.00 0.00
ATOM 190 H THR 22 -9.720 4.101 -0.717 1.00 0.00
ATOM 191 N SER 23 -11.182 1.395 -1.033 1.00 0.00
ATOM 192 CA SER 23 -12.073 0.301 -0.868 1.00 0.00
ATOM 193 C SER 23 -13.212 0.248 -1.845 1.00 0.00
ATOM 194 O SER 23 -13.598 -0.822 -2.379 1.00 0.00
ATOM 195 CB SER 23 -12.719 0.257 0.504 1.00 0.00
ATOM 196 OG SER 23 -11.696 0.511 1.452 1.00 0.00
ATOM 197 HG SER 23 -11.280 -0.263 1.813 1.00 0.00
ATOM 198 H SER 23 -10.852 1.887 -0.258 1.00 0.00
ATOM 199 N LYS 24 -13.822 1.451 -1.976 1.00 0.00
ATOM 200 CA LYS 24 -14.942 1.622 -2.900 1.00 0.00
ATOM 201 C LYS 24 -14.738 0.940 -4.163 1.00 0.00
ATOM 202 O LYS 24 -15.664 0.211 -4.600 1.00 0.00
ATOM 203 CB LYS 24 -15.177 3.060 -3.280 1.00 0.00
ATOM 204 CG LYS 24 -15.638 3.961 -2.161 1.00 0.00
ATOM 205 CD LYS 24 -15.575 5.376 -2.694 1.00 0.00
ATOM 206 CE LYS 24 -16.116 6.384 -1.665 1.00 0.00
ATOM 207 NZ LYS 24 -15.542 6.147 -0.396 1.00 0.00
ATOM 208 HZ1 LYS 24 -14.591 5.789 -0.589 1.00 0.00
ATOM 209 HZ2 LYS 24 -16.134 5.408 0.015 1.00 0.00
ATOM 210 HZ3 LYS 24 -15.407 7.064 0.101 1.00 0.00
ATOM 211 H LYS 24 -13.568 2.141 -1.363 1.00 0.00
ATOM 212 N GLU 25 -13.517 1.075 -4.784 1.00 0.00
ATOM 213 CA GLU 25 -13.171 0.452 -6.053 1.00 0.00
ATOM 214 C GLU 25 -13.461 -1.055 -6.012 1.00 0.00
ATOM 215 O GLU 25 -14.094 -1.611 -6.894 1.00 0.00
ATOM 216 CB GLU 25 -11.725 0.740 -6.387 1.00 0.00
ATOM 217 CG GLU 25 -11.290 2.190 -6.500 1.00 0.00
ATOM 218 CD GLU 25 -9.762 2.346 -6.748 1.00 0.00
ATOM 219 OE1 GLU 25 -8.993 2.361 -5.801 1.00 0.00
ATOM 220 OE2 GLU 25 -9.357 2.380 -7.894 1.00 0.00
ATOM 221 H GLU 25 -12.766 1.623 -4.385 1.00 0.00
ATOM 222 N LEU 26 -12.935 -1.667 -4.936 1.00 0.00
ATOM 223 CA LEU 26 -12.809 -3.079 -4.708 1.00 0.00
ATOM 224 C LEU 26 -14.241 -3.687 -4.410 1.00 0.00
ATOM 225 O LEU 26 -14.477 -4.879 -4.667 1.00 0.00
ATOM 226 CB LEU 26 -11.979 -3.459 -3.488 1.00 0.00
ATOM 227 CG LEU 26 -10.673 -2.770 -3.387 1.00 0.00
ATOM 228 CD1 LEU 26 -10.177 -3.063 -2.038 1.00 0.00
ATOM 229 CD2 LEU 26 -9.698 -3.065 -4.533 1.00 0.00
ATOM 230 H LEU 26 -12.593 -1.120 -4.210 1.00 0.00
ATOM 231 N LEU 27 -15.203 -2.953 -3.778 1.00 0.00
ATOM 232 CA LEU 27 -16.480 -3.537 -3.532 1.00 0.00
ATOM 233 C LEU 27 -17.277 -3.318 -4.792 1.00 0.00
ATOM 234 O LEU 27 -18.087 -4.162 -5.083 1.00 0.00
ATOM 235 CB LEU 27 -17.198 -2.872 -2.416 1.00 0.00
ATOM 236 CG LEU 27 -16.646 -3.351 -1.080 1.00 0.00
ATOM 237 CD1 LEU 27 -16.289 -2.199 -0.242 1.00 0.00
ATOM 238 CD2 LEU 27 -17.600 -4.361 -0.514 1.00 0.00
ATOM 239 H LEU 27 -15.019 -2.008 -3.578 1.00 0.00
ATOM 240 N LYS 28 -17.254 -2.138 -5.466 1.00 0.00
ATOM 241 CA LYS 28 -18.039 -1.965 -6.633 1.00 0.00
ATOM 242 C LYS 28 -17.658 -2.949 -7.793 1.00 0.00
ATOM 243 O LYS 28 -18 .513 -3.512 -8.486 1.00 0.00
ATOM 244 CB LYS 28 -17.890 -0.545 -7.191 1.00 0.00
ATOM 245 CG LYS 28 -18.530 0.616 -6.390 1.00 0.00
ATOM 246 CD LYS 28 -18.094 1.938 -7.013 1.00 0.00
ATOM 247 CE LYS 28 -18.688 3.025 -6.150 1.00 0.00
ATOM 248 NZ LYS 28 -18.028 4.306 -6.459 1.00 0.00
ATOM 249 HZ1 LYS 28 -18.207 4.533 -7.441 1.00 0.00
ATOM 250 HZ2 LYS 28 -16.995 4.255 -6.285 1.00 0.00
ATOM 251 HZ3 LYS 28 -18.386 5.058 -5.859 1.00 0.00
ATOM 252 H LYS 28 -16.825 -1.378 -5.066 1.00 0.00
ATOM 253 N ARG 29 -16.364 -2.891 -8.043 1.00 0.00
ATOM 254 CA ARG 29 -15.811 -3.604 -9.225 1.00 0.00
ATOM 255 C ARG 29 -14.910 -4.610 -8.634 1.00 0.00
ATOM 256 O ARG 29 -14.498 -4.486 -7.491 1.00 0.00
ATOM 257 CB ARG 29 -15.054 -2.635 -10.155 1.00 0.00
ATOM 258 CG ARG 29 -14.906 -3.126 -11.545 1.00 0.00
ATOM 259 CD ARG 29 -14.593 -1.961 -12.435 1.00 0.00
ATOM 260 NE ARG 29 -15.660 -0.961 -12.448 1.00 0.00
ATOM 261 CZ ARG 29 -15.442 0.230 -12.978 1.00 0.00
ATOM 262 NH1 ARG 29 -16.438 1.067 -13.145 1.00 0.00
ATOM 263 NH2 ARG 29 -14.211 0.601 -13.331 1.00 0.00
ATOM 264 HE ARG 29 -16.482 -1.158 -11.984 1.00 0.00
ATOM 265 HH12ARG 29 -16.405 2.060 -13.444 1.00 0.00
ATOM 266 HH11ARG 29 -17.324 0.644 -12.842 1.00 0.00
ATOM 267 HH22ARG 29 -14.057 1.460 -13.730 1.00 0.00
ATOM 268 HH21ARG 29 -13.359 0.039 -13.051 1.00 0.00
ATOM 269 H ARG 29 -15.692 -2.496 -7.400 1.00 0.00
ATOM 270 N ASP 30 -14.409 -5.604 -9.373 1.00 0.00
ATOM 271 CA ASP 30 -13.451 -6.564 -8.882 1.00 0.00
ATOM 272 C ASP 30 -13.766 -7.386 -7.577 1.00 0.00
ATOM 273 O ASP 30 -12.905 -8 .181 -7.170 1.00 0.00
ATOM 274 CB ASP 30 -11.989 -5.845 -8.786 1.00 0.00
ATOM 275 CG ASP 30 -11.574 -4.853 -7.743 1.00 0.00
ATOM 276 OD1 ASP 30 -11.647 -3.674 -7.958 1.00 0.00
ATOM 277 OD2 ASP 30 -11.279 -5.237 -6.615 1.00 0.00
ATOM 278 H ASP 30 -14.683 -5.662 -10.280 1.00 0.00
ATOM 279 N LEU 31 -14.978 -7.172 -7.013 1.00 0.00
ATOM 280 CA LEU 31 -15.426 -7.619 -5.666 1.00 0.00
ATOM 281 C LEU 31 -14.957 -9.043 -5.293 1.00 0.00
ATOM 282 O LEU 31 -15.143 -10.030 -6.040 1.00 0.00
ATOM 283 CB LEU 31 -16.984 -7.577 -5.536 1.00 0.00
ATOM 284 CG LEU 31 -17.907 -8.333 -6.625 1.00 0.00
ATOM 285 CD1 LEU 31 -19.112 -9.121 -6.114 1.00 0.00
ATOM 286 CD2 LEU 31 -18.386 -7.231 -7.538 1.00 0.00
ATOM 287 H LEU 31 -15.533 -6.491 -7.448 1.00 0.00
ATOM 288 N LYS 32 -14.481 -9.267 -4.087 1.00 0.00
ATOM 289 CA LYS 32 -13.902 -10 .544 -3.789 1.00 0.00
ATOM 290 C LYS 32 -14.197 -10.838 -2.326 1.00 0.00
ATOM 291 0 LYS 32 -15.195 -10.356 -1.786 1.00 0.00
ATOM 2 92 CB LYS 32 -12.406 -10.512 -3.919 1.00 0.00
ATOM 293 CG LYS 32 -11.925 -11.798 -4.633 1.00 0.00
ATOM 294 CD LYS 32 -11.113 -11.401 -5.818 1.00 0.00
ATOM 295 CE LYS 32 -11.584 -12.321 -6.892 1.00 0.00
ATOM 296 NZ LYS 32 -11.064 -11.886 -8.217 1.00 0.00
ATOM 297 HZ1 LYS 32 -11.344 -10.906 -8.357 1.00 0.00
ATOM 298 HZ2 LYS 32 -11.463 -12.586 -8.878 1.00 0.00
ATOM 299 HZ3 LYS 32 -10.040 -11.882 -8.177 1.00 0.00
ATOM 300 H LYS 32 -14.305 -8.574 -3.441 1.00 0.00
ATOM 301 N ASN 33 -13.489 -11.731 -1.637 1.00 0.00
ATOM 302 CA ASN 33 -13.796 -12.102 -0.233 1.00 0.00
ATOM 303 C ASN 33 -13.497 -11.014 0.710 1.00 0.00
ATOM 304 O ASN 33 -12 .574 -10.256 0.605 1.00 0.00
ATOM 305 CB ASN 33 -13.049 -13.373 0.156 1.00 0.00
ATOM 306 CG ASN 33 -11.571 -13.252 0.548 1.00 0.00
ATOM 307 OD1 ASN 33 -10.731 -13.233 -0.332 1.00 0.00
ATOM 308 ND2 ASN 33 -11.138 -13.139 1.782 1.00 0.00
ATOM 309 HD22ASN 33 -10.163 -13.128 2.020 1.00 0.00
ATOM 310 HD21ASN 33 -11.782 -13.102 2.494 1.00 0.00
ATOM 311 H ASN 33 -12.662 -12.094 -1.964 1.00 0.00
ATOM 312 N LEU 34 -14.404 -11.048 1.657 1.00 0.00
ATOM 313 CA LEU 34 -14.640 -10.211 2.811 1.00 0.00
ATOM 314 C LEU 34 -13.416 -9.346 3.247 1.00 0.00
ATOM 315 O LEU 34 -12.506 -9.752 3.973 1.00 0.00
ATOM 316 CB LEU 34 -15.036 -11.078 3.971 1.00 0.00
ATOM 317 CG LEU 34 -16.538 -11.469 4.242 1.00 0.00
ATOM 318 CD1 LEU 34 -16.677 -12.898 4.753 1.00 0.00
ATOM 319 CD2 LEU 34 -17.114 -10.361 5.109 1.00 0.00
ATOM 320 H LEU 34 -15.164 -11.641 1.548 1.00 0.00
ATOM 321 N VAL 35 -13.272 -8.134 2.707 1.00 0.00
ATOM 322 CA VAL 35 -12.220 -7.158 2.915 1.00 0.00
ATOM 323 C VAL 35 -12.546 -6.397 4.201 1.00 0.00
ATOM 324 O VAL 35 -13.741 -6.244 4.531 1.00 0.00
ATOM 325 CB VAL 35 -12.086 -6.118 1.712 1.00 0.00
ATOM 326 CGI VAL 35 -11.852 -6.974 0.571 1.00 0.00
ATOM 327 CG2 VAL 35 -13.255 -5.275 1.371 1.00 0.00
ATOM 328 H VAL 35 -13.942 -8.072 2.085 1.00 0.00
ATOM 329 N ILE 36 -11.477 -5.881 4.879 1.00 0.00
ATOM 330 CA ILE 36 -11.563 -5.047 6.079 1.00 0.00
ATOM 331 C ILE 36 -10.696 -3.813 6.163 1.00 0.00
ATOM 332 O ILE 36 -9.766 -3.786 5.364 1.00 0.00
ATOM 333 CB ILE 36 -11.260 -5.846 7.409 1.00 0.00
ATOM 334 CGI ILE 36 -10 .139 -6.805 7.211 1.00 0.00
ATOM 335 CG2 ILE 36 -12.604 -6.415 7.958 1.00 0.00
ATOM 336 CD1 ILE 36 -9.959 -7.715 8.382 1.00 0.00
ATOM 337 H ILE 36 -10.640 -5.964 4.393 1.00 0.00
ATOM 338 N LEU 37 -10.952 -2.823 7.004 1.00 0.00
ATOM 339 CA LEU 37 -10.158 -1.584 7.104 1.00 0.00
ATOM 340 C LEU 37 -9.632 -1.597 8.548 1.00 0.00
ATOM 341 O LEU 37 -10.405 -1.646 9.491 1.00 0.00
ATOM 342 CB LEU 37 -11.049 -0.330 6.902 1.00 0.00
ATOM 343 CG LEU 37 -11.823 -0.071 5.608 1.00 0.00
ATOM 344 CD1 LEU 37 -13.170 -0.699 5.554 1.00 0.00
ATOM 345 CD2 LEU 37 -12.180 1.417 5.612 1.00 0.00
ATOM 346 H LEU 37 -11.668 -2.936 7.645 1.00 0.00
ATOM 347 N ASP 38 -8.296 -1.584 8.795 1.00 0.00
ATOM 348 CA ASP 38 -7.667 -1.667 10.116 1.00 0.00
ATOM 349 C ASP 38 -7 .474 -0.274 10.743 1.00 0.00
ATOM 350 O ASP 38 -6.413 0.371 10.706 1.00 0.00
ATOM 351 CB ASP 38 -6.309 -2.413 10.074 1.00 0.00
ATOM 352 CG ASP 38 -5.605 -2.510 11.427 1.00 0.00
ATOM 353 OD1 ASP 38 -4.597 -1.867 11.572 1.00 0.00
ATOM 354 OD2 ASP 38 -6.022 -3.180 12.349 1.00 0.00
ATOM 355 H ASP 38 -7.612 -1.429 8.043 1.00 0.00
ATOM 356 N ARG 39 -8.552 0.201 11.352 1.00 0.00
ATOM 357 CA ARG 39 -8.559 1.497 12.043 1.00 0.00
ATOM 358 C ARG 39 -7.384 1.826 13.000 1.00 0.00
ATOM 359 O ARG 39 -7.636 1.846 14.189 1.00 0.00
ATOM 360 CB ARG 39 -9.912 1.560 12.781 1.00 0.00
ATOM 361 CG ARG 39 -10 .194 0.366 13.694 1.00 0.00
ATOM 362 CD ARG 39 -11.258 0.861 14.649 1.00 0.00
ATOM 363 NE ARG 39 -11.446 -0.145 15.633 1.00 0.00
ATOM 364 CZ ARG 39 -12.028 0.133 16.804 1.00 0.00
ATOM 365 NH1 ARG 39 -12.127 -0.875 17.672 1.00 0.00
ATOM 366 NH2 ARG 39 -12.485 1.344 17.004 1.00 0.00
ATOM 367 HE ARG 39 -11.008 -1.026 15.465 1.00 0.00
ATOM 368 HH12ARG 39 -12.752 -0.648 18.479 1.00 0.00
ATOM 369 HH11ARG 39 -11.886 -1.808 17.308 1.00 0.00
ATOM 370 HH22ARG 39 -12.971 1.657 17.835 1.00 0.00
ATOM 371 HH21ARG 39 -12.304 2.027 16.273 1.00 0.00
ATOM 372 H ARG 39 -9.244 -0.509 11.349 1.00 0.00
ATOM 373 N ILE 40 -6.194 2.284 12.457 1.00 0.00
ATOM 374 CA ILE 40 -4.942 2.659 13.168 1.00 0.00
ATOM 375 C ILE 40 -5.144 3.461 14.509 1.00 0.00
ATOM 376 O ILE 40 -4.504 3.230 15.540 1.00 0.00
ATOM 377 CB ILE 40 -4.100 3.460 12.138 1.00 0.00
ATOM 378 CGI ILE 40 -2.797 3.947 12.752 1.00 0.00
ATOM 379 CG2 ILE 40 -4.967 4.678 11.733 1.00 0.00
ATOM 380 CD1 ILE 40 -1.734 4.236 11.644 1.00 0.00
ATOM 381 H ILE 40 -6.046 2.166 11.456 1.00 0.00
ATOM 382 N GLU 41 -6.094 4.361 14.480 1.00 0.00
ATOM 383 CA GLU 41 -6.295 5.359 15.557 1.00 0.00
ATOM 384 C GLU 41 -7 .446 4.921 16.564 1.00 0.00
ATOM 385 O GLU 41 -7 .604 5.494 17.664 1.00 0.00
ATOM 386 CB GLU 41 -6.597 6.716 14.914 1.00 0.00
ATOM 387 CG GLU 41 -7.790 6.678 13.932 1.00 0.00
ATOM 388 CD GLU 41 -8.183 7.935 13.142 1.00 0.00
ATOM 389 OE1 GLU 41 -8.649 8.848 13.795 1.00 0.00
ATOM 390 OE2 GLU 41 -8.013 7.945 11.973 1.00 0.00
ATOM 391 H GLU 41 -6.852 4.169 13.852 1.00 0.00
ATOM 392 N ASN 42 -8.197 3.871 16.192 1.00 0.00
ATOM 393 CA ASN 42 -9.203 3.187 17.051 1.00 0.00
ATOM 394 C ASN 42 -10.419 3.831 17.614 1.00 0.00
ATOM 395 O ASN 42 -10.951 3.592 18.725 1.00 0.00
ATOM 396 CB ASN 42 -8.457 2.527 18.284 1.00 0.00
ATOM 397 CG ASN 42 -7.693 1.260 17.916 1.00 0.00
ATOM 398 OD1 ASN 42 -8.304 0.245 17.626 1.00 0.00
ATOM 399 ND2 ASN 42 -6.407 1.082 18.063 1.00 0.00
ATOM 400 HD22ASN 42 -5.949 0.283 17.651 1.00 0.00
ATOM 401 HD21ASN 42 -6.095 1.813 18.633 1.00 0.00
ATOM 402 H ASN 42 -7.825 3.428 15.351 1.00 0.00
ATOM 403 N PRO 43 -11.027 4.736 16.873 1.00 0.00
ATOM 404 CA PRO 43 -12.235 5.383 17.238 1.00 0.00
ATOM 405 C PRO 43 -13.429 4.755 16.443 1.00 0.00
ATOM 406 O PRO 43 -13.845 5.212 15.322 1.00 0.00
ATOM 407 CB PRO 43 -11.992 6.833 16.942 1.00 0.00
ATOM 408 CG PRO 43 -10.993 6.824 15.765 1.00 0.00
ATOM 409 CD PRO 43 -10.583 5.326 15.616 1.00 0.00
ATOM 410 N ALA 44 -14.108 3.765 17.029 1.00 0.00
ATOM 411 CA ALA 44 -15.133 2.937 16.393 1.00 0.00
ATOM 412 C ALA 44 -16.176 3.540 15.456 1.00 0.00
ATOM 413 O ALA 44 -16.705 2.800 14.667 1.00 0.00
ATOM 414 CB ALA 44 -15.815 2.170 17.501 1.00 0.00
ATOM 415 H ALA 44 -14.050 3.850 18.013 1.00 0.00
ATOM 416 N ALA 45 -16.528 4.836 15.589 1.00 0.00
ATOM 417 CA ALA 45 -17.504 5.517 14.857 1.00 0.00
ATOM 418 C ALA 45 -17.312 5.399 13.374 1.00 0.00
ATOM 419 O ALA 45 -18.295 5.643 12.625 1.00 0.00
ATOM 420 CB ALA 45 -17.478 7.055 15.161 1.00 0.00
ATOM 421 H ALA 45 -15.958 5.439 16.113 1.00 0.00
ATOM 422 N ILE 46 -16.112 5.094 12.830 1.00 0.00
ATOM 423 CA ILE 46 -15.850 4.868 11.451 1.00 0.00
ATOM 424 C ILE 46 -16.821 3.808 10.910 1.00 0.00
ATOM 425 O ILE 46 -17 .099 3.742 9.724 1.00 0.00
ATOM 426 CB ILE 46 -14.342 4.504 11.182 1.00 0.00
ATOM 427 CGI ILE 46 -13.384 5.476 11.826 1.00 0.00
ATOM 428 CG2 ILE 46 -14.115 4.606 9.730 1.00 0.00
ATOM 429 CD1 ILE 46 -13.736 6.987 11.716 1.00 0.00
ATOM 430 H ILE 46 -15.241 5.054 13.364 1.00 0.00
ATOM 431 N ALA 47 -17.448 2.921 11.740 1.00 0.00
ATOM 432 CA ALA 47 -18.439 1.943 11.300 1.00 0.00
ATOM 433 C ALA 47 -19.438 2.287 10.171 1.00 0.00
ATOM 434 O ALA 47 -19.424 1.560 9.173 1.00 0.00
ATOM 435 CB ALA 47 -19.344 1.502 12.500 1.00 0.00
ATOM 436 H ALA 47 -17.238 2.998 12.732 1.00 0.00
ATOM 437 N GLU 48 -20.073 3.461 10.196 1.00 0.00
ATOM 438 CA GLU 48 -21.057 3.702 9.189 1.00 0.00
ATOM 439 C GLU 48 -20.450 4.045 7.832 1.00 0.00
ATOM 440 O GLU 48 -21.074 3.759 6.806 1.00 0.00
ATOM 441 CB GLU 48 -21.954 4.735 9.683 1.00 0.00
ATOM 442 CG GLU 48 -23.048 4.193 10.596 1.00 0.00
ATOM 443 CD GLU 48 -23.101 5.025 11.917 1.00 0.00
ATOM 444 OE1 GLU 48 -24.129 5.610 12.275 1.00 0.00
ATOM 445 OE2 GLU 48 -22.065 5.065 12.668 1.00 0.00
ATOM 446 H GLU 48 -19.839 4.072 10.935 1.00 0.00
ATOM 447 N LEU 49 -19.250 4.630 7.879 1.00 0.00
ATOM 448 CA LEU 49 -18.558 4.954 6.667 1.00 0.00
ATOM 449 C LEU 49 -18.317 3.680 5.871 1.00 0.00
ATOM 450 O LEU 49 -18.626 3.514 4.688 1.00 0.00
ATOM 451 CB LEU 49 -17.286 5.662 7.128 1.00 0.00
ATOM 452 CG LEU 49 -17.512 6.865 7.983 1.00 0.00
ATOM 453 CD1 LEU 49 -16.161 7 .378 8.354 1.00 0.00
ATOM 454 CD2 LEU 49 -18.322 7.975 7.375 1.00 0.00
ATOM 455 H LEU 49 -18.749 4.630 8.647 1.00 0.00
ATOM 456 N LYS 50 -17.808 2 .688 6.566 1.00 0.00
ATOM 457 CA LYS 50 -17.634 1.324 5.994 1.00 0.00
ATOM 458 C LYS 50 -18.906 0.770 5.431 1.00 0.00
ATOM 459 O LYS 50 -18.980 0.434 4.260 1.00 0.00
ATOM 460 CB LYS 50 -17 .047 0.392 7.017 1.00 0.00
ATOM 461 CG LYS 50 -15.699 0.939 7.605 1.00 0.00
ATOM 462 CD LYS 50 -15.230 0.189 8.882 1.00 0.00
ATOM 463 CE LYS 50 -13.989 0.762 9.555 1.00 0.00
ATOM 464 NZ LYS 50 -13.587 0.132 10.761 1.00 0.00
ATOM 465 HZ1 LYS 50 -13.169 -0.823 10.647 1.00 0.00
ATOM 466 HZ2 LYS 50 -14.403 0.068 11.408 1.00 0.00
ATOM 467 HZ3 LYS 50 -12.865 0.685 11.330 1.00 0.00
ATOM 468 H LYS 50 -17.432 2.797 7.445 1.00 0.00
ATOM 469 N ALA 51 -19.971 0.785 6.254 1.00 0.00
ATOM 470 CA ALA 51 -21.284 0.223 5.890 1.00 0.00
ATOM 471 C ALA 51 -21.998 0.716 4.601 1.00 0.00
ATOM 472 O ALA 51 -22.785 -0.036 4.004 1.00 0.00
ATOM 473 CB ALA 51 -22.335 0.386 7.001 1.00 0.00
ATOM 474 H ALA 51 -19.882 1.292 7.123 1.00 0.00
ATOM 475 N ILE 52 -21.774 1.973 4.146 1.00 0.00
ATOM 476 CA ILE 52 -22.328 2.439 2.904 1.00 0.00
ATOM 477 C ILE 52 -21.871 1.549 1.761 1.00 0.00
ATOM 478 O ILE 52 -22.708 1.266 0.923 1.00 0.00
ATOM 479 CB ILE 52 -21.903 3.851 2.653 1.00 0.00
ATOM 480 CGI ILE 52 -22.427 4.689 3.798 1.00 0.00
ATOM 481 CG2 ILE 52 -22.512 4.349 1.352 1.00 0.00
ATOM 482 CD1 ILE 52 -21.761 6.077 3.968 1.00 0.00
ATOM 483 H ILE 52 -21.354 2.525 4.732 1.00 0.00
ATOM 484 N ASN 53 -20.612 1.144 1.679 1.00 0.00
ATOM 485 CA ASN 53 -20.016 0.317 0.578 1.00 0.00
ATOM 486 C ASN 53 -20.584 -1.115 0.479 1.00 0.00
ATOM 487 O ASN 53 -20.934 -1.520 -0.622 1.00 0.00
ATOM 488 CB ASN 53 -18.509 0.263 0.812 1.00 0.00
ATOM 489 CG ASN 53 -17.854 1.572 0.703 1.00 0.00
ATOM 490 OD1 ASN 53 -17.362 1.956 -0.366 1.00 0.00
ATOM 491 ND2 ASN 53 -17.660 2.289 1.774 1.00 0.00
ATOM 492 HD22ASN 53 -17.195 3.188 1.727 1.00 0.00
ATOM 493 HD21ASN 53 -17.918 2.012 2.682 1.00 0.00
ATOM 494 H ASN 53 -20.059 1.328 2.479 1.00 0.00
ATOM 495 N PRO 54 -20.865 -1.860 1.578 1.00 0.00
ATOM 496 CA PRO 54 -21.842 -2.875 1.616 1.00 0.00
ATOM 497 C PRO 54 -23.208 -2.561 1.052 1.00 0.00
ATOM 498 O PRO 54 -23.631 -3.296 0.137 1.00 0.00
ATOM 499 CB PRO 54 -21.835 -3.278 3.075 1.00 0.00
ATOM 500 CG PRO 54 -20.381 -3.260 3.390 1.00 0.00
ATOM 501 CD PRO 54 -20.069 -1.938 2.774 1.00 0.00
ATOM 502 N LYS 55 -23.725 -1.451 1.545 1.00 0.00
ATOM 503 CA LYS 55 -25.127 -1.063 1.221 1.00 0.00
ATOM 504 C LYS 55 -25.533 -0.826 -0.262 1.00 0.00
ATOM 505 O LYS 55 -26.562 -1.309 -0.641 1.00 0.00
ATOM 506 CB LYS 55 -25.703 0.263 1.879 1.00 0.00
ATOM 507 CG LYS 55 -26.499 -0.159 3.073 1.00 0.00
ATOM 508 CD LYS 55 -26.630 1.076 3.974 1.00 0.00
ATOM 509 CE LYS 55 -27.433 0.884 5.294 1.00 0.00
ATOM 510 NZ LYS 55 -27.429 1.932 6.265 1.00 0.00
ATOM 511 HZ1 LYS 55 -27.493 2.872 5.781 1.00 0.00
ATOM 512 HZ2 LYS 55 -26.493 2.016 6.697 1.00 0.00
ATOM 513 HZ3 LYS 55 -28.170 1.869 7.057 1.00 0.00
ATOM 514 H LYS 55 -23.141 -0 .851 1.983 1.00 0.00
ATOM 515 N VAL 56 -24.658 -0.157 -1.036 1.00 0.00
ATOM 516 CA VAL 56 -24.850 0 .075 -2.444 1.00 0.00
ATOM 517 C VAL 56 -24.197 -1.032 -3.343 1.00 0.00
ATOM 518 O VAL 56 -23.993 -0.711 -4.489 1.00 0.00
ATOM 519 CB VAL 56 -24.317 1.473 -2.933 1.00 0.00
ATOM 520 CGI VAL 56 -25.225 2.539 -2.497 1.00 0.00
ATOM 521 CG2 VAL 56 -22.870 1.684 -2.447 1.00 0.00
ATOM 522 H VAL 56 -23.881 0.214 -0.584 1.00 0.00
ATOM 523 N THR 57 -24.030 -2.316 -2.895 1.00 0.00
ATOM 524 CA THR 57 -23.366 -3.358 -3.712 1.00 0.00
ATOM 525 C THR 57 -24.046 -4.665 -3.325 1.00 0.00
ATOM 52 6 O THR 57 -25.261 -4.863 -3.557 1.00 0.00
ATOM 527 CB THR 57 -21.772 -3.502 -3.490 1.00 0.00
ATOM 528 OG1 THR 57 -21.209 -2.204 -3.408 1.00 0.00
ATOM 529 CG2 THR 57 -21.108 -4.447 -4.591 1.00 0.00
ATOM 530 HG1 THR 57 -21.446 -1.867 -2.533 1.00 0.00
ATOM 531 H THR 57 -24.380 -2.520 -2.046 1.00 0.00
ATOM 532 N VAL 58 -23.473 -5.587 -2.600 1.00 0.00
ATOM 533 CA VAL 58 -24.124 -6.805 -2.292 1.00 0.00
ATOM 534 C VAL 58 -24.224 -6.744 -0.789 1.00 0.00
ATOM 535 O VAL 58 -23.171 -6.852 -0.125 1.00 0.00
ATOM 536 CB VAL 58 -23.307 -8.036 -2.878 1.00 0.00
ATOM 537 CGI VAL 58 -23.716 -8.130 -4.306 1.00 0.00
ATOM 538 CG2 VAL 58 -21.766 -7 .878 -2.886 1.00 0.00
ATOM 539 H VAL 58 -22.599 -5.380 -2.176 1.00 0.00
ATOM 540 N THR 59 -25.410 -6.602 -0.229 1.00 0.00
ATOM 541 CA THR 59 -25.563 -6.378 1.219 1.00 0.00
ATOM 542 C THR 59 -25.407 -7.653 2.049 1.00 0.00
ATOM 543 O THR 59 -26.314 -8.144 2.689 1.00 0.00
ATOM 544 CB THR 59 -26.951 -5.660 1.359 1.00 0.00
ATOM 545 OG1 THR 59 -27.558 -5.477 0.020 1.00 0.00
ATOM 546 CG2 THR 59 -26.781 -4.325 2.071 1.00 0.00
ATOM 547 HG1 THR 59 -27.168 -4.663 -0.351 1.00 0.00
ATOM 548 H THR 59 -26.236 -6.613 -0.659 1.00 0.00
ATOM 549 N PHE 60 -24.221 -8.278 2.025 1.00 0.00
ATOM 550 CA PHE 60 -24.077 -9.527 2.747 1.00 0.00
ATOM 551 C PHE 60 -22.810 -9.431 3.611 1.00 0.00
ATOM 552 O PHE 60 -22.490 -10.369 4.272 1.00 0.00
ATOM 553 CB PHE 60 -23.950 -10.651 1.819 1.00 0.00
ATOM 554 CG PHE 60 -25.259 -11.058 1.117 1.00 0.00
ATOM 555 CD1 PHE 60 -25.496 -10.779 -0 .251 1.00 0.00
ATOM 556 CD2 PHE 60 -26.206 -11.687 1.880 1.00 0.00
ATOM 557 CE1 PHE 60 -26.780 -11.114 -0.782 1.00 0.00
ATOM 558 CE2 PHE 60 -27.444 -12.018 1.282 1.00 0.00
ATOM 559 CZ PHE 60 -27.757 -11.750 -0.007 1.00 0.00
ATOM 560 H PHE 60 -23.409 -7.853 1.641 1.00 0.00
ATOM 561 N TYR 61 -22.177 -8 .272 3.841 1.00 0.00
ATOM 562 CA TYR 61 -20.918 -8.055 4.564 1.00 0.00
ATOM 563 C TYR 61 -21.184 -7.683 6.012 1.00 0.00
ATOM 564 O TYR 61 -21.864 -6.711 6.263 1.00 0.00
ATOM 565 CB TYR 61 -20.086 -6.991 3.957 1.00 0.00
ATOM 566 CG TYR 61 -19.557 -7.312 2.573 1.00 0.00
ATOM 567 CD1 TYR 61 -20.392 -7.220 1.497 1.00 0.00
ATOM 568 CD2 TYR 61 -18 .244 -7.731 2.461 1.00 0.00
ATOM 569 CE1 TYR 61 -19.882 -7 .503 0.247 1.00 0.00
ATOM 570 CE2 TYR 61 -17.729 -8.028 1.226 1.00 0.00
ATOM 571 CZ TYR 61 -18.569 -7.892 0.152 1.00 0.00
ATOM 572 OH TYR 61 -18.130 -8.149 -1.069 1.00 0.00
ATOM 573 HH TYR 61 -18.951 -8.220 -1.698 1.00 0.00
ATOM 574 H TYR 61 -22.728 -7.489 3.723 1.00 0.00
ATOM 575 N PRO 62 -20.872 -8.501 7.044 1.00 0.00
ATOM 576 CA PRO 62 -20.531 -8.075 8 .375 1.00 0.00
ATOM 577 C PRO 62 -19.040 -7.848 8.520 1.00 0.00
ATOM 578 O PRO 62 -18.284 -8.689 8.069 1.00 0.00
ATOM 579 CB PRO 62 -21.120 -9.167 9.311 1.00 0.00
ATOM 580 CG PRO 62 -21.971 -10.108 8.391 1.00 0.00
ATOM 581 CD PRO 62 -21.283 -9.887 7.087 1.00 0.00
ATOM 582 N TYR 63 -18.607 -6.763 9.167 1.00 0.00
ATOM 583 CA TYR 63 -17.206 -6.557 9.371 1.00 0.00
ATOM 584 C TYR 63 -16.943 -6.599 10.929 1.00 0.00
ATOM 585 O TYR 63 -17.786 -6.278 11.783 1.00 0.00
ATOM 586 CB TYR 63 -16.771 -5.198 8.852 1.00 0.00
ATOM 587 CG TYR 63 -16.812 -4.876 7 .275 1.00 0.00
ATOM 588 CD1 TYR 63 -16.556 -3.553 6.912 1.00 0.00
ATOM 589 CD2 TYR 63 -17.027 -5.853 6.370 1.00 0.00
ATOM 590 CE1 TYR 63 -16.502 -3.269 5.554 1.00 0.00
ATOM 591 CE2 TYR 63 -16.973 -5.613 5.030 1.00 0.00
ATOM 592 CZ TYR 63 -16.712 -4.293 4.653 1.00 0.00
ATOM 593 OH TYR 63 -16.746 -4.049 3.301 1.00 0.00
ATOM 594 HH TYR 63 -16.360 -4.798 2.877 1.00 0.00
ATOM 595 H TYR 63 -19.285 -6.109 9.440 1.00 0.00
ATOM 596 N ASP 64 -15.687 -7.010 11.216 1.00 0.00
ATOM 597 CA ASP 64 -15.250 -7.037 12.566 1.00 0.00
ATOM 598 C ASP 64 -13.764 -7.011 12.564 1.00 0.00
ATOM 599 O ASP 64 -13.091 -7.685 11.759 1.00 0.00
ATOM 600 CB ASP 64 -15.674 -8.296 13.336 1.00 0.00
ATOM 601 CG ASP 64 -14.948 -8.617 14.664 1.00 0.00
ATOM 602 OD1 ASP 64 -14.695 -9.810 14.965 1.00 0.00
ATOM 603 OD2 ASP 64 -14.787 -7.754 15.538 1.00 0.00
ATOM 604 H ASP 64 -15.082 -7.287 10.500 1.00 0.00
ATOM 605 N VAL 65 -13.096 -6.066 13.283 1.00 0.00
ATOM 606 CA VAL 65 -11.704 -5.866 13.509 1.00 0.00
ATOM 607 C VAL 65 -11.369 -4.902 14.632 1.00 0.00
ATOM 608 O VAL 65 -12.108 -3.959 14.851 1.00 0.00
ATOM 609 CB VAL 65 -10.979 -5.325 12.288 1.00 0.00
ATOM 610 CGI VAL 65 -10.265 -6.536 11.759 1.00 0.00
ATOM 611 CG2 VAL 65 -11.875 -4.503 11.315 1.00 0.00
ATOM 612 H VAL 65 -13.696 -5.487 13.848 1.00 0.00
ATOM 613 N THR 66 -10.262 -5.277 15.304 1.00 0.00
ATOM 614 CA THR 66 -9.554 -4.580 16.360 1.00 0.00
ATOM 615 C THR 66 -10.190 -4.386 17.719 1.00 0.00
ATOM 616 O THR 66 -11.383 -4.335 17.937 1.00 0.00
ATOM 617 CB THR 66 -9.099 -3.189 15.806 1.00 0.00
ATOM 618 OG1 THR 66 -8.682 -3.305 14.436 1.00 0.00
ATOM 619 CG2 THR 66 -8.057 -2.659 16.692 1.00 0.00
ATOM 620 HG1 THR 66 -8.783 -2.509 13.937 1.00 0.00
ATOM 621 H THR 66 -9.809 -6.083 15.004 1.00 0.00
ATOM 622 N VAL 67 -9.291 -4.536 18.733 1.00 0.00
ATOM 623 CA VAL 67 -9.604 -4.362 20.179 1.00 0.00
ATOM 624 C VAL 67 -8.844 -3.015 20.444 1.00 0.00
ATOM 625 O VAL 67 -7.721 -2.965 20.069 1.00 0.00
ATOM 626 CB VAL 67 -8.958 -5.495 21.054 1.00 0.00
ATOM 627 CGI VAL 67 -8.847 -5.327 22.546 1.00 0.00
ATOM 628 CG2 VAL 67 -9.962 -6.582 21.059 1.00 0.00
ATOM 629 H VAL 67 -8.349 -4.656 18.536 1.00 0.00
ATOM 630 N PRO 68 -9.470 -1.966 20.915 1.00 0.00
ATOM 631 CA PRO 68 -8.845 -0.592 21.032 1.00 0.00
ATOM 632 C PRO 68 -7.437 -0.731 21.568 1.00 0.00
ATOM 633 O PRO 68 -6.597 -0.017 21.013 1.00 0.00
ATOM 634 CB PRO 68 -9.836 0.136 21.929 1.00 0.00
ATOM 635 CG PRO 68 -10.539 -1.029 22.636 1.00 0.00
ATOM 636 CD PRO 68 -10.845 -1.982 21.498 1.00 0.00
ATOM 637 N ILE 69 -6.999 -1.498 22.613 1.00 0.00
ATOM 638 CA ILE 69 -5.591 -1.657 22.953 1.00 0.00
ATOM 639 C ILE 69 -4.951 -2.630 21.984 1.00 0.00
ATOM 640 0 ILE 69 -4.535 -3.787 22.226 1.00 0.00
ATOM 641 CB ILE 69 -5.373 -2.100 24.508 1.00 0.00
ATOM 642 CGI ILE 69 -5.961 -3.518 24.840 1.00 0.00
ATOM 643 CG2 ILE 69 -6.186 -1.213 25.467 1.00 0.00
ATOM 644 CD1 ILE 69 -5.058 -4.701 25.094 1.00 0.00
ATOM 645 H ILE 69 -7.653 -1.795 23.222 1.00 0.00
ATOM 646 N ALA 70 -4.729 -2.186 20.757 1.00 0.00
ATOM 647 CA ALA 70 -4.273 -2.932 19.628 1.00 0.00
ATOM 648 C ALA 70 -2.892 -3.516 19.707 1.00 0.00
ATOM 649 O ALA 70 -1.953 -2.808 19.363 1.00 0.00
ATOM 650 CB ALA 70 -4.450 -2.059 18.322 1.00 0.00
ATOM 651 H ALA 70 -4.875 -1.245 20.620 1.00 0.00
ATOM 652 N ILE 71 -2.839 -4.780 20.145 1.00 0.00
ATOM 653 CA ILE 71 -1.568 -5.518 20.170 1.00 0.00
ATOM 654 C ILE 71 -1.772 -6.533 19.100 1.00 0.00
ATOM 655 O ILE 71 -2.786 -7.194 18.990 1.00 0.00
ATOM 656 CB ILE 71 -1.489 -6.097 21.600 1.00 0.00
ATOM 657 CGI ILE 71 -1.066 -4.988 22.452 1.00 0.00
ATOM 658 CG2 ILE 71 -0.527 -7.275 21.763 1.00 0.00
ATOM 659 CD1 ILE 71 -1.371 -5.401 23.938 1.00 0.00
ATOM 660 H ILE 71 -3.684 -5.272 20.358 1.00 0.00
ATOM 661 N THR 72 -0.736 -6.644 18.295 1.00 0.00
ATOM 662 CA THR 72 -0.590 -7 .675 17.210 1.00 0.00
ATOM 663 C THR 72 -1.488 -8.959 17.236 1.00 0.00
ATOM 664 O THR 72 -2.382 -9.081 16.388 1.00 0.00
ATOM 665 CB THR 72 0.860 -8.144 17.137 1.00 0.00
ATOM 666 OG1 THR 72 1.712 -6.987 17 .061 1.00 0.00
ATOM 667 CG2 THR 72 1.056 -9.132 16.051 1.00 0.00
ATOM 668 HG1 THR 72 2.169 -6.960 16.208 1.00 0.00
ATOM 669 H THR 72 -0.102 -5.961 18.254 1.00 0.00
ATOM 670 N THR 73 -1.273 -9.763 18 .267 1.00 0.00
ATOM 671 CA THR 73 -2.107 -10.925 18 .554 1.00 0.00
ATOM 672 C THR 73 -3.607 -10.821 18 .377 1.00 0.00
ATOM 673 O THR 73 -4.126 -11.493 17.615 1.00 0.00
ATOM 674 CB THR 73 -1.800 -11.338 20.011 1.00 0.00
ATOM 675 OG1 THR 73 -0.388 -11.143 20.314 1.00 0.00
ATOM 676 CG2 THR 73 -2.207 -12.808 20 .198 1.00 0.00
ATOM 677 HG1 THR 73 -0.067 -11.816 20 .921 1.00 0.00
ATOM 678 H THR 73 -0.560 -9.453 18.929 1.00 0.00
ATOM 679 N LYS 74 -4.295 -9.784 18.909 1.00 0.00
ATOM 680 CA LYS 74 -5.756 -9.541 18.750 1.00 0.00
ATOM 681 C LYS 74 -6.182 -9.255 17.304 1.00 0.00
ATOM 682 O LYS 74 -7.273 -9.573 16.855 1.00 0.00
ATOM 683 CB LYS 74 -6.215 -8.322 19.579 1.00 0.00
ATOM 684 CG LYS 74 -5.857 -8.482 21.105 1.00 0.00
ATOM 685 CD LYS 74 -6.944 -9.428 21.655 1.00 0.00
ATOM 686 CE LYS 74 -6.656 -10.143 22.970 1.00 0.00
ATOM 687 NZ LYS 74 -6.368 -9.074 23.932 1.00 0.00
ATOM 688 HZ1 LYS 74 -7.183 -8.374 24.114 1.00 0.00
ATOM 689 HZ2 LYS 74 -5.478 -8.510 23.588 1.00 0.00
ATOM 690 HZ3 LYS 74 -6.074 -9.656 24.740 1.00 0.00
ATOM 691 H LYS 74 -3.630 -9.220 19.385 1.00 0.00
ATOM 692 N LEU 75 -5.241 -8.767 16.604 1.00 0.00
ATOM 693 CA LEU 75 -5.497 -8.312 15.261 1.00 0.00
ATOM 694 C LEU 75 -5.361 -9.455 14.322 1.00 0.00
ATOM 695 O LEU 75 -6.235 -9.792 13.496 1.00 0.00
ATOM 696 CB LEU 75 -4.505 -7 .222 14.947 1.00 0.00
ATOM 697 CG LEU 75 -4.604 -5.804 15.637 1.00 0.00
ATOM 698 CD1 LEU 75 -3.357 -4.907 15.217 1.00 0.00
ATOM 699 CD2 LEU 75 -5.896 -5.081 15.219 1.00 0.00
ATOM 700 H LEU 75 -4.408 -8.531 17.059 1.00 0.00
ATOM 701 N LEU 76 -4.321 -10.223 14.592 1.00 0.00
ATOM 702 CA LEU 76 -3.868 -11.408 13.781 1.00 0.00
ATOM 703 C LEU 76 -5.016 -12.411 13.798 1.00 0.00
ATOM 704 O LEU 76 -5.388 -13.042 12.784 1.00 0.00
ATOM 705 CB LEU 76 -2.665 -12.067 14.403 1.00 0.00
ATOM 706 CG LEU 76 -1.254 -11.561 14.477 1.00 0.00
ATOM 707 CD1 LEU 76 -0.323 -12.722 14.796 1.00 0.00
ATOM 708 CD2 LEU 76 -0.884 -10.936 13.123 1.00 0.00
ATOM 709 H LEU 76 -3.804 -9.914 15.319 1.00 0.00
ATOM 710 N LYS 77 -5.542 -12.570 15.003 1.00 0.00
ATOM 711 CA LYS 77 -6.663 -13.516 15.223 1.00 0.00
ATOM 712 C LYS 77 -8.000 -13.233 14.470 1.00 0.00
ATOM 713 O LYS 77 -8.605 -14.200 13.976 1.00 0.00
ATOM 714 CB LYS 77 -7.041 -13.466 16.702 1.00 0.00
ATOM 715 CG LYS 77 -5.999 -13.901 17.634 1.00 0.00
ATOM 716 CD LYS 77 -5.457 -15.328 17.625 1.00 0.00
ATOM 717 CE LYS 77 -5.734 -15.875 18.938 1.00 0.00
ATOM 718 NZ LYS 77 -7.175 -15.974 19.171 1.00 0.00
ATOM 719 HZ1 LYS 77 -7.533 -16.668 18.485 1.00 0.00
ATOM 720 HZ2 LYS 77 -7.673 -15.094 19.053 1.00 0.00
ATOM 721 HZ3 LYS 77 -7.308 -16.355 20.176 1.00 0.00
ATOM 722 H LYS 77 -5.180 -12.045 15.741 1.00 0.00
ATOM 723 N THR 78 -8.562 -12.046 14.329 1.00 0.00
ATOM 724 CA THR 78 -9.896 -11.816 13.772 1.00 0.00
ATOM 725 C THR 78 -9.842 -12.152 12.266 1.00 0.00
ATOM 726 O THR 78 -10 .546 -12.881 11.604 1.00 0.00
ATOM 727 CB THR 78 -10.298 -10.330 13.974 1.00 0.00
ATOM 728 OG1 THR 78 -9.114 -9.586 13.606 1.00 0.00
ATOM 729 CG2 THR 78 -10.647 -9.978 15.381 1.00 0.00
ATOM 730 HG1 THR 78 -8.663 -9.329 14.420 1.00 0.00
ATOM 731 H THR 78 -8.067 -11.214 14.430 1.00 0.00
ATOM 732 N ILE 79 -8.843 -11.434 11.702 1.00 0.00
ATOM 733 CA ILE 79 -8.534 -11.408 10.278 1.00 0.00
ATOM 734 C ILE 79 -8.635 -12.833 9.730 1.00 0.00
ATOM 735 O ILE 79 -9.614 -13.065 9.014 1.00 0.00
ATOM 736 CB ILE 79 -7.151 -10.787 10.117 1.00 0.00
ATOM 737 CGI ILE 79 -6.898 -9.428 10.603 1.00 0.00
ATOM 738 CG2 ILE 79 -7 .210 -10.529 8.579 1.00 0.00
ATOM 739 CD1 ILE 79 -5.419 -8.986 10.502 1.00 0.00
ATOM 740 H ILE 79 -8.230 -10.944 12.313 1.00 0.00
ATOM 741 N PHE 80 -7 .714 -13.713 10.002 1.00 0.00
ATOM 742 CA PHE 80 -7 .608 -15.036 9.501 1.00 0.00
ATOM 743 C PHE 80 -8 .713 -15.919 10.007 1.00 0.00
ATOM 744 O PHE 80 -9.455 -16.460 9.165 1.00 0.00
ATOM 745 CB PHE 80 -6.273 -15.771 9.879 1.00 0.00
ATOM 746 CG PHE 80 -5.325 -16.141 8.713 1.00 0.00
ATOM 747 CD1 PHE 80 -5.142 -17.463 8.295 1.00 0.00
ATOM 748 CD2 PHE 80 -4.674 -15.098 8.110 1.00 0.00
ATOM 749 CE1 PHE 80 -4.318 -17.788 7.274 1.00 0.00
ATOM 750 CE2 PHE 80 -3.839 -15.384 7.071 1.00 0.00
ATOM 751 CZ PHE 80 -3.660 -16.732 6.672 1.00 0.00
ATOM 752 H PHE 80 -7.064 -13.386 10.613 1.00 0.00
ATOM 753 N ALA 81 -8.943 -16.114 11.308 1.00 0.00
ATOM 754 CA ALA 81 -9.891 -17.129 11.839 1.00 0.00
ATOM 755 C ALA 81 -11.371 -16.962 11.372 1.00 0.00
ATOM 756 O ALA 81 -12.200 -17.874 11.551 1.00 0.00
ATOM 757 CB ALA 81 -10.031 -17.145 13.441 1.00 0.00
ATOM 758 H ALA 81 -8.373 -15.510 11.979 1.00 0.00
ATOM 759 N GLN 82 -11.702 -15.800 10 .756 1.00 0.00
ATOM 760 CA GLN 82 -13.107 -15.606 10.383 1.00 0.00
ATOM 761 C GLN 82 -13.365 -15.600 8.971 1.00 0.00
ATOM 762 O GLN 82 -14.391 -15.360 8.412 1.00 0.00
ATOM 763 CB GLN 82 -13.772 -14.938 11.519 1.00 0.00
ATOM 764 CG GLN 82 -15.255 -15.029 11.699 1.00 0.00
ATOM 765 CD GLN 82 -15.821 -16.459 11.996 1.00 0.00
ATOM 766 OE1 GLN 82 -16.961 -16.535 12.442 1.00 0.00
ATOM 767 NE2 GLN 82 -15.120 -17.624 11.901 1.00 0.00
ATOM 768 HE22GLN 82 -15.556 -18.503 12.097 1.00 0.00
ATOM 769 HE21GLN 82 -14.163 -17.575 11.653 1.00 0.00
ATOM 770 H GLN 82 -11.259 -14.811 11.006 1.00 0.00
ATOM 771 N LEU 83 -12.532 -16.549 8.364 1.00 0.00
ATOM 772 CA LEU 83 -12.693 -16.960 6.986 1.00 0.00
ATOM 773 C LEU 83 -12.398 -15.920 5.948 1.00 0.00
ATOM 774 O LEU 83 -12.810 -16.063 4.775 1.00 0.00
ATOM 775 N LYS 84 -11.717 -14.877 6.348 1.00 0.00
ATOM 776 CA LYS 84 -11.265 -13.838 5.431 1.00 0.00
ATOM 777 C LYS 84 -9.806 -14.208 5.081 1.00 0.00
ATOM 778 O LYS 84 -9.083 -14.556 6.009 1.00 0.00
ATOM 779 N THR 85 -9.452 -14.070 3.817 1.00 0.00
ATOM 780 CA THR 85 -8.043 -14.332 3.466 1.00 0.00
ATOM 781 C THR 85 -7.505 -13.029 2.876 1.00 0.00
ATOM 782 O THR 85 -8.173 -12.519 1.974 1.00 0.00
ATOM 783 N VAL 86 -6.334 -12.609 3.357 1.00 0.00
ATOM 784 CA VAL 86 -5.823 -11.339 2.763 1.00 0.00
ATOM 785 C VAL 86 -4.631 -11.646 1.899 1.00 0.00
ATOM 786 O VAL 86 -3.855 -12.569 2.215 1.00 0.00
ATOM 787 N ASP 87 -4.366 -11.062 1.099 1.00 0.00
ATOM 788 CA ASP 87 -3.328 -11.309 0.104 1.00 0.00
ATOM 789 C ASP 87 -2.488 -10.151 -0.058 1.00 0.00
ATOM 790 O ASP 87 -2.242 -9.592 -0.496 1.00 0.00
ATOM 791 CB ASP 87 -4.177 -12.027 -0.931 1.00 0.00
ATOM 792 CG ASP 87 -3.335 -12.906 -1.905 1.00 0.00
ATOM 793 OD1 ASP 87 -2.565 -13.772 -1.437 1.00 0.00
ATOM 794 OD2 ASP 87 -3.484 -12.810 -3.119 1.00 0.00
ATOM 795 H ASP 87 -4.768 -10.322 1.408 1.00 0.00
ATOM 796 N VAL 88 -3.065 -8.993 0.233 1.00 0.00
ATOM 797 CA VAL 88 -2.361 -7.787 -0.005 1.00 0.00
ATOM 798 C VAL 88 -2.461 -6.971 1.278 1.00 0.00
ATOM 799 O VAL 88 -3.564 -6.920 1.917 1.00 0.00
ATOM 800 CB VAL 88 -2.934 -7.004 -1.306 1.00 0.00
ATOM 801 CGI VAL 88 -4.343 -6.499 -1.042 1.00 0.00
ATOM 802 CG2 VAL 88 -2.085 -5.751 -1.586 1.00 0.00
ATOM 803 H VAL 88 -3.878 -8.852 0.653 1.00 0.00
ATOM 804 N LEU 89 -1.421 -6.364 1.741 1.00 0.00
ATOM 805 CA LEU 89 -1.399 -5.575 3.028 1.00 0.00
ATOM 806 C LEU 89 -1.164 -4.150 2.506 1.00 0.00
ATOM 807 O LEU 89 -0.239 -3.978 1.641 1.00 0.00
ATOM 808 CB LEU 89 -0.154 -6.012 3.848 1.00 0.00
ATOM 809 CG LEU 89 -0.313 -6.360 5.356 1.00 0.00
ATOM 810 CD1 LEU 89 1.001 -6.822 5.887 1.00 0.00
ATOM 811 CD2 LEU 89 -0.725 -5.136 6.155 1.00 0.00
ATOM 812 H LEU 89 -0.642 -6.441 1.243 1.00 0.00
ATOM 813 N ILE 90 -1.929 -3.188 2.893 1.00 0.00
ATOM 814 CA ILE 90 -1.628 -1.829 2.446 1.00 0.00
ATOM 815 C ILE 90 -1.027 -1.252 3.642 1.00 0.00
ATOM 816 O ILE 90 -1.770 -0.754 4.519 1.00 0.00
ATOM 817 CB ILE 90 -2.841 -0.856 2.140 1.00 0.00
ATOM 818 CGI ILE 90 -3.394 -1.331 0.848 1.00 0.00
ATOM 819 CG2 ILE 90 -2.476 0.629 1.889 1.00 0.00
ATOM 820 CD1 ILE 90 -4.189 -2.720 0.766 1.00 0.00
ATOM 821 H ILE 90 -2.653 -3.322 3.470 1.00 0.00
ATOM 822 N ASN 91 0.339 -1.269 3.731 1.00 0.00
ATOM 823 CA ASN 91 1.010 -0.546 4.820 1.00 0.00
ATOM 824 C ASN 91 0.959 0.921 4.360 1.00 0.00
ATOM 825 O ASN 91 1.780 1.430 3.579 1.00 0.00
ATOM 826 CB ASN 91 2.544 -0.919 5.017 1.00 0.00
ATOM 827 CG ASN 91 2.703 -2.332 5.523 1.00 0.00
ATOM 828 OD1 ASN 91 2.081 -2.748 6.504 1.00 0.00
ATOM 829 ND2 ASN 91 3.527 -3.123 4.904 1.00 0.00
ATOM 830 HD22ASN 91 3.630 -3.979 5.228 1.00 0.00
ATOM 831 HD21ASN 91 4.025 -2.758 4.149 1.00 0.00
ATOM 832 H ASN 91 0.865 -1.781 3.053 1.00 0.00
ATOM 833 N GLY 92 -0.068 1.573 4.793 1.00 0.00
ATOM 834 CA GLY 92 -0.294 2.985 4.555 1.00 0.00
ATOM 835 C GLY 92 -0.233 3.649 5.870 1.00 0.00
ATOM 836 O GLY 92 -1.245 3.614 6.528 1.00 0.00
ATOM 837 H GLY 92 -0.648 0.983 5.282 1.00 0.00
ATOM 838 N ALA 93 0.913 4.066 6.442 1.00 0.00
ATOM 839 CA ALA 93 0.909 4.751 7.681 1.00 0.00
ATOM 840 C ALA 93 1.455 6.101 7.405 1.00 0.00
ATOM 841 O ALA 93 2.112 6.346 6.407 1.00 0.00
ATOM 842 CB ALA 93 1.855 4.176 8.762 1.00 0.00
ATOM 843 H ALA 93 1.693 4.061 5.903 1.00 0.00
ATOM 844 N GLY 94 0.971 7 .102 8.140 1.00 0.00
ATOM 845 CA GLY 94 1.411 8 .456 8 .051 1.00 0.00
ATOM 846 C GLY 94 0.230 9.408 8 .477 1.00 0.00
ATOM 847 O GLY 94 -0 .936 8 .995 8.561 1.00 0.00
ATOM 848 H GLY 94 0.307 6.853 8 .835 1.00 0.00
ATOM 849 N ILE 95 0.653 10 .644 8.716 1.00 0.00
ATOM 850 CA ILE 95 -0 .247 11.715 9.266 1.00 0.00
ATOM 851 C ILE 95 0.267 12.877 8.483 1.00 0.00
ATOM 852 O ILE 95 0.661 12.727 7.291 1.00 0.00
ATOM 853 CB ILE 95 -0.013 11.966 10.762 1.00 0.00
ATOM 854 CGI ILE 95 0.227 10.721 11.575 1.00 0.00
ATOM 855 CG2 ILE 95 -1.227 12.662 11.215 1.00 0.00
ATOM 856 CD1 ILE 95 1.032 11.024 12.846 1.00 0.00
ATOM 857 H ILE 95 1.528 10.935 8.416 1.00 0.00
ATOM 858 N LEU 96 0.421 14.125 8.949 1.00 0.00
ATOM 859 CA LEU 96 0.746 15.146 8.018 1.00 0.00
ATOM 860 C LEU 96 2.017 15.928 8.224 1.00 0.00
ATOM 861 O LEU 96 2.361 16.192 9.355 1.00 0.00
ATOM 8 62 CB LEU 96 -0.393 16.091 7.995 1.00 0.00
ATOM 863 CG LEU 96 -1.604 15.467 7.381 1.00 0.00
ATOM 864 CD1 LEU 96 -2.828 16.136 7.982 1.00 0.00
ATOM 865 CD2 LEU 96 -1.430 15.418 5.851 1.00 0.00
ATOM 866 H LEU 96 0.283 14.328 9.910 1.00 0.00
ATOM 867 N ASP 97 2.622 16.249 7.058 1.00 0.00
ATOM 868 CA ASP 97 3.805 17.083 7.072 1.00 0.00
ATOM 869 C ASP 97 3.511 18.545 7.468 1.00 0.00
ATOM 870 O ASP 97 3.831 19.532 6.827 1.00 0.00
ATOM 871 CB ASP 97 4.398 16.975 5.648 1.00 0.00
ATOM 872 CG ASP 97 5.834 16.509 5.515 1.00 0.00
ATOM 873 OD1 ASP 97 6.117 15.323 5.525 1.00 0.00
ATOM 874 OD2 ASP 97 6.653 17.366 5.354 1.00 0.00
ATOM 875 H ASP 97 2.275 15.990 6.230 1.00 0.00
ATOM 876 N ASP 98 2.856 18.786 8.609 1.00 0.00
ATOM 877 CA ASP 98 2.345 20.070 9.033 1.00 0.00
ATOM 878 C ASP 98 2.416 19.987 10.531 1.00 0.00
ATOM 879 O ASP 98 1.480 19.608 11.330 1.00 0.00
ATOM 880 CB ASP 98 0.947 20.241 8.567 1.00 0.00
ATOM 881 CG ASP 98 0.646 21.326 7.541 1.00 0.00
ATOM 882 OD1 ASP 98 0.690 20.988 6.379 1.00 0.00
ATOM 883 OD2 ASP 98 0.350 22.433 7.949 1.00 0.00
ATOM 884 H ASP 98 2.875 18.083 9.250 1.00 0.00
ATOM 885 N HIS 99 3.653 20.255 10.940 1.00 0.00
ATOM 886 CA HIS 99 4.024 20.353 12.321 1.00 0.00
ATOM 887 C HIS 99 5.378 20.922 12.312 1.00 0.00
ATOM 888 O HIS 99 6.0 92 20.694 11.387 1.00 0.00
ATOM 889 CB HIS 99 4.094 18.987 13.006 1.00 0.00
ATOM 890 CG HIS 99 2.898 18.138 13.362 1.00 0.00
ATOM 891 ND1 HIS 99 1.595 18.434 13.444 1.00 0.00
ATOM 892 CD2 HIS 99 3.014 16.803 13.655 1.00 0.00
ATOM 893 CE1 HIS 99 0.920 17.381 13.761 1.00 0.00
ATOM 894 NE2 HIS 99 1.777 16.421 13.865 1.00 0.00
ATOM 895 HE2 HIS 99 1.631 15.580 14.300 1.00 0.00
ATOM 896 HD1 HIS 99 1.203 19.278 13.217 1.00 0.00
ATOM 897 H HIS 99 4.420 20.397 10.365 1.00 0.00
ATOM 898 N GLN 100 5.722 21.684 13.310 1.00 0.00
ATOM 899 CA GLN 100 7.111 22.160 13.195 1.00 0.00
ATOM 900 C GLN 100 8 .143 21.044 13.427 1.00 0.00
ATOM 901 O GLN 100 8.100 20.435 14.491 1.00 0.00
ATOM 902 CB GLN 100 7.293 23.326 14.133 1.00 0.00
ATOM 903 CG GLN 100 6.898 23.104 15.570 1.00 0.00
ATOM 904 CD GLN 100 6.681 24.322 16.435 1.00 0.00
ATOM 905 OE1 GLN 100 7.083 25.423 16.043 1.00 0.00
ATOM 906 NE2 GLN 100 6.057 24.231 17.600 1.00 0.00
ATOM 907 HE22GLN 100 6.219 25.048 18 .147 1.00 0.00
ATOM 908 HE21GLN 100 5.600 23.426 17.990 1.00 0.00
ATOM 909 H GLN 100 5.211 21.872 14.083 1.00 0.00
ATOM 910 N ILE 101 8.936 20.716 12.378 1.00 0.00
ATOM 911 CA ILE 101 10.093 19.855 12.313 1.00 0.00
ATOM 912 C ILE 101 10.231 18.922 13.538 1.00 0.00
ATOM 913 O ILE 101 10.167 17 .715 13.310 1.00 0.00
ATOM 914 CB ILE 101 11.372 20.651 12.233 1.00 0.00
ATOM 915 CGI ILE 101 11.349 22 .079 11.542 1.00 0.00
ATOM 916 CG2 ILE 101 12.272 19.729 11.436 1.00 0.00
ATOM 917 CD1 ILE 101 11.861 23.169 12.563 1.00 0.00
ATOM 918 H ILE 101 8.595 21.045 11.536 1.00 0.00
ATOM 919 N GLU 102 10.520 19.390 14.738 1.00 0.00
ATOM 920 CA GLU 102 10.604 18.555 15.966 1.00 0.00
ATOM 921 C GLU 102 9.360 17.743 16.268 1.00 0.00
ATOM 922 0 GLU 102 9.532 16.551 16.427 1.00 0.00
ATOM 923 CB GLU 102 11.022 19.441 17 .169 1.00 0.00
ATOM 924 CG GLU 102 12.454 19.882 16.916 1.00 0.00
ATOM 925 CD GLU 102 12.499 21.405 16.840 1.00 0.00
ATOM 926 OE1 GLU 102 12.601 22.112 17.866 1.00 0.00
ATOM 927 OE2 GLU 102 12.475 21.924 15.751 1.00 0.00
ATOM 928 H GLU 102 10.798 20.343 14.778 1.00 0.00
ATOM 929 N ARG 103 8.197 18 .381 16.243 1.00 0.00
ATOM 930 CA ARG 103 6.980 17.633 16.383 1.00 0.00
ATOM 931 C ARG 103 6.952 16.434 15.400 1.00 0.00
ATOM 932 O ARG 103 6.772 15.253 15.767 1.00 0.00
ATOM 933 CB ARG 103 5.813 18.586 16.178 1.00 0.00
ATOM 934 CG ARG 103 5.600 19.330 17.530 1.00 0.00
ATOM 935 CD ARG 103 4.307 20 .148 17 .390 1.00 0.00
ATOM 936 NE ARG 103 4.443 21.193 16.375 1.00 0.00
ATOM 937 CZ ARG 103 3.415 21.993 16.157 1.00 0.00
ATOM 938 NH1 ARG 103 3.560 23.026 15.319 1.00 0.00
ATOM 939 NH2 ARG 103 2.242 21.918 16.784 1.00 0.00
ATOM 940 HE ARG 103 5.266 21.280 15.878 1.00 0.00
ATOM 941 HH12ARG 103 2.833 23.727 15.257 1.00 0.00
ATOM 942 HH11ARG 103 4.362 23.058 14.757 1.00 0.00
ATOM 943 HH22ARG 103 1.655 22.696 16.553 1.00 0.00
ATOM 944 HH21ARG 103 2.121 21.214 17.553 1.00 0.00
ATOM 945 H ARG 103 8.156 19.355 16.108 1.00 0.00
ATOM 946 N THR 104 7.176 16.743 14.116 1.00 0.00
ATOM 947 CA THR 104 7.068 15.772 12.992 1.00 0.00
ATOM 948 C THR 104 8.088 14.601 13.213 1.00 0.00
ATOM 949 O THR 104 7.749 13.420 13.082 1.00 0.00
ATOM 950 CB THR 104 7.392 16.523 11.655 1.00 0.00
ATOM 951 OG1 THR 104 6.840 17 .843 11.772 1.00 0.00
ATOM 952 CG2 THR 104 6.722 15.964 10.457 1.00 0.00
ATOM 953 HG1 THR 104 7.521 18 .489 11.503 1.00 0.00
ATOM 954 H THR 104 7.627 17.609 13.948 1.00 0.00
ATOM 955 N ILE 105 9.343 14.914 13.569 1.00 0.00
ATOM 956 CA ILE 105 10.402 13.936 13.865 1.00 0.00
ATOM 957 C ILE 105 10.067 13.061 15.089 1.00 0.00
ATOM 958 O ILE 105 10.219 11.863 15.076 1.00 0.00
ATOM 959 CB ILE 105 11.727 14.707 14.116 1.00 0.00
ATOM 960 CGI ILE 105 12.183 15.409 12.877 1.00 0.00
ATOM 961 CG2 ILE 105 12.830 13.743 14.531 1.00 0.00
ATOM 962 CD1 ILE 105 13.375 16.414 12.886 1.00 0.00
ATOM 963 H ILE 105 9.530 15.860 13.589 1.00 0.00
ATOM 964 N ALA 106 9.608 13.727 16.141 1.00 0.00
ATOM 965 CA ALA 106 9.295 12 .971 17 .346 1.00 0.00
ATOM 966 C ALA 106 8 .177 11.944 17 .128 1.00 0.00
ATOM 967 O ALA 106 8.393 10.800 17.512 1.00 0.00
ATOM 968 CB ALA 106 8.896 13.916 18.479 1.00 0.00
ATOM 969 H ALA 106 9.658 14.685 16.138 1.00 0.00
ATOM 970 N VAL 107 7.059 12.322 16.537 1.00 0.00
ATOM 971 CA VAL 107 6.018 11.308 16.373 1.00 0.00
ATOM 972 C VAL 107 6.301 10.474 15.147 1.00 0.00
ATOM 973 O VAL 107 5.418 9.743 14.700 1.00 0.00
ATOM 974 CB VAL 107 4.636 11.944 16.284 1.00 0.00
ATOM 975 CGI VAL 107 4.255 12.383 17.680 1.00 0.00
ATOM 976 CG2 VAL 107 4.628 13.055 15.223 1.00 0.00
ATOM 977 H VAL 107 6.990 13.257 16.247 1.00 0.00
ATOM 978 N ASN 108 7.542 10.432 14.621 1.00 0.00
ATOM 979 CA ASN 108 7 .812 9.526 13.449 1.00 0.00
ATOM 980 C ASN 108 7.661 8 .048 13.777 1.00 0.00
ATOM 981 O ASN 108 7.648 7 .247 12.847 1.00 0.00
ATOM 982 CB ASN 108 9.164 9.740 12.883 1.00 0.00
ATOM 983 CG ASN 108 9.182 9.658 11.358 1.00 0.00
ATOM 984 OD1 ASN 108 8.811 8 .668 10.797 1.00 0.00
ATOM 985 ND2 ASN 108 9.664 10.643 10.672 1.00 0.00
ATOM 986 HD22ASN 108 9.493 10 .635 9.697 1.00 0.00
ATOM 987 HD21ASN 108 10.060 11.420 11.111 1.00 0.00
ATOM 988 H ASN 108 8.333 10.900 14.981 1.00 0.00
ATOM 989 N TYR 109 7.423 7.636 15.072 1.00 0.00
ATOM 990 CA TYR 109 7 .198 6.200 15.524 1.00 0.00
ATOM 991 C TYR 109 6.052 5.621 14.711 1.00 0.00
ATOM 992 O TYR 109 6.224 4.511 14.147 1.00 0.00
ATOM 993 CB TYR 109 6.830 6.035 17.034 1.00 0.00
ATOM 994 CG TYR 109 7 .761 6.750 18.004 1.00 0.00
ATOM 995 CD1 TYR 109 9.156 6.712 17.989 1.00 0.00
ATOM 996 CD2 TYR 109 7.119 7.462 18.951 1.00 0.00
ATOM 997 CE1 TYR 109 9.796 7 .484 18.950 1.00 0.00
ATOM 998 CE2 TYR 109 7.732 8 .211 19.871 1.00 0.00
ATOM 999 CZ TYR 109 9.087 8 .229 19.855 1.00 0.00
ATOM 1000 OH TYR 109 9.791 9.061 20.692 1.00 0.00
ATOM 1001 HH TYR 109 10.723 9.062 20.525 1.00 0.00
ATOM 1002 H TYR 109 7.292 8.398 15.685 1.00 0.00
ATOM 1003 N THR 110 5.045 6.461 14.462 1.00 0.00
ATOM 1004 CA THR 110 3.759 6.103 13.782 1.00 0.00
ATOM 1005 C THR 110 4.064 5.641 12.351 1.00 0.00
ATOM 1006 O THR 110 3.357 4.787 11.771 1.00 0.00
ATOM 1007 CB THR 110 2.880 7 .350 13.828 1.00 0.00
ATOM 1008 OG1 THR 110 3.218 8.001 15.139 1.00 0.00
ATOM 1009 CG2 THR 110 1.470 7 .031 13.785 1.00 0.00
ATOM 1010 HG1 THR 110 3.428 8 .858 14.909 1.00 0.00
ATOM 1011 H THR 110 5.022 7 .339 14.974 1.00 0.00
ATOM 1012 N GLY 111 5.148 6.126 11.798 1.00 0.00
ATOM 1013 CA GLY 111 5.449 5.635 10.489 1.00 0.00
ATOM 1014 C GLY 111 6.570 4.605 10.392 1.00 0.00
ATOM 1015 O GLY 111 6.433 3.438 9.978 1.00 0.00
ATOM 1016 H GLY 111 5.857 6.641 12.320 1.00 0.00
ATOM 1017 N LEU 112 7.712 5.144 10 .787 1.00 0.00
ATOM 1018 CA LEU 112 8.992 4.387 10.875 1.00 0.00
ATOM 1019 C LEU 112 9.017 3.005 11.473 1.00 0.00
ATOM 1020 O LEU 112 8.955 1.978 10 .776 1.00 0.00
ATOM 1021 CB LEU 112 10.140 5.105 11.694 1.00 0.00
ATOM 1022 CG LEU 112 10.904 6.325 11.139 1.00 0.00
ATOM 1023 CD1 LEU 112 11.784 6.844 12.215 1.00 0.00
ATOM 1024 CD2 LEU 112 11.627 6.024 9.804 1.00 0.00
ATOM 1025 H LEU 112 7.761 6.146 10.991 1.00 0.00
ATOM 1026 N VAL 113 9.057 2.880 12.787 1.00 0.00
ATOM 1027 CA VAL 113 9.187 1.613 13.429 1.00 0.00
ATOM 1028 C VAL 113 7.945 0.740 13.313 1.00 0.00
ATOM 1029 O VAL 113 8.165 -0.417 13.120 1.00 0.00
ATOM 1030 CB VAL 113 9.591 1.805 14.887 1.00 0.00
ATOM 1031 CGI VAL 113 11.004 2.314 14.947 1.00 0.00
ATOM 1032 CG2 VAL 113 8.609 2 .704 15.605 1.00 0.00
ATOM 1033 H VAL 113 8.880 3.652 13.320 1.00 0.00
ATOM 1034 N GLN 114 6.734 1.303 13.197 1.00 0.00
ATOM 1035 CA GLN 114 5.507 0.525 13.107 1.00 0.00
ATOM 1036 C GLN 114 5.448 -0.475 11.896 1.00 0.00
ATOM 1037 O GLN 114 5.320 -1.664 12.033 1.00 0.00
ATOM 1038 CB GLN 114 4.332 1.455 13.072 1.00 0.00
ATOM 1039 CG GLN 114 3.011 0.886 13.622 1.00 0.00
ATOM 1040 CD GLN 114 1.848 1.070 12.718 1.00 0.00
ATOM 1041 OE1 GLN 114 0.958 0 .244 12.631 1.00 0.00
ATOM 1042 NE2 GLN 114 1.778 2.082 11.816 1.00 0.00
ATOM 1043 HE22GLN 114 1.209 1.969 11.110 1.00 0.00
ATOM 1044 HE21GLN 114 2.396 2.825 11.883 1.00 0.00
ATOM 1045 H GLN 114 6.692 2.308 13.276 1.00 0.00
ATOM 1046 N THR 115 5.655 0.060 10.720 1.00 0.00
ATOM 1047 CA THR 115 5.587 -0.613 9.396 1.00 0.00
ATOM 1048 C THR 115 6.707 -1.705 9.316 1.00 0.00
ATOM 1049 O THR 115 6.444 -2.790 8.826 1.00 0.00
ATOM 1050 CB THR 115 5.777 0.470 8.380 1.00 0.00
ATOM 1051 OG1 THR 115 4.685 1.414 8.606 1.00 0.00
ATOM 1052 CG2 THR 115 5.779 -0.092 6.900 1.00 0.00
ATOM 1053 HG1 THR 115 5.112 2.241 8 .897 1.00 0.00
ATOM 1054 H THR 115 5.782 1.060 10.663 1.00 0.00
ATOM 1055 N THR 116 7.883 -1.459 9.794 1.00 0.00
ATOM 1056 CA THR 116 8.962 -2.392 9.797 1.00 0.00
ATOM 1057 C THR 116 8.612 -3.593 10.669 1.00 0.00
ATOM 1058 O THR 116 8.901 -4 .776 10.383 1.00 0.00
ATOM 1059 CB THR 116 10.169 -1.642 10.338 1.00 0.00
ATOM 1060 OG1 THR 116 10.111 -0.344 9.745 1.00 0.00
ATOM 1061 CG2 THR 116 11.466 -2.373 10.141 1.00 0.00
ATOM 1062 HG1 THR 116 9.820 0.352 10.342 1.00 0.00
ATOM 1063 H THR 116 8.097 -0.512 10.057 1.00 0.00
ATOM 1064 N THR 117 7.924 -3.254 11.816 1.00 0.00
ATOM 1065 CA THR 117 7.482 -4.232 12.777 1.00 0.00
ATOM 1066 C THR 117 6.400 -5.083 12.050 1.00 0.00
ATOM 1067 O THR 117 6.413 -6.323 12.212 1.00 0.00
ATOM 1068 CB THR 117 6.992 -3.496 13.983 1.00 0.00
ATOM 1069 OG1 THR 117 8 .145 -3.017 14.617 1.00 0.00
ATOM 1070 CG2 THR 117 6.179 -4.307 14.938 1.00 0.00
ATOM 1071 HG1 THR 117 8 .493 -2.298 14.048 1.00 0.00
ATOM 1072 H THR 117 7 .559 -2.357 11.950 1.00 0.00
ATOM 1073 N ALA 118 5.486 -4.556 11.229 1.00 0.00
ATOM 1074 CA ALA 118 4.410 -5.367 10.692 1.00 0.00
ATOM 1075 C ALA 118 4.897 -6.406 9.676 1.00 0.00
ATOM 1076 O ALA 118 4.355 -7 .521 9.504 1.00 0.00
ATOM 1077 CB ALA 118 3.415 -4.480 10.002 1.00 0.00
ATOM 1078 H ALA 118 5.645 -3.677 10.930 1.00 0.00
ATOM 1079 N ILE 119 6.106 -6.258 9.054 1.00 0.00
ATOM 1080 CA ILE 119 6.617 -7.178 7.993 1.00 0.00
ATOM 1081 C ILE 119 6.921 -8 .565 8.547 1.00 0.00
ATOM 1082 O ILE 119 6.458 -9.582 8.003 1.00 0.00
ATOM 1083 CB ILE 119 7.930 -6.635 7.339 1.00 0.00
ATOM 1084 CGI ILE 119 7.742 -5.229 6.853 1.00 0.00
ATOM 1085 CG2 ILE 119 8.290 -7.509 6.074 1.00 0.00
ATOM 1086 CD1 ILE 119 6.488 -4.845 5.985 1.00 0.00
ATOM 1087 H ILE 119 6.659 -5.447 9.226 1.00 0.00
ATOM 1088 N LEU 120 7.385 -8 .616 9.806 1.00 0.00
ATOM 1089 CA LEU 120 7.672 -9.863 10.438 1.00 0.00
ATOM 1090 C LEU 120 6.355 -10.450 10.911 1.00 0.00
ATOM 1091 O LEU 120 6.080 -11.617 10.655 1.00 0.00
ATOM 1092 CB LEU 120 8.704 -9.665 11.619 1.00 0.00
ATOM 1093 CG LEU 120 9.920 -8 .872 11.184 1.00 0.00
ATOM 1094 CD1 LEU 120 9.832 -7 .435 11.850 1.00 0.00
ATOM 1095 CD2 LEU 120 11.158 -9.648 11.536 1.00 0.00
ATOM 1096 H LEU 120 7.299 -7.766 10.297 1.00 0.00
ATOM 1097 N ASP 121 5.480 -9.667 11.578 1.00 0.00
ATOM 1098 CA ASP 121 4.352 -10.221 12.260 1.00 0.00
ATOM 1099 C ASP 121 3.333 -10.903 11.404 1.00 0.00
ATOM 1100 O ASP 121 2.579 -11.799 11.801 1.00 0.00
ATOM 1101 CB ASP 121 3.751 -9.054 13.146 1.00 0.00
ATOM 1102 CG ASP 121 4.662 -8.546 14.225 1.00 0.00
ATOM 1103 OD1 ASP 121 5.335 -9.279 14.918 1.00 0.00
ATOM 1104 OD2 ASP 121 4.738 -7.333 14.458 1.00 0.00
ATOM 1105 H ASP 121 5.709 -8.663 11.527 1.00 0.00
ATOM 1106 N PHE 122 3.382 -10.510 10.142 1.00 0.00
ATOM 1107 CA PHE 122 2.544 -11.059 9.115 1.00 0.00
ATOM 1108 C PHE 122 3.228 -12.209 8.306 1.00 0.00
ATOM 1109 O PHE 122 2.582 -13.203 8.019 1.00 0.00
ATOM 1110 CB PHE 122 2.133 -9.981 8 .140 1.00 0.00
ATOM 1111 CG PHE 122 0 .963 -9.248 8.710 1.00 0.00
ATOM 1112 CD1 PHE 122 -0.292 -9.803 8.672 1.00 0.00
ATOM 1113 CD2 PHE 122 1.047 -8.029 9.272 1.00 0.00
ATOM 1114 CE1 PHE 122 -1.501 -9.208 9.123 1.00 0.00
ATOM 1115 CE2 PHE 122 -0.037 -7.343 9.766 1.00 0.00
ATOM 1116 CZ PHE 122 -1.328 -7.915 9.688 1.00 0.00
ATOM 1117 H PHE 122 4.044 -9.846 9.896 1.00 0.00
ATOM 1118 N TRP 123 4.508 -11.973 7.967 1.00 0.00
ATOM 1119 CA TRP 123 5.327 -12.913 7.183 1.00 0.00
ATOM 1120 C TRP 123 5.051 -14.379 7.058 1.00 0.00
ATOM 1121 O TRP 123 4.837 -14.863 5.934 1.00 0.00
ATOM 1122 CB TRP 123 6.817 -12.738 7.636 1.00 0.00
ATOM 1123 CG TRP 123 7.950 -13.411 6.864 1.00 0.00
ATOM 1124 CD1 TRP 123 8.402 -14.661 7.175 1.00 0.00
ATOM 1125 CD2 TRP 123 8.750 -12.885 5.865 1.00 0.00
ATOM 1126 NEl TRP 123 9.425 -14.931 6.427 1.00 0.00
ATOM 1127 CE2 TRP 123 9.674 -13.917 5.598 1.00 0.00
ATOM 1128 CE3 TRP 123 8.778 -11.726 5.127 1.00 0.00
ATOM 1129 CZ2 TRP 123 10.630 -13.807 4.630 1.00 0.00
ATOM 1130 CZ3 TRP 123 9.718 -11.593 4.145 1.00 0.00
ATOM 1131 CH2 TRP 123 10.665 -12.620 3.879 1.00 0.00
ATOM 1132 HE1 TRP 123 9.923 -15.764 6.504 1.00 0.00
ATOM 1133 H TRP 123 4.936 -11.066 8.332 1.00 0.00
ATOM 1134 N ASP 124 4.940 -15.046 8.213 1.00 0.00
ATOM 1135 CA ASP 124 4.766 -16.467 8.286 1.00 0.00
ATOM 1136 C ASP 124 3.454 -16.890 7.637 1.00 0.00
ATOM 1137 O ASP 124 3.430 -17.864 6.850 1.00 0.00
ATOM 1138 CB ASP 124 4.771 -16.986 9.725 1.00 0.00
ATOM 1139 CG ASP 124 3.725 -16.396 10.705 1.00 0.00
ATOM 1140 OD1 ASP 124 3.393 -15.250 10.667 1.00 0.00
ATOM 1141 OD2 ASP 124 3.121 -17 .104 11.532 1.00 0.00
ATOM 1142 H ASP 124 5.036 -14.529 9.047 1.00 0.00
ATOM 1143 N LYS 125 2.386 -16.144 7.767 1.00 0.00
ATOM 1144 CA LYS 125 1.065 -16.372 7.181 1.00 0.00
ATOM 1145 C LYS 125 1.000 -16.152 5.690 1.00 0.00
ATOM 1146 O LYS 125 0.279 -16.836 4.957 1.00 0.00
ATOM 1147 CB LYS 125 0.082 -15.427 7.839 1.00 0.00
ATOM 1148 CG LYS 125 -0.138 -15.868 9.328 1.00 0.00
ATOM 1149 CD LYS 125 -0.914 -15.026 10.272 1.00 0.00
ATOM 1150 CE LYS 125 -0.359 -15.470 11.646 1.00 0.00
ATOM 1151 NZ LYS 125 -1.467 -15.470 12.534 1.00 0.00
ATOM 1152 HZ1 LYS 125 -2 .17 9 -16.195 12.113 1.00 0.00
ATOM 1153 HZ2 LYS 125 -1.898 -14.524 12.656 1.00 0.00
ATOM 1154 HZ3 LYS 125 -1.091 -15.744 13.471 1.00 0.00
ATOM 1155 H LYS 125 2.469 -15.254 8.204 1.00 0.00
ATOM 1156 N ARG 126 1.845 -15.219 5.299 1.00 0.00
ATOM 1157 CA ARG 126 1.873 -14.898 3.857 1.00 0.00
ATOM 1158 C ARG 126 2.586 -15.953 3.049 1.00 0.00
ATOM 1159 O ARG 126 2.261 -16.078 1.861 1.00 0.00
ATOM 1160 CB ARG 126 2.563 -13.536 3.708 1.00 0.00
ATOM 1161 CG ARG 126 2.361 -12.443 4.726 1.00 0.00
ATOM 1162 CD ARG 12 6 0.944 -11.862 4.655 1.00 0.00
ATOM 1163 NE ARG 12 6 0.842 -10 .751 3.751 1.00 0.00
ATOM 1164 CZ ARG 12 6 -0.249 -9.967 3.729 1.00 0.00
ATOM 1165 NH1 ARG 12 6 -0.311 -8 .944 2 .877 1.00 0.00
ATOM 1166 NH2 ARG 12 6 -1.311 -10.334 4.490 1.00 0.00
ATOM 1167 HE ARG 12 6 1.695 -10.411 3.243 1.00 0.00
ATOM 1168 HH12ARG 126 -1.113 -8.367 2.915 1.00 0.00
ATOM 1169 HH11ARG 12 6 0.352 -8.865 2.174 1.00 0.00
ATOM 1170 HH22ARG 126 -2.110 -9.816 4.431 1.00 0.00
ATOM 1171 HH21ARG 126 -1.347 -11.223 5.020 1.00 0.00
ATOM 1172 H ARG 126 2.482 -14 .759 5.889 1.00 0.00
ATOM 1173 N LYS 127 3.520 -16.661 3.605 1.00 0.00
ATOM 1174 CA LYS 127 4.318 -17.625 2.924 1.00 0.00
ATOM 1175 C LYS 127 3.696 -18.983 3.033 1.00 0.00
ATOM 1176 O LYS 127 3.738 -19.820 2.116 1.00 0.00
ATOM 1177 CB LYS 127 5.652 -17.599 3.622 1.00 0.00
ATOM 1178 CG LYS 127 6.783 -18.126 2.807 1.00 0.00
ATOM 1179 CD LYS 127 8.161 -18.205 3.379 1.00 0.00
ATOM 1180 CE LYS 127 8.293 -19.203 4.590 1.00 0.00
ATOM 1181 NZ LYS 127 7.844 -20.573 4.270 1.00 0.00
ATOM 1182 HZ1 LYS 127 6.958 -20 .608 3.752 1.00 0.00
ATOM 1183 HZ2 LYS 127 7.7 62 -21.079 5.155 1.00 0.00
ATOM 1184 HZ3 LYS 127 8 .564 -21.026 3.721 1.00 0.00
ATOM 1185 H LYS 127 3.647 -16.470 4.564 1.00 0.00
ATOM 1186 N GLY 128 3.251 -19.360 4.260 1.00 0.00
ATOM 1187 CA GLY 128 2.438 -20.518 4.413 1.00 0.00
ATOM 1188 C GLY 128 1.154 -20.406 3.588 1.00 0.00
ATOM 1189 O GLY 128 0.470 -21.432 3.375 1.00 0.00
ATOM 1190 H GLY 128 3.610 -18.928 5.052 1.00 0.00
ATOM 1191 N GLY 12 9 0.638 -19.262 3.227 1.00 0.00
ATOM 1192 CA GLY 12 9 -0.505 -19.057 2.321 1.00 0.00
ATOM 1193 C GLY 129 0.020 -18.366 1.020 1.00 0.00
ATOM 1194 O GLY 129 -0.309 -17.184 0.888 1.00 0.00
ATOM 1195 H GLY 129 0.957 -18.456 3.670 1.00 0.00
ATOM 1196 N PRO 130 0.772 -19.048 0.156 1.00 0.00
ATOM 1197 CA PRO 130 1.850 -18.568 -0.715 1.00 0.00
ATOM 1198 C PRO 130 1.547 -17.399 -1.699 1.00 0.00
ATOM 1199 O PRO 130 1.483 -17.472 -2.901 1.00 0.00
ATOM 1200 CB PRO 130 2.310 -19.717 -1.491 1.00 0.00
ATOM 1201 CG PRO 130 1.712 -20.873 -0.803 1.00 0.00
ATOM 1202 CD PRO 130 0.361 -20.340 -0.291 1.00 0.00
ATOM 1203 N GLY 131 1.276 -16.310 -1.047 1.00 0.00
ATOM 1204 CA GLY 131 0.981 -15.037 -1.732 1.00 0.00
ATOM 1205 C GLY 131 1.541 -13.987 -0.795 1.00 0.00
ATOM 1206 O GLY 131 2.763 -13.961 -0.478 1.00 0.00
ATOM 1207 H GLY 131 1.476 -16.295 -0.099 1.00 0.00
ATOM 1208 N GLY 132 0 .543 -13.329 -0.242 1.00 0.00
ATOM 1209 CA GLY 132 0 .705 -12.228 0.673 1.00 0.00
ATOM 1210 C GLY 132 1.573 -11.076 0.205 1.00 0.00
ATOM 1211 O GLY 132 2.680 -10.848 0.611 1.00 0.00
ATOM 1212 H GLY 132 -0.267 -13.816 -0.390 1.00 0.00
ATOM 1213 N ILE 133 0.995 -10.360 -0.736 1.00 0.00
ATOM 1214 CA ILE 133 1.631 -9.210 -1.354 1.00 0.00
ATOM 1215 C ILE 133 1.676 -8.125 -0.285 1.00 0.00
ATOM 1216 O ILE 133 0.704 -7.594 0.229 1.00 0.00
ATOM 1217 CB ILE 133 0.780 -8 .742 -2.615 1.00 0.00
ATOM 1218 CGI ILE 133 0.778 -9.674 -3.789 1.00 0.00
ATOM 1219 CG2 ILE 133 1.381 -7 .441 -3.208 1.00 0.00
ATOM 1220 CD1 ILE 133 -0 .124 -10.905 -3.719 1.00 0.00
ATOM 1221 H ILE 133 0 .022 -10.631 -0.891 1.00 0.00
ATOM 1222 N ILE 134 2.813 -7.691 0.185 1.00 0.00
ATOM 1223 CA ILE 134 2.932 -6.558 1.116 1.00 0.00
ATOM 1224 C ILE 134 3.167 -5.237 0.332 1.00 0.00
ATOM 1225 O ILE 134 4.192 -5.106 -0 .287 1.00 0.00
ATOM 1226 CB ILE 134 4.067 -6.691 2.186 1.00 0.00
ATOM 1227 CGI ILE 134 3.933 -7.874 3.060 1.00 0.00
ATOM 1228 CG2 ILE 134 4.058 -5.395 2.977 1.00 0.00
ATOM 1229 CD1 ILE 134 4.942 -8 .957 2.640 1.00 0.00
ATOM 1230 H ILE 134 3.707 -8 .013 -0.078 1.00 0.00
ATOM 1231 N CYS 135 2.227 -4.291 0 .377 1.00 0.00
ATOM 1232 CA CYS 135 2.308 -3.151 -0.474 1.00 0.00
ATOM 1233 C CYS 135 2.425 -1.861 0.356 1.00 0.00
ATOM 1234 O CYS 135 1.568 -1.671 1.246 1.00 0.00
ATOM 1235 CB CYS 135 1.093 -2.982 -1.371 1.00 0.00
ATOM 1236 SG CYS 135 1.112 -3.940 -2.930 1.00 0.00
ATOM 1237 H CYS 135 1.700 -4.245 1.118 1.00 0.00
ATOM 1238 N ASN 136 3.432 -1.026 0.059 1.00 0.00
ATOM 1239 CA ASN 136 3.765 0.174 0.858 1.00 0.00
ATOM 1240 C ASN 136 3.510 1.369 0.024 1.00 0.00
ATOM 1241 O ASN 136 3.864 1.511 -1.148 1.00 0.00
ATOM 1242 CB ASN 136 5.180 0.209 1.268 1.00 0.00
ATOM 1243 CG ASN 136 5.687 -1.070 1.908 1.00 0.00
ATOM 1244 OD1 ASN 136 5.441 -1.494 3.069 1.00 0.00
ATOM 1245 ND2 ASN 136 6.407 -1.794 1.089 1.00 0.00
ATOM 1246 HD22ASN 136 6.867 -2.575 1.395 1.00 0.00
ATOM 1247 HD21ASN 136 6.400 -1.485 0.140 1.00 0.00
ATOM 1248 H ASN 136 3.899 -1.311 -0.690 1.00 0.00
ATOM 1249 N ILE 137 3.038 2.481 0.606 1.00 0.00
ATOM 1250 CA ILE 137 2.880 3.759 -0.120 1.00 0.00
ATOM 1251 C ILE 137 4.216 4.516 -0.186 1.00 0.00
ATOM 1252 O ILE 137 5.117 4.036 0.559 1.00 0.00
ATOM 1253 CB ILE 137 1.703 4.542 0.659 1.00 0.00
ATOM 1254 CGI ILE 137 1.130 5.674 -0.147 1.00 0.00
ATOM 1255 CG2 ILE 137 2.300 4.997 1.941 1.00 0.00
ATOM 1256 CD1 ILE 137 0.334 5.137 -1.331 1.00 0.00
ATOM 1257 H ILE 137 2.864 2.417 1.582 1.00 0.00
ATOM 1258 N GLY 138 4.499 5.538 -0 .947 1.00 0.00
ATOM 1259 CA GLY 138 5.749 6.217 -1.077 1.00 0.00
ATOM 1260 C GLY 138 5.255 7.650 -1.355 1.00 0.00
ATOM 1261 O GLY 138 4.030 7.929 -1.237 1.00 0.00
ATOM 1262 H GLY 138 3.673 5.965 -1.384 1.00 0.00
ATOM 1263 N SER 139 6.121 8.617 -1.479 1.00 0.00
ATOM 1264 CA SER 139 5.736 9.927 -1.873 1.00 0.00
ATOM 1265 C SER 139 6.970 10.721 -2.333 1.00 0.00
ATOM 1266 O SER 139 8 .046 10.632 -1.642 1.00 0.00
ATOM 1267 CB SER 139 5.079 10.759 -0.752 1.00 0.00
ATOM 1268 OG SER 139 4.258 10.236 0.262 1.00 0.00
ATOM 1269 HG SER 139 3.590 9.698 -0.217 1.00 0.00
ATOM 1270 H SER 139 7.068 8.448 -1.233 1.00 0.00
ATOM 1271 N VAL 140 6.861 11.479 -3.451 1.00 0.00
ATOM 1272 CA VAL 140 7.996 12.203 -4.050 1.00 0.00
ATOM 1273 C VAL 140 9.124 12.730 -3.182 1.00 0.00
ATOM 1274 O VAL 140 10.271 12.602 -3.576 1.00 0.00
ATOM 1275 CB VAL 140 7.498 13.412 -4.877 1.00 0.00
ATOM 1276 CGI VAL 140 6.757 12.944 -6.143 1.00 0.00
ATOM 1277 CG2 VAL 140 6.568 14.311 -4.037 1.00 0.00
ATOM 1278 H VAL 140 5.983 11.499 -3.933 1.00 0.00
ATOM 1279 N THR 141 8.796 13.342 -2.026 1.00 0.00
ATOM 1280 CA THR 141 9.746 14.021 -1.125 1.00 0.00
ATOM 1281 C THR 141 11.032 13.148 -0.901 1.00 0.00
ATOM 1282 O THR 141 12.099 13.697 -1.050 1.00 0.00
ATOM 1283 CB THR 141 9.077 14.194 0.243 1.00 0.00
ATOM 1284 OG1 THR 141 7.690 14.211 0.030 1.00 0.00
ATOM 1285 CG2 THR 141 9.531 15.457 0.993 1.00 0.00
ATOM 1286 HG1 THR 141 7.286 14.126 0.885 1.00 0.00
ATOM 1287 H THR 141 7.861 13.375 -1.763 1.00 0.00
ATOM 1288 N GLY 142 10.954 11.830 -0.737 1.00 0.00
ATOM 1289 CA GLY 142 12.072 10.894 -0.515 1.00 0.00
ATOM 1290 C GLY 142 12.978 10.647 -1.717 1.00 0.00
ATOM 1291 O GLY 142 14.068 10.085 -1.553 1.00 0.00
ATOM 1292 H GLY 142 10.050 11.432 -0.936 1.00 0.00
ATOM 1293 N PHE 143 12.553 11.154 -2.834 1.00 0.00
ATOM 1294 CA PHE 143 13.268 10.916 -4.099 1.00 0.00
ATOM 1295 C PHE 143 14.097 12.130 -4.486 1.00 0.00
ATOM 1296 O PHE 143 15.268 12.030 -4.862 1.00 0.00
ATOM 1297 CB PHE 143 12.287 10.604 -5.203 1.00 0.00
ATOM 1298 CG PHE 143 11.669 9.211 -5.246 1.00 0.00
ATOM 1299 CD1 PHE 143 12.137 8.377 -6.218 1.00 0.00
ATOM 1300 CD2 PHE 143 10.745 8.791 -4.343 1.00 0.00
ATOM 1301 CE1 PHE 143 11.669 7.110 -6.331 1.00 0.00
ATOM 1302 CE2 PHE 143 10.288 7.507 -4.488 1.00 0.00
ATOM 1303 CZ PHE 143 10.730 6.634 -5.472 1.00 0.00
ATOM 1304 H PHE 143 11.773 11.697 -2.921 1.00 0.00
ATOM 1305 N ASN 144 13.439 13.319 -4.440 1.00 0.00
ATOM 1306 CA ASN 144 14.101 14.549 -4.834 1.00 0.00
ATOM 1307 C ASN 144 15.271 14.864 -3.944 1.00 0.00
ATOM 1308 O ASN 144 15.159 14.821 -2.729 1.00 0.00
ATOM 1309 CB ASN 144 13.164 15.771 -4.934 1.00 0.00
ATOM 1310 CG ASN 144 13.782 16.863 -5.766 1.00 0.00
ATOM 1311 OD1 ASN 144 14.363 17.774 -5.200 1.00 0.00
ATOM 1312 ND2 ASN 144 13.667 16.797 -7.108 1.00 0.00
ATOM 1313 HD22ASN 144 14.066 17.517 -7 . 677 1.00 0.00
ATOM 1314 HD21ASN 144 13.179 16.041 -7.546 1.00 0.00
ATOM 1315 H ASN 144 12.479 13.410 -4.183 1.00 0.00
ATOM 1316 N ALA 145 16.402 15.174 -4.599 1.00 0.00
ATOM 1317 CA ALA 145 17.621 15.484 -3.862 1.00 0.00
ATOM 1318 C ALA 145 17.643 16.766 -3.066 1.00 0.00
ATOM 1319 O ALA 145 18.086 16.700 -1.912 1.00 0.00
ATOM 1320 CB ALA 145 18 .773 15.509 -4.851 1.00 0.00
ATOM 1321 H ALA 145 16.370 15.177 -5.554 1.00 0.00
ATOM 1322 N ILE 146 17.155 17.879 -3.651 1.00 0.00
ATOM 1323 CA ILE 146 17.037 19.118 -2.888 1.00 0.00
ATOM 1324 C ILE 146 15.753 19.159 -2.084 1.00 0.00
ATOM 1325 O ILE 146 15.715 19.839 -1.070 1.00 0.00
ATOM 1326 CB ILE 146 17.116 20.321 -3.852 1.00 0.00
ATOM 1327 CGI ILE 146 18.366 20.191 -4.746 1.00 0.00
ATOM 1328 CG2 ILE 146 17.209 21.636 -3.059 1.00 0.00
ATOM 1329 CD1 ILE 146 18.167 21.001 -6.039 1.00 0.00
ATOM 1330 H ILE 146 16.824 17 .853 -4.597 1.00 0.00
ATOM 1331 N TYR 147 14.687 18.435 -2.507 1.00 0.00
ATOM 1332 CA TYR 147 13.434 18.405 -1.750 1.00 0.00
ATOM 1333 C TYR 147 13.421 17.353 -0.657 1.00 0.00
ATOM 1334 O TYR 147 12.409 17.168 -0.001 1.00 0.00
ATOM 1335 CB TYR 147 12.315 18.179 -2.796 1.00 0.00
ATOM 1336 CG TYR 147 10.904 18.015 -2.242 1.00 0.00
ATOM 1337 CD1 TYR 147 10.123 16.950 -2.694 1.00 0.00
ATOM 1338 CD2 TYR 147 10.385 18.918 -1.310 1.00 0.00
ATOM 1339 CE1 TYR 147 8.785 16.847 -2.300 1.00 0.00
ATOM 1340 CE2 TYR 147 9.051 18.805 -0.908 1.00 0.00
ATOM 1341 CZ TYR 147 8.237 17.792 -1.431 1.00 0.00
ATOM 1342 OH TYR 147 6.885 17.716 -1.095 1.00 0.00
ATOM 1343 HH TYR 147 6.596 18.439 -0.548 1.00 0.00
ATOM 1344 H TYR 147 14.740 17.865 -3.327 1.00 0.00
ATOM 1345 N GLN 148 14.555 16.652 -0.443 1.00 0.00
ATOM 1346 CA GLN 148 14.676 15.516 0.496 1.00 0.00
ATOM 1347 C GLN 148 15.022 16.013 1.890 1.00 0.00
ATOM 1348 O GLN 148 15.510 15.282 2.697 1.00 0.00
ATOM 1349 CB GLN 148 15.861 14.645 -0.043 1.00 0.00
ATOM 1350 CG GLN 148 15.839 13.189 0.436 1.00 0.00
ATOM 1351 CD GLN 148 16.823 12 .323 -0.364 1.00 0.00
ATOM 1352 OE1 GLN 148 17.985 12 .168 0.007 1.00 0.00
ATOM 1353 NE2 GLN 148 16.423 11.657 -1.509 1.00 0.00
ATOM 1354 HE22GLN 148 17.071 11.341 -2.141 1.00 0.00
ATOM 1355 HE21GLN 148 15.457 11.608 -1.588 1.00 0.00
ATOM 1356 H GLN 148 15.408 16.723 -1.042 1.00 0.00
ATOM 1357 N VAL 149 14.630 17.193 2.333 1.00 0.00
ATOM 1358 CA VAL 149 15.070 17.747 3.641 1.00 0.00
ATOM 1359 C VAL 149 14.271 17.032 4.811 1.00 0.00
ATOM 1360 O VAL 149 13.079 16.806 4.699 1.00 0.00
ATOM 1361 CB VAL 149 14.887 19.252 3.635 1.00 0.00
ATOM 1362 CGI VAL 149 15.724 19.863 2.503 1.00 0.00
ATOM 1363 CG2 VAL 149 13.432 19.620 3.446 1.00 0.00
ATOM 1364 H VAL 149 14.081 17.746 1.712 1.00 0.00
ATOM 1365 N PRO 150 14.875 16.785 5.993 1.00 0.00
ATOM 1366 CA PRO 150 14.670 15.556 6.737 1.00 0.00
ATOM 1367 C PRO 150 13.164 15.248 7 .022 1.00 0.00
ATOM 1368 O PRO 150 12.669 14.212 6.765 1.00 0.00
ATOM 1369 CB PRO 150 15.487 15.752 8.012 1.00 0.00
ATOM 1370 CG PRO 150 15.375 17.295 8.147 1.00 0.00
ATOM 1371 CD PRO 150 15.598 17.814 6.765 1.00 0.00
ATOM 1372 N VAL 151 12.513 16.231 7.703 1.00 0.00
ATOM 1373 CA VAL 151 11.133 16.307 8.231 1.00 0.00
ATOM 1374 C VAL 151 10.414 15.045 8.445 1.00 0.00
ATOM 1375 O VAL 151 10.246 14.703 9.653 1.00 0.00
ATOM 1376 CB VAL 151 10.121 17.213 7.411 1.00 0.00
ATOM 1377 CGI VAL 151 10.643 18.630 7.669 1.00 0.00
ATOM 1378 CG2 VAL 151 10.183 17.086 5.916 1.00 0.00
ATOM 1379 H VAL 151 13.050 17.060 7.766 1.00 0.00
ATOM 1380 N TYR 152 9.986 14.381 7.396 1.00 0.00
ATOM 1381 CA TYR 152 9.343 13.090 7.457 1.00 0.00
ATOM 1382 C TYR 152 10.007 12.274 6.299 1.00 0.00
ATOM 1383 O TYR 152 9.932 11.052 6.298 1.00 0.00
ATOM 1384 CB TYR 152 7.795 13.232 7.115 1.00 0.00
ATOM 1385 CG TYR 152 6.898 12.297 7 .846 1.00 0.00
ATOM 1386 CD1 TYR 152 6.907 12.364 9.258 1.00 0.00
ATOM 1387 CD2 TYR 152 6.065 11.446 7.178 1.00 0.00
ATOM 1388 CE1 TYR 152 5.972 11.550 9.967 1.00 0.00
ATOM 1389 CE2 TYR 152 5.235 10.626 7.812 1.00 0.00
ATOM 1390 CZ TYR 152 5.201 10.692 9.173 1.00 0.00
ATOM 1391 OH TYR 152 4.344 9.824 9.818 1.00 0.00
ATOM 1392 HH TYR 152 4.726 9.771 10.676 1.00 0.00
ATOM 1393 H TYR 152 10.147 14.876 6.523 1.00 0.00
ATOM 1394 N SER 153 10.729 12.883 5.391 1.00 0.00
ATOM 1395 CA SER 153 11.346 12.280 4.171 1.00 0.00
ATOM 1396 C SER 153 12.000 10.940 4.283 1.00 0.00
ATOM 1397 O SER 153 11.839 10.075 3.393 1.00 0.00
ATOM 1398 CB SER 153 12.227 13.300 3.708 1.00 0.00
ATOM 1399 OG SER 153 11.417 14.475 3.680 1.00 0.00
ATOM 1400 HG SER 153 12.014 15.223 3.540 1.00 0.00
ATOM 1401 H SER 153 10.904 13.816 5.565 1.00 0.00
ATOM 1402 N GLY 154 12.691 10 .710 5.376 1.00 0.00
ATOM 1403 CA GLY 154 13.393 9.398 5.525 1.00 0.00
ATOM 1404 C GLY 154 12.360 8.223 5.617 1.00 0.00
ATOM 1405 O GLY 154 12.728 7 .104 5.238 1.00 0.00
ATOM 1406 H GLY 154 12.700 11.401 6.088 1.00 0.00
ATOM 1407 N THR 155 11.159 8.458 6.155 1.00 0.00
ATOM 1408 CA THR 155 10.100 7.455 6.239 1.00 0.00
ATOM 1409 C THR 155 9.712 6.972 4.773 1.00 0.00
ATOM 1410 O THR 155 9.603 5.752 4.544 1.00 0.00
ATOM 1411 CB THR 155 8.808 8.057 6.899 1.00 0.00
ATOM 1412 OG1 THR 155 9.206 8.775 8.049 1.00 0.00
ATOM 1413 CG2 THR 155 7.782 6.945 7.133 1.00 0.00
ATOM 1414 HG1 THR 155 8.946 8.228 8.816 1.00 0.00
ATOM 1415 H THR 155 11.025 9.295 6.531 1.00 0.00
ATOM 1416 N LYS 156 9.630 7.955 3.906 1.00 0.00
ATOM 1417 CA LYS 156 9.332 7.644 2.510 1.00 0.00
ATOM 1418 C LYS 156 10.484 7.016 1.768 1.00 0.00
ATOM 1419 O LYS 156 10.377 6.216 0.905 1.00 0.00
ATOM 1420 CB LYS 156 8.841 8.957 1.826 1.00 0.00
ATOM 1421 CG LYS 156 7 .471 9.361 2.356 1.00 0.00
ATOM 1422 CD LYS 156 7 .427 10.865 2.071 1.00 0.00
ATOM 1423 CE LYS 156 6.451 11.602 2.960 1.00 0.00
ATOM 1424 NZ LYS 156 6.130 12.891 2.479 1.00 0.00
ATOM 1425 HZ1 LYS 156 5.950 13.436 3.311 1.00 0.00
ATOM 1426 HZ2 LYS 156 5.299 12.754 1.904 1.00 0.00
ATOM 1427 HZ3 LYS 156 6.998 13.270 1.948 1.00 0.00
ATOM 1428 H LYS 156 9.619 8 .914 4.210 1.00 0.00
ATOM 1429 N ALA 157 11.683 7.361 2.223 1.00 0.00
ATOM 1430 CA ALA 157 12.820 6.716 1.651 1.00 0.00
ATOM 1431 C ALA 157 12.883 5.218 2.012 1.00 0.00
ATOM 1432 0 ALA 157 13.231 4.356 1.217 1.00 0.00
ATOM 1433 CB ALA 157 14.017 7 .394 2.066 1.00 0.00
ATOM 1434 H ALA 157 11.718 8 .225 2.810 1.00 0.00
ATOM 1435 N ALA 158 12.602 4.907 3.264 1.00 0.00
ATOM 1436 CA ALA 158 12.561 3.568 3.801 1.00 0.00
ATOM 1437 C ALA 158 11.655 2.739 2.999 1.00 0.00
ATOM 1438 O ALA 158 12.099 1.732 2.448 1.00 0.00
ATOM 1439 CB ALA 158 12.007 3.724 5.205 1.00 0.00
ATOM 1440 H ALA 158 12.378 5.589 3.885 1.00 0.00
ATOM 1441 N VAL 159 10.428 3.277 2.846 1.00 0.00
ATOM 1442 CA VAL 159 9.454 2.430 2.208 1.00 0.00
ATOM 1443 C VAL 159 9.738 2.048 0.769 1.00 0.00
ATOM 1444 O VAL 159 9.115 1.100 0.274 1.00 0.00
ATOM 1445 CB VAL 159 7 .905 2.998 2.271 1.00 0.00
ATOM 1446 CGI VAL 159 7 .402 3.158 3.700 1.00 0.00
ATOM 1447 CG2 VAL 159 7 .848 4.342 1.612 1.00 0.00
ATOM 1448 H VAL 159 10.181 4 .242 3.031 1.00 0.00
ATOM 1449 N VAL 160 10.741 2.717 0.127 1.00 0.00
ATOM 1450 CA VAL 160 11.151 2.356 -1.241 1.00 0.00
ATOM 1451 C VAL 160 12.132 1.176 -1.132 1.00 0.00
ATOM 1452 O VAL 160 11.831 0.172 -1.695 1.00 0.00
ATOM 1453 CB VAL 160 11.852 3.440 -2.059 1.00 0.00
ATOM 1454 CGI VAL 160 11.778 3.191 -3.543 1.00 0.00
ATOM 1455 CG2 VAL 160 11.319 4.766 -1.715 1.00 0.00
ATOM 1456 H VAL 160 11.308 3.366 0.627 1.00 0.00
ATOM 1457 N ASN 161 13.148 1.454 -0.278 1.00 0.00
ATOM 1458 CA ASN 161 14.310 0.598 -0.269 1.00 0.00
ATOM 1459 C ASN 161 14.076 -0.796 0.320 1.00 0.00
ATOM 1460 O ASN 161 14.757 -1.797 -0.053 1.00 0.00
ATOM 1461 CB ASN 161 15.533 1.277 0.475 1.00 0.00
ATOM 1462 CG ASN 161 16.104 2.386 -0.346 1.00 0.00
ATOM 1463 OD1 ASN 161 16.978 2 .307 -1.204 1.00 0.00
ATOM 1464 ND2 ASN 161 15.723 3.602 -0.067 1.00 0.00
ATOM 1465 HD22ASN 161 16.170 4.135 -0.693 1.00 0.00
ATOM 1466 HD21ASN 161 15.101 3.792 0.697 1.00 0.00
ATOM 1467 H ASN 161 13.005 2 .047 0.484 1.00 0.00
ATOM 1468 N PHE 162 13.331 -0.900 1.415 1.00 0.00
ATOM 1469 CA PHE 162 13.048 -2.245 1.915 1.00 0.00
ATOM 1470 C PHE 162 12 .640 -3.325 0.993 1.00 0.00
ATOM 1471 O PHE 162 12.961 -4.505 1.156 1.00 0.00
ATOM 1472 CB PHE 162 12.096 -2.060 3.050 1.00 0.00
ATOM 1473 CG PHE 162 12.880 -2.342 4.313 1.00 0.00
ATOM 1474 CD1 PHE 162 13.302 -3.631 4.613 1.00 0.00
ATOM 1475 CD2 PHE 162 13.262 -1.289 5.178 1.00 0.00
ATOM 1476 CE1 PHE 162 14.116 -3.847 5.754 1.00 0.00
ATOM 1477 CE2 PHE 162 14.027 -1.539 6.264 1.00 0.00
ATOM 1478 CZ PHE 162 14.478 -2.793 6.578 1.00 0.00
ATOM 1479 H PHE 162 12.939 -0.126 1.923 1.00 0.00
ATOM 1480 N THR 163 11.890 -2.934 -0.055 1.00 0.00
ATOM 1481 CA THR 163 11.346 -3.960 -0.961 1.00 0.00
ATOM 1482 C THR 163 12.537 -4.637 -1.632 1.00 0.00
ATOM 1483 O THR 163 12.724 -5.816 -1.436 1.00 0.00
ATOM 1484 CB THR 163 10.388 -3.202 -1.954 1.00 0.00
ATOM 1485 OG1 THR 163 9.442 -2.656 -1.075 1.00 0.00
ATOM 1486 CG2 THR 163 9.773 -3.982 -3.118 1.00 0.00
ATOM 1487 HG1 THR 163 9.048 -1.863 -1.444 1.00 0.00
ATOM 1488 H THR 163 11.505 -2.016 -0.067 1.00 0.00
ATOM 1489 N SER 164 13.328 -3.897 -2.464 1.00 0.00
ATOM 1490 CA SER 164 14.586 -4.366 -3.073 1.00 0.00
ATOM 1491 C SER 164 15.495 -5.036 -1.987 1.00 0.00
ATOM 1492 O SER 164 16.108 -6.014 -2.285 1.00 0.00
ATOM 1493 CB SER 164 15.270 -3.066 -3.724 1.00 0.00
ATOM 1494 OG SER 164 14.400 -2.404 -4.563 1.00 0.00
ATOM 1495 HG SER 164 14.353 -2.905 -5.409 1.00 0.00
ATOM 1496 H SER 164 13.131 -2.941 -2.592 1.00 0.00
ATOM 1497 N SER 165 15.402 -4.552 -0.717 1.00 0.00
ATOM 1498 CA SER 165 16.092 -5.207 0.330 1.00 0.00
ATOM 1499 C SER 165 15.586 -6.593 0.782 1.00 0.00
ATOM 1500 O SER 165 16.336 -7.542 0.908 1.00 0.00
ATOM 1501 CB SER 165 16.154 -4.285 1.506 1.00 0.00
ATOM 1502 OG SER 165 16.859 -3.013 1.322 1.00 0.00
ATOM 1503 HG SER 165 16.397 -2.497 0.670 1.00 0.00
ATOM 1504 H SER 165 15.009 -3.650 -0.564 1.00 0.00
ATOM 1505 N LEU 166 14.275 -6.828 0.803 1.00 0.00
ATOM 1506 CA LEU 166 13.717 -8.099 1.247 1.00 0.00
ATOM 1507 C LEU 166 13.733 -9.106 0.186 1.00 0.00
ATOM 1508 O LEU 166 14.217 -10 .229 0.260 1.00 0.00
ATOM 1509 CB LEU 166 12.243 -7 .823 1.796 1.00 0.00
ATOM 1510 CG LEU 166 12.060 -7 .075 3.114 1.00 0.00
ATOM 1511 CD1 LEU 166 10.593 -6.894 3.499 1.00 0.00
ATOM 1512 CD2 LEU 166 12.717 -7.894 4.219 1.00 0.00
ATOM 1513 H LEU 166 13.647 -6.095 0 .639 1.00 0.00
ATOM 1514 N ALA 167 13.409 -8.630 -1.022 1.00 0.00
ATOM 1515 CA ALA 167 13.179 -9.432 -2.232 1.00 0.00
ATOM 1516 C ALA 167 14.235 -10.357 -2.725 1.00 0.00
ATOM 1517 O ALA 167 13.972 -11.294 -3.475 1.00 0.00
ATOM 1518 CB ALA 167 12.829 -8.408 -3.341 1.00 0.00
ATOM 1519 H ALA 167 13.154 -7.647 -1.100 1.00 0.00
ATOM 1520 N LYS 168 15.495 -10.101 -2.290 1.00 0.00
ATOM 1521 CA LYS 168 16.639 -11.045 -2.510 1.00 0.00
ATOM 1522 C LYS 168 16.385 -12.455 -1.965 1.00 0.00
ATOM 1523 O LYS 168 16.416 -13.405 -2.741 1.00 0.00
ATOM 1524 CB LYS 168 17.973 -10.568 -1.930 1.00 0.00
ATOM 1525 CG LYS 168 18.461 -9.461 -2.792 1.00 0.00
ATOM 1526 CD LYS 168 19.835 -9.039 -2.291 1.00 0.00
ATOM 1527 CE LYS 168 20.281 -7.730 -2.851 1.00 0.00
ATOM 1528 NZ LYS 168 21.690 -7.581 -2.652 1.00 0.00
ATOM 1529 HZ1 LYS 168 22.107 -8.226 -3.371 1.00 0.00
ATOM 1530 HZ2 LYS 168 21.993 -7.954 -1.704 1.00 0.00
ATOM 1531 HZ3 LYS 168 22.046 -6.633 -2.791 1.00 0.00
ATOM 1532 H LYS 168 15.670 -9.205 -1.851 1.00 0.00
ATOM 1533 N LEU 169 16.271 -12.612 -0.678 1.00 0.00
ATOM 1534 CA LEU 169 16.024 -13.898 -0.221 1.00 0.00
ATOM 1535 C LEU 169 14.538 -14.115 -0.153 1.00 0.00
ATOM 1536 O LEU 169 14.092 -14 .492 0.916 1.00 0.00
ATOM 1537 CB LEU 169 16.780 -13.968 1.086 1.00 0.00
ATOM 1538 CG LEU 169 18.251 -14.324 1.132 1.00 0.00
ATOM 1539 CD1 LEU 169 18.867 -13.916 2.515 1.00 0.00
ATOM 1540 CD2 LEU 169 18.372 -15.855 0.927 1.00 0.00
ATOM 1541 H LEU 169 16.165 -11.853 -0.074 1.00 0.00
ATOM 1542 N ALA 170 13.768 -13.913 -1.234 1.00 0.00
ATOM 1543 CA ALA 170 12.324 -14.024 -1.167 1.00 0.00
ATOM 1544 C ALA 170 11.832 -15.185 -2.001 1.00 0.00
ATOM 1545 O ALA 170 12.140 -15.321 -3.188 1.00 0.00
ATOM 1546 CB ALA 170 11.691 -12.779 -1.654 1.00 0.00
ATOM 1547 H ALA 170 14.137 -13.630 -2.126 1.00 0.00
ATOM 1548 N PRO 171 11.011 -16.109 -1.423 1.00 0.00
ATOM 1549 CA PRO 171 10.376 -17.237 -2.082 1.00 0.00
ATOM 1550 C PRO 171 9.398 -16.740 -3.202 1.00 0.00
ATOM 1551 O PRO 171 8.220 -16.750 -3.050 1.00 0.00
ATOM 1552 CB PRO 171 9.624 -17.934 -0.992 1.00 0.00
ATOM 1553 CG PRO 171 10.485 -17.703 0.182 1.00 0.00
ATOM 1554 CD PRO 171 10.861 -16.221 -0.001 1.00 0.00
ATOM 1555 N ILE 172 9.852 -16.263 -4.359 1.00 0.00
ATOM 1556 CA ILE 172 9.015 -15.762 -5.462 1.00 0.00
ATOM 1557 C ILE 172 8.089 -16.726 -6.156 1.00 0.00
ATOM 1558 O ILE 172 7.810 -16.731 -7.368 1.00 0.00
ATOM 1559 CB ILE 172 9.881 -15.100 -6.538 1.00 0.00
ATOM 1560 CGI ILE 172 11.080 -15.928 -6.946 1.00 0.00
ATOM 1561 CG2 ILE 172 10.302 -13.734 -6.016 1.00 0.00
ATOM 1562 CD1 ILE 172 11.700 -15.559 -8.281 1.00 0.00
ATOM 1563 H ILE 172 10.845 -16.121 -4.385 1.00 0.00
ATOM 1564 N THR 173 7 .453 -17 .590 -5.415 1.00 0.00
ATOM 1565 CA THR 173 6.359 -18.420 -5.791 1.00 0.00
ATOM 1566 C THR 173 5.135 -17.562 -5.805 1.00 0.00
ATOM 1567 O THR 173 4.270 -17.634 -6.682 1.00 0.00
ATOM 1568 CB THR 173 6.292 -19.600 -4.779 1.00 0.00
ATOM 1569 OG1 THR 173 7.665 -20 .138 -4.627 1.00 0.00
ATOM 1570 CG2 THR 173 5.444 -20.737 -5.339 1.00 0.00
ATOM 1571 HG1 THR 173 7.687 -20 .720 -3.913 1.00 0.00
ATOM 1572 H THR 173 7.829 -17 .870 -4.576 1.00 0.00
ATOM 1573 N GLY 174 4.958 -16.681 -4.875 1.00 0.00
ATOM 1574 CA GLY 174 3.768 -15.821 -4.792 1.00 0.00
ATOM 1575 C GLY 174 4.057 -14.609 -3.829 1.00 0.00
ATOM 1576 O GLY 174 3.677 -13.454 -4.046 1.00 0.00
ATOM 1577 H GLY 174 5.783 -16.498 -4.374 1.00 0.00
ATOM 1578 N VAL 175 4.906 -14.908 -2.922 1.00 0.00
ATOM 1579 CA VAL 175 5.464 -13.946 -1.963 1.00 0.00
ATOM 1580 C VAL 175 6.097 -12.802 -2 .827 1.00 0.00
ATOM 1581 O VAL 175 6.984 -13.140 -3.697 1.00 0.00
ATOM 1582 CB VAL 175 6.614 -14.493 -1.078 1.00 0.00
ATOM 1583 CGI VAL 175 7.072 -13.455 -0.056 1.00 0.00
ATOM 1584 CG2 VAL 175 6.165 -15.886 -0 .405 1.00 0.00
ATOM 1585 H VAL 175 5.137 -15.855 -2.839 1.00 0.00
ATOM 1586 N THR 176 5.603 -11.584 -2.614 1.00 0.00
ATOM 1587 CA THR 176 5.907 -10.395 -3.337 1.00 0.00
ATOM 1588 C THR 176 5.594 -9.145 -2.484 1.00 0.00
ATOM 1589 O THR 176 4.764 -9.195 -1.654 1.00 0.00
ATOM 1590 CB THR 176 5.009 -10.360 -4.632 1.00 0.00
ATOM 1591 OG1 THR 176 5.416 -11.414 -5.441 1.00 0.00
ATOM 1592 CG2 THR 176 5.085 -9.069 -5.428 1.00 0.00
ATOM 1593 HG1 THR 176 4.918 -12.173 -5.059 1.00 0.00
ATOM 1594 H THR 176 4.928 -11.583 -1.872 1.00 0.00
ATOM 1595 N ALA 177 6.218 -7.940 -2.838 1.00 0.00
ATOM 1596 CA ALA 177 6.006 -6.686 -2.125 1.00 0.00
ATOM 1597 C ALA 177 6.044 -5.536 -3.164 1.00 0.00
ATOM 1598 O ALA 177 6.606 -5.832 -4.182 1.00 0.00
ATOM 1599 CB ALA 177 7.072 -6.366 -1.061 1.00 0.00
ATOM 1600 H ALA 177 6.754 -7.908 -3.708 1.00 0.00
ATOM 1601 N TYR 178 5.528 -4.357 -2.999 1.00 0.00
ATOM 1602 CA TYR 178 5.578 -3.277 -3.988 1.00 0.00
ATOM 1603 C TYR 178 5.360 -1.994 -3.248 1.00 0.00
ATOM 1604 O TYR 178 4.784 -1.969 -2.113 1.00 0.00
ATOM 1605 CB TYR 178 4.534 -3.305 -5.029 1.00 0.00
ATOM 1606 CG TYR 178 5.252 -3.343 -6.340 1.00 0.00
ATOM 1607 CD1 TYR 178 5.897 -2.230 -6.803 1.00 0.00
ATOM 1608 CD2 TYR 178 5.186 -4.494 -7.104 1.00 0.00
ATOM 1609 CE1 TYR 178 6.491 -2.135 -8.044 1.00 0.00
ATOM 1610 CE2 TYR 178 5.819 -4.387 -8.346 1.00 0.00
ATOM 1611 CZ TYR 178 6.443 -3.261 -8.832 1.00 0.00
ATOM 1612 OH TYR 178 7.079 -3.305 -10.040 1.00 0.00
ATOM 1613 HH TYR 178 7.628 -2.505 -10.220 1.00 0.00
ATOM 1614 H TYR 178 5.12 6 -4.162 -2.118 1.00 0.00
ATOM 1615 N THR 179 5.935 -0.952 -3.875 1.00 0.00
ATOM 1616 CA THR 179 5.656 0.436 -3.479 1.00 0.00
ATOM 1617 C THR 179 4.925 1.240 -4.581 1.00 0.00
ATOM 1618 O THR 179 5.332 1.197 -5.740 1.00 0.00
ATOM 1619 CB THR 179 7.076 1.016 -3.071 1.00 0.00
ATOM 1620 OG1 THR 179 7.807 0.004 -2.379 1.00 0.00
ATOM 1621 CG2 THR 179 6.941 2 .251 -2.203 1.00 0.00
ATOM 1622 HG1 THR 179 8.077 0.374 -1.460 1.00 0.00
ATOM 1623 H THR 179 6.513 -1.096 -4.632 1.00 0.00
ATOM 1624 N VAL 180 3.864 1.953 -4.190 1.00 0.00
ATOM 1625 CA VAL 180 3.117 2.779 -5.198 1.00 0.00
ATOM 1626 C VAL 180 3.712 4.179 -4.826 1.00 0.00
ATOM 1627 O VAL 180 3.674 4.511 -3.601 1.00 0.00
ATOM 1628 CB VAL 180 1.560 2.663 -4.827 1.00 0.00
ATOM 1629 CGI VAL 180 0.749 3.025 -6.026 1.00 0.00
ATOM 1630 CG2 VAL 180 1.143 1.259 -4.366 1.00 0.00
ATOM 1631 H VAL 180 3.798 2.167 -3.288 1.00 0.00
ATOM 1632 N ASN 181 4.258 5.027 -5.710 1.00 0.00
ATOM 1633 CA ASN 181 4.808 6.365 -5.258 1.00 0.00
ATOM 1634 C ASN 181 3.769 7.477 -5.322 1.00 0.00
ATOM 1635 O ASN 181 3.225 7.872 -4.285 1.00 0.00
ATOM 1636 CB ASN 181 6.049 6.827 -6.054 1.00 0.00
ATOM 1637 CG ASN 181 6.599 8.215 -5.584 1.00 0.00
ATOM 1638 OD1 ASN 181 7 .199 8.391 -4.559 1.00 0.00
ATOM 1639 ND2 ASN 181 6.398 9.172 -6.462 1.00 0.00
ATOM 1640 HD22ASN 181 6.452 10.080 -6.065 1.00 0.00
ATOM 1641 HD21ASN 181 6.067 9.041 -7.409 1.00 0.00
ATOM 1642 H ASN 181 4.107 4.808 -6.655 1.00 0.00
ATOM 1643 N PRO 182 3.470 8 .120 -6.479 1.00 0.00
ATOM 1644 CA PRO 182 3.311 9.616 -6.619 1.00 0.00
ATOM 1645 C PRO 182 3.104 10.586 -5.425 1.00 0.00
ATOM 1646 O PRO 182 4.113 11.143 -4.934 1.00 0.00
ATOM 1647 CB PRO 182 2 .246 9.744 -7.695 1.00 0.00
ATOM 1648 CG PRO 182 2.744 8.626 -8.656 1.00 0.00
ATOM 1649 CD PRO 182 3.064 7.503 -7.712 1.00 0.00
ATOM 1650 N GLY 183 1.896 10.643 -4.894 1.00 0.00
ATOM 1651 CA GLY 183 1.661 11.491 -3.801 1.00 0.00
ATOM 1652 C GLY 183 0.637 12.463 -4.331 1.00 0.00
ATOM 1653 O GLY 183 -0.112 12.212 -5.255 1.00 0.00
ATOM 1654 H GLY 183 1.085 10.196 -5.244 1.00 0.00
ATOM 1655 N ILE 184 0.542 13.628 -3.649 1.00 0.00
ATOM 1656 CA ILE 184 -0.455 14.636 -4.006 1.00 0.00
ATOM 1657 C ILE 184 -1.884 14.132 -3.999 1.00 0.00
ATOM 1658 O ILE 184 -2.507 14.082 -5.050 1.00 0.00
ATOM 1659 CB ILE 184 -0.053 15.354 -5.314 1.00 0.00
ATOM 1660 CGI ILE 184 1.414 15.825 -5.243 1.00 0.00
ATOM 1661 CG2 ILE 184 -0.970 16.567 -5.570 1.00 0.00
ATOM 1662 CD1 ILE 184 1.629 16.772 -4.045 1.00 0.00
ATOM 1663 H ILE 184 1.147 13.833 -2.877 1.00 0.00
ATOM 1664 N THR 185 -2 .428 13.745 -2.825 1.00 0.00
ATOM 1665 CA THR 185 -3.739 13.119 -2.822 1.00 0.00
ATOM 1666 C THR 185 -4.933 14.068 -2.905 1.00 0.00
ATOM 1667 O THR 185 -5.285 14.883 -2.029 1.00 0.00
ATOM 1668 CB THR 185 -3.870 12.253 -1.538 1.00 0.00
ATOM 1669 OG1 THR 185 -2.589 11.706 -1.255 1.00 0.00
ATOM 1670 CG2 THR 185 -4.751 11.097 -1.812 1.00 0.00
ATOM 1671 HG1 THR 185 -2.748 11.087 -0.550 1.00 0.00
ATOM 1672 H THR 185 -1.899 13.743 -1.994 1.00 0.00
ATOM 1673 N ARG 186 -5.490 14.009 -4.116 1.00 0.00
ATOM 1674 CA ARG 186 -6.692 14.767 -4.391 1.00 0.00
ATOM 1675 C ARG 186 -7.842 13.986 -3.747 1.00 0.00
ATOM 1676 O ARG 186 -8.188 12.910 -4.244 1.00 0.00
ATOM 1677 CB ARG 186 -6.860 14.860 -5.865 1.00 0.00
ATOM 1678 CG ARG 186 -6.240 16.034 -6.605 1.00 0.00
ATOM 1679 CD ARG 186 -4.716 15.929 -6.617 1.00 0.00
ATOM 1680 NE ARG 186 -3.969 17.159 -6.687 1.00 0.00
ATOM 1681 CZ ARG 186 -3.617 17.764 -7.847 1.00 0.00
ATOM 1682 NH1 ARG 186 -2.957 18.970 -7.795 1.00 0.00
ATOM 1683 NH2 ARG 186 -3.712 17.168 -9.039 1.00 0.00
ATOM 1684 HE ARG 186 -3.595 17.586 -5.886 1.00 0.00
ATOM 1685 HH12ARG 186 -2.584 19.292 -8.664 1.00 0.00
ATOM 1686 HH11ARG 186 -2 .7 67 19.460 -6.880 1.00 0.00
ATOM 1687 HH22ARG 186 -3.503 17.726 -9.845 1.00 0.00
ATOM 1688 HH21ARG 186 -3.936 16.169 -9.143 1.00 0.00
ATOM 1689 H ARG 186 -5.028 13.328 -4.726 1.00 0.00
ATOM 1690 N THR 187 -8.453 14.535 -2.710 1.00 0.00
ATOM 1691 CA THR 187 -9.637 13.988 -2.069 1.00 0.00
ATOM 1692 C THR 187 -10.788 13.697 -3.102 1.00 0.00
ATOM 1693 O THR 187 -11.029 14.507 -4.009 1.00 0.00
ATOM 1694 CB THR 187 -9.995 15.076 -1.002 1.00 0.00
ATOM 1695 OG1 THR 187 -8.893 15.378 -0.176 1.00 0.00
ATOM 1696 CG2 THR 187 -11.145 14.589 -0.145 1.00 0.00
ATOM 1697 HG1 THR 187 -8.570 14.608 0.105 1.00 0.00
ATOM 1698 H THR 187 -8.168 15.394 -2.335 1.00 0.00
ATOM 1699 N THR 188 -11.304 12.472 -2.917 1.00 0.00
ATOM 1700 CA THR 188 -12.422 11.918 -3.597 1.00 0.00
ATOM 1701 C THR 188 -11.962 11.454 -4.985 1.00 0.00
ATOM 1702 O THR 188 -12.283 10.344 -5.340 1.00 0.00
ATOM 1703 CB THR 188 -13.639 12.913 -3.752 1.00 0.00
ATOM 1704 OG1 THR 188 -13.675 13.621 -2.492 1.00 0.00
ATOM 1705 CG2 THR 188 -15.016 12.259 -3.977 1.00 0.00
ATOM 1706 HG1 THR 188 -14.421 14.193 -2.474 1.00 0.00
ATOM 1707 H THR 188 -11.054 11.969 -2.134 1.00 0.00
ATOM 1708 N LEU 189 -11.228 12.270 -5.756 1.00 0.00
ATOM 1709 CA LEU 189 -10.859 12.034 -7.113 1.00 0.00
ATOM 1710 C LEU 189 -9.613 11.143 -7 .244 1.00 0.00
ATOM 1711 O LEU 189 -9.256 10.689 -8.373 1.00 0.00
ATOM 1712 CB LEU 189 -10 .684 13.479 -7.664 1.00 0.00
ATOM 1713 CG LEU 189 -11.771 14.239 -8.398 1.00 0.00
ATOM 1714 CD1 LEU 189 -13.145 14.048 -7.878 1.00 0.00
ATOM 1715 CD2 LEU 189 -11.280 15.705 -8.359 1.00 0.00
ATOM 1716 H LEU 189 -10.903 13.088 -5.343 1.00 0.00
ATOM 1717 N VAL 190 -8.914 10.866 -6.182 1.00 0.00
ATOM 1718 CA VAL 190 -7.744 9.998 -6.169 1.00 0.00
ATOM 1719 C VAL 190 -8.089 8.663 -6.757 1.00 0.00
ATOM 1720 O VAL 190 -7.122 7.969 -7.018 1.00 0.00
ATOM 1721 CB VAL 190 -7.261 9.989 -4.662 1.00 0.00
ATOM 1722 CGI VAL 190 -8.423 9.352 -3.817 1.00 0.00
ATOM 1723 CG2 VAL 190 -5.976 9.183 -4.492 1.00 0.00
ATOM 1724 H VAL 190 -9.204 11.292 -5.357 1.00 0.00
ATOM 1725 N HIS 191 -9.305 8.222 -7.093 1.00 0.00
ATOM 1726 CA HIS 191 -9.526 7 .012 -7.848 1.00 0.00
ATOM 1727 C HIS 191 -8.610 6.854 -9.038 1.00 0.00
ATOM 1728 O HIS 191 -7.999 5.798 -9.145 1.00 0.00
ATOM 1729 CB HIS 191 -10.980 6.960 -8 .287 1.00 0.00
ATOM 1730 CG HIS 191 -11.977 6.731 -7.146 1.00 0.00
ATOM 1731 ND1 HIS 191 -12.004 5.684 -6.337 1.00 0.00
ATOM 1732 CD2 HIS 191 -12.933 7.587 -6.754 1.00 0.00
ATOM 1733 CE1 HIS 191 -12.976 5.900 -5.404 1.00 0.00
ATOM 1734 NE2 HIS 191 -13.540 7.082 -5.659 1.00 0.00
ATOM 1735 HE2 HIS 191 -14.310 7.533 -5.269 1.00 0.00
ATOM 1736 HD1 HIS 191 -11.350 4.937 -6.416 1.00 0.00
ATOM 1737 H HIS 191 -10.053 8 .757 -6.783 1.00 0.00
ATOM 1738 N LYS 192 -8.285 7.990 -9.696 1.00 0.00
ATOM 1739 CA LYS 192 -7.350 8.123 -10.790 1.00 0.00
ATOM 1740 C LYS 192 -5.996 7.415 -10.456 1.00 0.00
ATOM 1741 O LYS 192 -5.709 6.402 -11.087 1.00 0.00
ATOM 1742 CB LYS 192 -7.209 9.589 -11.100 1.00 0.00
ATOM 1743 CG LYS 192 -8.492 9.999 -11.844 1.00 0.00
ATOM 1744 CD LYS 192 -8.685 11.537 -11.903 1.00 0.00
ATOM 1745 CE LYS 192 -7.580 12.425 -12.540 1.00 0.00
ATOM 1746 NZ LYS 192 -7.915 13.837 -12.577 1.00 0.00
ATOM 1747 HZ1 LYS 192 -8.912 13.925 -12.889 1.00 0.00
ATOM 1748 HZ2 LYS 192 -7 .198 14.279 -13.190 1.00 0.00
ATOM 1749 HZ3 LYS 192 -7.784 14.248 -11.614 1.00 0.00
ATOM 1750 H LYS 192 -8.665 8.789 -9.263 1.00 0.00
ATOM 1751 N PHE 193 -5.392 7 .732 -9.294 1.00 0.00
ATOM 1752 CA PHE 193 -4.078 7.185 -9.053 1.00 0.00
ATOM 1753 C PHE 193 -4.194 5.835 -8.347 1.00 0.00
ATOM 1754 O PHE 193 -3.428 4.865 -8.591 1.00 0.00
ATOM 1755 CB PHE 193 -3.183 8.038 -8.191 1.00 0.00
ATOM 1756 CG PHE 193 -3.062 9.562 -8.467 1.00 0.00
ATOM 1757 CD1 PHE 193 -2.725 10.084 -9.676 1.00 0.00
ATOM 1758 CD2 PHE 193 -3.248 10 .446 -7 .419 1.00 0.00
ATOM 1759 CE1 PHE 193 -2.560 11.446 -9.815 1.00 0.00
ATOM 1760 CE2 PHE 193 -3.085 11.827 -7.566 1.00 0.00
ATOM 1761 CZ PHE 193 -2.724 12.345 -8.783 1.00 0.00
ATOM 1762 H PHE 193 -5.958 8 .167 -8.688 1.00 0.00
ATOM 1763 N ASN 194 -5.202 5.708 -7 .541 1.00 0.00
ATOM 1764 CA ASN 194 -5.401 4.508 -6.705 1.00 0.00
ATOM 1765 C ASN 194 -5.861 3.270 -7.528 1.00 0.00
ATOM 1766 O ASN 194 -5.787 2.114 -7.119 1.00 0.00
ATOM 1767 CB ASN 194 -6.427 4.873 -5.573 1.00 0.00
ATOM 1768 CG ASN 194 -5.835 5.546 -4.390 1.00 0.00
ATOM 1769 OD1 ASN 194 -4.777 6.184 -4.414 1.00 0.00
ATOM 1770 ND2 ASN 194 -6.374 5.275 -3.258 1.00 0.00
ATOM 1771 HD22ASN 194 -5.924 5.860 -2.578 1.00 0.00
ATOM 1772 HD21ASN 194 -7.147 4.675 -3.157 1.00 0.00
ATOM 1773 H ASN 194 -5.787 6.490 -7.436 1.00 0.00
ATOM 1774 N SER 195 -6.248 3.572 -8.789 1.00 0.00
ATOM 1775 CA SER 195 -6.462 2.462 -9.697 1.00 0.00
ATOM 1776 C SER 195 -5.175 1.689 -9.811 1.00 0.00
ATOM 1777 O SER 195 -5.273 0.484 -9.981 1.00 0.00
ATOM 1778 CB SER 195 -6.867 3.058 -11.032 1.00 0.00
ATOM 1779 OG SER 195 -8.164 3.573 -10.982 1.00 0.00
ATOM 1780 HG SER 195 -7.958 4.496 -10.637 1.00 0.00
ATOM 1781 H SER 195 -6.299 4.516 -9.054 1.00 0.00
ATOM 1782 N TRP 196 -3.926 2.182 -9.657 1.00 0.00
ATOM 1783 CA TRP 196 -2.692 1.371 -9.719 1.00 0.00
ATOM 1784 C TRP 196 -2.672 0.280 -8.701 1.00 0.00
ATOM 1785 O TRP 196 -2.084 -0.794 -9.019 1.00 0.00
ATOM 1786 CB TRP 196 -1.572 2.356 -9.629 1.00 0.00
ATOM 1787 CG TRP 196 -0.650 2.637 -10.855 1.00 0.00
ATOM 1788 CD1 TRP 196 0.681 3.036 -10.629 1.00 0.00
ATOM 1789 CD2 TRP 196 -1.048 2.563 -12.206 1.00 0.00
ATOM 1790 NE1 TRP 196 1.171 3.191 -11.799 1.00 0.00
ATOM 1791 CE2 TRP 196 0.193 2.963 -12.707 1.00 0.00
ATOM 1792 CE3 TRP 196 -2.092 2.264 -13.092 1.00 0.00
ATOM 1793 CZ2 TRP 196 0.415 3.057 -14.039 1.00 0.00
ATOM 1794 CZ3 TRP 196 -1.846 2.377 -14.400 1.00 0.00
ATOM 1795 CH2 TRP 196 -0.572 2.797 -14.896 1.00 0.00
ATOM 1796 HE1 TRP 196 2.062 3.492 -11.943 1.00 0.00
ATOM 1797 H TRP 196 -3.785 3.123 -9.433 1.00 0.00
ATOM 1798 N LEU 197 -3.361 0.381 -7.507 1.00 0.00
ATOM 1799 CA LEU 197 -3.384 -0.718 -6.561 1.00 0.00
ATOM 1800 C LEU 197 -4.185 -1.940 -7.109 1.00 0.00
ATOM 1801 O LEU 197 -3.893 -3.128 -6.841 1.00 0.00
ATOM 1802 CB LEU 197 -4.099 -0.278 -5.353 1.00 0.00
ATOM 1803 CG LEU 197 -3.248 0.282 -4.144 1.00 0.00
ATOM 1804 CD1 LEU 197 -4.009 1.422 -3.541 1.00 0.00
ATOM 1805 CD2 LEU 197 -3.084 -0.769 -3.041 1.00 0.00
ATOM 1806 H LEU 197 -3.852 1.164 -7.221 1.00 0.00
ATOM 1807 N ASP 198 -5.177 -1.676 -7.891 1.00 0.00
ATOM 1808 CA ASP 198 -5.977 -2.771 -8.470 1.00 0.00
ATOM 1809 C ASP 198 -5.215 -3.582 -9.561 1.00 0.00
ATOM 1810 O ASP 198 -5.738 -4.590 -10.053 1.00 0.00
ATOM 1811 CB ASP 198 -7.254 -2.141 -8.987 1.00 0.00
ATOM 1812 CG ASP 198 -8.056 -1.424 -7.893 1.00 0.00
ATOM 1813 ODl ASP 198 -7.684 -0.359 -7.409 1.00 0.00
ATOM 1814 OD2 ASP 198 -9.070 -1.975 -7.451 1.00 0.00
ATOM 1815 H ASP 198 -5.354 -0.767 -8.185 1.00 0.00
ATOM 1816 N VAL 199 -4.010 -3.153 -9.947 1.00 0.00
ATOM 1817 CA VAL 199 -3.245 -3.862 -10.918 1.00 0.00
ATOM 1818 C VAL 199 -1.957 -4.428 -10.319 1.00 0.00
ATOM 1819 O VAL 199 -1.148 -5.106 -10.989 1.00 0.00
ATOM 1820 CB VAL 199 -2.786 -2.998 -12 .177 1.00 0.00
ATOM 1821 CGI VAL 199 -3.696 -3.493 -13.307 1.00 0.00
ATOM 1822 CG2 VAL 199 -2.856 -1.476 -11.985 1.00 0.00
ATOM 1823 H VAL 199 -3.589 -2.490 -9.333 1.00 0.00
ATOM 1824 N GLU 200 -1.708 -4.247 -9.020 1.00 0.00
ATOM 1825 CA GLU 200 -0.434 -4.671 -8.532 1.00 0.00
ATOM 1826 C GLU 200 -0.498 -6.171 -8.180 1.00 0.00
ATOM 1827 O GLU 200 -1.557 -6.767 -7.898 1.00 0.00
ATOM 1828 CB GLU 200 -0.077 -3.936 -7.234 1.00 0.00
ATOM 1829 CG GLU 200 0.386 -2.467 -7.518 1.00 0.00
ATOM 1830 CD GLU 200 0.693 -1.674 -6.295 1.00 0.00
ATOM 1831 OE1 GLU 200 1.7 62 -1.185 -6.157 1.00 0.00
ATOM 1832 OE2 GLU 200 -0.233 -1.655 -5.501 1.00 0.00
ATOM 1833 H GLU 200 -2.427 -3.917 -8.398 1.00 0.00
ATOM 1834 N PRO 201 0.615 -6.935 -8.389 1.00 0.00
ATOM 1835 CA PRO 201 1.425 -6.862 -9.609 1.00 0.00
ATOM 1836 C PRO 201 0.930 -7.952 -10.573 1.00 0.00
ATOM 1837 O PRO 201 1.691 -8.726 -11.047 1.00 0.00
ATOM 1838 CB PRO 201 2.797 -7.032 -9.086 1.00 0.00
ATOM 1839 CG PRO 201 2.719 -6.945 -7.598 1.00 0.00
ATOM 1840 CD PRO 201 1.381 -7.609 -7.395 1.00 0.00
ATOM 1841 N GLN 202 -0.352 -7.935 -10.966 1.00 0.00
ATOM 1842 CA GLN 202 -0.944 -8.937 -11.765 1.00 0.00
ATOM 1843 C GLN 202 -0.542 -8.757 -13.208 1.00 0.00
ATOM 1844 O GLN 202 -0.453 -9.714 -13.970 1.00 0.00
ATOM 1845 CB GLN 202 -2.492 -9.056 -11.864 1.00 0.00
ATOM 1846 CG GLN 202 -3.414 -8.897 -10.675 1.00 0.00
ATOM 1847 CD GLN 202 -4.169 -7.637 -10.724 1.00 0.00
ATOM 1848 OE1 GLN 202 -4.803 -7.246 -11.737 1.00 0.00
ATOM 1849 NE2 GLN 202 -4.039 -6.843 -9.685 1.00 0.00
ATOM 1850 HE22GLN 202 -4.583 -6.042 -9.724 1.00 0.00
ATOM 1851 HE21GLN 202 -3.481 -7.148 -8.923 1.00 0.00
ATOM 1852 H GLN 202 -0.931 -7.129 -10.773 1.00 0.00
ATOM 1853 N VAL 203 -0.350 -7.492 -13.605 1.00 0.00
ATOM 1854 CA VAL 203 0.103 -6.999 -14.921 1.00 0.00
ATOM 1855 C VAL 203 -0.738 -7 .536 -16.078 1.00 0.00
ATOM 1856 O VAL 203 -1.678 -8.313 -15.960 1.00 0.00
ATOM 1857 CB VAL 203 1.690 -7.266 -15.270 1.00 0.00
ATOM 1858 CGI VAL 203 2.497 -6.600 -14.136 1.00 0.00
ATOM 1859 CG2 VAL 203 2.050 -8.673 -15.456 1.00 0.00
ATOM 1860 H VAL 203 -0.307 -6.766 -12.915 1.00 0.00
ATOM 1861 N ALA 204 -0.550 -6.942 -17.204 1.00 0.00
ATOM 1862 CA ALA 204 -1.387 -7.187 -18.385 1.00 0.00
ATOM 1863 C ALA 204 -1.025 -8.518 -18.998 1.00 0.00
ATOM 1864 O ALA 204 -0.001 -9.238 -18.693 1.00 0.00
ATOM 1865 CB ALA 204 -1.128 -6.048 -19.416 1.00 0.00
ATOM 1866 H ALA 204 0.219 -6.318 -17.250 1.00 0.00
ATOM 1867 N GLU 205 -2.009 -9.070 -19.729 1.00 0.00
ATOM 1868 CA GLU 205 -1.799 -10.287 -20.528 1.00 0.00
ATOM 1869 C GLU 205 -0.792 -10.021 -21.646 1.00 0.00
ATOM 1870 O GLU 205 0.096 -10.828 -22.018 1.00 0.00
ATOM 1871 CB GLU 205 -3.108 -10.736 -21.100 1.00 0.00
ATOM 1872 CG GLU 205 -3.958 -11.413 -20 .074 1.00 0.00
ATOM 1873 CD GLU 205 -3.762 -12.897 -20.015 1.00 0.00
ATOM 1874 OE1 GLU 205 -4.493 -13.606 -20.712 1.00 0.00
ATOM 1875 OE2 GLU 205 -2.879 -13.349 -19.212 1.00 0.00
ATOM 1876 H GLU 205 -2.889 -8.779 -19.603 1.00 0.00
ATOM 1877 N LYS 206 -0.822 -8.753 -22.114 1.00 0.00
ATOM 1878 CA LYS 206 0.089 -8.445 -23.204 1.00 0.00
ATOM 1879 C LYS 206 1.351 -7.941 -22.461 1.00 0.00
ATOM 1880 O LYS 206 1.479 -6.823 -22.019 1.00 0.00
ATOM 1881 CB LYS 206 -0.346 -7.253 -23.987 1.00 0.00
ATOM 1882 CG LYS 206 -1.270 -7.737 -24.995 1.00 0.00
ATOM 1883 CD LYS 206 -1.553 -6.709 -26.079 1.00 0.00
ATOM 1884 CE LYS 206 -2.548 -7.422 -26.863 1.00 0.00
ATOM 1885 NZ LYS 206 -3.218 -6.457 -27.725 1.00 0.00
ATOM 1886 HZ1 LYS 206 -2.756 -6.174 -28.589 1.00 0.00
ATOM 1887 HZ2 LYS 206 -3.362 -5.581 -27.160 1.00 0.00
ATOM 1888 HZ3 LYS 206 -4.137 -6.824 -27.979 1.00 0.00
ATOM 1889 H LYS 206 -1.479 -8.126 -21.765 1.00 0.00
ATOM 1890 N LEU 207 2.364 -8.829 -22.359 1.00 0.00
ATOM 1891 CA LEU 207 3.701 -8.880 -21.751 1.00 0.00
ATOM 1892 C LEU 207 3.898 -10.389 -21.838 1.00 0.00
ATOM 1893 O LEU 207 3.769 -10.853 -23.006 1.00 0.00
ATOM 1894 CB LEU 207 3.667 -8.430 -20.284 1.00 0.00
ATOM 1895 CG LEU 207 3.620 -6.922 -19.938 1.00 0.00
ATOM 1896 CD1 LEU 207 2.615 -6.762 -18.794 1.00 0.00
ATOM 1897 CD2 LEU 207 5.016 -6.332 -19.674 1.00 0.00
ATOM 1898 H LEU 207 2.148 -9.663 -22.899 1.00 0.00
ATOM 1899 N LEU 208 4.195 -11.206 -20.846 1.00 0.00
ATOM 1900 CA LEU 208 4.442 -12.675 -21.068 1.00 0.00
ATOM 1901 C LEU 208 3.301 -13.451 -20.307 1.00 0.00
ATOM 1902 O LEU 208 3.445 -14.545 -19.786 1.00 0.00
ATOM 1903 CB LEU 208 5.904 -12.979 -20.512 1.00 0.00
ATOM 1904 CG LEU 208 6.690 -14.206 -20.846 1.00 0.00
ATOM 1905 CD1 LEU 208 6.580 -14.688 -22.348 1.00 0.00
ATOM 1906 CD2 LEU 208 8.060 -13.899 -20.408 1.00 0.00
ATOM 1907 H LEU 208 4.315 -10.878 -19.974 1.00 0.00
ATOM 1908 N ALA 209 2.178 -12.721 -20.325 1.00 0.00
ATOM 1909 CA ALA 209 0.874 -13.150 -19.764 1.00 0.00
ATOM 1910 C ALA 209 0.960 -13.881 -18.445 1.00 0.00
ATOM 1911 O ALA 209 0.813 -15.103 -18.340 1.00 0.00
ATOM 1912 CB ALA 209 0.113 -14.066 -20.868 1.00 0.00
ATOM 1913 H ALA 209 2.082 -11.914 -20.812 1.00 0.00
ATOM 1914 N HIS 210 1.315 -13.053 -17.517 1.00 0.00
ATOM 1915 CA HIS 210 1.565 -13.307 -16.107 1.00 0.00
ATOM 1916 C HIS 210 2.136 -14.675 -15.689 1.00 0.00
ATOM 1917 O HIS 210 3.380 -14.668 -15.581 1.00 0.00
ATOM 1918 CB HIS 210 0.347 -13.142 -15.187 1.00 0.00
ATOM 1919 CG HIS 210 -0.945 -12.493 -15.635 1.00 0.00
ATOM 1920 ND1 HIS 210 -1.178 -11.382 -16.356 1.00 0.00
ATOM 1921 CD2 HIS 210 -2.175 -12.978 -15.220 1.00 0.00
ATOM 1922 CE1 HIS 210 -2.486 -11.179 -16.397 1.00 0.00
ATOM 1923 NE2 HIS 210 -3.061 -12.127 -15.723 1.00 0.00
ATOM 1924 HE2 HIS 210 -3.984 -11.981 -15.385 1.00 0.00
ATOM 1925 HD1 HIS 210 -0.525 -10.637 -16.523 1.00 0.00
ATOM 1926 H HIS 210 1.550 -12.192 -17.763 1.00 0.00
ATOM 1927 N PRO 211 1.513 -15.815 -15.312 1.00 0.00
ATOM 1928 CA PRO 211 2.197 -16.963 -14.864 1.00 0.00
ATOM 1929 C PRO 211 3.532 -17.376 -15.570 1.00 0.00
ATOM 1930 O PRO 211 4.494 -17.794 -14.963 1.00 0.00
ATOM 1931 CB PRO 211 1.206 -18.096 -14.890 1.00 0.00
ATOM 1932 CG PRO 211 -0.096 -17.359 -14.946 1.00 0.00
ATOM 1933 CD PRO 211 0.255 -16.215 -15.810 1.00 0.00
ATOM 1934 N THR 212 3.512 -17.276 -16.879 1.00 0.00
ATOM 1935 CA THR 212 4.596 -17.650 -17.780 1.00 0.00
ATOM 1936 C THR 212 5.930 -17.046 -17.376 1.00 0.00
ATOM 1937 O THR 212 7.031 -17.599 -17.610 1.00 0.00
ATOM 1938 CB THR 212 4.263 -17.149 -19.225 1.00 0.00
ATOM 1939 OG1 THR 212 2.813 -17.274 -19.391 1.00 0.00
ATOM 1940 CG2 THR 212 5.018 -18.005 -20.231 1.00 0.00
ATOM 1941 HG1 THR 212 2.428 -16.400 -19.173 1.00 0.00
ATOM 1942 H THR 212 2.755 -16.837 -17.335 1.00 0.00
ATOM 1943 N GLN 213 5.995 -15.865 -16.638 1.00 0.00
ATOM 1944 CA GLN 213 7.193 -15.245 -16.150 1.00 0.00
ATOM 1945 C GLN 213 7.642 -15.808 -14.819 1.00 0.00
ATOM 1946 O GLN 213 8.857 -16.168 -14.839 1.00 0.00
ATOM 1947 CB GLN 213 7.061 -13.694 -15.939 1.00 0.00
ATOM 1948 CG GLN 213 6.783 -12.937 -17.186 1.00 0.00
ATOM 1949 CD GLN 213 5.700 -11.807 -17.113 1.00 0.00
ATOM 1950 OE1 GLN 213 4.507 -11.916 -16.734 1.00 0.00
ATOM 1951 NE2 GLN 213 6.173 -10.600 -17.417 1.00 0.00
ATOM 1952 HE22GLN 213 5.471 -9.889 -17.252 1.00 0.00
ATOM 1953 HE21GLN 213 7.103 -10.499 -17.681 1.00 0.00
ATOM 1954 H GLN 213 5.182 -15.383 -16.412 1.00 0.00
ATOM 1955 N PRO 214 6.850 -15.993 -13.758 1.00 0.00
ATOM 1956 CA PRO 214 7.163 -16.957 -12.677 1.00 0.00
ATOM 1957 C PRO 214 7.923 -18.240 -13.106 1.00 0.00
ATOM 1958 O PRO 214 9.057 -18.525 -12.796 1.00 0.00
ATOM 1959 CB PRO 214 5.805 -17.158 -12.005 1.00 0.00
ATOM 1960 CG PRO 214 5.180 -15.841 -12.120 1.00 0.00
ATOM 1961 CD PRO 214 5.565 -15.367 -13.494 1.00 0.00
ATOM 1962 N SER 215 7.173 -18.979 -13.941 1.00 0.00
ATOM 1963 CA SER 215 7.665 -20.270 -14.417 1.00 0.00
ATOM 1964 C SER 215 9.061 -20.307 -14.976 1.00 0.00
ATOM 1965 O SER 215 9.948 -21.062 -14.609 1.00 0.00
ATOM 1966 CB SER 215 6.673 -20.829 -15.458 1.00 0.00
ATOM 1967 OG SER 215 5.316 -20.628 -15.253 1.00 0.00
ATOM 1968 HG SER 215 5.261 -19.967 -14.563 1.00 0.00
ATOM 1969 H SER 215 6.253 -18.693 -14.178 1.00 0.00
ATOM 1970 N LEU 216 9.385 -19.410 -15.968 1.00 0.00
ATOM 1971 CA LEU 216 10.677 -19.537 -16.595 1.00 0.00
ATOM 1972 C LEU 216 11.825 -18.824 -15.997 1.00 0.00
ATOM 1973 O LEU 216 12.991 -19.321 -15.895 1.00 0.00
ATOM 1974 CB LEU 216 10 .545 -19.158 -18.053 1.00 0.00
ATOM 1975 CG LEU 216 9.794 -20.201 -18.889 1.00 0.00
ATOM 1976 CD1 LEU 216 9.365 -19.478 -20.075 1.00 0.00
ATOM 1977 CD2 LEU 216 10.672 -21.398 -19.304 1.00 0.00
ATOM 1978 H LEU 216 8.783 -18.731 -16.336 1.00 0.00
ATOM 1979 N ALA 217 11.493 -17.675 -15.324 1.00 0.00
ATOM 1980 CA ALA 217 12.523 -16.801 -14.692 1.00 0.00
ATOM 1981 C ALA 217 13.558 -17.432 -13.779 1.00 0.00
ATOM 1982 O ALA 217 14.739 -17.542 -14.185 1.00 0.00
ATOM 1983 CB ALA 217 11.942 -15.687 -13.813 1.00 0.00
ATOM 1984 H ALA 217 10.598 -17.322 -15.215 1.00 0.00
ATOM 1985 N CYS 218 13.184 -17.825 -12.536 1.00 0.00
ATOM 1986 CA CYS 218 14.120 -18.246 -11.487 1.00 0.00
ATOM 1987 C CYS 218 15.193 -19.226 -11.907 1.00 0.00
ATOM 1988 O CYS 218 16.386 -19.003 -11.571 1.00 0.00
ATOM 1989 CB CYS 218 13.225 -18.826 -10.295 1.00 0.00
ATOM 1990 SG CYS 218 13.805 -18.295 -8.641 1.00 0.00
ATOM 1991 H CYS 218 12.256 -17.658 -12.280 1.00 0.00
ATOM 1992 N ALA 219 14.958 -20.320 -12.628 1.00 0.00
ATOM 1993 CA ALA 219 16.051 -21.247 -13.017 1.00 0.00
ATOM 1994 C ALA 219 16.821 -20.879 -14.250 1.00 0.00
ATOM 1995 O ALA 219 18.083 -20.932 -14.322 1.00 0.00
ATOM 1996 CB ALA 219 15.538 -22.640 -13.158 1.00 0.00
ATOM 1997 H ALA 219 14.056 -20.337 -12.969 1.00 0.00
ATOM 1998 N GLU 220 16.137 -20.447 -15.317 1.00 0.00
ATOM 1999 CA GLU 220 16.785 -20.100 -16.550 1.00 0.00
ATOM 2000 C GLU 220 17.538 -18.696 -16.441 1.00 0.00
ATOM 2001 O GLU 220 18.535 -18.489 -17.123 1.00 0.00
ATOM 2002 CB GLU 220 15.676 -20.114 -17.617 1.00 0.00
ATOM 2003 CG GLU 220 16.189 -20.326 -19.035 1.00 0.00
ATOM 2004 CD GLU 220 15.115 -20.621 -20.074 1.00 0.00
ATOM 2005 OE1 GLU 220 14.330 -19.751 -20.321 1.00 0.00
ATOM 2006 OE2 GLU 220 15.145 -21.730 -20.701 1.00 0.00
ATOM 2007 H GLU 220 15.183 -20.244 -15.227 1.00 0.00
ATOM 2008 N ASN 221 17.030 -17.764 -15.651 1.00 0.00
ATOM 2009 CA ASN 221 17.620 -16.486 -15.499 1.00 0.00
ATOM 2010 C ASN 221 17.856 -16.395 -13.998 1.00 0.00
ATOM 2011 O ASN 221 17.150 -15.767 -13.185 1.00 0.00
ATOM 2012 CB ASN 221 16.691 -15.413 -16.027 1.00 0.00
ATOM 2013 CG ASN 221 17.401 -14.095 -16.088 1.00 0.00
ATOM 2014 OD1 ASN 221 18.110 -13.747 -15.139 1.00 0.00
ATOM 2015 ND2 ASN 221 17.146 -13.379 -17.167 1.00 0.00
ATOM 2016 HD22ASN 221 17.540 -12.520 -17.365 1.00 0.00
ATOM 2017 HD21ASN 221 16.450 -13.789 -17.757 1.00 0.00
ATOM 2018 H ASN 221 16.277 -18.055 -15.046 1.00 0.00
ATOM 2019 N PHE 222 18.950 -17.081 -13.576 1.00 0.00
ATOM 2020 CA PHE 222 19.303 -17.100 -12.168 1.00 0.00
ATOM 2021 C PHE 222 20.223 -15.896 -11.976 1.00 0.00
ATOM 2022 O PHE 222 21.411 -16.029 -11.643 1.00 0.00
ATOM 2023 CB PHE 222 20.052 -18.391 -11.742 1.00 0.00
ATOM 2024 CG PHE 222 19.986 -18.832 -10.276 1.00 0.00
ATOM 2025 CD1 PHE 222 20.213 -20.138 -10.007 1.00 0.00
ATOM 2026 CD2 PHE 222 19.718 -17.996 -9.220 1.00 0.00
ATOM 2027 CE1 PHE 222 20.209 -20.667 -8.727 1.00 0.00
ATOM 2028 CE2 PHE 222 19.729 -18.485 -7.927 1.00 0.00
ATOM 2029 CZ PHE 222 19.967 -19.814 -7 .677 1.00 0.00
ATOM 2030 H PHE 222 19.624 -17.502 -14.133 1.00 0.00
ATOM 2031 N VAL 223 19.688 -14.718 -12.222 1.00 0.00
ATOM 2032 CA VAL 223 20.324 -13.448 -11.990 1.00 0.00
ATOM 2033 C VAL 223 19.206 -12.404 -11.884 1.00 0.00
ATOM 2034 O VAL 223 19.374 -11.234 -11.431 1.00 0.00
ATOM 2035 CB VAL 223 21.281 -12.977 -13.157 1.00 0.00
ATOM 2036 CGI VAL 223 22.675 -13.578 -12.935 1.00 0.00
ATOM 2037 CG2 VAL 223 20.922 -13.501 -14.479 1.00 0.00
ATOM 2038 H VAL 223 18.813 -14.743 -12.611 1.00 0.00
ATOM 2039 N LYS 224 17.987 -12.847 -12.237 1.00 0.00
ATOM 2040 CA LYS 224 16.700 -12.179 -12.070 1.00 0.00
ATOM 2041 C LYS 224 16.763 -10.736 -12.561 1.00 0.00
ATOM 2042 O LYS 224 17.172 -10.665 -13.703 1.00 0.00
ATOM 2043 CB LYS 224 16.327 -12.323 -10.623 1.00 0.00
ATOM 2044 CG LYS 224 15.871 -13.767 -10.512 1.00 0.00
ATOM 2045 CD LYS 224 15.825 -14.284 -9.067 1.00 0.00
ATOM 2046 CE LYS 224 17.157 -14.854 -8.811 1.00 0.00
ATOM 2047 NZ LYS 224 17.244 -15.878 -7 .802 1.00 0.00
ATOM 2048 HZ1 LYS 224 16.533 -16.576 -8.083 1.00 0.00
ATOM 2049 HZ2 LYS 224 16.996 -15.430 -6.868 1.00 0.00
ATOM 2050 HZ3 LYS 224 18.166 -16.281 -7.772 1.00 0.00
ATOM 2051 H LYS 224 17.978 -13.601 -12 .839 1.00 0.00
ATOM 2052 N ALA 225 16.641 -9.669 -11.694 1.00 0.00
ATOM 2053 CA ALA 225 16.852 -8.238 -12.001 1.00 0.00
ATOM 2054 C ALA 225 17.970 -7.929 -12.972 1.00 0.00
ATOM 2055 O ALA 225 17.656 -7 .231 -13.917 1.00 0.00
ATOM 2056 CB ALA 225 17.201 -7.451 -10.764 1.00 0.00
ATOM 2057 H ALA 225 16.418 -9.916 -10.808 1.00 0.00
ATOM 2058 N ILE 226 19.192 -8.480 -12.873 1.00 0.00
ATOM 2059 CA ILE 226 20.323 -8.175 -13.713 1.00 0.00
ATOM 2060 C ILE 226 19.980 -8.416 -15.155 1.00 0.00
ATOM 2061 O ILE 226 20.305 -7.557 -15.985 1.00 0.00
ATOM 2062 CB ILE 226 21.644 -9.041 -13.279 1.00 0.00
ATOM 2063 CGI ILE 226 21.992 -8.632 -11.823 1.00 0.00
ATOM 2064 CG2 ILE 226 22.783 -8 .883 -14.355 1.00 0.00
ATOM 2065 CD1 ILE 226 22.374 -7.135 -11.834 1.00 0.00
ATOM 2066 H ILE 226 19.258 -9.157 -12.105 1.00 0.00
ATOM 2067 N GLU 227 19.402 -9.575 -15.525 1.00 0.00
ATOM 2068 CA GLU 227 19.179 -9.815 -16.927 1.00 0.00
ATOM 2069 C GLU 227 17.762 -9.696 -17.439 1.00 0.00
ATOM 2070 O GLU 227 17.552 -9.042 -18.493 1.00 0.00
ATOM 2071 CB GLU 227 19.783 -11.195 -17.237 1.00 0.00
ATOM 2072 CG GLU 227 19.801 -11.517 -18.742 1.00 0.00
ATOM 2073 CD GLU 227 20.131 -12.916 -19.163 1.00 0.00
ATOM 2074 OE1 GLU 227 19.295 -13.532 -19.811 1.00 0.00
ATOM 2075 OE2 GLU 227 21.150 -13.422 -18 .776 1.00 0.00
ATOM 2076 H GLU 227 19.127 -10.207 -14.868 1.00 0.00
ATOM 2077 N LEU 228 16.761 -10.183 -16.761 1.00 0.00
ATOM 2078 CA LEU 228 15.312 -10.138 -17.195 1.00 0.00
ATOM 2079 C LEU 228 15.014 -8.624 -17.472 1.00 0.00
ATOM 2080 O LEU 228 14.200 -8.394 -18.366 1.00 0.00
ATOM 2081 CB LEU 228 14.342 -10.617 -16.092 1.00 0.00
ATOM 2082 CG LEU 228 14.310 -12.066 -15.661 1.00 0.00
ATOM 2083 CD1 LEU 228 13.451 -12 .074 -14.385 1.00 0.00
ATOM 2084 CD2 LEU 228 13.700 -12.954 -16.731 1.00 0.00
ATOM 2085 H LEU 228 16.941 -10.526 -15.866 1.00 0.00
ATOM 2086 N ASN 229 15.640 -7.793 -16.697 1.00 0.00
ATOM 2087 CA ASN 229 15.531 -6.330 -16.666 1.00 0.00
ATOM 2088 C ASN 229 14.092 -5.745 -16.992 1.00 0.00
ATOM 2089 O ASN 229 13.503 -5.201 -16.058 1.00 0.00
ATOM 2090 CB ASN 229 16.488 -5.734 -17.595 1.00 0.00
ATOM 2091 CG ASN 229 16.465 -4.208 -17.428 1.00 0.00
ATOM 2092 OD1 ASN 229 15.733 -3.525 -18.116 1.00 0.00
ATOM 2093 ND2 ASN 229 17.217 -3.551 -16.549 1.00 0.00
ATOM 2094 HD22ASN 229 16.988 -2.593 -16.555 1.00 0.00
ATOM 2095 HD21ASN 229 17.890 -4.042 -16.024 1.00 0.00
ATOM 2096 H ASN 229 16.365 -8.171 -16.147 1.00 0.00
ATOM 2097 N GLN 230 13.589 -5.821 -18.253 1.00 0.00
ATOM 2098 CA GLN 230 12.250 -5.388 -18.542 1.00 0.00
ATOM 2099 C GLN 230 11.189 -6.461 -18.244 1.00 0.00
ATOM 2100 O GLN 230 10.111 -6.167 -17.666 1.00 0.00
ATOM 2101 CB GLN 230 12.015 -4.974 -19.979 1.00 0.00
ATOM 2102 CG GLN 230 12.541 -3.608 -20.465 1.00 0.00
ATOM 2103 CD GLN 230 11.971 -3.186 -21.812 1.00 0.00
ATOM 2104 OE1 GLN 230 11.595 -2.028 -22.008 1.00 0.00
ATOM 2105 NE2 GLN 230 11.903 -3.930 -22.952 1.00 0.00
ATOM 2106 HE22GLN 230 11.639 -3.363 -23.635 1.00 0.00
ATOM 2107 HE21GLN 230 12.204 -4.835 -23.100 1.00 0.00
ATOM 2108 H GLN 230 14.156 -6.357 -18.903 1.00 0.00
ATOM 2109 N ASN 231 11.526 -7.646 -18.665 1.00 0.00
ATOM 2110 CA ASN 231 10.654 -8.800 -18.530 1.00 0.00
ATOM 2111 C ASN 231 10.580 -9.460 -17.157 1.00 0.00
ATOM 2112 O ASN 231 10.931 -10.612 -16.805 1.00 0.00
ATOM 2113 CB ASN 231 11.030 -9.876 -19.527 1.00 0.00
ATOM 2114 CG ASN 231 9.928 -10.218 -20.521 1.00 0.00
ATOM 2115 OD1 ASN 231 8.729 -10.406 -20.215 1.00 0.00
ATOM 2116 ND2 ASN 231 10.261 -10.046 -21.810 1.00 0.00
ATOM 2117 HD22ASN 231 9.500 -10.058 -22.504 1.00 0.00
ATOM 2118 HD21ASN 231 11.192 -9.777 -21.984 1.00 0.00
ATOM 2119 H ASN 231 12.454 -7.849 -18.886 1.00 0.00
ATOM 2120 N GLY 232 10 .060 -8.628 -16.278 1.00 0.00
ATOM 2121 CA GLY 232 9.867 -9.000 -14.919 1.00 0.00
ATOM 2122 C GLY 232 8 .913 -7.955 -14.395 1.00 0.00
ATOM 2123 O GLY 232 7.900 -7.552 -14.998 1.00 0.00
ATOM 2124 H GLY 232 9.612 -7.768 -16.521 1.00 0.00
ATOM 2125 N ALA 233 9.316 -7.507 -13.214 1.00 0.00
ATOM 2126 CA ALA 233 8.580 -6.539 -12.366 1.00 0.00
ATOM 2127 C ALA 233 9.302 -6.405 -11.074 1.00 0.00
ATOM 2128 O ALA 233 10.370 -7.028 -10.947 1.00 0.00
ATOM 2129 CB ALA 233 7.233 -7.099 -12.042 1.00 0.00
ATOM 2130 H ALA 233 10.224 -7.799 -12.875 1.00 0.00
ATOM 2131 N ILE 234 8.852 -5.607 -10.138 1.00 0.00
ATOM 2132 CA ILE 234 9.347 -5.526 -8.803 1.00 0.00
ATOM 2133 C ILE 234 10.826 -5.198 -8.755 1.00 0.00
ATOM 2134 O ILE 234 11.069 -3.962 -8.860 1.00 0.00
ATOM 2135 CB ILE 234 9.176 -6.803 -8.057 1.00 0.00
ATOM 2136 CGI ILE 234 7.784 -7.504 -8.287 1.00 0.00
ATOM 2137 CG2 ILE 234 9.143 -6.388 -6.595 1.00 0.00
ATOM 2138 CD1 ILE 234 7 .768 -9.029 -8.017 1.00 0.00
ATOM 2139 H ILE 234 8.285 -4.920 -10.390 1.00 0.00
ATOM 2140 N TRP 235 11.886 -6.010 -8.519 1.00 0.00
ATOM 2141 CA TRP 235 13.311 -5.640 -8.651 1.00 0.00
ATOM 2142 C TRP 235 13.748 -4.387 -8.007 1.00 0.00
ATOM 2143 O TRP 235 13.940 -4.316 -6.822 1.00 0.00
ATOM 2144 CB TRP 235 13.569 -5.772 -10.197 1.00 0.00
ATOM 2145 CG TRP 235 13.459 -7.123 -10.746 1.00 0.00
ATOM 2146 CD1 TRP 235 13.226 -7.185 -12.088 1.00 0.00
ATOM 2147 CD2 TRP 235 13.394 -8.427 -10.138 1.00 0.00
ATOM 2148 NE1 TRP 235 12.994 -8.488 -12.297 1.00 0.00
ATOM 2149 CE2 TRP 235 13.084 -9.220 -11.193 1.00 0.00
ATOM 2150 CE3 TRP 235 13.524 -9.148 -8.948 1.00 0.00
ATOM 2151 CZ2 TRP 235 12.911 -10.575 -11.114 1.00 0.00
ATOM 2152 CZ3 TRP 235 13.366 -10.517 -8.791 1.00 0.00
ATOM 2153 CH2 TRP 235 13.050 -11.232 -9.879 1.00 0.00
ATOM 2154 HE1 TRP 235 12.915 -8.836 -13.185 1.00 0.00
ATOM 2155 H TRP 235 11.693 -6.949 -8.367 1.00 0.00
ATOM 2156 N LYS 236 13.897 -3.384 -8.768 1.00 0.00
ATOM 2157 CA LYS 236 14.306 -2.065 -8.392 1.00 0.00
ATOM 2158 C LYS 236 13.399 -1.070 -9.138 1.00 0.00
ATOM 2159 O LYS 236 13.854 0 .081 -9.320 1.00 0.00
ATOM 2160 CB LYS 236 15.787 -1.798 -8.774 1.00 0.00
ATOM 2161 CG LYS 236 16.741 -2.106 -7.698 1.00 0.00
ATOM 2162 CD LYS 236 18 .058 -2.081 -8.352 1.00 0.00
ATOM 2163 CE LYS 236 18.704 -0.688 -8 .556 1.00 0.00
ATOM 2164 NZ LYS 236 18.290 -0 .147 -9.892 1.00 0.00
ATOM 2165 HZ1 LYS 236 17.218 0.033 -9.903 1.00 0.00
ATOM 2166 HZ2 LYS 236 18.546 -0.812 -10.624 1.00 0.00
ATOM 2167 HZ3 LYS 236 18.826 0.721 -10.104 1.00 0.00
ATOM 2168 H LYS 236 13.837 -3.528 -9.731 1.00 0.00
ATOM 2169 N LEU 237 12.157 -1.515 -9.273 1.00 0.00
ATOM 2170 CA LEU 237 11.171 -0.763 -10.039 1.00 0.00
ATOM 2171 C LEU 237 10.049 -0.438 -9.053 1.00 0.00
ATOM 2172 O LEU 237 9.457 -1.313 -8.431 1.00 0.00
ATOM 2173 CB LEU 237 10.552 -1.624 -11.062 1.00 0.00
ATOM 2174 CG LEU 237 11.588 -2.384 -12.010 1.00 0.00
ATOM 2175 CD1 LEU 237 11.038 -3.515 -12.834 1.00 0.00
ATOM 2176 CD2 LEU 237 12.026 -1.286 -13.034 1.00 0.00
ATOM 2177 H LEU 237 11.801 -2.188 -8.691 1.00 0.00
ATOM 2178 N ASP 238 9.790 0 .848 -8.864 1.00 0.00
ATOM 2179 CA ASP 238 8.736 1.229 -8.005 1.00 0.00
ATOM 2180 C ASP 238 7 .715 1.769 -8.955 1.00 0.00
ATOM 2181 O ASP 238 8.074 2.219 -10.037 1.00 0.00
ATOM 2182 CB ASP 238 9.163 2.387 -6.973 1.00 0.00
ATOM 2183 CG ASP 238 9.824 3.625 -7.638 1.00 0.00
ATOM 2184 OD1 ASP 238 9.158 4.633 -7.666 1.00 0.00
ATOM 2185 OD2 ASP 238 10.954 3.522 -8.139 1.00 0.00
ATOM 2186 H ASP 238 10.346 1.490 -9.318 1.00 0.00
ATOM 2187 N LEU 239 6.420 1.769 -8.571 1.00 0.00
ATOM 2188 CA LEU 239 5.463 2.432 -9.460 1.00 0.00
ATOM 2189 C LEU 239 5.393 3.948 -9.180 1.00 0.00
ATOM 2190 O LEU 239 4.703 4.515 -8.311 1.00 0.00
ATOM 2191 CB LEU 239 4.069 1.886 -9.259 1.00 0.00
ATOM 2192 CG LEU 239 3.864 0.372 -9.579 1.00 0.00
ATOM 2193 CD1 LEU 239 2.500 -0.061 -9.039 1.00 0.00
ATOM 2194 CD2 LEU 239 4.097 0.146 -11.109 1.00 0.00
ATOM 2195 H LEU 239 6.081 1.186 -7.885 1.00 0.00
ATOM 2196 N GLY 240 6.181 4.718 -9.954 1.00 0.00
ATOM 2197 CA GLY 240 6.071 6.183 -9.875 1.00 0.00
ATOM 2198 C GLY 240 6.077 6.762 -11.266 1.00 0.00
ATOM 2199 O GLY 240 7.127 6.643 -11.889 1.00 0.00
ATOM 2200 H GLY 240 6.695 4.293 -10.721 1.00 0.00
ATOM 2201 N THR 241 4.857 7 .142 -11.727 1.00 0.00
ATOM 2202 CA THR 241 4.706 7.929 -12.878 1.00 0.00
ATOM 2203 C THR 241 4.887 9.391 -12.500 1.00 0.00
ATOM 2204 O THR 241 5.758 10 .083 -13.043 1.00 0.00
ATOM 2205 CB THR 241 3.344 7.758 -13.480 1.00 0.00
ATOM 2206 OG1 THR 241 2.455 7.681 -12.320 1.00 0.00
ATOM 2207 CG2 THR 241 3.115 6.651 -14.383 1.00 0.00
ATOM 2208 HG1 THR 241 1.517 7.654 -12.592 1.00 0.00
ATOM 2209 H THR 241 4.076 6.971 -11.184 1.00 0.00
ATOM 2210 N LEU 242 4.020 9.936 -11.654 1.00 0.00
ATOM 2211 CA LEU 242 4.288 11.273 -11.217 1.00 0.00
ATOM 2212 C LEU 242 5.271 11.103 -10.061 1.00 0.00
ATOM 2213 O LEU 242 5.052 10.570 -8.970 1.00 0.00
ATOM 2214 CB LEU 242 3.010 11.851 -10.714 1.00 0.00
ATOM 2215 CG LEU 242 2.492 13.313 -11.036 1.00 0.00
ATOM 2216 CD1 LEU 242 1.882 13.995 -9.825 1.00 0.00
ATOM 2217 CD2 LEU 242 3.697 14.156 -11.483 1.00 0.00
ATOM 2218 H LEU 242 3.314 9.393 -11.127 1.00 0.00
ATOM 2219 N GLU 243 6.474 11.640 -10.361 1.00 0.00
ATOM 2220 CA GLU 243 7.524 11.709 -9.353 1.00 0.00
ATOM 2221 C GLU 243 8.380 12 .934 -9.571 1.00 0.00
ATOM 2222 O GLU 243 8.354 13.821 -8.732 1.00 0.00
ATOM 2223 CB GLU 243 8.340 10.408 -9.204 1.00 0.00
ATOM 2224 CG GLU 243 8.505 9.677 -10.552 1.00 0.00
ATOM 2225 CD GLU 243 9.951 9.716 -10.971 1.00 0.00
ATOM 2226 OE1 GLU 243 10.308 10.499 -11.837 1.00 0.00
ATOM 2227 OE2 GLU 243 10.758 8.963 -10.458 1.00 0.00
ATOM 2228 H GLU 243 6.660 12.027 -11.267 1.00 0.00
ATOM 2229 N ALA 244 9.116 13.006 -10.702 1.00 0.00
ATOM 2230 CA ALA 244 9.876 14.210 -11.002 1.00 0.00
ATOM 2231 C ALA 244 9.858 14.417 -12.494 1.00 0.00
ATOM 2232 O ALA 244 10.648 13.806 -13.198 1.00 0.00
ATOM 2233 CB ALA 244 11.317 14.033 -10.489 1.00 0.00
ATOM 2234 H ALA 244 9.154 12.249 -11.358 1.00 0.00
ATOM 2235 N ILE 245 8.942 15.270 -12.998 1.00 0.00
ATOM 2236 CA ILE 245 8.784 15.352 -14.441 1.00 0.00
ATOM 2237 C ILE 245 9.144 16.695 -15.027 1.00 0.00
ATOM 2238 O ILE 245 8.259 17.413 -15.464 1.00 0.00
ATOM 2239 CB ILE 245 7.380 14.860 -14.852 1.00 0.00
ATOM 2240 CGI ILE 245 7.135 13.458 -14.256 1.00 0.00
ATOM 2241 CG2 ILE 245 7.276 14.790 -16.389 1.00 0.00
ATOM 2242 CD1 ILE 245 5.669 13.037 -14.472 1.00 0.00
ATOM 2243 H ILE 245 8.323 15.799 -12.414 1.00 0.00
ATOM 2244 N GLN 246 10.454 17.020 -15.077 1.00 0.00
ATOM 2245 CA GLN 246 10.907 18.171 -15.845 1.00 0.00
ATOM 2246 C GLN 246 10.460 19.544 -15.412 1.00 0.00
ATOM 2247 O GLN 246 11.289 20.289 -14.915 1.00 0.00
ATOM 2248 CB GLN 246 10.655 17.971 -17.354 1.00 0.00
ATOM 2249 CG GLN 246 11.754 17.077 -17.962 1.00 0.00
ATOM 2250 CD GLN 246 11.359 15.624 -18.013 1.00 0.00
ATOM 2251 OE1 GLN 246 10.376 15.237 -17.401 1.00 0.00
ATOM 2252 NE2 GLN 246 12.127 14.799 -18.756 1.00 0.00
ATOM 2253 HE22GLN 246 11.901 13.825 -18.818 1.00 0.00
ATOM 2254 HE21GLN 246 12.925 15.148 -19.250 1.00 0.00
ATOM 2255 H GLN 246 11.158 16.426 -14.685 1.00 0.00
ATOM 2256 N TRP 247 9.182 19.917 -15.630 1.00 0.00
ATOM 2257 CA TRP 247 8.796 21.311 -15.453 1.00 0.00
ATOM 2258 C TRP 247 8.098 21.616 -14.155 1.00 0.00
ATOM 2259 O TRP 247 7.769 20.707 -13.408 1.00 0.00
ATOM 2260 CB TRP 247 7.785 21.683 -16.558 1.00 0.00
ATOM 2261 CG TRP 247 8.437 22.398 -17.702 1.00 0.00
ATOM 2262 CD1 TRP 247 9.007 21.838 -18.780 1.00 0.00
ATOM 2263 CD2 TRP 247 8.548 23.894 -17.845 1.00 0.00
ATOM 2264 NE1 TRP 247 9.439 22 .793 -19.563 1.00 0.00
ATOM 2265 CE2 TRP 247 9.191 24.019 -19.062 1.00 0.00
ATOM 2266 CE3 TRP 247 8.163 24.990 -17.074 1.00 0.00
ATOM 2267 CZ2 TRP 247 9.493 25 .264 -19.611 1.00 0.00
ATOM 2268 CZ3 TRP 247 8.4 62 26.246 -17.617 1.00 0.00
ATOM 2269 CH2 TRP 247 9.108 26.379 -18.855 1.00 0.00
ATOM 2270 HE1 TRP 247 9.911 22.624 -20.464 1.00 0.00
ATOM 2271 H TRP 247 8 .501 19.272 -15.982 1.00 0.00
ATOM 2272 N THR 248 7.849 22.925 -13.917 1.00 0.00
ATOM 2273 CA THR 248 6.981 23.338 -12.823 1.00 0.00
ATOM 2274 C THR 248 7.673 23.877 -11.601 1.00 0.00
ATOM 2275 O THR 248 7.675 25.086 -11.429 1.00 0.00
ATOM 2276 CB THR 248 5.674 22.537 -12.674 1.00 0.00
ATOM 2277 OG1 THR 248 5.106 22.407 -13.984 1.00 0.00
ATOM 2278 CG2 THR 248 4.707 23.299 -11.748 1.00 0.00
ATOM 2279 HG1 THR 248 4.315 21.879 -13.968 1.00 0.00
ATOM 2280 H THR 248 8.189 23.649 -14.518 1.00 0.00
ATOM 2281 N LYS 249 8.286 23.032 -10.747 1.00 0.00
ATOM 2282 CA LYS 249 9.073 23.618 -9.673 1.00 0.00
ATOM 2283 C LYS 249 8 .417 23.949 -8.353 1.00 0.00
ATOM 2284 O LYS 249 9.160 24.260 -7.435 1.00 0.00
ATOM 2285 CB LYS 249 10.526 23.109 -9.594 1.00 0.00
ATOM 2286 CG LYS 249 11.420 24.041 -10.432 1.00 0.00
ATOM 2287 CD LYS 249 11.048 23.946 -11.925 1.00 0.00
ATOM 2288 CE LYS 249 12.064 24.759 -12.754 1.00 0.00
ATOM 2289 NZ LYS 249 11.724 26.191 -12.811 1.00 0.00
ATOM 2290 HZ1 LYS 249 12.552 26.726 -13.253 1.00 0.00
ATOM 2291 HZ2 LYS 249 11.547 26.603 -11.828 1.00 0.00
ATOM 2292 HZ3 LYS 249 10.851 26.342 -13.428 1.00 0.00
ATOM 2293 H LYS 249 8.273 22.035 -10.856 1.00 0.00
ATOM 2294 N HIS 250 7.068 23.904 -8.230 1.00 0.00
ATOM 2295 CA HIS 250 6.42 9 24.252 -6.966 1.00 0.00
ATOM 2296 C HIS 250 6.357 25.736 -6.718 1.00 0.00
ATOM 2297 O HIS 250 7.389 26.388 -6.765 1.00 0.00
ATOM 2298 CB HIS 250 7 .065 23.538 -5.756 1.00 0.00
ATOM 2299 CG HIS 250 6.562 22.127 -5.704 1.00 0.00
ATOM 2300 ND1 HIS 250 5.604 21.741 -4.895 1.00 0.00
ATOM 2301 CD2 HIS 250 7.019 21.108 -6.461 1.00 0.00
ATOM 2302 CE1 HIS 250 5.380 20.480 -5.070 1.00 0.00
ATOM 2303 NE2 HIS 250 6.162 20.067 -5.959 1.00 0.00
ATOM 2304 HE2 HIS 250 6.183 19.115 -6.291 1.00 0.00
ATOM 2305 HD1 HIS 250 5.103 22.346 -4.227 1.00 0.00
ATOM 2306 H HIS 250 6.466 23.636 -8.983 1.00 0.00
ATOM 2307 N TRP 251 5.147 26.277 -6.446 1.00 0.00
ATOM 2308 CA TRP 251 5.054 27.702 -6.154 1.00 0.00
ATOM 2309 C TRP 251 5.453 27.993 -4.730 1.00 0.00
ATOM 2310 O TRP 251 6.595 28.379 -4.543 1.00 0.00
ATOM 2311 CB TRP 251 3.741 28.424 -6.531 1.00 0.00
ATOM 2312 CG TRP 251 3.054 27.845 -7.730 1.00 0.00
ATOM 2313 CD1 TRP 251 1.900 27.160 -7.732 1.00 0.00
ATOM 2314 CD2 TRP 251 3.532 27.948 -9.155 1.00 0.00
ATOM 2315 NE1 TRP 251 1.608 26.844 -8.967 1.00 0.00
ATOM 2316 CE2 TRP 251 2.531 27.287 -9.842 1.00 0.00
ATOM 2317 CE3 TRP 251 4.639 28.517 -9.786 1.00 0.00
ATOM 2318 CZ2 TRP 251 2.557 27.152 -11.229 1.00 0.00
ATOM 2319 CZ3 TRP 251 4.672 28.388 -11.180 1.00 0.00
ATOM 2320 CH2 TRP 251 3.658 27 .720 -11.883 1.00 0.00
ATOM 2321 HE1 TRP 251 0 .758 26.326 -9.239 1.00 0.00
ATOM 2322 H TRP 251 4.316 25.719 -6.403 1.00 0.00
ATOM 2323 N ASP 252 4.570 27.823 -3.717 1.00 0.00
ATOM 2324 CA ASP 252 3.226 27.349 -3.997 1.00 0.00
ATOM 2325 C ASP 252 2.150 28.326 -3.590 1.00 0.00
ATOM 2326 O ASP 252 1.151 27.912 -3.024 1.00 0.00
ATOM 2327 CB ASP 252 2.970 25.897 -3.541 1.00 0.00
ATOM 2328 CG ASP 252 3.594 25.613 -2.205 1.00 0.00
ATOM 2329 OD1 ASP 252 3.344 26.322 -1.246 1.00 0.00
ATOM 2330 OD2 ASP 252 4.363 24.673 -2.087 1.00 0.00
ATOM 2331 H ASP 252 4.817 28.024 -2.766 1.00 0.00
ATOM 2332 N SER 253 2.340 29.632 -3.890 1.00 0.00
ATOM 2333 CA SER 253 1.286 30.606 -3.647 1.00 0.00
ATOM 2334 C SER 253 0.793 30.657 -2.222 1.00 0.00
ATOM 2335 O SER 253 -0.405 30.777 -2.013 1.00 0.00
ATOM 2336 CB SER 253 0.131 30.416 -4.654 1.00 0.00
ATOM 2337 OG SER 253 0.625 30.147 -5.972 1.00 0.00
ATOM 2338 HG SER 253 1.077 30.908 -6.320 1.00 0.00
ATOM 2339 H SER 253 3.171 29.968 -4.334 1.00 0.00
ATOM 2340 N GLY 254 1.692 30.569 -1.219 1.00 0.00
ATOM 2341 CA GLY 254 1.209 30.613 0.153 1.00 0.00
ATOM 2342 C GLY 254 2.297 30.892 1.156 1.00 0.00
ATOM 2343 O GLY 254 3.247 31.586 0.833 1.00 0.00
ATOM 2344 H GLY 254 2.673 30.463 -1.391 1.00 0.00
ATOM 2345 N ILE 255 2.163 30.345 2.382 1.00 0.00
ATOM 2346 CA ILE 255 3.208 30.561 3.369 1.00 0.00
ATOM 2347 C ILE 255 4.003 29.297 3.540 1.00 0.00
ATOM 2348 CB ILE 255 2.687 31.046 4.739 1.00 0.00
ATOM 2349 CGI ILE 255 1.559 32.084 4.579 1.00 0.00
ATOM 2350 CG2 ILE 255 3.852 31.690 5.514 1.00 0.00
ATOM 2351 CDl ILE 255 0 .194 31.369 4.588 1.00 0.00
ATOM 2352 01 ILE 255 5.214 29.319 3.410 1.00 0.00
ATOM 2353 02 ILE 255 3.434 28.249 3.798 1.00 0.00
ATOM 2354 H ILE 255 1.380 29.769 2.624 1.00 0.00
TER 2355 ILE 255
HETATM 2356 P NDP 1 -3.035 11.304 7.405 1.00 0.00
HETATM 2357 01 NDP 1 -2.521 12.425 8.240 1.00 0.00
HETATM 2358 02 NDP 1 -2.093 10.680 6.435 1.00 0.00
HETATM 2359 05 NDP 1 -3.743 10.109 8.202 1.00 0.00
HETATM 2360 C5 NDP 1 -4.711 10.331 9.231 1.00 0.00
HETATM 2361 C4 NDP 1 -4.823 9.018 10.028 1.00 0.00
HETATM 2362 04 NDP 1 -3.821 9.204 10.859 1.00 0.00
HETATM 2363 CI NDP 1 -4.086 8.637 12.203 1.00 0.00
HETATM 2364 N9 NDP 1 -3.924 9.721 13.183 1.00 0.00
HETATM 2365 C8 NDP 1 -4.036 11.065 13.084 1.00 0.00
HETATM 2366 N7 NDP 1 -3.627 11.824 14.009 1.00 0.00
HETATM 2367 C5 NDP 1 -3.419 10.855 15.046 1.00 0.00
HETATM 2368 C6 NDP 1 -2.819 11.029 16.493 1.00 0.00
HETATM 2369 N1 NDP 1 -2.559 9.888 16.967 1.00 0.00
HETATM 2370 C2 NDP 1 -2.723 8.698 16.253 1.00 0.00
HETATM 2371 N3 NDP 1 -3.298 8 .378 15.066 1.00 0.00
HETATM 2372 C4 NDP 1 -3.445 9.633 14.433 1.00 0.00
HETATM 2373 C2 NDP 1 -5.511 8 .211 12.025 1.00 0.00
HETATM 2374 C3 NDP 1 -6.101 9.232 10.950 1.00 0.00
HETATM 2375 03 NDP 1 -4.290 11.743 6.515 1.00 0.00
HETATM 2376 P NDP 1 -4.908 13.137 6.027 1.00 0.00
HETATM 2377 01 NDP 1 -4.696 14.277 6.962 1.00 0.00
HETATM 2378 02 NDP 1 -6.118 12.742 5.253 1.00 0.00
HETATM 2379 05 NDP 1 -3.908 13.295 4.788 1.00 0.00
HETATM 2380 C5 NDP 1 -3.520 12.357 3.437 1.00 0.00
HETATM 2381 C4 NDP 1 -3.660 13.252 2.192 1.00 0.00
HETATM 2382 04 NDP 1 -2.381 14.014 2.120 1.00 0.00
HETATM 2383 CI NDP 1 -1.639 13.659 0.971 1.00 0.00
HETATM 2384 N1 NDP 1 -0.323 13.798 1.096 1.00 0.00
HETATM 2385 C2 NDP 1 0 .496 13.367 2.047 1.00 0.00
HETATM 2386 C3 NDP 1 1.764 13.178 1.939 1.00 0.00
HETATM 2387 NC7 NDP 1 2.203 12.727 3.042 1.00 0.00
HETATM 2388 07 NDP 1 3.407 12.674 2.849 1.00 0.00
HETATM 2389 C4 NDP 1 2.433 13.984 0.873 1.00 0.00
HETATM 2390 C5 NDP 1 1.588 14.640 -0.084 1.00 0.00
HETATM 2391 C6 NDP 1 0.200 14.566 -0.022 1.00 0.00
HETATM 2392 C2 NDP 1 -2.154 12.318 0.655 1.00 0.00
HETATM 2393 C3 NDP 1 -3.668 12.406 0.989 1.00 0.00
HETATM 2394 C2 C 2 4.840 14.545 -1.744 1.00 0.00
HETATM 2395 01 C 2 5.434 14.219 -0.485 1.00 0.00
HETATM 2396 H5 C 2 6.371 14.370 -0.528 1.00 0.00
HETATM 2397 C3 C 2 5.485 15.827 -2.301 1.00 0.00
HETATM 2398 H9 C 2 6.378 15.564 -2.887 1.00 0.00
HETATM 2399 H10 C 2 5.775 16.483 -1.466 1.00 0.00
HETATM 2400 Hll C 2 4.763 16.350 -2.945 1.00 0.00
HETATM 2401 C4 C 2 5.034 13.393 -2.748 1.00 0.00
HETATM 2402 H12 C 2 4.440 13.591 -3.652 1.00 0.00
HETATM 2403 H13 C 2 4.705 12 .449 -2.291 1.00 0.00
HETATM 2404 H14 C 2 6.098 13.319 -3.017 1.00 0.00
HETATM 2405 H8 C 2 3.769 14.657 -1.517 1.00 0.00
CONECT 894 8 92 893 895
CONECT 895 894
CONECT 1734 1732 1733 1735
CONECT 1735 1734
CONECT 1923 1921 1922 1924
CONECT 1924 1923
CONECT 2303 2301 2302 2304
CONECT 2304 2303
CONECT 2347 2346 2352 2353
CONECT 2352 2347
CONECT 2353 2347
CONECT 2356 2357 2358 2359 2375
CONECT 2357 2356
CONECT 2358 2356
CONECT 2359 2356 2360
CONECT 2360 2359 2361
CONECT 2361 2360 2362 2374
CONECT 2362 2361 2363
CONECT 2363 2362 2364 2373
CONECT 2364 2363 2365 2372
CONECT 2365 2364 2366
CONECT 2366 2365 2367
CONECT 2367 2366 2368 2372
CONECT 2368 2367 2369
CONECT 2369 2368 2370
CONECT 2370 2369 2371
CONECT 2371 2370 2372
CONECT 2372 2364 2367 2371
CONECT 2373 2363 2374
CONECT 2374 2361 2373
CONECT 2375 2356 2376
CONECT 2376 2375 2377 2378 2379
CONECT 2377 2376
CONECT 2378 2376
CONECT 2379 2376 2380
CONECT 2380 2379 2381
CONECT 2381 2380 2382 2393
CONECT 2382 2381 2383
CONECT 2383 2382 2384 2392
CONECT 2384 2383 2385 2391
CONECT 2385 2384 2386
CONECT 2386 2385 2387 2389
CONECT 2387 2386 2388
CONECT 2388 2387
CONECT 2389 2386 2390
CONECT 2390 2389 2391
CONECT 2391 2384 2390
CONECT 2392 2383 2393
CONECT 2393 2381 2392
CONECT 2394 2395 2397 2401 2405
CONECT 2395 2394 2396
CONECT 2396 2395









MASTER 00000000 2404 1 61 20
END
